data_1pfl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pfl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.486 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.555 ' O ' HD21 ' A' ' 10' ' ' LEU . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.582 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.554 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HA ' ' CA ' ' A' ' 114' ' ' GLY 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.504 ' H ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.582 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.431 ' CZ3' HG23 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.505 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 54.6 p90 . . . . . 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.447 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.2 mp0 . . . . . 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.769 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 122.139 0.971 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.431 HG23 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 127' ' ' CYS . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.423 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 64.5 t60 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.57 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 123' ' ' ILE . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 30' ' ' VAL . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 43' ' ' THR . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 29.3 p90 . . . . . 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.2 tp60 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.412 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm . . . . . 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.508 2.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.498 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.494 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 31.0 t-80 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.509 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.539 ' O ' HD21 ' A' ' 10' ' ' LEU . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' CG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.447 HG23 ' CG1' ' A' ' 123' ' ' ILE . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.466 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 113' ' ' MET . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 50' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' A' ' 58' ' ' PHE . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.805 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt . . . . . 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.515 2.824 0 CA-C-O 122.087 0.946 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.486 ' CD1' ' CB ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.526 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.419 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 131' ' ' ALA . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.501 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.597 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.76 ' HG ' ' HB1' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.45 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HA ' HG12 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 HG11 HG23 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 47.1 p90 . . . . . 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 25.0 tp60 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.679 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 89' ' ' THR . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.523 3.218 0 CA-C-O 122.199 1.0 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 111' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HA ' HG21 ' A' ' 102' ' ' VAL . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HG ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.518 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.406 HG21 ' HG ' ' A' ' 112' ' ' LEU . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.464 ' HA ' HG23 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.442 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.429 ' HB3' HG23 ' A' ' 101' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.314 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' CE2' ' HA3' ' A' ' 23' ' ' GLY . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.495 ' CZ ' ' CG ' ' A' ' 113' ' ' MET . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 43' ' ' THR . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.438 ' HA ' ' OD1' ' A' ' 61' ' ' ASN . 17.5 p90 . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' CD1' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.561 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 . . . . . 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 89' ' ' THR . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.523 3.187 0 CA-C-O 122.153 0.978 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.42 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.459 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 20' ' ' ALA . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.495 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.456 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.531 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.406 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.457 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.861 0.362 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.601 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.691 ' HG ' ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.427 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB1' ' HG ' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' ' CZ2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.444 ' CZ2' ' HE3' ' A' ' 25' ' ' LYS . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 . . . . . 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 58' ' ' PHE . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.534 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.456 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 89' ' ' THR . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.513 2.724 0 CA-C-O 122.319 1.057 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 124' ' ' ASN . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 101' ' ' THR . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.442 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 127' ' ' CYS . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.53 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 123' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 123' ' ' ILE . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.531 ' HA ' HG23 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.459 ' N ' HD21 ' A' ' 112' ' ' LEU . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.403 ' HB3' HG12 ' A' ' 110' ' ' VAL . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 25.8 t-80 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.452 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.533 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.657 ' CD2' ' CB ' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.593 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.521 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HB ' ' A' ' 34' ' ' VAL . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.657 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.429 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.421 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.431 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG11 ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.543 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.0 OUTLIER . . . . . 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.459 HD23 ' CE1' ' A' ' 58' ' ' PHE . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.536 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.693 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' CB ' ' A' ' 104' ' ' LYS . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 4.2 mp0 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.498 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.467 ' ND2' ' HD3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 122.253 1.025 . . . . 0.0 111.682 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 77' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.412 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HA ' HG21 ' A' ' 102' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.452 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.213 0.53 . . . . 0.0 110.051 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.653 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 6' ' ' TYR 0.267 0.0 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.753 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.419 ' HA ' ' CE ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 13' ' ' ASP . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.57 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' OD2' ' CD1' ' A' ' 39' ' ' PHE . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.753 ' CB ' ' HB3' ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.4 ' CG1' ' CE ' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.455 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 50' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 . . . . . 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 46' ' ' GLU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.419 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 15.0 tp60 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 64' ' ' THR . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.509 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.484 ' HB2' HG13 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 . . . . . 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.793 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 7.7 m-20 . . . . . 0 CA--C 1.447 -3.009 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' ' CZ ' ' A' ' 24' ' ' TYR . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.416 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 101' ' ' THR . 1.1 t30 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.405 ' HB3' HG23 ' A' ' 101' ' ' THR . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.414 ' HA ' HG23 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.417 ' HE3' ' CD1' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.463 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 139' ' ' TYR . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.402 ' CD2' ' OG ' ' A' ' 137' ' ' SER . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.403 0 CA-C-O 120.987 0.422 . . . . 0.0 111.038 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.483 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.551 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.628 ' ND2' ' HG ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HG ' ' ND2' ' A' ' 9' ' ' ASN . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' O ' ' OD2' ' A' ' 13' ' ' ASP 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' CB ' ' CD1' ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.445 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 113' ' ' MET . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 . . . . . 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.8 tp60 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.502 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 4.3 mp0 . . . . . 0 CA--C 1.561 1.386 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 135' ' ' ARG . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.481 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.488 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' HB ' HD13 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' CE ' ' CZ ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.402 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.402 ' OG1' ' OG1' ' A' ' 105' ' ' THR . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 130' ' ' MET . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.44 ' HA ' HG21 ' A' ' 102' ' ' VAL . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.573 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 15' ' ' THR . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.417 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HA ' HD21 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.401 ' HB3' HG12 ' A' ' 110' ' ' VAL . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.922 0.391 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.549 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.592 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.438 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 18' ' ' ASP . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.414 HG12 ' OE1' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.558 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 47.0 p90 . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' CG2' ' A' ' 64' ' ' THR . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.413 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.423 HG12 ' CE ' ' A' ' 85' ' ' MET . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 84' ' ' SER . 24.5 mm-40 . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 76' ' ' SER . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.706 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.225 0 CA-C-O 122.208 1.004 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.42 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.487 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.433 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.592 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.463 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.556 ' HA ' HG23 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.445 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.191 0.519 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.667 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.579 ' O ' HD21 ' A' ' 10' ' ' LEU . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.677 ' CG ' ' HB1' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' ' CG ' ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' HG21 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.417 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.404 ' CG2' ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 50' ' ' LEU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 . . . . . 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.577 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.779 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 89' ' ' THR . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 3.3 mtmt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 122.169 0.985 . . . . 0.0 111.93 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' CE ' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 127' ' ' CYS . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.517 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.447 HG13 HG23 ' A' ' 15' ' ' THR . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.433 ' N ' HD21 ' A' ' 112' ' ' LEU . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.402 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 131' ' ' ALA . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.466 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.584 0 CA-C-O 121.092 0.473 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.588 ' O ' HD21 ' A' ' 10' ' ' LEU . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.525 ' ND2' ' CD1' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.589 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' OD2' ' A' ' 13' ' ' ASP 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 3' ' ' TRP . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.487 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' ND2' ' A' ' 61' ' ' ASN . 29.8 p90 . . . . . 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.421 ' HB3' HD13 ' A' ' 65' ' ' LEU . 22.6 tp60 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' CG ' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.777 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.494 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.777 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 5.3 m-20 . . . . . 0 CA--C 1.461 -2.475 0 CA-C-O 121.569 0.699 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.414 ' N ' HG11 ' A' ' 100' ' ' VAL . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 111' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.403 HG13 ' OG1' ' A' ' 103' ' ' THR . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' VAL . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.103 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.424 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 6' ' ' TYR . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.466 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.438 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.539 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.613 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.441 HG23 ' CG1' ' A' ' 123' ' ' ILE . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 39' ' ' PHE . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 18' ' ' ASP . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.424 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 63' ' ' LEU . 21.1 p90 . . . . . 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 61' ' ' ASN . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 58' ' ' PHE . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.41 ' NE2' ' CG2' ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.483 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 36.0 mm-40 . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.575 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.757 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-O 122.336 1.065 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.489 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.441 ' CG1' HG23 ' A' ' 15' ' ' THR . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.499 ' HA ' HG22 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 29.9 t-80 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.438 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.449 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.646 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.447 HG23 ' CG1' ' A' ' 123' ' ' ILE . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 23' ' ' GLY . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 3.7 p90 . . . . . 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 58' ' ' PHE . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 . . . . . 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.559 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.518 2.947 0 CA-C-O 122.135 0.969 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.496 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.414 ' HB3' HG12 ' A' ' 110' ' ' VAL . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.449 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.474 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.875 0.369 . . . . 0.0 111.577 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.568 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.673 HD22 ' CB ' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.507 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.446 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 58' ' ' PHE . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' C ' ' CG1' ' A' ' 51' ' ' VAL . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 HG11 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.551 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.9 p90 . . . . . 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG12 ' CE ' ' A' ' 85' ' ' MET . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.422 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 104' ' ' LYS . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 5.4 mmmt . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.521 3.103 0 CA-C-O 122.611 1.196 . . . . 0.0 113.358 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.412 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.477 ' HA ' HG21 ' A' ' 102' ' ' VAL . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HG ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.167 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.474 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.465 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.452 0 CA-C-O 120.65 0.262 . . . . 0.0 111.063 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' HA ' HD22 ' A' ' 10' ' ' LEU . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HG ' ' CB ' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.52 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.465 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.478 ' CE1' ' CD1' ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 50' ' ' LEU . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 HG23 HG12 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.6 p90 . . . . . 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.453 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.492 ' OG ' ' CG ' ' A' ' 90' ' ' LYS . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.781 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 . . . . . 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 89' ' ' THR . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.511 2.619 0 CA-C-O 122.256 1.027 . . . . 0.0 111.423 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' HD11 ' A' ' 77' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' NZ ' ' HB ' ' A' ' 51' ' ' VAL . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.418 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.453 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 102' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.478 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 15' ' ' THR . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.525 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.465 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.444 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.388 0 CA-C-O 120.891 0.377 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.617 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.526 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD2' ' CG ' ' A' ' 39' ' ' PHE . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HA ' ' CG1' ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.432 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 4.2 p90 . . . . . 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.452 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.2 mt . . . . . 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.563 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.7 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 4.5 m-20 . . . . . 0 CA--C 1.457 -2.609 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.452 ' CG2' ' CB ' ' A' ' 127' ' ' CYS . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 77' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 10' ' ' LEU . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.52 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.427 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.446 ' HA ' HG23 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.452 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 24.2 t-80 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.444 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.477 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.533 ' ND2' ' N ' ' A' ' 10' ' ' LEU 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 11' ' ' MET . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.479 HG23 ' CG1' ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.603 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.475 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' HD13 ' A' ' 7' ' ' ILE . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.405 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 58' ' ' PHE . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 HG11 ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 51.2 p90 . . . . . 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.446 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.496 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.778 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.533 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.5 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 . . . . . 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.5 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.533 ' CG ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 113' ' ' MET . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 87' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 105' ' ' THR . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.446 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.463 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.508 ' HA ' HG11 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 15' ' ' THR . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.406 ' HB3' HG23 ' A' ' 101' ' ' THR . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.403 ' HE3' ' CB ' ' A' ' 9' ' ' ASN . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.465 ' CE1' ' OH ' ' A' ' 6' ' ' TYR . 22.7 t-80 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.477 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.422 ' CE3' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HA ' HD13 ' A' ' 10' ' ' LEU . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.445 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' H ' HD12 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 21' ' ' ILE . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.51 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' CD1' ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 113' ' ' MET . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 1.1 p90 . . . . . 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.556 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.459 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 77' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.4 HG22 ' OG1' ' A' ' 108' ' ' THR . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.4 ' OG1' HG22 ' A' ' 105' ' ' THR . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.512 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA3' HD12 ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 HD12 ' HA3' ' A' ' 114' ' ' GLY . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.477 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.434 ' HA ' HD21 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.438 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 137' ' ' SER . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.456 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.454 0 CA-C-O 121.015 0.436 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.518 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.519 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.466 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 58' ' ' PHE . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' CD2' ' A' ' 24' ' ' TYR . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 59' ' ' TYR . 3.3 p90 . . . . . 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.429 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' THR . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.419 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.554 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.283 1.04 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.554 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.54 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 89' ' ' THR . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.419 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 2.1 mtmt . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.54 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 27.6 m-20 . . . . . 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 124' ' ' ASN . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' HB ' HD13 ' A' ' 87' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.406 ' OG1' HG13 ' A' ' 110' ' ' VAL . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.452 ' CE ' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.406 HG13 ' OG1' ' A' ' 103' ' ' THR . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' HG23 ' A' ' 15' ' ' THR . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.403 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.456 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 87.51 -67.61 3.25 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.486 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -54.6 -44.31 72.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.081 -0.658 . . . . 0.0 109.28 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.555 ' O ' HD21 ' A' ' 10' ' ' LEU . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.582 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.554 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HA ' ' CA ' ' A' ' 114' ' ' GLY 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.504 ' H ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.431 ' CZ3' HG23 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CE1' HD11 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.505 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.63 144.24 5.82 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -10.48 50.2 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.971 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -46.58 135.79 8.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -112.12 27.73 9.39 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.5 t -170.05 -41.79 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 118.154 -1.419 . . . . 0.0 112.926 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 p -46.2 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 54.6 p90 -37.53 -20.82 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD13 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.447 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 9.0 mt -103.55 121.8 43.63 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.92 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.072 1.749 . . . . 0.0 114.941 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.6 t70 -101.32 24.28 9.77 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 171.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.43 28.22 8.65 Favored Glycine 0 C--N 1.364 2.138 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.2 mp0 -153.89 -58.29 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.769 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -95.16 146.37 24.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -89.69 170.16 10.68 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-O 121.668 0.747 . . . . 0.0 111.733 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.4 p -156.19 108.37 2.56 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.611 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.49 44.51 2.71 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.8 23.75 77.59 Favored Glycine 0 N--CA 1.506 3.311 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -84.93 168.78 18.92 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.802 -0.822 . . . . 0.0 110.007 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.67 137.67 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.415 2.743 . . . . 0.0 110.147 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 98' ' ' PHE . 71.5 p -96.89 170.79 8.92 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.036 0.922 . . . . 0.0 109.387 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.85 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 47.8 m-85 -154.68 172.84 17.24 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.433 ' OD1' HG12 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -140.38 154.79 46.84 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.999 -176.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.431 HG23 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 127' ' ' CYS . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.559 ' CA ' ' HA ' ' A' ' 16' ' ' CYS . . . -165.11 132.53 2.7 Favored Glycine 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.85 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.565 0.1 OUTLIER -156.44 111.94 2.93 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 173.974 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.8 tt0 -119.8 89.67 3.17 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 101.54 -3.504 . . . . 0.0 101.54 155.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.454 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.27 0.61 0.05 OUTLIER Glycine 2 CA--C 1.683 10.537 1 CA-C-N 128.656 5.207 . . . . 0.0 108.679 -178.983 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 115' ' ' LYS . 5.7 p -22.11 132.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.4 2.77 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -71.01 -53.54 14.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.529 -2.123 . . . . 0.0 108.845 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.07 21.93 6.45 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.33 -37.42 0.93 Allowed Glycine 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.535 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.423 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.478 ' HA ' HG23 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 64.5 t60 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.005 0.431 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.462 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -140.0 -36.47 0.12 Allowed Glycine 0 N--CA 1.508 3.477 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.509 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -47.66 -48.23 29.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.982 -0.716 . . . . 0.0 112.03 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 123' ' ' ILE . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.424 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' ' HG ' ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 30' ' ' VAL . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 43' ' ' THR . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.08 132.37 10.51 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -18.4 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -48.77 128.66 15.85 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.39 33.0 5.17 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.964 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 t -170.73 -10.95 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 118.261 -1.376 . . . . 0.0 114.19 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -79.26 -96.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 118.724 0.693 . . . . 0.0 111.329 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 29.3 p90 -38.02 -22.43 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.2 tp60 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' ASP . 6.1 mt -96.74 126.0 41.59 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.49 76.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.073 1.749 . . . . 0.0 114.639 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 35.8 t70 -101.12 23.99 10.05 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 19.55 24.07 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -147.9 -51.99 0.19 Allowed 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.46 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm -81.97 156.29 24.77 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.402 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.6 t -145.98 -172.08 3.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.3 p -154.41 177.43 11.17 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.375 0.607 . . . . 0.0 111.119 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.84 47.78 88.02 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.99 24.17 64.56 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -73.06 166.56 42.39 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 122.052 -0.675 . . . . 0.0 110.123 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -93.29 120.91 0.41 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 123.007 2.471 . . . . 0.0 109.179 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.435 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 43.1 p -97.46 170.75 8.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.463 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 54.5 m-85 -143.31 145.05 32.38 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -118.74 146.34 44.84 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.673 -176.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.498 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . -148.29 152.35 24.43 Favored Glycine 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.85 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 51.8 mttt -127.43 164.81 21.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.56 ' O ' ' O ' ' A' ' 115' ' ' LYS . 22.2 tt0 -16.63 154.21 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.348 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -175.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.98 12.74 79.24 Favored Glycine 0 CA--C 1.562 3.015 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -169.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.85 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.13 93.17 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 113.899 -1.151 . . . . 0.0 112.285 -174.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.25 -23.69 51.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.0 63.2 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 -37.13 12.43 Favored Glycine 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.494 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 31.0 t-80 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.509 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.11 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -54.29 12.89 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.539 ' O ' HD21 ' A' ' 10' ' ' LEU . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD12 ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' CG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.447 HG23 ' CG1' ' A' ' 123' ' ' ILE . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.466 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.466 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 113' ' ' MET . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 50' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -52.99 179.69 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 -20.37 28.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -51.23 134.36 27.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 50.94 1.58 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.262 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -170.51 -11.28 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 p -93.83 -89.49 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.31 -0.869 . . . . 0.0 109.97 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 -37.68 -20.84 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' CD1' ' A' ' 58' ' ' PHE . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.4 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' CD1' HG13 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ASP . 50.8 mt -105.51 125.97 51.59 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.36 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.945 1.698 . . . . 0.0 114.852 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.9 t70 -101.26 26.05 7.56 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 171.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 29.94 10.08 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 -155.76 -59.65 0.1 Allowed 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.805 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt -74.55 172.9 11.18 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -130.06 163.31 26.81 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.686 0.755 . . . . 0.0 110.536 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.8 p -156.95 109.8 2.54 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.27 52.02 1.19 Allowed Glycine 0 N--CA 1.505 3.245 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.32 23.18 66.2 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -82.39 168.55 22.77 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.854 -0.792 . . . . 0.0 109.633 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -92.82 134.59 1.19 Allowed 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 123.377 2.718 . . . . 0.0 111.12 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 24.7 p -105.24 159.63 15.73 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 97' ' ' THR . 39.1 m-85 -145.29 134.01 22.24 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -105.22 137.71 42.57 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.954 1.252 . . . . 0.0 110.835 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.444 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.486 ' CD1' ' CB ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.526 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -129.46 134.24 7.85 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.74 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 31.4 mttt -124.91 153.78 42.14 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 115' ' ' LYS . 23.7 tp10 -16.97 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.845 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 74.85 15.78 80.72 Favored Glycine 0 CA--C 1.562 3.017 1 N-CA-C 100.258 -5.137 . . . . 0.0 100.258 -168.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.2 p -101.54 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.382 1.994 0 CA-C-N 113.8 -1.2 . . . . 0.0 111.956 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -86.41 -29.96 22.47 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.9 -18.22 57.12 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.4 -35.95 11.39 Favored Glycine 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.419 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 131' ' ' ALA . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.402 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 97.98 24.75 11.25 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.501 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.99 -45.43 64.51 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.647 -0.914 . . . . 0.0 110.399 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.597 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.564 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.76 ' HG ' ' HB1' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.76 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.45 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HA ' HG12 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 HG11 HG23 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -50.65 156.13 2.71 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -16.86 55.01 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -55.6 121.67 9.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.94 33.12 5.58 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.678 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.0 t -170.47 -10.4 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.711 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.4 p -85.55 -86.02 0.14 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.602 1.092 . . . . 0.0 112.19 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 47.1 p90 -37.53 -18.75 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 25.0 tp60 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.679 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.598 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -77.15 47.72 0.57 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 3.0 pt20 -111.39 57.86 0.63 Allowed 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.2 t70 -15.76 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 123.208 1.48 . . . . 0.0 113.068 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.62 15.0 25.99 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.675 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 5.9 mp0 -150.08 -54.37 0.16 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.679 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.17 164.25 24.37 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -115.78 179.47 3.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.236 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -136.44 38.66 2.68 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.72 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.3 -107.38 0.44 Allowed Glycine 0 N--CA 1.51 3.581 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.47 13.32 64.2 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.44 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -82.9 168.72 21.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 CA-C-N 117.889 0.844 . . . . 0.0 109.964 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.48 147.08 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.562 2.842 . . . . 0.0 110.969 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 17.8 p -119.62 156.0 31.23 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' A' ' 115' ' ' LYS . 50.3 m-85 -143.4 139.96 30.22 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -116.35 141.18 48.5 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.956 -176.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 111' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HA ' HG21 ' A' ' 102' ' ' VAL . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HG ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.518 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -140.76 150.07 21.44 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.855 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 19.8 mttt -129.57 165.9 20.78 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' O ' ' A' ' 115' ' ' LYS . 8.6 tt0 -16.8 152.16 0.0 OUTLIER 'General case' 1 N--CA 1.545 4.318 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.4 79.28 Favored Glycine 0 CA--C 1.563 3.064 1 N-CA-C 100.729 -4.948 . . . . 0.0 100.729 -168.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.855 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.46 93.57 2.89 Favored 'Isoleucine or valine' 0 C--N 1.376 1.736 0 CA-C-N 113.886 -1.157 . . . . 0.0 111.656 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -73.85 -35.45 64.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.12 -20.32 47.97 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.16 28.65 Favored Glycine 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' A' ' 118' ' ' VAL . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.464 ' HA ' HG23 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.429 ' HB3' HG23 ' A' ' 101' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.49 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 138.35 -136.03 7.83 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -47.51 -47.96 27.51 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.399 -0.471 . . . . 0.0 111.786 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.443 ' CE2' ' HA3' ' A' ' 23' ' ' GLY . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.495 ' CZ ' ' CG ' ' A' ' 113' ' ' MET . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 43' ' ' THR . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.67 -160.88 0.05 OUTLIER Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 54' ' ' ASP . 4.6 mmtt -92.03 -62.89 1.32 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' O ' ' CE1' ' A' ' 58' ' ' PHE . 3.4 t0 -26.02 91.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 122.45 1.119 . . . . 0.0 111.346 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -71.92 18.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.103 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.54 -19.8 0.08 Allowed 'General case' 0 N--CA 1.533 3.722 0 C-N-CA 119.024 -1.07 . . . . 0.0 113.866 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 p -66.41 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 54' ' ' ASP . 17.5 p90 -37.49 -21.31 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' CD1' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.561 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ASP . 5.6 mt -98.3 118.24 34.49 Favored 'General case' 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -47.85 78.08 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 123.82 1.772 . . . . 0.0 115.062 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.8 t70 -101.01 23.87 10.14 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 111.916 -2.402 . . . . 0.0 104.574 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.97 26.84 8.17 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 -153.61 -60.72 0.14 Allowed 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 89' ' ' THR . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.09 153.86 29.84 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -97.44 176.98 5.68 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.707 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -149.9 98.86 2.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.958 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.47 29.01 10.52 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.65 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.58 -16.4 31.51 Favored Glycine 0 N--CA 1.511 3.69 0 CA-C-N 118.235 1.017 . . . . 0.0 111.268 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -50.45 169.3 0.21 Allowed Pre-proline 0 N--CA 1.513 2.713 0 CA-C-N 118.237 1.018 . . . . 0.0 110.048 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -90.88 137.42 2.25 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 123.163 2.576 . . . . 0.0 110.428 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 54.9 p -103.56 168.03 9.42 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' O ' ' A' ' 97' ' ' THR . 53.7 m-85 -149.92 139.79 21.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -113.59 141.86 46.68 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.328 -176.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.42 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 20' ' ' ALA . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.495 ' CG ' ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . -143.12 146.84 17.95 Favored Glycine 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 7.9 mttt -126.03 164.03 21.74 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.566 ' O ' ' O ' ' A' ' 115' ' ' LYS . 12.3 tt0 -16.76 152.41 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.152 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -175.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.95 13.76 80.64 Favored Glycine 0 CA--C 1.566 3.268 1 N-CA-C 100.631 -4.988 . . . . 0.0 100.631 -168.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.833 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -101.94 102.45 13.55 Favored 'Isoleucine or valine' 0 C--N 1.382 2.006 0 CA-C-N 113.885 -1.158 . . . . 0.0 112.667 -174.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -81.43 -33.72 31.97 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.17 -15.91 61.79 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 -33.36 16.9 Favored Glycine 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.456 ' CD1' ' HA3' ' A' ' 114' ' ' GLY . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.531 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.406 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -170.57 -64.46 0.04 OUTLIER Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.457 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -55.97 -42.64 76.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.235 -0.568 . . . . 0.0 110.062 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.601 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.691 ' HG ' ' HB1' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.427 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.435 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB1' ' HG ' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' ' CZ2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.444 ' CZ2' ' HE3' ' A' ' 25' ' ' LYS . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.582 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.43 146.53 15.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -10.57 51.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 122.818 -0.225 . . . . 0.0 111.017 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -46.89 131.21 12.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 36.02 4.73 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.526 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -168.01 -32.66 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.998 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 p -67.57 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.362 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 -37.24 -21.83 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 58' ' ' PHE . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.534 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HA ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ASP . 80.1 mt -99.57 120.39 39.59 Favored 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -47.91 76.84 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 126.036 1.734 . . . . 0.0 114.953 -174.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 78' ' ' LEU . 27.7 t70 -101.18 24.86 8.86 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 171.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.21 29.45 6.75 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -157.73 -60.0 0.08 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.456 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -77.34 175.1 10.06 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 95' ' ' ALA . 1.1 t -125.38 176.79 6.56 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.147 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -97.37 -54.22 3.21 Favored 'General case' 0 N--CA 1.513 2.7 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.67 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.45 104.69 0.19 Allowed Glycine 0 N--CA 1.502 3.066 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.73 -14.3 61.96 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' CB ' ' OG ' ' A' ' 91' ' ' SER . . . -74.12 172.13 9.35 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.746 -0.855 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 95' ' ' ALA . 61.0 Cg_endo -93.26 130.49 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.263 2.642 . . . . 0.0 111.274 -177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.442 ' CG2' ' HB3' ' A' ' 91' ' ' SER . 49.9 p -106.83 168.18 9.37 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 59.8 m-85 -146.51 135.19 22.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -111.95 143.91 42.14 Favored 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.186 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 124' ' ' ASN . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 101' ' ' THR . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.442 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 127' ' ' CYS . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.53 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 123' ' ' ILE . . . -149.37 153.14 24.98 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 30.2 mttt -128.21 165.35 20.63 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 115' ' ' LYS . 7.4 tt0 -16.92 152.82 0.0 OUTLIER 'General case' 1 N--CA 1.543 4.192 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -175.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 11.79 83.99 Favored Glycine 0 CA--C 1.562 3.029 1 N-CA-C 100.681 -4.968 . . . . 0.0 100.681 -168.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.833 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.27 99.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.901 -1.15 . . . . 0.0 111.668 -175.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -76.67 -33.82 58.26 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.34 -14.11 61.15 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.31 -35.62 10.6 Favored Glycine 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 123' ' ' ILE . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.531 ' HA ' HG23 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.459 ' N ' HD21 ' A' ' 112' ' ' LEU . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.403 ' HB3' HG12 ' A' ' 110' ' ' VAL . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 25.8 t-80 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.496 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 84.61 27.41 35.52 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.452 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -49.76 -49.83 46.81 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 122.097 -0.649 . . . . 0.0 110.921 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.533 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.529 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.657 ' CD2' ' CB ' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.593 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.521 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HB ' ' A' ' 34' ' ' VAL . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.657 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.429 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.421 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 113' ' ' MET . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG23 HG11 ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.37 107.94 1.58 Allowed Glycine 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -30.94 58.08 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.444 -0.445 . . . . 0.0 110.195 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.09 73.64 10.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -171.68 52.0 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.495 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 22.9 t -69.02 -10.79 59.3 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.581 -0.699 . . . . 0.0 111.729 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 p -67.86 -54.66 17.21 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.423 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.543 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -38.64 -27.41 0.02 OUTLIER 'General case' 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.476 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.459 HD23 ' CE1' ' A' ' 58' ' ' PHE . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.536 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.693 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' CB ' ' A' ' 104' ' ' LYS . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.11 123.54 43.47 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -47.95 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.155 1.782 . . . . 0.0 115.005 -174.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -101.12 29.2 4.8 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.19 23.11 25.59 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 4.2 mp0 -150.71 -57.98 0.17 Allowed 'General case' 0 C--N 1.369 1.447 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.498 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.84 146.13 24.42 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.3 t -95.1 165.54 12.37 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.332 0.587 . . . . 0.0 110.512 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.3 p -133.53 122.81 24.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.5 -88.19 1.46 Allowed Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.96 29.21 2.46 Favored Glycine 0 N--CA 1.506 3.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -78.13 167.51 35.07 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 122.091 -0.652 . . . . 0.0 109.938 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.25 132.31 1.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.032 2.488 . . . . 0.0 110.586 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.408 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 23.0 p -95.16 158.24 15.55 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.786 0.803 . . . . 0.0 109.164 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.625 ' HB3' ' CG ' ' A' ' 115' ' ' LYS . 24.7 m-85 -149.27 157.45 43.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' N ' ' HG2' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -132.34 165.41 24.29 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.06 -1.65 . . . . 0.0 111.682 -176.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 77' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.412 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HA ' HG21 ' A' ' 102' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.683 ' C ' ' HG3' ' A' ' 115' ' ' LYS . . . -178.5 121.48 0.76 Allowed Glycine 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.683 ' HG3' ' C ' ' A' ' 114' ' ' GLY 0.301 0.0 OUTLIER -164.17 117.29 1.4 Allowed 'General case' 1 N--CA 1.368 -4.525 0 C-N-CA 114.503 -2.879 . . . . 0.0 115.802 175.116 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 118' ' ' VAL . 11.1 tt0 -114.26 89.9 3.21 Favored 'General case' 0 C--O 1.26 1.656 1 N-CA-C 100.101 -4.037 . . . . 0.0 100.101 160.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.21 -0.74 0.07 OUTLIER Glycine 2 CA--C 1.659 9.09 0 CA-C-N 125.711 3.869 . . . . 0.0 108.46 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 115' ' ' LYS . 8.9 p -26.45 138.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.39 2.362 0 C-N-CA 126.191 1.796 . . . . 0.0 114.737 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.48 -49.92 65.0 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.279 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.34 16.9 19.3 Favored Glycine 0 N--CA 1.506 3.308 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.64 -34.77 2.0 Allowed Glycine 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.517 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.452 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.461 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 115.3 -73.23 0.25 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.38 -36.81 61.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.811 -0.817 . . . . 0.0 110.051 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.653 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 6' ' ' TYR 0.267 0.0 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.753 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.419 ' HA ' ' CE ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 13' ' ' ASP . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.57 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' OD2' ' CD1' ' A' ' 39' ' ' PHE . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.753 ' CB ' ' HB3' ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.4 ' CG1' ' CE ' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.455 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' CB ' HD13 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 50' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -49.49 151.72 3.75 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.87 20.4 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.09 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -40.56 126.86 2.4 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 122.917 0.487 . . . . 0.0 109.746 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 39.52 3.91 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.578 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -166.99 -58.1 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 118.958 -1.097 . . . . 0.0 113.042 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 60' ' ' VAL . 14.1 p -43.5 -98.27 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.058 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 -36.75 -22.76 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 57' ' ' SER . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 46' ' ' GLU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.535 HD11 ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 15.0 tp60 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 64' ' ' THR . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.509 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' HB2' HG13 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 92.6 mt -100.26 121.68 41.85 Favored 'General case' 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.58 78.64 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 123.88 1.8 . . . . 0.0 114.968 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.2 t70 -101.08 26.06 7.44 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 111.652 -2.522 . . . . 0.0 104.287 171.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.25 28.17 8.27 Favored Glycine 0 C--N 1.362 1.98 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 -155.24 -63.4 0.12 Allowed 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.483 ' CG ' HG12 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.793 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -83.39 138.1 33.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 t -130.48 -160.12 1.02 Allowed 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.184 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -102.83 176.55 5.12 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 121.305 0.574 . . . . 0.0 111.616 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.3 0.47 Allowed Glycine 0 N--CA 1.506 3.331 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.58 -33.23 1.43 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB2' ' OG ' ' A' ' 91' ' ' SER . . . -81.06 169.91 17.47 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 122.309 -0.524 . . . . 0.0 109.606 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 95' ' ' ALA . 64.2 Cg_endo -99.17 125.03 0.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.951 0 C-N-CA 123.057 2.505 . . . . 0.0 109.754 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.405 ' OG1' ' CE ' ' A' ' 115' ' ' LYS . 3.0 p -91.81 164.96 13.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.569 ' HA ' ' HG3' ' A' ' 115' ' ' LYS . 36.7 m-85 -146.15 144.63 30.08 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.595 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 7.7 m-20 -111.88 -166.29 1.06 Allowed 'General case' 0 CA--C 1.447 -3.009 0 O-C-N 120.805 -1.184 . . . . 0.0 108.579 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' ' CZ ' ' A' ' 24' ' ' TYR . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.416 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.453 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 132.52 161.61 10.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.608 ' HG2' HG13 ' A' ' 118' ' ' VAL 0.411 10.0 mtmt -157.29 120.7 4.1 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 113.036 -1.582 . . . . 0.0 109.51 169.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.2 tt0 -111.55 92.43 4.03 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 162.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.34 -0.72 0.13 Allowed Glycine 2 CA--C 1.648 8.393 0 CA-C-N 123.136 2.698 . . . . 0.0 109.225 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.608 HG13 ' HG2' ' A' ' 115' ' ' LYS . 14.4 p -39.16 155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 125.576 1.55 . . . . 0.0 114.992 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -85.48 -55.4 4.02 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.491 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.77 4.17 28.17 Favored Glycine 0 N--CA 1.508 3.499 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.74 -27.09 6.49 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 101' ' ' THR . 1.1 t30 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.405 ' HB3' HG23 ' A' ' 101' ' ' THR . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.414 ' HA ' HG23 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.417 ' HE3' ' CD1' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.463 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 139' ' ' TYR . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.402 ' CD2' ' OG ' ' A' ' 137' ' ' SER . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.492 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 163.65 166.96 23.38 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -49.1 -53.18 21.79 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.133 -0.627 . . . . 0.0 111.038 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' CE2' ' O ' ' A' ' 2' ' ' GLY . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.551 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.628 ' ND2' ' HG ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HG ' ' ND2' ' A' ' 9' ' ' ASN . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' O ' ' OD2' ' A' ' 13' ' ' ASP 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.573 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' CB ' ' CD1' ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.445 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' ' CG ' ' A' ' 113' ' ' MET . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -55.08 152.56 13.41 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -17.46 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.53 134.4 29.31 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -133.58 44.4 2.78 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.393 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 t -170.06 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 O-C-N 121.207 -0.933 . . . . 0.0 112.654 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 p -53.83 -90.25 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 -37.24 -21.74 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.8 tp60 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.502 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ASP . 90.7 mt -94.58 121.85 36.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -47.81 78.27 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.176 1.79 . . . . 0.0 114.541 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.4 t70 -101.12 26.3 7.2 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 104.635 -2.358 . . . . 0.0 104.635 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.26 26.07 11.67 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 4.3 mp0 -153.0 -60.39 0.14 Allowed 'General case' 0 C--N 1.37 1.475 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 135' ' ' ARG . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.481 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.488 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -73.98 170.92 14.43 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -122.89 163.65 19.92 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.128 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -109.81 75.0 0.92 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.714 0.769 . . . . 0.0 109.483 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.61 96.46 0.01 OUTLIER Glycine 0 N--CA 1.508 3.492 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.45 -35.11 5.17 Favored Glycine 0 N--CA 1.504 3.179 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -70.0 165.61 41.09 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.999 -0.706 . . . . 0.0 110.487 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.5 131.8 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.412 2.741 . . . . 0.0 110.888 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.458 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 62.2 p -100.37 161.71 13.43 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 97' ' ' THR . 35.4 m-85 -143.16 107.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -90.72 133.42 35.17 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' HB ' HD13 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' CE ' ' CZ ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.402 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.402 ' OG1' ' OG1' ' A' ' 105' ' ' THR . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 130' ' ' MET . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.44 ' HA ' HG21 ' A' ' 102' ' ' VAL . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.573 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -132.18 132.85 6.85 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.823 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.1 mttt -114.78 158.84 21.32 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.0 tp10 -16.77 154.58 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -175.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 71.78 15.02 75.71 Favored Glycine 0 CA--C 1.56 2.847 1 N-CA-C 100.959 -4.857 . . . . 0.0 100.959 -169.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.823 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.4 p -101.9 102.71 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.916 -1.142 . . . . 0.0 112.42 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -84.25 -35.26 23.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.13 -7.76 62.52 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 -39.66 8.91 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' HG23 ' A' ' 15' ' ' THR . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.417 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HA ' HD21 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.401 ' HB3' HG12 ' A' ' 110' ' ' VAL . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 149.97 -98.48 0.19 Allowed Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -50.97 -42.56 60.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.141 -0.623 . . . . 0.0 110.945 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.549 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.592 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.438 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 18' ' ' ASP . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.414 HG12 ' OE1' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.558 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -41.28 147.3 0.38 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -3.07 43.14 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.84 135.2 42.23 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.71 0.767 . . . . 0.0 109.192 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -99.49 18.16 18.55 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.279 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -170.21 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 C-N-CA 118.029 -1.468 . . . . 0.0 113.792 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -57.07 -97.7 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 47.0 p90 -37.66 -21.94 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.413 ' O ' ' CG2' ' A' ' 64' ' ' THR . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.413 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.423 HG12 ' CE ' ' A' ' 85' ' ' MET . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.706 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.46 45.06 1.24 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.449 ' HG2' ' CA ' ' A' ' 76' ' ' SER . 0.2 OUTLIER -110.8 58.24 0.61 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' GLN . 12.2 t70 -16.79 122.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.719 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.33 20.18 12.75 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.441 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 24.5 mm-40 -162.09 -65.35 0.05 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 76' ' ' SER . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.706 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -99.69 135.13 41.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -116.63 -166.27 1.14 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -83.99 -167.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.492 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.82 -76.99 0.16 Allowed Glycine 0 N--CA 1.51 3.588 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.72 22.29 5.8 Favored Glycine 0 N--CA 1.514 3.839 0 O-C-N 121.8 -0.823 . . . . 0.0 111.874 -178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.511 ' HB2' ' OG ' ' A' ' 91' ' ' SER . . . -97.55 161.52 25.6 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.536 1.168 . . . . 0.0 109.683 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.8 124.18 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.927 2.418 . . . . 0.0 110.136 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 98' ' ' PHE . 66.8 p -91.96 172.0 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.944 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 35.1 m-85 -151.92 169.16 22.97 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -141.01 158.35 44.06 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.829 -175.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.556 HG23 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.42 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.487 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' O ' HD21 ' A' ' 111' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.433 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.592 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . -165.46 146.69 11.4 Favored Glycine 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.944 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.542 12.8 mttt -163.42 113.4 1.33 Allowed 'General case' 0 CA--C 1.596 2.727 0 N-CA-C 121.03 3.715 . . . . 0.0 121.03 175.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 118' ' ' VAL . 6.4 tt0 -118.92 90.04 3.25 Favored 'General case' 0 C--O 1.261 1.678 0 N-CA-C 100.976 -3.712 . . . . 0.0 100.976 156.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.519 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.25 1.2 0.07 OUTLIER Glycine 2 CA--C 1.678 10.273 1 CA-C-N 127.819 4.827 . . . . 0.0 108.669 -179.043 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.783 HG13 ' HA ' ' A' ' 115' ' ' LYS . 7.3 p -25.33 137.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.401 2.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -171.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.412 ' N ' HG21 ' A' ' 118' ' ' VAL . 1.7 t60 -74.64 -54.88 6.59 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.523 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.81 15.4 10.15 Favored Glycine 0 N--CA 1.503 3.147 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.74 -33.12 2.71 Favored Glycine 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.463 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.556 ' HA ' HG23 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.445 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -134.51 55.9 0.73 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -50.88 -46.73 60.53 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 117.916 0.858 . . . . 0.0 110.023 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.667 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.579 ' O ' HD21 ' A' ' 10' ' ' LEU . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.677 ' CG ' ' HB1' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' ' CG ' ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' HG21 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.417 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.404 ' CG2' ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 50' ' ' LEU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.31 158.19 2.51 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -16.36 49.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.134 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' CD2' ' A' ' 58' ' ' PHE . 7.6 t70 -39.62 113.46 0.34 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 123.077 0.551 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -101.34 12.23 37.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.2 t -166.67 -47.14 0.02 OUTLIER 'General case' 0 N--CA 1.53 3.553 0 CA-C-N 120.433 1.47 . . . . 0.0 114.225 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 59' ' ' TYR . 1.9 p -51.74 -81.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 -37.08 -22.23 0.01 OUTLIER 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.77 43.46 1.54 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 82' ' ' GLU . 4.2 pt20 -111.72 59.86 0.62 Allowed 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.0 t70 -17.26 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.129 1.442 . . . . 0.0 112.798 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.22 6.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -170.94 -69.14 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.577 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.779 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 3.3 mtmt -88.45 116.74 26.9 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 1.1 t -88.91 -168.1 2.08 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.047 -175.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -79.71 -166.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.155 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.72 101.92 1.59 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.2 -29.21 9.88 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB2' ' OG ' ' A' ' 91' ' ' SER . . . -58.48 163.71 4.65 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 122.14 -0.623 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -90.69 128.59 1.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 123.14 2.56 . . . . 0.0 108.897 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 98' ' ' PHE . 52.0 p -93.22 178.44 5.73 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.965 0.888 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.818 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 48.1 m-85 -154.07 173.64 15.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.522 ' OD1' HG12 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -144.6 155.39 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.93 -176.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' CE ' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 127' ' ' CYS . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.517 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . -165.59 138.68 5.36 Favored Glycine 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.556 74.7 mttt -160.86 113.62 1.97 Allowed 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 173.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -118.39 90.45 3.34 Favored 'General case' 0 C--O 1.263 1.771 0 N-CA-C 101.415 -3.55 . . . . 0.0 101.415 157.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.83 1.1 0.08 OUTLIER Glycine 2 CA--C 1.676 10.108 1 CA-C-N 127.39 4.632 . . . . 0.0 108.228 -177.691 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.779 HG13 ' HA ' ' A' ' 115' ' ' LYS . 7.1 p -21.55 133.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.392 2.447 0 C-N-CA 127.178 2.191 . . . . 0.0 116.56 -171.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -74.55 -54.31 7.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.66 -2.064 . . . . 0.0 108.224 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.57 18.41 8.03 Favored Glycine 0 N--CA 1.505 3.271 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.34 -35.52 1.44 Allowed Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.447 HG13 HG23 ' A' ' 15' ' ' THR . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.433 ' N ' HD21 ' A' ' 112' ' ' LEU . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.402 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 131' ' ' ALA . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 133.06 -43.92 1.24 Allowed Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.466 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.25 -57.54 8.57 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 122.071 -0.664 . . . . 0.0 110.811 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.588 ' O ' HD21 ' A' ' 10' ' ' LEU . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.525 ' ND2' ' CD1' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.589 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' OD2' ' A' ' 13' ' ' ASP 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 3' ' ' TRP . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' HG22 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.487 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.74 136.84 7.64 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -27.32 4.18 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.84 126.61 28.14 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -136.23 51.42 2.02 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.547 0.689 . . . . 0.0 110.742 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -155.47 -10.49 0.11 Allowed 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.772 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.1 p -93.82 -87.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 110.652 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' ND2' ' A' ' 61' ' ' ASN . 29.8 p90 -37.29 -22.05 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.421 ' HB3' HD13 ' A' ' 65' ' ' LEU . 22.6 tp60 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' CG ' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.777 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.27 123.96 43.97 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -47.98 78.47 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 126.006 1.723 . . . . 0.0 115.314 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.08 31.05 3.79 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.02 17.73 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 -155.12 -61.93 0.12 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.494 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.777 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -75.9 148.32 38.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -97.62 174.78 6.47 Favored 'General case' 0 N--CA 1.516 2.835 0 CA-C-O 121.524 0.678 . . . . 0.0 112.169 -176.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -147.39 96.93 2.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.48 82.47 0.52 Allowed Glycine 0 N--CA 1.508 3.47 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.386 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.69 5.39 37.63 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.643 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -78.71 160.42 72.04 Favored Pre-proline 0 N--CA 1.508 2.455 0 CA-C-N 119.355 1.577 . . . . 0.0 109.384 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -91.02 132.75 1.56 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.046 2.497 . . . . 0.0 109.284 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 91' ' ' SER . 1.9 p -94.49 164.61 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.596 ' HA ' ' HG3' ' A' ' 115' ' ' LYS . 42.2 m-85 -148.19 138.71 22.87 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 5.3 m-20 -113.57 151.06 32.13 Favored 'General case' 0 CA--C 1.461 -2.475 0 O-C-N 120.707 -1.245 . . . . 0.0 109.307 -175.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.414 ' N ' HG11 ' A' ' 100' ' ' VAL . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 111' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.403 HG13 ' OG1' ' A' ' 103' ' ' THR . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' HG21 ' A' ' 102' ' ' VAL . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 131.65 153.95 7.63 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.635 ' HG2' HG13 ' A' ' 118' ' ' VAL 0.381 9.4 mtmt -151.21 119.07 6.17 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 112.472 -1.864 . . . . 0.0 107.942 167.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.4 tt0 -112.65 92.45 4.02 Favored 'General case' 0 C--N 1.257 -3.435 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 163.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.57 -3.13 0.05 OUTLIER Glycine 2 CA--C 1.653 8.704 0 CA-C-N 123.775 2.988 . . . . 0.0 109.609 -177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.635 HG13 ' HG2' ' A' ' 115' ' ' LYS . 7.6 p -35.64 139.32 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.616 -1.52 . . . . 0.0 114.114 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -78.94 -49.14 13.28 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.117 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' N ' HG21 ' A' ' 118' ' ' VAL . . . 123.64 -14.44 8.11 Favored Glycine 0 N--CA 1.508 3.451 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.89 -19.28 29.46 Favored Glycine 1 N--CA 1.518 4.103 0 CA-C-N 118.46 1.13 . . . . 0.0 111.104 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.424 ' HA ' HD21 ' A' ' 112' ' ' LEU . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.401 ' HG2' ' HB3' ' A' ' 6' ' ' TYR . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.466 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -155.32 -106.38 0.26 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.438 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -48.42 -48.72 37.0 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 122.191 -0.594 . . . . 0.0 111.299 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.613 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.608 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.441 HG23 ' CG1' ' A' ' 123' ' ' ILE . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.407 ' CG ' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 39' ' ' PHE . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 18' ' ' ASP . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.424 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.19 -123.88 0.01 OUTLIER Glycine 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -71.11 0.14 8.33 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.31 0.644 . . . . 0.0 112.233 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 7.4 t0 -16.96 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 124.074 0.95 . . . . 0.0 113.502 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -165.96 -9.57 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.581 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 30.8 t -171.74 -57.31 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 120.14 1.336 . . . . 0.0 111.555 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' TYR . 13.5 p -38.36 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CE1' HD23 ' A' ' 63' ' ' LEU . 21.1 p90 -38.12 -16.32 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 56' ' ' SER . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 61' ' ' ASN . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 HD23 ' CE1' ' A' ' 58' ' ' PHE . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' NE2' ' CG2' ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.483 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 40.8 mt -92.65 120.67 33.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -47.13 81.26 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 123.997 1.856 . . . . 0.0 114.296 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.1 t70 -100.52 29.35 4.48 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 26.43 16.7 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 107.201 -2.36 . . . . 0.0 107.201 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 36.0 mm-40 -157.0 -55.06 0.08 Allowed 'General case' 0 C--N 1.369 1.419 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.575 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.757 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.41 ' CG2' ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -85.07 167.44 15.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 t -131.42 178.92 6.35 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.862 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -121.8 38.12 4.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.38 0.609 . . . . 0.0 109.69 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.57 -74.57 0.56 Allowed Glycine 0 N--CA 1.506 3.345 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.82 -6.9 73.89 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -96.68 168.91 9.61 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.118 0.959 . . . . 0.0 110.223 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -94.66 149.58 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.52 2.813 . . . . 0.0 110.56 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.436 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 12.5 p -120.6 155.2 34.24 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 97' ' ' THR . 47.4 m-85 -144.61 151.41 38.99 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -120.31 140.31 51.46 Favored 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.495 -176.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.489 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.24 152.65 24.23 Favored Glycine 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 20.7 mttt -131.02 167.33 19.23 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 28.9 tt0 -17.11 155.62 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.481 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.01 14.56 73.56 Favored Glycine 0 CA--C 1.563 3.05 1 N-CA-C 101.007 -4.837 . . . . 0.0 101.007 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.833 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -102.39 104.3 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.401 -174.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -85.99 -36.59 19.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.42 -16.65 44.65 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.59 -29.89 28.52 Favored Glycine 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.441 ' CG1' HG23 ' A' ' 15' ' ' THR . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.499 ' HA ' HG22 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 29.9 t-80 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.438 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -153.66 -48.85 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.449 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -48.78 -48.22 41.3 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.184 -0.598 . . . . 0.0 111.186 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.646 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.447 HG23 ' CG1' ' A' ' 123' ' ' ILE . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.413 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 23' ' ' GLY . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -178.54 0.33 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -4.44 57.31 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 122.636 -0.332 . . . . 0.0 110.813 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.8 t0 -41.69 114.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.654 0.74 . . . . 0.0 110.196 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 10.68 27.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.356 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.4 t -166.34 -56.99 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 117.833 -1.547 . . . . 0.0 115.04 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 p -39.07 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 3.7 p90 -36.82 -23.35 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 HD22 ' CD1' ' A' ' 58' ' ' PHE . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.511 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 80' ' ' ASP . 66.7 mt -96.85 128.03 43.4 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -47.55 76.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.348 1.859 . . . . 0.0 114.57 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 78' ' ' LEU . 12.8 t0 -101.58 29.65 4.74 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.52 31.14 22.59 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 -154.44 -56.83 0.11 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.559 ' HG3' ' HA ' ' A' ' 75' ' ' ASP 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.724 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -87.65 169.62 11.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.458 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -132.44 179.07 6.35 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.039 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -135.13 88.17 2.4 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.319 0.58 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.67 -93.69 1.6 Allowed Glycine 0 N--CA 1.502 3.054 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.13 -9.66 36.17 Favored Glycine 0 N--CA 1.508 3.474 0 O-C-N 122.006 -0.702 . . . . 0.0 111.6 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -56.8 165.3 1.77 Allowed Pre-proline 0 N--CA 1.512 2.642 0 CA-C-N 118.73 1.265 . . . . 0.0 109.531 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -89.33 140.65 3.85 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.336 2.691 . . . . 0.0 111.941 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.462 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 25.4 p -116.36 156.24 27.05 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' A' ' 97' ' ' THR . 42.0 m-85 -144.5 130.4 19.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 -107.45 143.21 36.13 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 118.643 -1.223 . . . . 0.0 112.899 -175.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HE2' ' CE2' ' A' ' 24' ' ' TYR . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.496 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . -144.21 146.7 17.46 Favored Glycine 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 34.2 mttt -125.39 161.68 26.5 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -17.19 152.43 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.372 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 -175.81 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.7 13.16 82.37 Favored Glycine 0 CA--C 1.56 2.896 1 N-CA-C 100.798 -4.921 . . . . 0.0 100.798 -168.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.841 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.99 97.41 5.61 Favored 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.777 -1.212 . . . . 0.0 111.353 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -77.05 -30.3 55.55 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.33 -21.85 42.02 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.64 -32.01 34.91 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.414 ' HB3' HG12 ' A' ' 110' ' ' VAL . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.449 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.334 0.588 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . -157.17 -88.71 0.07 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.474 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -48.59 -44.09 36.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.214 -0.58 . . . . 0.0 111.577 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.568 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.673 HD22 ' CB ' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.507 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.446 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 3' ' ' TRP . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 58' ' ' PHE . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' C ' ' CG1' ' A' ' 51' ' ' VAL . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 HG11 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.13 116.47 5.1 Favored Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -33.4 1.99 Allowed 'General case' 0 N--CA 1.519 3.001 0 CA-C-O 121.397 0.618 . . . . 0.0 110.116 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.45 88.5 5.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HB2' ' CD2' ' A' ' 58' ' ' PHE . 28.8 ptt85 -166.61 51.62 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.025 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 27.4 t -89.84 -10.88 43.71 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.259 -0.9 . . . . 0.0 110.842 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 p -80.54 -60.35 2.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.849 -0.532 . . . . 0.0 110.51 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.551 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.9 p90 -37.9 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.509 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.468 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG12 ' CE ' ' A' ' 85' ' ' MET . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.422 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 104' ' ' LYS . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 80' ' ' ASP . 66.2 mt -99.08 124.65 44.24 Favored 'General case' 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.38 78.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.895 1.678 . . . . 0.0 114.626 -173.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.9 t70 -101.06 25.69 7.84 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 171.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.69 29.58 9.17 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 -156.78 -57.42 0.09 Allowed 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.511 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 5.4 mmmt -95.78 141.96 28.63 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 4.6 t -119.19 -166.21 1.23 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.733 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.6 p -85.43 -168.84 2.38 Favored 'General case' 0 N--CA 1.508 2.44 0 CA-C-O 121.388 0.613 . . . . 0.0 111.707 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.59 105.94 2.03 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.76 10.47 40.42 Favored Glycine 0 N--CA 1.505 3.277 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.436 ' HB2' ' OG ' ' A' ' 91' ' ' SER . . . -100.2 164.66 15.94 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.831 -0.805 . . . . 0.0 109.842 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.34 127.44 1.4 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.773 2.315 . . . . 0.0 109.278 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.8 p -103.22 177.48 4.83 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.64 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 52.7 m-85 -152.33 151.99 31.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -129.16 171.62 12.23 Favored 'General case' 0 N--CA 1.521 3.103 0 CA-C-N 121.03 1.741 . . . . 0.0 113.358 -174.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 111' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.412 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' HA ' HG21 ' A' ' 102' ' ' VAL . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HG ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.522 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 115' ' ' LYS . . . -178.78 118.67 0.62 Allowed Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' HA ' HG13 ' A' ' 118' ' ' VAL 0.319 0.0 OUTLIER -165.28 117.86 1.18 Allowed 'General case' 0 N--CA 1.403 -2.821 0 C-N-CA 115.23 -2.588 . . . . 0.0 117.924 176.307 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 118' ' ' VAL . 14.8 tt0 -114.39 90.37 3.32 Favored 'General case' 0 C--O 1.255 1.382 1 N-CA-C 100.07 -4.048 . . . . 0.0 100.07 159.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.33 -0.19 0.1 OUTLIER Glycine 2 CA--C 1.664 9.397 1 CA-C-N 126.042 4.019 . . . . 0.0 108.942 -177.989 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' A' ' 115' ' ' LYS . 8.8 p -27.11 144.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.386 2.155 0 C-N-CA 126.648 1.979 . . . . 0.0 115.436 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.405 ' N ' HG21 ' A' ' 118' ' ' VAL . 5.0 t60 -74.66 -55.64 5.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.018 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 120.31 -11.8 10.53 Favored Glycine 0 N--CA 1.512 3.759 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.444 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.36 -27.64 29.77 Favored Glycine 1 N--CA 1.518 4.167 0 CA-C-N 118.302 1.051 . . . . 0.0 110.906 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.474 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -117.65 -83.52 0.95 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.465 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -50.87 -49.83 58.34 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 122.197 -0.59 . . . . 0.0 111.063 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' HA ' HD22 ' A' ' 10' ' ' LEU . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HG ' ' CB ' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.52 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.465 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.478 ' CE1' ' CD1' ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HA ' HG23 ' A' ' 30' ' ' VAL . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 50' ' ' LEU . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG23 HG12 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.92 160.81 0.47 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -70.65 -4.71 24.81 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.186 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 53' ' ' LYS . 13.0 t70 -20.41 125.51 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 124.2 1.0 . . . . 0.0 112.257 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -89.59 -7.11 55.51 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 t -170.69 -49.83 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 120.627 1.558 . . . . 0.0 114.171 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -35.16 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 1.6 p90 -37.06 -25.66 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HA ' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.453 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.492 ' OG ' ' CG ' ' A' ' 90' ' ' LYS . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.781 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 80' ' ' ASP . 89.7 mt -95.54 125.5 40.18 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 8.9 pt20 -47.82 76.53 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.924 1.69 . . . . 0.0 114.834 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 22.3 t70 -101.09 22.95 11.5 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 171.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 28.54 8.54 Favored Glycine 0 C--N 1.366 2.22 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 -155.13 -54.11 0.09 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.781 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt -78.31 168.03 20.45 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -116.92 177.95 4.52 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.627 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -141.5 88.59 2.15 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.555 0.693 . . . . 0.0 110.283 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.9 96.64 0.01 OUTLIER Glycine 0 N--CA 1.501 3.018 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.73 -14.21 65.75 Favored Glycine 0 N--CA 1.505 3.3 0 O-C-N 122.031 -0.688 . . . . 0.0 112.017 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -91.34 164.95 22.74 Favored Pre-proline 0 N--CA 1.508 2.463 0 CA-C-N 118.706 1.253 . . . . 0.0 110.985 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -92.93 151.88 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.379 2.719 . . . . 0.0 110.29 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 46.9 p -116.12 170.5 8.46 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 97' ' ' THR . 61.9 m-85 -155.8 152.68 28.73 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -123.5 143.63 50.05 Favored 'General case' 0 N--CA 1.511 2.619 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.423 -177.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' HD11 ' A' ' 77' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' NZ ' ' HB ' ' A' ' 51' ' ' VAL . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.418 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.453 HG21 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 102' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.478 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.98 150.62 22.64 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 9.1 mttp -134.27 165.95 23.92 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tp10 -16.46 149.68 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 75.77 13.99 82.54 Favored Glycine 0 CA--C 1.565 3.218 1 N-CA-C 100.61 -4.996 . . . . 0.0 100.61 -168.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.836 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.72 98.09 6.45 Favored 'Isoleucine or valine' 0 C--N 1.378 1.844 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.881 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -79.47 -37.17 37.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.58 -20.82 46.67 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.05 -27.13 26.85 Favored Glycine 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 15' ' ' THR . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.525 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 125' ' ' LYS . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.465 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -122.94 -107.6 1.88 Allowed Glycine 0 N--CA 1.506 3.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.444 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.46 -44.97 69.36 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 122.021 -0.694 . . . . 0.0 110.389 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.617 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.526 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD2' ' CG ' ' A' ' 39' ' ' PHE . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HA ' ' CG1' ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.432 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG1' ' HG ' ' A' ' 109' ' ' LEU . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.16 178.63 2.76 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -8.48 59.21 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.997 -0.602 . . . . 0.0 110.411 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -48.65 120.42 3.75 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.464 0.65 . . . . 0.0 109.48 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -116.83 32.55 6.09 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.393 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -165.24 -70.11 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.974 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 p -38.72 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' ' CE1' ' A' ' 59' ' ' TYR . 4.2 p90 -37.01 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 70' ' ' CYS . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.452 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 80' ' ' ASP . 32.2 mt -110.41 121.8 46.18 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -47.85 76.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.632 1.682 . . . . 0.0 115.323 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 13.9 t70 -101.51 24.63 9.41 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.95 26.9 9.91 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -149.4 -64.31 0.22 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.563 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.7 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -83.63 134.25 34.8 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 2.4 t -111.91 -163.26 0.84 Allowed 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.846 0.355 . . . . 0.0 111.222 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -128.89 168.07 16.47 Favored 'General case' 0 N--CA 1.516 2.871 0 CA-C-O 121.959 0.885 . . . . 0.0 112.078 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.49 -115.42 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.479 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 53.73 0.58 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB2' ' OG ' ' A' ' 91' ' ' SER . . . -99.96 167.6 10.79 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 122.427 -0.455 . . . . 0.0 110.112 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -95.7 123.1 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 122.93 2.42 . . . . 0.0 108.253 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.0 p -90.48 177.85 6.27 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.684 ' HA ' ' HB2' ' A' ' 115' ' ' LYS . 57.5 m-85 -151.84 157.09 41.44 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.708 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 4.5 m-20 -127.83 -171.47 2.45 Favored 'General case' 0 CA--C 1.457 -2.609 0 O-C-N 120.946 -1.096 . . . . 0.0 109.732 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.452 ' CG2' ' CB ' ' A' ' 127' ' ' CYS . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 77' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HD2' ' CZ ' ' A' ' 24' ' ' TYR . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 10' ' ' LEU . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.52 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.598 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . 163.51 139.25 2.59 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.708 ' HG3' ' N ' ' A' ' 99' ' ' ASN 0.269 0.0 OUTLIER -171.18 116.07 0.43 Allowed 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.815 -1.693 . . . . 0.0 111.482 165.499 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.2 tt0 -115.49 91.9 3.75 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 161.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.03 -2.89 0.05 OUTLIER Glycine 2 CA--C 1.662 9.236 0 CA-C-N 125.116 3.598 . . . . 0.0 110.104 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.674 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 6.3 p -38.29 150.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 125.845 1.658 . . . . 0.0 114.717 -176.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.452 ' N ' HG21 ' A' ' 118' ' ' VAL . 81.8 t60 -75.66 -55.14 5.94 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 112.773 -2.012 . . . . 0.0 108.722 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.72 14.58 12.24 Favored Glycine 0 N--CA 1.511 3.647 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.95 -25.47 3.59 Favored Glycine 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.427 ' CG2' ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.446 ' HA ' HG23 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.452 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 24.2 t-80 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.444 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 118.29 -60.43 0.48 Allowed Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.477 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.42 -47.56 62.95 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.027 -0.69 . . . . 0.0 109.78 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.533 ' ND2' ' N ' ' A' ' 10' ' ' LEU 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 11' ' ' MET . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' ALA . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.479 HG23 ' CG1' ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.603 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.475 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' N ' HD13 ' A' ' 7' ' ' ILE . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.405 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG11 HG23 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 58' ' ' PHE . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 HG11 ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.53 129.78 6.1 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -14.49 32.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -52.42 135.13 33.95 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.7 36.81 3.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.506 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -170.16 -35.7 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.922 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 p -52.18 -104.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 51.2 p90 -37.57 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 58' ' ' PHE . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.446 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.496 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.778 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.533 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 80' ' ' ASP . 2.1 mt -97.3 127.25 43.1 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.67 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.712 1.72 . . . . 0.0 114.773 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 78' ' ' LEU . 28.0 t0 -101.24 28.31 5.49 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 171.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.66 28.91 22.85 Favored Glycine 0 C--N 1.36 1.891 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 -153.84 -53.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.5 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.533 ' CG ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -81.8 171.3 14.69 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 95' ' ' ALA . 1.2 t -121.98 161.11 23.52 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.638 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.2 p -106.89 -80.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.644 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.0 96.56 0.86 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.53 21.13 62.21 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -81.77 166.98 34.33 Favored Pre-proline 0 N--CA 1.509 2.485 0 O-C-N 121.853 -0.792 . . . . 0.0 109.287 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -89.64 131.09 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.179 2.586 . . . . 0.0 111.162 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 68.7 p -100.88 165.83 11.15 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 45.5 m-85 -145.57 113.82 6.62 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -100.9 136.11 41.27 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 113' ' ' MET . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 87' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 105' ' ' THR . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.446 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.463 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.508 ' HA ' HG11 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -142.32 140.84 10.27 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.87 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 44.4 mttt -112.09 167.45 10.39 Favored 'General case' 0 C--O 1.197 -1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.4 tt0 -16.75 151.22 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.416 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -176.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.28 83.58 Favored Glycine 0 CA--C 1.561 2.969 1 N-CA-C 100.696 -4.962 . . . . 0.0 100.696 -168.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.87 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.8 OUTLIER -101.94 105.79 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 114.08 -1.06 . . . . 0.0 112.081 -175.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -83.88 -38.5 21.05 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.11 3.43 61.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.17 -32.42 5.55 Favored Glycine 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 15' ' ' THR . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.406 ' HB3' HG23 ' A' ' 101' ' ' THR . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.403 ' HE3' ' CB ' ' A' ' 9' ' ' ASN . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 134' ' ' LEU . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.465 ' CE1' ' OH ' ' A' ' 6' ' ' TYR . 22.7 t-80 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.477 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -151.77 -100.27 0.2 Allowed Glycine 0 N--CA 1.513 3.786 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.422 ' CE3' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.68 -45.33 38.8 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 121.936 -0.743 . . . . 0.0 111.293 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 133' ' ' HIS . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HA ' HD13 ' A' ' 10' ' ' LEU . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.445 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' HD23 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' H ' HD12 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 39' ' ' PHE . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 21' ' ' ILE . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.51 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' CD1' ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 113' ' ' MET . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' HG23 ' A' ' 30' ' ' VAL . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -65.85 114.33 6.52 Favored Glycine 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -31.82 63.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.431 -0.452 . . . . 0.0 110.193 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -84.6 74.48 10.41 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 1.6 tpt180 -171.44 52.96 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.5 t -69.33 -10.22 56.9 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.579 -0.701 . . . . 0.0 110.977 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -73.87 -55.57 6.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.004 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 55' ' ' ARG . 1.1 p90 -38.23 -28.32 0.02 OUTLIER 'General case' 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 58' ' ' PHE . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.556 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' C ' ' HA ' ' A' ' 83' ' ' PHE . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 80' ' ' ASP . 39.4 mt -98.43 127.91 44.57 Favored 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -47.69 74.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 126.451 1.901 . . . . 0.0 114.829 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 78' ' ' LEU . 8.2 t0 -101.14 23.83 10.28 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.84 27.79 10.85 Favored Glycine 0 C--N 1.36 1.884 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 -153.18 -56.03 0.12 Allowed 'General case' 0 C--N 1.364 1.235 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.459 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 98' ' ' PHE . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -81.82 172.45 13.33 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 1.4 t -143.14 178.41 7.72 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.778 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 p -97.26 -31.66 12.31 Favored 'General case' 0 N--CA 1.515 2.78 0 CA-C-O 121.112 0.482 . . . . 0.0 109.836 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.49 -72.12 0.12 Allowed Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.35 74.26 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 91' ' ' SER . . . -64.08 167.05 8.68 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.05 -0.676 . . . . 0.0 109.285 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 63.2 Cg_endo -97.5 136.84 0.42 Allowed 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 123.235 2.623 . . . . 0.0 112.282 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 91' ' ' SER . 69.6 p -112.51 152.8 28.37 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 97' ' ' THR . 25.9 m-85 -139.71 88.24 2.23 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -72.79 132.53 43.71 Favored 'General case' 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 -174.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 77' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.4 HG22 ' OG1' ' A' ' 108' ' ' THR . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.4 ' OG1' HG22 ' A' ' 105' ' ' THR . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 130' ' ' MET . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.512 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA3' HD12 ' A' ' 123' ' ' ILE . . . -131.32 118.19 2.32 Favored Glycine 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.793 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 13.6 mttt -102.83 159.56 15.37 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.58 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.8 tt0 -17.12 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.639 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.37 14.96 77.08 Favored Glycine 0 CA--C 1.564 3.102 1 N-CA-C 100.698 -4.961 . . . . 0.0 100.698 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.793 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.4 p -101.83 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.385 2.132 0 CA-C-N 114.004 -1.098 . . . . 0.0 112.273 -174.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.25 -40.7 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.28 41.65 2.74 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.9 -45.86 0.04 OUTLIER Glycine 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 HD12 ' HA3' ' A' ' 114' ' ' GLY . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.477 ' HA ' ' CG2' ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.449 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.434 ' HA ' HD21 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.438 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 137' ' ' SER . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 119.96 32.41 1.18 Allowed Glycine 0 N--CA 1.506 3.338 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.456 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -52.92 -45.65 67.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.873 -0.781 . . . . 0.0 110.559 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.518 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.519 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' CD2' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' PHE . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.466 ' CD2' HG13 ' A' ' 51' ' ' VAL . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.451 ' CH2' ' HE3' ' A' ' 25' ' ' LYS . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 58' ' ' PHE . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' CD2' ' A' ' 24' ' ' TYR . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.07 -132.39 0.01 OUTLIER Glycine 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -69.29 -0.93 6.9 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 123.159 0.584 . . . . 0.0 112.475 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 53' ' ' LYS . 41.4 t0 -17.8 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.89 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 31.3 t -172.24 -50.21 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 p -43.73 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.689 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 59' ' ' TYR . 3.3 p90 -37.03 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 56' ' ' SER . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.509 ' CD2' ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' THR . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.419 ' OG ' ' CD ' ' A' ' 90' ' ' LYS . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.554 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.99 51.33 0.78 Allowed 'General case' 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -110.31 -108.86 0.34 Allowed 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.41 63.34 0.87 Allowed 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' CE1' ' A' ' 83' ' ' PHE . . . 76.62 -15.14 6.2 Favored Glycine 1 N--CA 1.523 4.496 0 O-C-N 120.646 -1.284 . . . . 0.0 112.342 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.62 -63.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.675 1.238 . . . . 0.0 109.97 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.554 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.54 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.419 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 2.1 mtmt -81.71 125.21 30.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.403 ' OG ' ' CB ' ' A' ' 95' ' ' ALA . 1.2 t -89.6 177.61 6.5 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.924 0.869 . . . . 0.0 112.267 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.0 p -83.02 -31.53 27.39 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.215 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.22 -53.05 0.48 Allowed Glycine 0 N--CA 1.503 3.163 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.29 -14.15 66.93 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . . . -85.55 170.61 12.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.843 -0.798 . . . . 0.0 110.079 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' ALA . 60.9 Cg_endo -96.03 160.61 1.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.381 2.721 . . . . 0.0 109.414 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.49 ' HB ' ' HE3' ' A' ' 115' ' ' LYS . 16.3 p -122.06 166.75 14.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.624 ' O ' HG22 ' A' ' 89' ' ' THR . 43.9 m-85 -152.46 102.03 2.71 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' H ' ' HG2' ' A' ' 115' ' ' LYS . 27.6 m-20 -74.51 139.03 43.54 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 124' ' ' ASN . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' HB ' HD13 ' A' ' 87' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.406 ' OG1' HG13 ' A' ' 110' ' ' VAL . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.452 ' CE ' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.406 HG13 ' OG1' ' A' ' 103' ' ' THR . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . 145.12 148.54 4.84 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.642 ' HA ' ' CG1' ' A' ' 118' ' ' VAL 0.434 18.8 mttt -151.96 118.53 5.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 111.717 -2.242 . . . . 0.0 106.759 167.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -112.72 91.89 3.82 Favored 'General case' 0 C--N 1.244 -3.996 1 N-CA-C 98.83 -4.508 . . . . 0.0 98.83 161.696 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.46 -0.82 0.13 Allowed Glycine 2 CA--C 1.653 8.668 0 CA-C-N 123.798 2.999 . . . . 0.0 109.216 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.642 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 12.6 p -35.37 154.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.391 2.371 0 O-C-N 120.486 -1.597 . . . . 0.0 113.816 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.464 ' N ' HG21 ' A' ' 118' ' ' VAL . 11.8 t60 -99.07 -45.05 6.07 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.351 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.03 115.02 3.92 Favored Glycine 0 N--CA 1.503 3.121 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.83 -35.84 2.2 Favored Glycine 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' HG23 ' A' ' 15' ' ' THR . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.403 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.456 ' HG ' ' CH2' ' A' ' 3' ' ' TRP . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.505 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 32' ' ' ALA . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.919 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.818 ' SG ' HD11 ' A' ' 112' ' ' LEU 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.514 ' N ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.919 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 110' ' ' VAL . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 29' ' ' SER . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' HG13 ' A' ' 22' ' ' VAL . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.715 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.888 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 7' ' ' ILE . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.791 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.949 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.813 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 63' ' ' LEU . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.961 HD23 HD13 ' A' ' 63' ' ' LEU . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HD21 ' A' ' 63' ' ' LEU . 54.6 p90 . . . . . 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.961 HD13 HD23 ' A' ' 50' ' ' LEU . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.949 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HB3' HD12 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.542 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.917 HG11 ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.917 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 83' ' ' PHE . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.2 mp0 . . . . . 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.844 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.922 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.655 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 122.139 0.971 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.815 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HD3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.715 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.053 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 HG13 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HG ' HG23 ' A' ' 123' ' ' ILE . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.619 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.585 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.918 HG23 ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.651 ' HA ' HG21 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.418 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.679 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 15.5 t-80 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 110' ' ' VAL . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.526 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.802 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.956 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ASP . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.956 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.992 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 110' ' ' VAL . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 42' ' ' ILE . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.521 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.63 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 7' ' ' ILE . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.74 ' CZ ' HD12 ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.637 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 63' ' ' LEU . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD23 HD13 ' A' ' 63' ' ' LEU . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CD2' HD21 ' A' ' 63' ' ' LEU . 29.3 p90 . . . . . 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD12 ' HG ' ' A' ' 87' ' ' LEU . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.629 ' C ' HD23 ' A' ' 65' ' ' LEU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.806 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.806 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.518 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.802 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 6.1 mp0 . . . . . 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.818 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.908 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm . . . . . 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.851 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.508 2.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 113' ' ' MET . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.882 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' TYR . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.63 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 134' ' ' LEU . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.992 HD12 ' HB3' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.582 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 112' ' ' LEU . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.95 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 22.2 t60 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.882 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.834 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.571 ' ND2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.974 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.571 ' OD2' ' ND2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.853 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 110' ' ' VAL . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 29' ' ' SER . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.834 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HA ' HG11 ' A' ' 40' ' ' VAL . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.908 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.846 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.763 HG22 HD23 ' A' ' 63' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.917 HD23 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.917 HD13 HD23 ' A' ' 50' ' ' LEU . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.908 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.4 tp-100 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.602 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HG12 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 50.8 mt . . . . . 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.875 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.875 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt . . . . . 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.665 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.824 0 CA-C-O 122.087 0.946 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.935 HG12 HD13 ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.62 HG23 ' SG ' ' A' ' 127' ' ' CYS . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 77' ' ' LEU . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 134' ' ' LEU . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.553 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.543 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 112' ' ' LEU . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.896 ' HA ' HG21 ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' A' ' 103' ' ' THR . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.605 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.631 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.65 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.803 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.727 HG12 HG22 ' A' ' 110' ' ' VAL . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 29' ' ' SER . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' VAL . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.619 HG21 ' O ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.622 ' CZ3' HG22 ' A' ' 108' ' ' THR . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.818 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 19' ' ' ALA . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.919 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 63' ' ' LEU . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 63' ' ' LEU . 47.1 p90 . . . . . 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.807 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.1 tp-100 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.573 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.925 ' HB2' HG11 ' A' ' 72' ' ' VAL . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.795 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.77 ' HG2' HG13 ' A' ' 72' ' ' VAL 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.857 HD11 ' HB ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 89' ' ' THR . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.523 3.218 0 CA-C-O 122.199 1.0 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 83' ' ' PHE . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.82 HG21 ' HB3' ' A' ' 134' ' ' LEU . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.743 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.799 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.743 HD21 HD13 ' A' ' 109' ' ' LEU . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.875 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.875 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.615 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' A' ' 105' ' ' THR . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.314 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.906 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.448 HD11 ' HE2' ' A' ' 130' ' ' MET . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 42' ' ' ILE . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 22' ' ' VAL . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.45 HG22 HG23 ' A' ' 7' ' ' ILE . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.581 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.858 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.678 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.661 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 63' ' ' LEU . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 63' ' ' LEU . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' ' OD1' ' A' ' 61' ' ' ASN . 17.5 p90 . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.979 HD11 ' HE2' ' A' ' 85' ' ' MET . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.858 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG11 ' A' ' 72' ' ' VAL . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.965 HD13 HG12 ' A' ' 102' ' ' VAL . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 . . . . . 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.979 ' HE2' HD11 ' A' ' 63' ' ' LEU . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.731 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.896 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 68' ' ' GLN . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.523 3.187 0 CA-C-O 122.153 0.978 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.62 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.965 HG12 HD13 ' A' ' 77' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.552 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.821 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.598 ' OG1' HD22 ' A' ' 134' ' ' LEU . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 ' CG2' ' A' ' 102' ' ' VAL . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.801 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.594 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.801 HG23 ' HG ' ' A' ' 112' ' ' LEU . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.872 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 132' ' ' SER . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.616 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.861 0.362 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.662 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.85 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.721 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.41 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 HG22 ' A' ' 110' ' ' VAL . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 29' ' ' SER . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.85 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 19' ' ' ALA . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.97 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.853 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 63' ' ' LEU . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.72 HD23 HD13 ' A' ' 63' ' ' LEU . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 . . . . . 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 49' ' ' VAL . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 63' ' ' LEU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.97 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.7 tp-100 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.549 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.727 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 78' ' ' LEU . 80.1 mt . . . . . 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 38.2 mm-40 . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.507 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.633 ' HG2' HD12 ' A' ' 87' ' ' LEU . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.81 ' C ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.81 HD13 ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 89' ' ' THR . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.513 2.724 0 CA-C-O 122.319 1.057 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 87' ' ' LEU . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.727 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.943 HG21 ' HB3' ' A' ' 134' ' ' LEU . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 134' ' ' LEU . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 109' ' ' LEU . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.933 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.893 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' HG ' ' A' ' 112' ' ' LEU . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' CB ' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.432 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.711 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 33.2 t60 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.868 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.719 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.571 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 29' ' ' SER . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HZ1' ' HZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 22' ' ' VAL . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.594 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.764 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.745 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.849 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.687 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.687 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG22 HD23 ' A' ' 63' ' ' LEU . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.882 HD12 ' HG ' ' A' ' 87' ' ' LEU . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD12 ' A' ' 65' ' ' LEU . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.582 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.844 HD13 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.888 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 82' ' ' GLU . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 102' ' ' VAL . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.46 ' CB ' ' HB3' ' A' ' 76' ' ' SER . 4.2 mp0 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.815 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.882 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.844 ' NH1' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' THR . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.828 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.841 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 122.253 1.025 . . . . 0.0 111.682 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 113' ' ' MET . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.693 ' HB ' HD11 ' A' ' 87' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.914 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.924 HG21 HD13 ' A' ' 134' ' ' LEU . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.569 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.719 ' HA3' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.565 HG23 ' HG ' ' A' ' 112' ' ' LEU . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.76 ' HA ' HG21 ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.213 0.53 . . . . 0.0 110.051 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.969 ' HA ' HD12 ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.624 ' ND2' ' HB3' ' A' ' 126' ' ' LYS 0.267 0.2 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 7' ' ' ILE . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 13' ' ' ASP . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.627 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.914 ' HB1' HD22 ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.633 HG12 ' HE2' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.728 HG11 HG21 ' A' ' 42' ' ' ILE . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 22' ' ' VAL . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.728 HG21 HG11 ' A' ' 22' ' ' VAL . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.662 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.944 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 63' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HA ' HD22 ' A' ' 63' ' ' LEU . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 . . . . . 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 61' ' ' ASN . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' LEU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.617 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.8 tp-100 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.569 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 104' ' ' LYS . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 78' ' ' LEU . 92.6 mt . . . . . 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 . . . . . 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.787 HD22 HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' CE ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 7.7 m-20 . . . . . 0 CA--C 1.447 -3.009 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.881 HG22 HD23 ' A' ' 111' ' ' LEU . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 130' ' ' MET . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 HG22 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.966 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 101' ' ' THR . 20.8 t-20 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.624 ' HB3' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 112' ' ' LEU . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.406 ' HA ' HG21 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.759 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 110' ' ' VAL . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.403 0 CA-C-O 120.987 0.422 . . . . 0.0 111.038 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.004 HD22 ' HB2' ' A' ' 19' ' ' ALA . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB2' HD23 ' A' ' 10' ' ' LEU 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.004 ' HB2' HD22 ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 42' ' ' ILE . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.594 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 39' ' ' PHE . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 46' ' ' GLU . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 . . . . . 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.804 HD12 ' HG ' ' A' ' 87' ' ' LEU . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.4 tp-100 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.695 HG22 ' HE2' ' A' ' 85' ' ' MET . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 104' ' ' LYS . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.3 mp0 . . . . . 0 CA--C 1.561 1.386 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.695 ' HE2' HG22 ' A' ' 72' ' ' VAL . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.753 ' C ' HD13 ' A' ' 87' ' ' LEU . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.804 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' THR . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.535 ' CE ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.535 HD23 ' CE ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' ' 20' ' ' ALA . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.614 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 112' ' ' LEU . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.881 ' HA ' HG21 ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.48 ' HB3' HD22 ' A' ' 9' ' ' ASN . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.664 ' HA ' HD23 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 HG21 ' A' ' 110' ' ' VAL . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.922 0.391 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.646 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.693 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.661 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.848 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.4 HD11 ' HE2' ' A' ' 130' ' ' MET . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 29' ' ' SER . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 22' ' ' VAL . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 40' ' ' VAL . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.525 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.813 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 19' ' ' ALA . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.72 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.932 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.932 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.642 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.064 HD23 HD13 ' A' ' 63' ' ' LEU . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 63' ' ' LEU . 47.0 p90 . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.064 HD13 HD23 ' A' ' 50' ' ' LEU . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 63' ' ' LEU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.433 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.808 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 84' ' ' SER . 24.5 mm-40 . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' SER . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.825 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.877 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.676 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.225 0 CA-C-O 122.208 1.004 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 113' ' ' MET . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.892 HG21 ' HB3' ' A' ' 134' ' ' LEU . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.765 HD13 HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 134' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 109' ' ' LEU . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.935 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.63 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.935 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.632 ' HA ' HG21 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.578 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.672 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.191 0.519 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.718 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.423 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.582 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 6' ' ' TYR . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 29' ' ' SER . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' HG13 ' A' ' 22' ' ' VAL . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.597 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 7' ' ' ILE . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 1.014 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.954 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.954 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 . . . . . 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.802 HD13 ' HG ' ' A' ' 50' ' ' LEU . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.014 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' HB3' HD12 ' A' ' 65' ' ' LEU . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.676 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' HE2' ' A' ' 85' ' ' MET . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.815 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.712 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.618 HD21 ' NZ ' ' A' ' 104' ' ' LYS . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.725 ' HE2' HG22 ' A' ' 72' ' ' VAL 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 89' ' ' THR . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.808 ' HD3' HD11 ' A' ' 73' ' ' ILE . 3.3 mtmt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.603 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 122.169 0.985 . . . . 0.0 111.93 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.59 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.845 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.791 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.597 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.472 ' HG ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.938 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.845 ' HG ' HG22 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.924 ' HG ' HG23 ' A' ' 123' ' ' ILE . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.729 ' HA ' HG13 ' A' ' 100' ' ' VAL . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.582 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.924 HG23 ' HG ' ' A' ' 112' ' ' LEU . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.626 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.584 0 CA-C-O 121.092 0.473 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.931 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 122' ' ' LEU . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 10' ' ' LEU 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.574 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.931 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 42' ' ' ILE . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.617 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.853 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 7' ' ' ILE . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.952 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.61 HD13 HG21 ' A' ' 22' ' ' VAL . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 49' ' ' VAL . 29.8 p90 . . . . . 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' A' ' 87' ' ' LEU . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 63' ' ' LEU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB3' HD12 ' A' ' 65' ' ' LEU . 4.3 tp-100 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' HE2' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.816 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.691 HD21 ' HE3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.842 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.816 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.842 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 89' ' ' THR . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.605 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 5.3 m-20 . . . . . 0 CA--C 1.461 -2.475 0 CA-C-O 121.569 0.699 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 124' ' ' ASN . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.646 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.651 HG23 ' SG ' ' A' ' 127' ' ' CYS . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HE3' HD21 ' A' ' 77' ' ' LEU . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 134' ' ' LEU . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.538 HG21 HD23 ' A' ' 134' ' ' LEU . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 134' ' ' LEU . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 ' HB3' ' A' ' 20' ' ' ALA . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.827 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.548 ' HG2' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.103 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.723 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.827 HG23 HD12 ' A' ' 112' ' ' LEU . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.85 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HD2' ' ND2' ' A' ' 9' ' ' ASN . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.749 ' SD ' HG13 ' A' ' 110' ' ' VAL . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 135' ' ' ARG . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.874 HD13 HG21 ' A' ' 110' ' ' VAL . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.539 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.875 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 110' ' ' VAL . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 42' ' ' ILE . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.541 ' CZ3' HG22 ' A' ' 108' ' ' THR . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 19' ' ' ALA . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.79 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 22' ' ' VAL . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.645 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 63' ' ' LEU . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE1' HD21 ' A' ' 63' ' ' LEU . 21.1 p90 . . . . . 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 72' ' ' VAL . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.944 HD13 HD23 ' A' ' 50' ' ' LEU . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.641 ' NE2' HG22 ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 87' ' ' LEU . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.725 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.788 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 HG12 ' A' ' 102' ' ' VAL . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 36.0 mm-40 . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.769 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.788 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.641 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.533 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.923 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-O 122.336 1.065 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.543 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.739 HG22 HD22 ' A' ' 111' ' ' LEU . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 109' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 134' ' ' LEU . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.541 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 109' ' ' LEU . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.959 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.718 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.959 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' HG21 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.546 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.637 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 43.1 t60 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.878 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' ASP . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 134' ' ' LEU . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.847 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.586 HG23 ' HB3' ' A' ' 19' ' ' ALA . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.968 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HD23 ' A' ' 63' ' ' LEU . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 HD13 ' A' ' 63' ' ' LEU . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.7 p90 . . . . . 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.974 HD11 ' HE2' ' A' ' 85' ' ' MET . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 63' ' ' LEU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.968 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.4 tp-100 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' A' ' 87' ' ' LEU . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HE2' ' A' ' 90' ' ' LYS . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.94 ' HB2' HG11 ' A' ' 72' ' ' VAL . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.677 HD13 HG12 ' A' ' 102' ' ' VAL . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 78' ' ' LEU . 66.7 mt . . . . . 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 . . . . . 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.974 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.91 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 89' ' ' THR . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.518 2.947 0 CA-C-O 122.135 0.969 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 112' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.927 HG21 ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 87' ' ' LEU . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' HD23 ' A' ' 109' ' ' LEU . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.586 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.829 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.012 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.012 HG23 ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.927 ' HA ' HG21 ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.488 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.925 HD13 HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.875 0.369 . . . . 0.0 111.577 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.855 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.938 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.621 ' HB2' HD12 ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.556 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.938 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 110' ' ' VAL . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 42' ' ' ILE . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.855 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 7' ' ' ILE . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD12 ' A' ' 109' ' ' LEU . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 63' ' ' LEU . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.766 ' HA ' HD22 ' A' ' 63' ' ' LEU . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.727 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.9 p90 . . . . . 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 49' ' ' VAL . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.5 tp-100 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.729 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.874 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.874 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 102' ' ' VAL . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.6 mp0 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.745 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 89' ' ' THR . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HD3' HD11 ' A' ' 73' ' ' ILE . 5.4 mmmt . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.903 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.521 3.103 0 CA-C-O 122.611 1.196 . . . . 0.0 113.358 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.921 HG21 ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 77' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.954 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 20' ' ' ALA . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.527 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.167 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 HD12 ' A' ' 112' ' ' LEU . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.921 ' HA ' HG21 ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.687 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.954 HD13 HG21 ' A' ' 110' ' ' VAL . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.419 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.481 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.452 0 CA-C-O 120.65 0.262 . . . . 0.0 111.063 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.591 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.957 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.588 HG22 HD11 ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.957 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 42' ' ' ILE . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 22' ' ' VAL . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.819 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 7' ' ' ILE . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.67 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.886 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.694 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.694 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.855 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.704 HD23 HD13 ' A' ' 63' ' ' LEU . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.6 p90 . . . . . 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD12 ' HG ' ' A' ' 87' ' ' LEU . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.5 tp-100 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.806 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 102' ' ' VAL . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.7 mt . . . . . 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 . . . . . 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.836 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.824 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 89' ' ' THR . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.928 ' N ' HD21 ' A' ' 99' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.619 0 CA-C-O 122.256 1.027 . . . . 0.0 111.423 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.877 HG21 ' HB3' ' A' ' 134' ' ' LEU . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.649 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.801 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.913 HG21 HD13 ' A' ' 134' ' ' LEU . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 110' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.728 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.638 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.728 HG23 ' HG ' ' A' ' 112' ' ' LEU . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.954 ' HA ' HG21 ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.478 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 132' ' ' SER . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.681 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.913 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.468 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.388 0 CA-C-O 120.891 0.377 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.659 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.739 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.791 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.965 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 110' ' ' VAL . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 29' ' ' SER . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 19' ' ' ALA . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 1.021 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.685 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.801 HG22 HD23 ' A' ' 63' ' ' LEU . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.778 HD23 HD13 ' A' ' 63' ' ' LEU . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CD1' HD21 ' A' ' 63' ' ' LEU . 4.2 p90 . . . . . 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 87' ' ' LEU . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.021 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.779 ' SG ' HD23 ' A' ' 87' ' ' LEU . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 102' ' ' VAL . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 78' ' ' LEU . 32.2 mt . . . . . 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 89' ' ' THR . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.609 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 4.5 m-20 . . . . . 0 CA--C 1.457 -2.609 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.909 ' HB ' HD22 ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.963 HG22 HD23 ' A' ' 111' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.555 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.744 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.558 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 134' ' ' LEU . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' A' ' 123' ' ' ILE . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.577 ' HA ' HG21 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.453 ' CB ' HG22 ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.621 ' SD ' HG13 ' A' ' 110' ' ' VAL . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.5 t60 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 110' ' ' VAL . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.51 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.798 HD13 HD12 ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.554 ' CB ' ' HE1' ' A' ' 130' ' ' MET 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.962 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.659 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.962 ' HB1' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 42' ' ' ILE . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HB3' HG11 ' A' ' 47' ' ' VAL . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 22' ' ' VAL . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 108' ' ' THR . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 30' ' ' VAL . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 19' ' ' ALA . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.941 ' CE1' HD12 ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.793 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HG11 ' A' ' 22' ' ' VAL . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.689 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.901 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD23 HD13 ' A' ' 63' ' ' LEU . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 63' ' ' LEU . 51.2 p90 . . . . . 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.637 HD13 HD23 ' A' ' 50' ' ' LEU . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 63' ' ' LEU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.941 HD12 ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' THR . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' OE1' HG22 ' A' ' 89' ' ' THR . 2.2 tp-100 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 65' ' ' LEU . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.551 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG13 ' SD ' ' A' ' 85' ' ' MET . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.817 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 104' ' ' LYS . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 . . . . . 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 103' ' ' THR . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.791 ' SD ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.817 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.85 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 68' ' ' GLN . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.032 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.75 HG12 ' CD1' ' A' ' 77' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 77' ' ' LEU . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.96 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.478 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 134' ' ' LEU . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 102' ' ' VAL . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.567 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 112' ' ' LEU . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 1.032 ' HA ' HG21 ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 134' ' ' LEU . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.445 ' CD2' ' OH ' ' A' ' 6' ' ' TYR . 17.2 t60 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB3' HG21 ' A' ' 105' ' ' THR . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.601 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 32' ' ' ALA . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.055 HD11 ' HB3' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.476 ' N ' HD22 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.055 ' HB3' HD11 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 1.024 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.724 HD13 HD11 ' A' ' 134' ' ' LEU . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 42' ' ' ILE . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.603 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.826 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.831 ' CG2' HD13 ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.602 ' HA ' HG11 ' A' ' 40' ' ' VAL . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.783 ' CE1' HD12 ' A' ' 65' ' ' LEU . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 35' ' ' PRO . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.577 HD11 HD22 ' A' ' 65' ' ' LEU . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 1.1 p90 . . . . . 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 64' ' ' THR . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.766 ' C ' HD23 ' A' ' 65' ' ' LEU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.83 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.759 ' NE2' HG22 ' A' ' 89' ' ' THR . 1.5 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.83 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.794 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.617 ' CD1' HG12 ' A' ' 102' ' ' VAL . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.892 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.892 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.759 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 112' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.98 HG21 ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.649 ' HB ' HD11 ' A' ' 87' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.652 HG23 ' SG ' ' A' ' 127' ' ' CYS . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.603 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 134' ' ' LEU . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.024 HD12 ' HB3' ' A' ' 20' ' ' ALA . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.589 HG23 HD12 ' A' ' 112' ' ' LEU . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.98 ' HA ' HG21 ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.7 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.891 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.454 0 CA-C-O 121.015 0.436 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.616 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.868 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.577 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.991 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.79 HG12 HG22 ' A' ' 110' ' ' VAL . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 29' ' ' SER . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 22' ' ' VAL . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 40' ' ' VAL . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.596 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.633 HG23 ' HB3' ' A' ' 19' ' ' ALA . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.831 HD23 HD13 ' A' ' 63' ' ' LEU . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 47' ' ' VAL . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 61' ' ' ASN . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 60' ' ' VAL . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD12 ' HG ' ' A' ' 87' ' ' LEU . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 65' ' ' LEU . 8.3 tp-100 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.464 ' SG ' HD23 ' A' ' 87' ' ' LEU . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.901 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.774 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB2' HG11 ' A' ' 72' ' ' VAL . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.283 1.04 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.777 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.719 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.837 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HD3' HD11 ' A' ' 73' ' ' ILE . 2.1 mtmt . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 27.6 m-20 . . . . . 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.824 HG22 HD23 ' A' ' 111' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 127' ' ' CYS . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.752 HG21 ' HB3' ' A' ' 134' ' ' LEU . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.596 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.72 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.782 HG23 ' HG ' ' A' ' 112' ' ' LEU . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.572 ' HA ' HG21 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.465 ' HB3' HG21 ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 132' ' ' SER . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.646 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB2' ' OG1' ' A' ' 103' ' ' THR . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 129' ' ' GLU . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 110' ' ' VAL . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 87.51 -67.61 3.25 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.505 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -54.6 -44.31 72.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.081 -0.658 . . . . 0.0 109.28 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 32' ' ' ALA . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.919 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.818 ' SG ' HD11 ' A' ' 112' ' ' LEU 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.514 ' N ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.919 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 110' ' ' VAL . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 29' ' ' SER . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' HG13 ' A' ' 22' ' ' VAL . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.715 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.888 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 7' ' ' ILE . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.791 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.949 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.813 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 63' ' ' LEU . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.961 HD23 HD13 ' A' ' 63' ' ' LEU . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.63 144.24 5.82 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -10.48 50.2 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.971 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -46.58 135.79 8.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -112.12 27.73 9.39 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.5 t -170.05 -41.79 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 118.154 -1.419 . . . . 0.0 112.926 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 60' ' ' VAL . 19.1 p -46.2 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HD21 ' A' ' 63' ' ' LEU . 54.6 p90 -37.53 -20.82 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.961 HD13 HD23 ' A' ' 50' ' ' LEU . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.949 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HB3' HD12 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.542 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.917 HG11 ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.917 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 83' ' ' PHE . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 9.0 mt -103.55 121.8 43.63 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.92 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.072 1.749 . . . . 0.0 114.941 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.6 t70 -101.32 24.28 9.77 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 171.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.43 28.22 8.65 Favored Glycine 0 C--N 1.364 2.138 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.2 mp0 -153.89 -58.29 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.844 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.922 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -95.16 146.37 24.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.724 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -89.69 170.16 10.68 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-O 121.668 0.747 . . . . 0.0 111.733 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 91' ' ' SER . 55.4 p -156.19 108.37 2.56 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.49 44.51 2.71 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.8 23.75 77.59 Favored Glycine 0 N--CA 1.506 3.311 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -84.93 168.78 18.92 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.802 -0.822 . . . . 0.0 110.007 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -91.67 137.67 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.415 2.743 . . . . 0.0 110.147 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.593 HG22 ' H ' ' A' ' 91' ' ' SER . 71.5 p -96.89 170.79 8.92 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.036 0.922 . . . . 0.0 109.387 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.946 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 47.8 m-85 -154.68 172.84 17.24 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.88 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -140.38 154.79 46.84 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.999 -176.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.815 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HD3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.715 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.053 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 HG13 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HG ' HG23 ' A' ' 123' ' ' ILE . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.619 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.755 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.11 132.53 2.7 Favored Glycine 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.946 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.565 0.1 OUTLIER -156.44 111.94 2.93 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 173.974 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.8 tt0 -119.8 89.67 3.17 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 101.54 -3.504 . . . . 0.0 101.54 155.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.27 0.61 0.05 OUTLIER Glycine 2 CA--C 1.683 10.537 1 CA-C-N 128.656 5.207 . . . . 0.0 108.679 -178.983 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.88 HG13 ' OD1' ' A' ' 99' ' ' ASN . 5.7 p -22.11 132.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.4 2.77 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -71.01 -53.54 14.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.529 -2.123 . . . . 0.0 108.845 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.07 21.93 6.45 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.33 -37.42 0.93 Allowed Glycine 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.585 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.918 HG23 ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.651 ' HA ' HG21 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.418 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.679 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 15.5 t-80 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 110' ' ' VAL . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.005 0.431 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.462 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -140.0 -36.47 0.12 Allowed Glycine 0 N--CA 1.508 3.477 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.526 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -47.66 -48.23 29.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.982 -0.716 . . . . 0.0 112.03 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.802 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.956 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ASP . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.956 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.992 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 110' ' ' VAL . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 42' ' ' ILE . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.521 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.63 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 7' ' ' ILE . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.74 ' CZ ' HD12 ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.637 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 63' ' ' LEU . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD23 HD13 ' A' ' 63' ' ' LEU . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -46.08 132.37 10.51 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -18.4 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -48.77 128.66 15.85 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.39 33.0 5.17 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.964 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 t -170.73 -10.95 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 118.261 -1.376 . . . . 0.0 114.19 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.4 p -79.26 -96.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 118.724 0.693 . . . . 0.0 111.329 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CD2' HD21 ' A' ' 63' ' ' LEU . 29.3 p90 -38.02 -22.43 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD12 ' HG ' ' A' ' 87' ' ' LEU . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.629 ' C ' HD23 ' A' ' 65' ' ' LEU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.806 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.806 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.518 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.802 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' ASP . 6.1 mt -96.74 126.0 41.59 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.49 76.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.073 1.749 . . . . 0.0 114.639 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 35.8 t70 -101.12 23.99 10.05 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 19.55 24.07 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 6.1 mp0 -147.9 -51.99 0.19 Allowed 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.818 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.908 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm -81.97 156.29 24.77 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t -145.98 -172.08 3.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 65.3 p -154.41 177.43 11.17 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.375 0.607 . . . . 0.0 111.119 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.84 47.78 88.02 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.99 24.17 64.56 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -73.06 166.56 42.39 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 122.052 -0.675 . . . . 0.0 110.123 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.6 Cg_endo -93.29 120.91 0.41 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 123.007 2.471 . . . . 0.0 109.179 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 91' ' ' SER . 43.1 p -97.46 170.75 8.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 54.5 m-85 -143.31 145.05 32.38 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -118.74 146.34 44.84 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.673 -176.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 113' ' ' MET . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.882 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' TYR . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.63 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 134' ' ' LEU . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.992 HD12 ' HB3' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.582 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . -148.29 152.35 24.43 Favored Glycine 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 51.8 mttt -127.43 164.81 21.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.56 ' O ' ' O ' ' A' ' 115' ' ' LYS . 22.2 tt0 -16.63 154.21 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.348 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -175.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.98 12.74 79.24 Favored Glycine 0 CA--C 1.562 3.015 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -169.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.833 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.13 93.17 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 113.899 -1.151 . . . . 0.0 112.285 -174.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.25 -23.69 51.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.0 63.2 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 -37.13 12.43 Favored Glycine 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 112' ' ' LEU . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.95 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 22.2 t60 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.882 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.11 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -47.82 -54.29 12.89 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.834 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.571 ' ND2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.974 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.571 ' OD2' ' ND2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.853 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 110' ' ' VAL . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 29' ' ' SER . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.834 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HA ' HG11 ' A' ' 40' ' ' VAL . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.908 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.846 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.763 HG22 HD23 ' A' ' 63' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.917 HD23 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -52.99 179.69 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 -20.37 28.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -51.23 134.36 27.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 50.94 1.58 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.262 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -170.51 -11.28 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 p -93.83 -89.49 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.31 -0.869 . . . . 0.0 109.97 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 -37.68 -20.84 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.917 HD13 HD23 ' A' ' 50' ' ' LEU . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.4 tp-100 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.602 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HG12 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ASP . 50.8 mt -105.51 125.97 51.59 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.36 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.945 1.698 . . . . 0.0 114.852 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.9 t70 -101.26 26.05 7.56 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 171.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 29.94 10.08 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 -155.76 -59.65 0.1 Allowed 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.875 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.875 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt -74.55 172.9 11.18 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -130.06 163.31 26.81 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.686 0.755 . . . . 0.0 110.536 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 91' ' ' SER . 43.8 p -156.95 109.8 2.54 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.27 52.02 1.19 Allowed Glycine 0 N--CA 1.505 3.245 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.32 23.18 66.2 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -82.39 168.55 22.77 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.854 -0.792 . . . . 0.0 109.633 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -92.82 134.59 1.19 Allowed 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 123.377 2.718 . . . . 0.0 111.12 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' SER . 24.7 p -105.24 159.63 15.73 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 97' ' ' THR . 39.1 m-85 -145.29 134.01 22.24 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -105.22 137.71 42.57 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.954 1.252 . . . . 0.0 110.835 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.935 HG12 HD13 ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.62 HG23 ' SG ' ' A' ' 127' ' ' CYS . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 77' ' ' LEU . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 134' ' ' LEU . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.553 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.543 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.599 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -129.46 134.24 7.85 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.73 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 31.4 mttt -124.91 153.78 42.14 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 115' ' ' LYS . 23.7 tp10 -16.97 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.845 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 74.85 15.78 80.72 Favored Glycine 0 CA--C 1.562 3.017 1 N-CA-C 100.258 -5.137 . . . . 0.0 100.258 -168.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.73 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.2 p -101.54 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.382 1.994 0 CA-C-N 113.8 -1.2 . . . . 0.0 111.956 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -86.41 -29.96 22.47 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.9 -18.22 57.12 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.4 -35.95 11.39 Favored Glycine 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 112' ' ' LEU . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.896 ' HA ' HG21 ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' A' ' 103' ' ' THR . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.605 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 97.98 24.75 11.25 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.99 -45.43 64.51 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.647 -0.914 . . . . 0.0 110.399 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.631 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.65 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.803 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.727 HG12 HG22 ' A' ' 110' ' ' VAL . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 29' ' ' SER . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' VAL . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.619 HG21 ' O ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.622 ' CZ3' HG22 ' A' ' 108' ' ' THR . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.818 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 19' ' ' ALA . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.919 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 63' ' ' LEU . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -50.65 156.13 2.71 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -16.86 55.01 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -55.6 121.67 9.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.94 33.12 5.58 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.678 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 33.0 t -170.47 -10.4 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.711 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.4 p -85.55 -86.02 0.14 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.602 1.092 . . . . 0.0 112.19 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 63' ' ' LEU . 47.1 p90 -37.53 -18.75 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.807 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.1 tp-100 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.573 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.925 ' HB2' HG11 ' A' ' 72' ' ' VAL . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.415 ' HA ' ' CD ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.8 pt? -77.15 47.72 0.57 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 3.0 pt20 -111.39 57.86 0.63 Allowed 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.2 t70 -15.76 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 123.208 1.48 . . . . 0.0 113.068 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.62 15.0 25.99 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.675 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 5.9 mp0 -150.08 -54.37 0.16 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.795 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.77 ' HG2' HG13 ' A' ' 72' ' ' VAL 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.857 HD11 ' HB ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.17 164.25 24.37 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.851 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -115.78 179.47 3.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.236 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -136.44 38.66 2.68 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.72 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.3 -107.38 0.44 Allowed Glycine 0 N--CA 1.51 3.581 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.47 13.32 64.2 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.851 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -82.9 168.72 21.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 CA-C-N 117.889 0.844 . . . . 0.0 109.964 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.7 Cg_endo -94.48 147.08 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.562 2.842 . . . . 0.0 110.969 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 91' ' ' SER . 17.8 p -119.62 156.0 31.23 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 115' ' ' LYS . 50.3 m-85 -143.4 139.96 30.22 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -116.35 141.18 48.5 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.956 -176.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 83' ' ' PHE . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.82 HG21 ' HB3' ' A' ' 134' ' ' LEU . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.743 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.799 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.743 HD21 HD13 ' A' ' 109' ' ' LEU . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.875 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -140.76 150.07 21.44 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 19.8 mttt -129.57 165.9 20.78 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' O ' ' A' ' 115' ' ' LYS . 8.6 tt0 -16.8 152.16 0.0 OUTLIER 'General case' 1 N--CA 1.545 4.318 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.4 79.28 Favored Glycine 0 CA--C 1.563 3.064 1 N-CA-C 100.729 -4.948 . . . . 0.0 100.729 -168.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.845 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.46 93.57 2.89 Favored 'Isoleucine or valine' 0 C--N 1.376 1.736 0 CA-C-N 113.886 -1.157 . . . . 0.0 111.656 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -73.85 -35.45 64.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.12 -20.32 47.97 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.16 28.65 Favored Glycine 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.875 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.615 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' A' ' 105' ' ' THR . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.49 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 138.35 -136.03 7.83 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -47.51 -47.96 27.51 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.399 -0.471 . . . . 0.0 111.786 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.906 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.448 HD11 ' HE2' ' A' ' 130' ' ' MET . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 42' ' ' ILE . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 22' ' ' VAL . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.45 HG22 HG23 ' A' ' 7' ' ' ILE . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.581 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.858 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.678 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.661 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 63' ' ' LEU . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 63' ' ' LEU . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.67 -160.88 0.05 OUTLIER Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 54' ' ' ASP . 4.6 mmtt -92.03 -62.89 1.32 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' O ' ' CE1' ' A' ' 58' ' ' PHE . 3.4 t0 -26.02 91.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 122.45 1.119 . . . . 0.0 111.346 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -71.92 18.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.103 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.54 -19.8 0.08 Allowed 'General case' 0 N--CA 1.533 3.722 0 C-N-CA 119.024 -1.07 . . . . 0.0 113.866 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 60' ' ' VAL . 52.2 p -66.41 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' ' OD1' ' A' ' 61' ' ' ASN . 17.5 p90 -37.49 -21.31 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.979 HD11 ' HE2' ' A' ' 85' ' ' MET . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.858 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG11 ' A' ' 72' ' ' VAL . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.965 HD13 HG12 ' A' ' 102' ' ' VAL . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ASP . 5.6 mt -98.3 118.24 34.49 Favored 'General case' 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -47.85 78.08 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 123.82 1.772 . . . . 0.0 115.062 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.8 t70 -101.01 23.87 10.14 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 111.916 -2.402 . . . . 0.0 104.574 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.97 26.84 8.17 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 -153.61 -60.72 0.14 Allowed 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.979 ' HE2' HD11 ' A' ' 63' ' ' LEU . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.731 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.896 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 68' ' ' GLN . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.09 153.86 29.84 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.692 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -97.44 176.98 5.68 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.707 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -149.9 98.86 2.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.958 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.47 29.01 10.52 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.65 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.58 -16.4 31.51 Favored Glycine 0 N--CA 1.511 3.69 0 CA-C-N 118.235 1.017 . . . . 0.0 111.268 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.692 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -50.45 169.3 0.21 Allowed Pre-proline 0 N--CA 1.513 2.713 0 CA-C-N 118.237 1.018 . . . . 0.0 110.048 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.5 Cg_endo -90.88 137.42 2.25 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 123.163 2.576 . . . . 0.0 110.428 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 91' ' ' SER . 54.9 p -103.56 168.03 9.42 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CE2' ' HE2' ' A' ' 115' ' ' LYS . 53.7 m-85 -149.92 139.79 21.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -113.59 141.86 46.68 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.328 -176.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.62 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.965 HG12 HD13 ' A' ' 77' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.552 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.821 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.598 ' OG1' HD22 ' A' ' 134' ' ' LEU . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 ' CG2' ' A' ' 102' ' ' VAL . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.801 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -143.12 146.84 17.95 Favored Glycine 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 7.9 mttt -126.03 164.03 21.74 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.566 ' O ' ' O ' ' A' ' 115' ' ' LYS . 12.3 tt0 -16.76 152.41 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.152 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -175.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.95 13.76 80.64 Favored Glycine 0 CA--C 1.566 3.268 1 N-CA-C 100.631 -4.988 . . . . 0.0 100.631 -168.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.827 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -101.94 102.45 13.55 Favored 'Isoleucine or valine' 0 C--N 1.382 2.006 0 CA-C-N 113.885 -1.158 . . . . 0.0 112.667 -174.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -81.43 -33.72 31.97 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.17 -15.91 61.79 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 -33.36 16.9 Favored Glycine 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.594 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.801 HG23 ' HG ' ' A' ' 112' ' ' LEU . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.872 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 132' ' ' SER . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.616 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -170.57 -64.46 0.04 OUTLIER Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -55.97 -42.64 76.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.235 -0.568 . . . . 0.0 110.062 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.662 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.85 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.721 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 HG22 ' A' ' 110' ' ' VAL . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 29' ' ' SER . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.85 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 19' ' ' ALA . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.97 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.853 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 63' ' ' LEU . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.72 HD23 HD13 ' A' ' 63' ' ' LEU . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -52.43 146.53 15.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -10.57 51.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 122.818 -0.225 . . . . 0.0 111.017 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -46.89 131.21 12.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 36.02 4.73 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.526 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -168.01 -32.66 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.998 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 p -67.57 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.362 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 -37.24 -21.83 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 49' ' ' VAL . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 63' ' ' LEU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.97 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.7 tp-100 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.549 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.727 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 78' ' ' LEU . 80.1 mt -99.57 120.39 39.59 Favored 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -47.91 76.84 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 126.036 1.734 . . . . 0.0 114.953 -174.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 78' ' ' LEU . 27.7 t70 -101.18 24.86 8.86 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 171.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.21 29.45 6.75 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 38.2 mm-40 -157.73 -60.0 0.08 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.507 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.633 ' HG2' HD12 ' A' ' 87' ' ' LEU . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.81 ' C ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.81 HD13 ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -77.34 175.1 10.06 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.962 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t -125.38 176.79 6.56 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.147 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -97.37 -54.22 3.21 Favored 'General case' 0 N--CA 1.513 2.7 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.67 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.45 104.69 0.19 Allowed Glycine 0 N--CA 1.502 3.066 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.73 -14.3 61.96 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.962 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -74.12 172.13 9.35 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.746 -0.855 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.0 Cg_endo -93.26 130.49 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.263 2.642 . . . . 0.0 111.274 -177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 91' ' ' SER . 49.9 p -106.83 168.18 9.37 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 59.8 m-85 -146.51 135.19 22.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -111.95 143.91 42.14 Favored 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.186 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 87' ' ' LEU . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.727 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.943 HG21 ' HB3' ' A' ' 134' ' ' LEU . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 134' ' ' LEU . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 109' ' ' LEU . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.933 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.893 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -149.37 153.14 24.98 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 30.2 mttt -128.21 165.35 20.63 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 115' ' ' LYS . 7.4 tt0 -16.92 152.82 0.0 OUTLIER 'General case' 1 N--CA 1.543 4.192 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -175.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 11.79 83.99 Favored Glycine 0 CA--C 1.562 3.029 1 N-CA-C 100.681 -4.968 . . . . 0.0 100.681 -168.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.813 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.27 99.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.901 -1.15 . . . . 0.0 111.668 -175.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -76.67 -33.82 58.26 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.34 -14.11 61.15 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.31 -35.62 10.6 Favored Glycine 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' HG ' ' A' ' 112' ' ' LEU . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' CB ' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.432 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.711 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 33.2 t60 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.496 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 84.61 27.41 35.52 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -49.76 -49.83 46.81 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 122.097 -0.649 . . . . 0.0 110.921 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.868 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.719 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.571 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 29' ' ' SER . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HZ1' ' HZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 22' ' ' VAL . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.594 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.764 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.745 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.849 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.687 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.687 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG22 HD23 ' A' ' 63' ' ' LEU . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.37 107.94 1.58 Allowed Glycine 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -30.94 58.08 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.444 -0.445 . . . . 0.0 110.195 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.09 73.64 10.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -171.68 52.0 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.519 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 22.9 t -69.02 -10.79 59.3 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.581 -0.699 . . . . 0.0 111.729 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.7 p -67.86 -54.66 17.21 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.423 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -38.64 -27.41 0.02 OUTLIER 'General case' 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.476 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 57' ' ' SER . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.882 HD12 ' HG ' ' A' ' 87' ' ' LEU . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD12 ' A' ' 65' ' ' LEU . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.582 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.844 HD13 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.888 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 82' ' ' GLU . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 102' ' ' VAL . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.11 123.54 43.47 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -47.95 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.155 1.782 . . . . 0.0 115.005 -174.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -101.12 29.2 4.8 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.19 23.11 25.59 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.46 ' CB ' ' HB3' ' A' ' 76' ' ' SER . 4.2 mp0 -150.71 -57.98 0.17 Allowed 'General case' 0 C--N 1.369 1.447 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.815 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.882 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.844 ' NH1' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.828 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.84 146.13 24.42 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.3 t -95.1 165.54 12.37 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.332 0.587 . . . . 0.0 110.512 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.3 p -133.53 122.81 24.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.5 -88.19 1.46 Allowed Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.96 29.21 2.46 Favored Glycine 0 N--CA 1.506 3.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -78.13 167.51 35.07 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 122.091 -0.652 . . . . 0.0 109.938 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.588 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.0 Cg_endo -91.25 132.31 1.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.032 2.488 . . . . 0.0 110.586 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 91' ' ' SER . 23.0 p -95.16 158.24 15.55 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.786 0.803 . . . . 0.0 109.164 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.687 ' HB3' ' CG ' ' A' ' 115' ' ' LYS . 24.7 m-85 -149.27 157.45 43.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.627 ' CG ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -132.34 165.41 24.29 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.06 -1.65 . . . . 0.0 111.682 -176.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 113' ' ' MET . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.693 ' HB ' HD11 ' A' ' 87' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.914 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.924 HG21 HD13 ' A' ' 134' ' ' LEU . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.569 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 115' ' ' LYS . . . -178.5 121.48 0.76 Allowed Glycine 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HG3' ' C ' ' A' ' 114' ' ' GLY 0.301 0.0 OUTLIER -164.17 117.29 1.4 Allowed 'General case' 1 N--CA 1.368 -4.525 0 C-N-CA 114.503 -2.879 . . . . 0.0 115.802 175.116 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 118' ' ' VAL . 11.1 tt0 -114.26 89.9 3.21 Favored 'General case' 0 C--O 1.26 1.656 1 N-CA-C 100.101 -4.037 . . . . 0.0 100.101 160.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.21 -0.74 0.07 OUTLIER Glycine 2 CA--C 1.659 9.09 0 CA-C-N 125.711 3.869 . . . . 0.0 108.46 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.857 HG21 ' CD1' ' A' ' 123' ' ' ILE . 8.9 p -26.45 138.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.39 2.362 0 C-N-CA 126.191 1.796 . . . . 0.0 114.737 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.48 -49.92 65.0 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.279 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.34 16.9 19.3 Favored Glycine 0 N--CA 1.506 3.308 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.64 -34.77 2.0 Allowed Glycine 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.857 ' CD1' HG21 ' A' ' 118' ' ' VAL . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.76 ' HA ' HG21 ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.461 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 115.3 -73.23 0.25 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.38 -36.81 61.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.811 -0.817 . . . . 0.0 110.051 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.969 ' HA ' HD12 ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.624 ' ND2' ' HB3' ' A' ' 126' ' ' LYS 0.267 0.2 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 7' ' ' ILE . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.765 HG23 HG23 ' A' ' 118' ' ' VAL . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.627 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.914 ' HB1' HD22 ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.633 HG12 ' HE2' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.728 HG11 HG21 ' A' ' 42' ' ' ILE . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 22' ' ' VAL . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.728 HG21 HG11 ' A' ' 22' ' ' VAL . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.662 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.944 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 63' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HA ' HD22 ' A' ' 63' ' ' LEU . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -49.49 151.72 3.75 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.87 20.4 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.09 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -40.56 126.86 2.4 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 122.917 0.487 . . . . 0.0 109.746 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 39.52 3.91 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.578 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -166.99 -58.1 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 118.958 -1.097 . . . . 0.0 113.042 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.1 p -43.5 -98.27 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.058 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 -36.75 -22.76 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 57' ' ' SER . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' LEU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.617 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.8 tp-100 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.569 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 104' ' ' LYS . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 78' ' ' LEU . 92.6 mt -100.26 121.68 41.85 Favored 'General case' 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.58 78.64 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 123.88 1.8 . . . . 0.0 114.968 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.2 t70 -101.08 26.06 7.44 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 111.652 -2.522 . . . . 0.0 104.287 171.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.25 28.17 8.27 Favored Glycine 0 C--N 1.362 1.98 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 -155.24 -63.4 0.12 Allowed 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.787 HD22 HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' CE ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER -83.39 138.1 33.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -130.48 -160.12 1.02 Allowed 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.184 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -102.83 176.55 5.12 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 121.305 0.574 . . . . 0.0 111.616 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.3 0.47 Allowed Glycine 0 N--CA 1.506 3.331 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.58 -33.23 1.43 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -81.06 169.91 17.47 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 122.309 -0.524 . . . . 0.0 109.606 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 64.2 Cg_endo -99.17 125.03 0.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.951 0 C-N-CA 123.057 2.505 . . . . 0.0 109.754 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.405 ' OG1' ' CE ' ' A' ' 115' ' ' LYS . 3.0 p -91.81 164.96 13.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 36.7 m-85 -146.15 144.63 30.08 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.719 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 7.7 m-20 -111.88 -166.29 1.06 Allowed 'General case' 0 CA--C 1.447 -3.009 0 O-C-N 120.805 -1.184 . . . . 0.0 108.579 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.881 HG22 HD23 ' A' ' 111' ' ' LEU . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 130' ' ' MET . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 HG22 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 132.52 161.61 10.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG3' ' N ' ' A' ' 99' ' ' ASN 0.411 10.0 mtmt -157.29 120.7 4.1 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 113.036 -1.582 . . . . 0.0 109.51 169.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.2 tt0 -111.55 92.43 4.03 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 162.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.34 -0.72 0.13 Allowed Glycine 2 CA--C 1.648 8.393 0 CA-C-N 123.136 2.698 . . . . 0.0 109.225 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.765 HG23 HG23 ' A' ' 15' ' ' THR . 14.4 p -39.16 155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 125.576 1.55 . . . . 0.0 114.992 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -85.48 -55.4 4.02 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.491 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.77 4.17 28.17 Favored Glycine 0 N--CA 1.508 3.499 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.74 -27.09 6.49 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.966 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 101' ' ' THR . 20.8 t-20 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.624 ' HB3' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 112' ' ' LEU . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.406 ' HA ' HG21 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.759 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 110' ' ' VAL . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.492 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 163.65 166.96 23.38 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -49.1 -53.18 21.79 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.133 -0.627 . . . . 0.0 111.038 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.004 HD22 ' HB2' ' A' ' 19' ' ' ALA . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB2' HD23 ' A' ' 10' ' ' LEU 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.004 ' HB2' HD22 ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 42' ' ' ILE . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.594 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 39' ' ' PHE . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 46' ' ' GLU . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -55.08 152.56 13.41 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -17.46 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.53 134.4 29.31 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -133.58 44.4 2.78 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.393 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 t -170.06 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 O-C-N 121.207 -0.933 . . . . 0.0 112.654 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -53.83 -90.25 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 -37.24 -21.74 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 57' ' ' SER . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.804 HD12 ' HG ' ' A' ' 87' ' ' LEU . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB3' HD12 ' A' ' 65' ' ' LEU . 3.4 tp-100 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.695 HG22 ' HE2' ' A' ' 85' ' ' MET . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 104' ' ' LYS . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ASP . 90.7 mt -94.58 121.85 36.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -47.81 78.27 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.176 1.79 . . . . 0.0 114.541 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.4 t70 -101.12 26.3 7.2 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 104.635 -2.358 . . . . 0.0 104.635 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.26 26.07 11.67 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.3 mp0 -153.0 -60.39 0.14 Allowed 'General case' 0 C--N 1.37 1.475 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.695 ' HE2' HG22 ' A' ' 72' ' ' VAL . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.753 ' C ' HD13 ' A' ' 87' ' ' LEU . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.804 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' THR . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -73.98 170.92 14.43 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.743 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -122.89 163.65 19.92 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.128 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -109.81 75.0 0.92 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.714 0.769 . . . . 0.0 109.483 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.61 96.46 0.01 OUTLIER Glycine 0 N--CA 1.508 3.492 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.45 -35.11 5.17 Favored Glycine 0 N--CA 1.504 3.179 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -70.0 165.61 41.09 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.999 -0.706 . . . . 0.0 110.487 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -91.5 131.8 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.412 2.741 . . . . 0.0 110.888 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 91' ' ' SER . 62.2 p -100.37 161.71 13.43 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 35.4 m-85 -143.16 107.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -90.72 133.42 35.17 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.535 ' CE ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.535 HD23 ' CE ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' ' 20' ' ' ALA . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.614 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.654 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -132.18 132.85 6.85 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.1 mttt -114.78 158.84 21.32 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.0 tp10 -16.77 154.58 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -175.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 71.78 15.02 75.71 Favored Glycine 0 CA--C 1.56 2.847 1 N-CA-C 100.959 -4.857 . . . . 0.0 100.959 -169.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.813 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.4 p -101.9 102.71 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.916 -1.142 . . . . 0.0 112.42 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -84.25 -35.26 23.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.13 -7.76 62.52 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 -39.66 8.91 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 112' ' ' LEU . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.881 ' HA ' HG21 ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.48 ' HB3' HD22 ' A' ' 9' ' ' ASN . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.664 ' HA ' HD23 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 HG21 ' A' ' 110' ' ' VAL . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 149.97 -98.48 0.19 Allowed Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -50.97 -42.56 60.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.141 -0.623 . . . . 0.0 110.945 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.646 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.693 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.661 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.848 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.4 HD11 ' HE2' ' A' ' 130' ' ' MET . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 29' ' ' SER . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 22' ' ' VAL . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 40' ' ' VAL . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.525 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.813 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 19' ' ' ALA . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.72 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.932 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.932 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.642 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.064 HD23 HD13 ' A' ' 63' ' ' LEU . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -41.28 147.3 0.38 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -3.07 43.14 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.84 135.2 42.23 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.71 0.767 . . . . 0.0 109.192 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -99.49 18.16 18.55 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.279 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -170.21 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 C-N-CA 118.029 -1.468 . . . . 0.0 113.792 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.1 p -57.07 -97.7 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 63' ' ' LEU . 47.0 p90 -37.66 -21.94 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.064 HD13 HD23 ' A' ' 50' ' ' LEU . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 63' ' ' LEU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.433 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.808 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.46 45.06 1.24 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HG2' ' CA ' ' A' ' 76' ' ' SER . 0.2 OUTLIER -110.8 58.24 0.61 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' GLN . 12.2 t70 -16.79 122.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.719 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.33 20.18 12.75 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.441 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 24.5 mm-40 -162.09 -65.35 0.05 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' SER . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.825 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.877 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.533 HG21 ' HZ3' ' A' ' 115' ' ' LYS . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -99.69 135.13 41.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.667 ' H ' HG22 ' A' ' 97' ' ' THR . 1.0 OUTLIER -116.63 -166.27 1.14 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -83.99 -167.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.492 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.82 -76.99 0.16 Allowed Glycine 0 N--CA 1.51 3.588 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.72 22.29 5.8 Favored Glycine 0 N--CA 1.514 3.839 0 O-C-N 121.8 -0.823 . . . . 0.0 111.874 -178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -97.55 161.52 25.6 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.536 1.168 . . . . 0.0 109.683 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.5 Cg_endo -92.8 124.18 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.927 2.418 . . . . 0.0 110.136 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 91' ' ' SER . 66.8 p -91.96 172.0 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 1.036 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 35.1 m-85 -151.92 169.16 22.97 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.884 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -141.01 158.35 44.06 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.829 -175.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 113' ' ' MET . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.892 HG21 ' HB3' ' A' ' 134' ' ' LEU . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.765 HD13 HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 134' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 109' ' ' LEU . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.935 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.63 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.707 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.46 146.69 11.4 Favored Glycine 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 1.036 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.542 12.8 mttt -163.42 113.4 1.33 Allowed 'General case' 0 CA--C 1.596 2.727 0 N-CA-C 121.03 3.715 . . . . 0.0 121.03 175.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 118' ' ' VAL . 6.4 tt0 -118.92 90.04 3.25 Favored 'General case' 0 C--O 1.261 1.678 0 N-CA-C 100.976 -3.712 . . . . 0.0 100.976 156.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.555 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.25 1.2 0.07 OUTLIER Glycine 2 CA--C 1.678 10.273 1 CA-C-N 127.819 4.827 . . . . 0.0 108.669 -179.043 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.884 HG13 ' OD1' ' A' ' 99' ' ' ASN . 7.3 p -25.33 137.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.401 2.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -171.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -74.64 -54.88 6.59 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.523 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.81 15.4 10.15 Favored Glycine 0 N--CA 1.503 3.147 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.74 -33.12 2.71 Favored Glycine 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.935 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.632 ' HA ' HG21 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.578 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.672 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -134.51 55.9 0.73 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -50.88 -46.73 60.53 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 117.916 0.858 . . . . 0.0 110.023 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.718 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.423 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.582 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 6' ' ' TYR . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 29' ' ' SER . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' HG13 ' A' ' 22' ' ' VAL . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.597 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 7' ' ' ILE . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.014 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.954 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.954 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -51.31 158.19 2.51 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -16.36 49.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.134 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 58' ' ' PHE . 7.6 t70 -39.62 113.46 0.34 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 123.077 0.551 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -101.34 12.23 37.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.2 t -166.67 -47.14 0.02 OUTLIER 'General case' 0 N--CA 1.53 3.553 0 CA-C-N 120.433 1.47 . . . . 0.0 114.225 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.9 p -51.74 -81.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 -37.08 -22.23 0.01 OUTLIER 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.802 HD13 ' HG ' ' A' ' 50' ' ' LEU . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.014 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' HB3' HD12 ' A' ' 65' ' ' LEU . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.676 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' HE2' ' A' ' 85' ' ' MET . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.815 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.712 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.618 HD21 ' NZ ' ' A' ' 104' ' ' LYS . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.77 43.46 1.54 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 82' ' ' GLU . 4.2 pt20 -111.72 59.86 0.62 Allowed 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.0 t70 -17.26 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.129 1.442 . . . . 0.0 112.798 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.22 6.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -170.94 -69.14 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.725 ' HE2' HG22 ' A' ' 72' ' ' VAL 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.808 ' HD3' HD11 ' A' ' 73' ' ' ILE . 3.3 mtmt -88.45 116.74 26.9 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.868 ' H ' HG22 ' A' ' 97' ' ' THR . 1.1 t -88.91 -168.1 2.08 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.047 -175.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -79.71 -166.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.155 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.72 101.92 1.59 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.2 -29.21 9.88 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -58.48 163.71 4.65 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 122.14 -0.623 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.5 Cg_endo -90.69 128.59 1.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 123.14 2.56 . . . . 0.0 108.897 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.868 HG22 ' H ' ' A' ' 91' ' ' SER . 52.0 p -93.22 178.44 5.73 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.965 0.888 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.907 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 48.1 m-85 -154.07 173.64 15.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.742 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -144.6 155.39 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.93 -176.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.59 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.845 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.791 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.597 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' HG ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.938 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.845 ' HG ' HG22 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.924 ' HG ' HG23 ' A' ' 123' ' ' ILE . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.729 ' HA ' HG13 ' A' ' 100' ' ' VAL . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.645 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.59 138.68 5.36 Favored Glycine 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.907 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.556 74.7 mttt -160.86 113.62 1.97 Allowed 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 173.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -118.39 90.45 3.34 Favored 'General case' 0 C--O 1.263 1.771 0 N-CA-C 101.415 -3.55 . . . . 0.0 101.415 157.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.503 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.83 1.1 0.08 OUTLIER Glycine 2 CA--C 1.676 10.108 1 CA-C-N 127.39 4.632 . . . . 0.0 108.228 -177.691 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.865 HG21 HD12 ' A' ' 123' ' ' ILE . 7.1 p -21.55 133.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.392 2.447 0 C-N-CA 127.178 2.191 . . . . 0.0 116.56 -171.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -74.55 -54.31 7.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.66 -2.064 . . . . 0.0 108.224 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.57 18.41 8.03 Favored Glycine 0 N--CA 1.505 3.271 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.34 -35.52 1.44 Allowed Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.924 HG23 ' HG ' ' A' ' 112' ' ' LEU . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.626 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 133.06 -43.92 1.24 Allowed Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.25 -57.54 8.57 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 122.071 -0.664 . . . . 0.0 110.811 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.931 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 122' ' ' LEU . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 10' ' ' LEU 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.574 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.931 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 42' ' ' ILE . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.617 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.853 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 7' ' ' ILE . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.952 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 22' ' ' VAL . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -45.74 136.84 7.64 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -27.32 4.18 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.84 126.61 28.14 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -136.23 51.42 2.02 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.547 0.689 . . . . 0.0 110.742 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -155.47 -10.49 0.11 Allowed 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.772 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.1 p -93.82 -87.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 110.652 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 49' ' ' VAL . 29.8 p90 -37.29 -22.05 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' A' ' 87' ' ' LEU . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 63' ' ' LEU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB3' HD12 ' A' ' 65' ' ' LEU . 4.3 tp-100 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' HE2' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.816 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.691 HD21 ' HE3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.27 123.96 43.97 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -47.98 78.47 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 126.006 1.723 . . . . 0.0 115.314 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.08 31.05 3.79 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.02 17.73 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 -155.12 -61.93 0.12 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.842 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.816 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.842 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -75.9 148.32 38.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.787 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -97.62 174.78 6.47 Favored 'General case' 0 N--CA 1.516 2.835 0 CA-C-O 121.524 0.678 . . . . 0.0 112.169 -176.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -147.39 96.93 2.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.48 82.47 0.52 Allowed Glycine 0 N--CA 1.508 3.47 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.386 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.69 5.39 37.63 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.643 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.787 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -78.71 160.42 72.04 Favored Pre-proline 0 N--CA 1.508 2.455 0 CA-C-N 119.355 1.577 . . . . 0.0 109.384 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.2 Cg_endo -91.02 132.75 1.56 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.046 2.497 . . . . 0.0 109.284 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.648 HG23 ' HB3' ' A' ' 91' ' ' SER . 1.9 p -94.49 164.61 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.633 ' CA ' ' HG3' ' A' ' 115' ' ' LYS . 42.2 m-85 -148.19 138.71 22.87 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 5.3 m-20 -113.57 151.06 32.13 Favored 'General case' 0 CA--C 1.461 -2.475 0 O-C-N 120.707 -1.245 . . . . 0.0 109.307 -175.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 124' ' ' ASN . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.646 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.651 HG23 ' SG ' ' A' ' 127' ' ' CYS . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HE3' HD21 ' A' ' 77' ' ' LEU . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 134' ' ' LEU . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.538 HG21 HD23 ' A' ' 134' ' ' LEU . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 134' ' ' LEU . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 ' HB3' ' A' ' 20' ' ' ALA . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.827 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.548 ' HG2' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 131.65 153.95 7.63 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.742 ' HG2' HG11 ' A' ' 118' ' ' VAL 0.381 9.4 mtmt -151.21 119.07 6.17 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 112.472 -1.864 . . . . 0.0 107.942 167.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.4 tt0 -112.65 92.45 4.02 Favored 'General case' 0 C--N 1.257 -3.435 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 163.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.57 -3.13 0.05 OUTLIER Glycine 2 CA--C 1.653 8.704 0 CA-C-N 123.775 2.988 . . . . 0.0 109.609 -177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 123' ' ' ILE . 7.6 p -35.64 139.32 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.616 -1.52 . . . . 0.0 114.114 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -78.94 -49.14 13.28 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.117 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.44 8.11 Favored Glycine 0 N--CA 1.508 3.451 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.89 -19.28 29.46 Favored Glycine 1 N--CA 1.518 4.103 0 CA-C-N 118.46 1.13 . . . . 0.0 111.104 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.723 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 118' ' ' VAL . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.85 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HD2' ' ND2' ' A' ' 9' ' ' ASN . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.749 ' SD ' HG13 ' A' ' 110' ' ' VAL . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 135' ' ' ARG . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.874 HD13 HG21 ' A' ' 110' ' ' VAL . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -155.32 -106.38 0.26 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -48.42 -48.72 37.0 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 122.191 -0.594 . . . . 0.0 111.299 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.875 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' CG ' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 110' ' ' VAL . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 42' ' ' ILE . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.541 ' CZ3' HG22 ' A' ' 108' ' ' THR . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 19' ' ' ALA . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.79 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 22' ' ' VAL . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.645 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 63' ' ' LEU . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.19 -123.88 0.01 OUTLIER Glycine 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -71.11 0.14 8.33 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.31 0.644 . . . . 0.0 112.233 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 53' ' ' LYS . 7.4 t0 -16.96 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 124.074 0.95 . . . . 0.0 113.502 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -165.96 -9.57 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.581 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 30.8 t -171.74 -57.31 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 120.14 1.336 . . . . 0.0 111.555 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 60' ' ' VAL . 13.5 p -38.36 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE1' HD21 ' A' ' 63' ' ' LEU . 21.1 p90 -38.12 -16.32 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 72' ' ' VAL . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 57' ' ' SER . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.944 HD13 HD23 ' A' ' 50' ' ' LEU . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.641 ' NE2' HG22 ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 87' ' ' LEU . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.725 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.788 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 HG12 ' A' ' 102' ' ' VAL . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 40.8 mt -92.65 120.67 33.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -47.13 81.26 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 123.997 1.856 . . . . 0.0 114.296 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.1 t70 -100.52 29.35 4.48 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 26.43 16.7 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 107.201 -2.36 . . . . 0.0 107.201 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 36.0 mm-40 -157.0 -55.06 0.08 Allowed 'General case' 0 C--N 1.369 1.419 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.769 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.788 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.641 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.07 167.44 15.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 97' ' ' THR . 1.5 t -131.42 178.92 6.35 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.862 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -121.8 38.12 4.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.38 0.609 . . . . 0.0 109.69 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.57 -74.57 0.56 Allowed Glycine 0 N--CA 1.506 3.345 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.82 -6.9 73.89 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.672 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -96.68 168.91 9.61 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.118 0.959 . . . . 0.0 110.223 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.9 Cg_endo -94.66 149.58 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.52 2.813 . . . . 0.0 110.56 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 91' ' ' SER . 12.5 p -120.6 155.2 34.24 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 97' ' ' THR . 47.4 m-85 -144.61 151.41 38.99 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -120.31 140.31 51.46 Favored 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.495 -176.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.543 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.739 HG22 HD22 ' A' ' 111' ' ' LEU . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 109' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 134' ' ' LEU . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.541 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 109' ' ' LEU . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.959 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.718 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.24 152.65 24.23 Favored Glycine 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 20.7 mttt -131.02 167.33 19.23 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 28.9 tt0 -17.11 155.62 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.481 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.01 14.56 73.56 Favored Glycine 0 CA--C 1.563 3.05 1 N-CA-C 101.007 -4.837 . . . . 0.0 101.007 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.811 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -102.39 104.3 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.401 -174.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -85.99 -36.59 19.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.42 -16.65 44.65 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.59 -29.89 28.52 Favored Glycine 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.715 HD13 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.959 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' HG21 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.546 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.637 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 43.1 t60 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -153.66 -48.85 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -48.78 -48.22 41.3 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.184 -0.598 . . . . 0.0 111.186 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.878 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' ASP . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 134' ' ' LEU . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.847 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.586 HG23 ' HB3' ' A' ' 19' ' ' ALA . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.968 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HD23 ' A' ' 63' ' ' LEU . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 HD13 ' A' ' 63' ' ' LEU . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -178.54 0.33 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -4.44 57.31 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 122.636 -0.332 . . . . 0.0 110.813 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.8 t0 -41.69 114.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.654 0.74 . . . . 0.0 110.196 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 10.68 27.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.356 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.4 t -166.34 -56.99 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 117.833 -1.547 . . . . 0.0 115.04 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 60' ' ' VAL . 12.9 p -39.07 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.7 p90 -36.82 -23.35 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 57' ' ' SER . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.974 HD11 ' HE2' ' A' ' 85' ' ' MET . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 63' ' ' LEU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.968 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.4 tp-100 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' A' ' 87' ' ' LEU . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HE2' ' A' ' 90' ' ' LYS . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.94 ' HB2' HG11 ' A' ' 72' ' ' VAL . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.677 HD13 HG12 ' A' ' 102' ' ' VAL . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 78' ' ' LEU . 66.7 mt -96.85 128.03 43.4 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -47.55 76.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.348 1.859 . . . . 0.0 114.57 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 78' ' ' LEU . 12.8 t0 -101.58 29.65 4.74 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.52 31.14 22.59 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 -154.44 -56.83 0.11 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.974 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.91 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 89' ' ' THR . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -87.65 169.62 11.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.8 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -132.44 179.07 6.35 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.039 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -135.13 88.17 2.4 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.319 0.58 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.67 -93.69 1.6 Allowed Glycine 0 N--CA 1.502 3.054 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.13 -9.66 36.17 Favored Glycine 0 N--CA 1.508 3.474 0 O-C-N 122.006 -0.702 . . . . 0.0 111.6 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.8 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -56.8 165.3 1.77 Allowed Pre-proline 0 N--CA 1.512 2.642 0 CA-C-N 118.73 1.265 . . . . 0.0 109.531 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.4 Cg_endo -89.33 140.65 3.85 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.336 2.691 . . . . 0.0 111.941 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.668 HG23 ' HB3' ' A' ' 91' ' ' SER . 25.4 p -116.36 156.24 27.05 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' A' ' 97' ' ' THR . 42.0 m-85 -144.5 130.4 19.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 -107.45 143.21 36.13 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 118.643 -1.223 . . . . 0.0 112.899 -175.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 112' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.927 HG21 ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 87' ' ' LEU . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' HD23 ' A' ' 109' ' ' LEU . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.586 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.829 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.012 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -144.21 146.7 17.46 Favored Glycine 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 34.2 mttt -125.39 161.68 26.5 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -17.19 152.43 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.372 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 -175.81 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.7 13.16 82.37 Favored Glycine 0 CA--C 1.56 2.896 1 N-CA-C 100.798 -4.921 . . . . 0.0 100.798 -168.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.835 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.99 97.41 5.61 Favored 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.777 -1.212 . . . . 0.0 111.353 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.05 -30.3 55.55 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.33 -21.85 42.02 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.64 -32.01 34.91 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.012 HG23 ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.927 ' HA ' HG21 ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.488 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.925 HD13 HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.334 0.588 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . -157.17 -88.71 0.07 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -48.59 -44.09 36.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.214 -0.58 . . . . 0.0 111.577 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.855 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.938 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.621 ' HB2' HD12 ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.556 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.938 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 110' ' ' VAL . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 42' ' ' ILE . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.855 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 7' ' ' ILE . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD12 ' A' ' 109' ' ' LEU . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 63' ' ' LEU . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.766 ' HA ' HD22 ' A' ' 63' ' ' LEU . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.13 116.47 5.1 Favored Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -33.4 1.99 Allowed 'General case' 0 N--CA 1.519 3.001 0 CA-C-O 121.397 0.618 . . . . 0.0 110.116 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.45 88.5 5.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' HB2' ' CD2' ' A' ' 58' ' ' PHE . 28.8 ptt85 -166.61 51.62 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.025 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 27.4 t -89.84 -10.88 43.71 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.259 -0.9 . . . . 0.0 110.842 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.5 p -80.54 -60.35 2.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.849 -0.532 . . . . 0.0 110.51 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.727 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.9 p90 -37.9 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' SER . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 49' ' ' VAL . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.5 tp-100 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.729 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.874 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.874 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 102' ' ' VAL . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 80' ' ' ASP . 66.2 mt -99.08 124.65 44.24 Favored 'General case' 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.38 78.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.895 1.678 . . . . 0.0 114.626 -173.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.9 t70 -101.06 25.69 7.84 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 171.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.69 29.58 9.17 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.6 mp0 -156.78 -57.42 0.09 Allowed 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.745 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HD3' HD11 ' A' ' 73' ' ' ILE . 5.4 mmmt -95.78 141.96 28.63 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.6 t -119.19 -166.21 1.23 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.733 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.6 p -85.43 -168.84 2.38 Favored 'General case' 0 N--CA 1.508 2.44 0 CA-C-O 121.388 0.613 . . . . 0.0 111.707 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.59 105.94 2.03 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.76 10.47 40.42 Favored Glycine 0 N--CA 1.505 3.277 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -100.2 164.66 15.94 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.831 -0.805 . . . . 0.0 109.842 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.0 Cg_endo -90.34 127.44 1.4 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.773 2.315 . . . . 0.0 109.278 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.8 p -103.22 177.48 4.83 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.677 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 52.7 m-85 -152.33 151.99 31.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.586 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -129.16 171.62 12.23 Favored 'General case' 0 N--CA 1.521 3.103 0 CA-C-N 121.03 1.741 . . . . 0.0 113.358 -174.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.921 HG21 ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 77' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.954 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 20' ' ' ALA . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.555 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.674 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -178.78 118.67 0.62 Allowed Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 98' ' ' PHE 0.319 0.0 OUTLIER -165.28 117.86 1.18 Allowed 'General case' 0 N--CA 1.403 -2.821 0 C-N-CA 115.23 -2.588 . . . . 0.0 117.924 176.307 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 118' ' ' VAL . 14.8 tt0 -114.39 90.37 3.32 Favored 'General case' 0 C--O 1.255 1.382 1 N-CA-C 100.07 -4.048 . . . . 0.0 100.07 159.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.33 -0.19 0.1 OUTLIER Glycine 2 CA--C 1.664 9.397 1 CA-C-N 126.042 4.019 . . . . 0.0 108.942 -177.989 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.805 HG21 HD12 ' A' ' 123' ' ' ILE . 8.8 p -27.11 144.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.386 2.155 0 C-N-CA 126.648 1.979 . . . . 0.0 115.436 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -74.66 -55.64 5.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.018 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 120.31 -11.8 10.53 Favored Glycine 0 N--CA 1.512 3.759 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.444 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.36 -27.64 29.77 Favored Glycine 1 N--CA 1.518 4.167 0 CA-C-N 118.302 1.051 . . . . 0.0 110.906 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.805 HD12 HG21 ' A' ' 118' ' ' VAL . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.921 ' HA ' HG21 ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.687 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.954 HD13 HG21 ' A' ' 110' ' ' VAL . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.419 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -117.65 -83.52 0.95 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.481 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -50.87 -49.83 58.34 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 122.197 -0.59 . . . . 0.0 111.063 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.591 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.957 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.588 HG22 HD11 ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.957 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 42' ' ' ILE . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 22' ' ' VAL . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.819 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 7' ' ' ILE . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.67 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.886 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.694 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.694 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.855 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.704 HD23 HD13 ' A' ' 63' ' ' LEU . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.92 160.81 0.47 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -70.65 -4.71 24.81 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.186 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 13.0 t70 -20.41 125.51 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 124.2 1.0 . . . . 0.0 112.257 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -89.59 -7.11 55.51 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 31.4 t -170.69 -49.83 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 120.627 1.558 . . . . 0.0 114.171 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -35.16 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.6 p90 -37.06 -25.66 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD12 ' HG ' ' A' ' 87' ' ' LEU . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 65' ' ' LEU . 2.5 tp-100 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.806 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 102' ' ' VAL . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.7 mt -95.54 125.5 40.18 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 8.9 pt20 -47.82 76.53 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.924 1.69 . . . . 0.0 114.834 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 22.3 t70 -101.09 22.95 11.5 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 171.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 28.54 8.54 Favored Glycine 0 C--N 1.366 2.22 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 -155.13 -54.11 0.09 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.836 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.824 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt -78.31 168.03 20.45 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.733 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -116.92 177.95 4.52 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.627 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 95' ' ' ALA . 72.9 p -141.5 88.59 2.15 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.555 0.693 . . . . 0.0 110.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.9 96.64 0.01 OUTLIER Glycine 0 N--CA 1.501 3.018 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.73 -14.21 65.75 Favored Glycine 0 N--CA 1.505 3.3 0 O-C-N 122.031 -0.688 . . . . 0.0 112.017 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.733 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -91.34 164.95 22.74 Favored Pre-proline 0 N--CA 1.508 2.463 0 CA-C-N 118.706 1.253 . . . . 0.0 110.985 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.7 Cg_endo -92.93 151.88 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.379 2.719 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 91' ' ' SER . 46.9 p -116.12 170.5 8.46 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 97' ' ' THR . 61.9 m-85 -155.8 152.68 28.73 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -123.5 143.63 50.05 Favored 'General case' 0 N--CA 1.511 2.619 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.423 -177.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.877 HG21 ' HB3' ' A' ' 134' ' ' LEU . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.649 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.801 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.913 HG21 HD13 ' A' ' 134' ' ' LEU . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 110' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.728 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.638 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.98 150.62 22.64 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.83 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 9.1 mttp -134.27 165.95 23.92 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tp10 -16.46 149.68 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 75.77 13.99 82.54 Favored Glycine 0 CA--C 1.565 3.218 1 N-CA-C 100.61 -4.996 . . . . 0.0 100.61 -168.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.83 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.72 98.09 6.45 Favored 'Isoleucine or valine' 0 C--N 1.378 1.844 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.881 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -79.47 -37.17 37.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.58 -20.82 46.67 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.05 -27.13 26.85 Favored Glycine 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.728 HG23 ' HG ' ' A' ' 112' ' ' LEU . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.954 ' HA ' HG21 ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.478 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 132' ' ' SER . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.681 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.913 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 5' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -122.94 -107.6 1.88 Allowed Glycine 0 N--CA 1.506 3.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.468 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.46 -44.97 69.36 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 122.021 -0.694 . . . . 0.0 110.389 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.601 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.659 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.739 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.791 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.965 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 110' ' ' VAL . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 29' ' ' SER . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 19' ' ' ALA . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.021 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.685 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.801 HG22 HD23 ' A' ' 63' ' ' LEU . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.778 HD23 HD13 ' A' ' 63' ' ' LEU . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.16 178.63 2.76 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -8.48 59.21 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.997 -0.602 . . . . 0.0 110.411 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -48.65 120.42 3.75 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.464 0.65 . . . . 0.0 109.48 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -116.83 32.55 6.09 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.393 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -165.24 -70.11 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.974 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 p -38.72 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CD1' HD21 ' A' ' 63' ' ' LEU . 4.2 p90 -37.01 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 87' ' ' LEU . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.021 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.779 ' SG ' HD23 ' A' ' 87' ' ' LEU . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 102' ' ' VAL . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 78' ' ' LEU . 32.2 mt -110.41 121.8 46.18 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -47.85 76.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.632 1.682 . . . . 0.0 115.323 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 13.9 t70 -101.51 24.63 9.41 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.95 26.9 9.91 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -149.4 -64.31 0.22 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 89' ' ' THR . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -83.63 134.25 34.8 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 2.4 t -111.91 -163.26 0.84 Allowed 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.846 0.355 . . . . 0.0 111.222 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -128.89 168.07 16.47 Favored 'General case' 0 N--CA 1.516 2.871 0 CA-C-O 121.959 0.885 . . . . 0.0 112.078 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.49 -115.42 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.479 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 53.73 0.58 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -99.96 167.6 10.79 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 122.427 -0.455 . . . . 0.0 110.112 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 64.7 Cg_endo -95.7 123.1 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 122.93 2.42 . . . . 0.0 108.253 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 91' ' ' SER . 22.0 p -90.48 177.85 6.27 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 115' ' ' LYS . 57.5 m-85 -151.84 157.09 41.44 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.836 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 4.5 m-20 -127.83 -171.47 2.45 Favored 'General case' 0 CA--C 1.457 -2.609 0 O-C-N 120.946 -1.096 . . . . 0.0 109.732 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.909 ' HB ' HD22 ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.963 HG22 HD23 ' A' ' 111' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.555 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.744 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.558 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 134' ' ' LEU . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' A' ' 123' ' ' ILE . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . 163.51 139.25 2.59 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HG3' ' N ' ' A' ' 99' ' ' ASN 0.269 0.0 OUTLIER -171.18 116.07 0.43 Allowed 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.815 -1.693 . . . . 0.0 111.482 165.499 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.2 tt0 -115.49 91.9 3.75 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 161.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.03 -2.89 0.05 OUTLIER Glycine 2 CA--C 1.662 9.236 0 CA-C-N 125.116 3.598 . . . . 0.0 110.104 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.769 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 6.3 p -38.29 150.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 125.845 1.658 . . . . 0.0 114.717 -176.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -75.66 -55.14 5.94 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 112.773 -2.012 . . . . 0.0 108.722 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.72 14.58 12.24 Favored Glycine 0 N--CA 1.511 3.647 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.95 -25.47 3.59 Favored Glycine 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.577 ' HA ' HG21 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.453 ' CB ' HG22 ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.621 ' SD ' HG13 ' A' ' 110' ' ' VAL . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.5 t60 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 110' ' ' VAL . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 118.29 -60.43 0.48 Allowed Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.51 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.42 -47.56 62.95 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.027 -0.69 . . . . 0.0 109.78 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.798 HD13 HD12 ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.554 ' CB ' ' HE1' ' A' ' 130' ' ' MET 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.962 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.659 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.432 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.962 ' HB1' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 42' ' ' ILE . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HB3' HG11 ' A' ' 47' ' ' VAL . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 22' ' ' VAL . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 108' ' ' THR . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 30' ' ' VAL . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 19' ' ' ALA . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.941 ' CE1' HD12 ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.793 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HG11 ' A' ' 22' ' ' VAL . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.689 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.901 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD23 HD13 ' A' ' 63' ' ' LEU . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.53 129.78 6.1 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -14.49 32.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -52.42 135.13 33.95 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.7 36.81 3.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.506 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -170.16 -35.7 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.922 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 p -52.18 -104.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 63' ' ' LEU . 51.2 p90 -37.57 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.637 HD13 HD23 ' A' ' 50' ' ' LEU . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 63' ' ' LEU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.941 HD12 ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' THR . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' OE1' HG22 ' A' ' 89' ' ' THR . 2.2 tp-100 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 65' ' ' LEU . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.551 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG13 ' SD ' ' A' ' 85' ' ' MET . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.817 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 104' ' ' LYS . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 80' ' ' ASP . 2.1 mt -97.3 127.25 43.1 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.67 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.712 1.72 . . . . 0.0 114.773 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 78' ' ' LEU . 28.0 t0 -101.24 28.31 5.49 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 171.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.66 28.91 22.85 Favored Glycine 0 C--N 1.36 1.891 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 -153.84 -53.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 103' ' ' THR . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.791 ' SD ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.817 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 68' ' ' GLN . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -81.8 171.3 14.69 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.77 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -121.98 161.11 23.52 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.638 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.2 p -106.89 -80.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.644 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.0 96.56 0.86 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.53 21.13 62.21 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.77 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -81.77 166.98 34.33 Favored Pre-proline 0 N--CA 1.509 2.485 0 O-C-N 121.853 -0.792 . . . . 0.0 109.287 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.6 Cg_endo -89.64 131.09 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.179 2.586 . . . . 0.0 111.162 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 68.7 p -100.88 165.83 11.15 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 45.5 m-85 -145.57 113.82 6.62 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -100.9 136.11 41.27 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.032 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.75 HG12 ' CD1' ' A' ' 77' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 77' ' ' LEU . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.96 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.478 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 134' ' ' LEU . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 102' ' ' VAL . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.567 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.769 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -142.32 140.84 10.27 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 44.4 mttt -112.09 167.45 10.39 Favored 'General case' 0 C--O 1.197 -1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.4 tt0 -16.75 151.22 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.416 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -176.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.28 83.58 Favored Glycine 0 CA--C 1.561 2.969 1 N-CA-C 100.696 -4.962 . . . . 0.0 100.696 -168.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.861 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.8 OUTLIER -101.94 105.79 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 114.08 -1.06 . . . . 0.0 112.081 -175.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -83.88 -38.5 21.05 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.11 3.43 61.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.17 -32.42 5.55 Favored Glycine 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 112' ' ' LEU . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 1.032 ' HA ' HG21 ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 134' ' ' LEU . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.445 ' CD2' ' OH ' ' A' ' 6' ' ' TYR . 17.2 t60 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB3' HG21 ' A' ' 105' ' ' THR . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -151.77 -100.27 0.2 Allowed Glycine 0 N--CA 1.513 3.786 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.68 -45.33 38.8 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 121.936 -0.743 . . . . 0.0 111.293 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 32' ' ' ALA . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.055 HD11 ' HB3' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.415 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' N ' HD22 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.055 ' HB3' HD11 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.024 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.724 HD13 HD11 ' A' ' 134' ' ' LEU . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 42' ' ' ILE . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.603 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.826 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.831 ' CG2' HD13 ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.602 ' HA ' HG11 ' A' ' 40' ' ' VAL . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.783 ' CE1' HD12 ' A' ' 65' ' ' LEU . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 35' ' ' PRO . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.577 HD11 HD22 ' A' ' 65' ' ' LEU . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -65.85 114.33 6.52 Favored Glycine 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -31.82 63.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.431 -0.452 . . . . 0.0 110.193 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -84.6 74.48 10.41 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 1.6 tpt180 -171.44 52.96 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.5 t -69.33 -10.22 56.9 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.579 -0.701 . . . . 0.0 110.977 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -73.87 -55.57 6.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.004 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 55' ' ' ARG . 1.1 p90 -38.23 -28.32 0.02 OUTLIER 'General case' 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 64' ' ' THR . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.766 ' C ' HD23 ' A' ' 65' ' ' LEU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.83 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.759 ' NE2' HG22 ' A' ' 89' ' ' THR . 1.5 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.83 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.794 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.617 ' CD1' HG12 ' A' ' 102' ' ' VAL . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 80' ' ' ASP . 39.4 mt -98.43 127.91 44.57 Favored 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -47.69 74.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 126.451 1.901 . . . . 0.0 114.829 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 78' ' ' LEU . 8.2 t0 -101.14 23.83 10.28 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.84 27.79 10.85 Favored Glycine 0 C--N 1.36 1.884 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 -153.18 -56.03 0.12 Allowed 'General case' 0 C--N 1.364 1.235 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.892 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.892 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.759 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -81.82 172.45 13.33 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.83 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.4 t -143.14 178.41 7.72 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.778 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 p -97.26 -31.66 12.31 Favored 'General case' 0 N--CA 1.515 2.78 0 CA-C-O 121.112 0.482 . . . . 0.0 109.836 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.49 -72.12 0.12 Allowed Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.35 74.26 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -64.08 167.05 8.68 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.05 -0.676 . . . . 0.0 109.285 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 63.2 Cg_endo -97.5 136.84 0.42 Allowed 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 123.235 2.623 . . . . 0.0 112.282 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 91' ' ' SER . 69.6 p -112.51 152.8 28.37 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' THR . 25.9 m-85 -139.71 88.24 2.23 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -72.79 132.53 43.71 Favored 'General case' 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 -174.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 112' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.98 HG21 ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.649 ' HB ' HD11 ' A' ' 87' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.652 HG23 ' SG ' ' A' ' 127' ' ' CYS . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.603 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 134' ' ' LEU . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.024 HD12 ' HB3' ' A' ' 20' ' ' ALA . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.786 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -131.32 118.19 2.32 Favored Glycine 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.775 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 13.6 mttt -102.83 159.56 15.37 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.58 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.8 tt0 -17.12 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.639 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.37 14.96 77.08 Favored Glycine 0 CA--C 1.564 3.102 1 N-CA-C 100.698 -4.961 . . . . 0.0 100.698 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.786 HG21 ' C ' ' A' ' 114' ' ' GLY . 1.4 p -101.83 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.385 2.132 0 CA-C-N 114.004 -1.098 . . . . 0.0 112.273 -174.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.25 -40.7 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.28 41.65 2.74 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.9 -45.86 0.04 OUTLIER Glycine 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.671 HD11 HG23 ' A' ' 118' ' ' VAL . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.98 ' HA ' HG21 ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.7 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.891 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 119.96 32.41 1.18 Allowed Glycine 0 N--CA 1.506 3.338 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -52.92 -45.65 67.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.873 -0.781 . . . . 0.0 110.559 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.616 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.868 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.577 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.991 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.79 HG12 HG22 ' A' ' 110' ' ' VAL . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 29' ' ' SER . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 22' ' ' VAL . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 40' ' ' VAL . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.596 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.633 HG23 ' HB3' ' A' ' 19' ' ' ALA . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.831 HD23 HD13 ' A' ' 63' ' ' LEU . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 47' ' ' VAL . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.07 -132.39 0.01 OUTLIER Glycine 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -69.29 -0.93 6.9 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 123.159 0.584 . . . . 0.0 112.475 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' OD2' HD21 ' A' ' 78' ' ' LEU . 41.4 t0 -17.8 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.89 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.491 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 31.3 t -172.24 -50.21 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.9 p -43.73 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.689 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.3 p90 -37.03 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 56' ' ' SER . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 57' ' ' SER . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 60' ' ' VAL . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD12 ' HG ' ' A' ' 87' ' ' LEU . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 65' ' ' LEU . 8.3 tp-100 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.464 ' SG ' HD23 ' A' ' 87' ' ' LEU . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.901 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.774 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB2' HG11 ' A' ' 72' ' ' VAL . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -110.99 51.33 0.78 Allowed 'General case' 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 76' ' ' SER . 2.2 pt20 -110.31 -108.86 0.34 Allowed 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.41 63.34 0.87 Allowed 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' CE1' ' A' ' 83' ' ' PHE . . . 76.62 -15.14 6.2 Favored Glycine 1 N--CA 1.523 4.496 0 O-C-N 120.646 -1.284 . . . . 0.0 112.342 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.62 -63.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.675 1.238 . . . . 0.0 109.97 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.777 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.719 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.837 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HD3' HD11 ' A' ' 73' ' ' ILE . 2.1 mtmt -81.71 125.21 30.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.782 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -89.6 177.61 6.5 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.924 0.869 . . . . 0.0 112.267 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.0 p -83.02 -31.53 27.39 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.215 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.22 -53.05 0.48 Allowed Glycine 0 N--CA 1.503 3.163 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.29 -14.15 66.93 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.782 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -85.55 170.61 12.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.843 -0.798 . . . . 0.0 110.079 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.9 Cg_endo -96.03 160.61 1.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.381 2.721 . . . . 0.0 109.414 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 89' ' ' THR . 16.3 p -122.06 166.75 14.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.785 ' O ' HG23 ' A' ' 89' ' ' THR . 43.9 m-85 -152.46 102.03 2.71 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.659 ' H ' ' HG2' ' A' ' 115' ' ' LYS . 27.6 m-20 -74.51 139.03 43.54 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.824 HG22 HD23 ' A' ' 111' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 127' ' ' CYS . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.752 HG21 ' HB3' ' A' ' 134' ' ' LEU . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.596 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.72 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . 145.12 148.54 4.84 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.725 ' HA ' ' CG1' ' A' ' 118' ' ' VAL 0.434 18.8 mttt -151.96 118.53 5.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 111.717 -2.242 . . . . 0.0 106.759 167.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -112.72 91.89 3.82 Favored 'General case' 0 C--N 1.244 -3.996 1 N-CA-C 98.83 -4.508 . . . . 0.0 98.83 161.696 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.46 -0.82 0.13 Allowed Glycine 2 CA--C 1.653 8.668 0 CA-C-N 123.798 2.999 . . . . 0.0 109.216 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.725 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 12.6 p -35.37 154.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.391 2.371 0 O-C-N 120.486 -1.597 . . . . 0.0 113.816 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -99.07 -45.05 6.07 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.351 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.03 115.02 3.92 Favored Glycine 0 N--CA 1.503 3.121 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.83 -35.84 2.2 Favored Glycine 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.782 HG23 ' HG ' ' A' ' 112' ' ' LEU . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.572 ' HA ' HG21 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.465 ' HB3' HG21 ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 132' ' ' SER . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.646 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB2' ' OG1' ' A' ' 103' ' ' THR . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 129' ' ' GLU . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 110' ' ' VAL . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.505 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 32' ' ' ALA . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.665 HD21 HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.919 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.818 ' SG ' HD11 ' A' ' 112' ' ' LEU 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.514 ' N ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.919 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 110' ' ' VAL . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 29' ' ' SER . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' HG13 ' A' ' 22' ' ' VAL . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.715 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.888 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 7' ' ' ILE . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.791 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.949 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.813 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 63' ' ' LEU . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.961 HD23 HD13 ' A' ' 63' ' ' LEU . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HD21 ' A' ' 63' ' ' LEU . 54.6 p90 . . . . . 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.961 HD13 HD23 ' A' ' 50' ' ' LEU . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.949 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HB3' HD12 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.542 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.917 HG11 ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.917 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 83' ' ' PHE . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.2 mp0 . . . . . 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.844 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.922 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 122.139 0.971 . . . . 0.0 111.999 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.815 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HD3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.715 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.053 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 HG13 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HG ' HG23 ' A' ' 123' ' ' ILE . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.619 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.585 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.918 HG23 ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.651 ' HA ' HG21 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.418 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.679 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 64.5 t60 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 110' ' ' VAL . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.526 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.802 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.956 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ASP . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.956 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.992 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 110' ' ' VAL . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 42' ' ' ILE . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.521 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.63 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 7' ' ' ILE . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.74 ' CZ ' HD12 ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.637 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 63' ' ' LEU . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD23 HD13 ' A' ' 63' ' ' LEU . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CD2' HD21 ' A' ' 63' ' ' LEU . 29.3 p90 . . . . . 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD12 ' HG ' ' A' ' 87' ' ' LEU . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.629 ' C ' HD23 ' A' ' 65' ' ' LEU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.806 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.2 tp60 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.806 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.518 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.802 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 6.1 mp0 . . . . . 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.818 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.908 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm . . . . . 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.508 2.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 113' ' ' MET . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.882 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' TYR . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.63 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 134' ' ' LEU . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.992 HD12 ' HB3' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.582 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 112' ' ' LEU . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.95 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 31.0 t-80 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.882 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.834 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.511 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.974 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.853 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 110' ' ' VAL . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 29' ' ' SER . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.834 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HA ' HG11 ' A' ' 40' ' ' VAL . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.908 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.846 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.763 HG22 HD23 ' A' ' 63' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.917 HD23 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 . . . . . 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.917 HD13 HD23 ' A' ' 50' ' ' LEU . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.908 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 65' ' ' LEU . 24.6 tp60 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.602 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HG12 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 50.8 mt . . . . . 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.875 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.875 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt . . . . . 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.515 2.824 0 CA-C-O 122.087 0.946 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.935 HG12 HD13 ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.62 HG23 ' SG ' ' A' ' 127' ' ' CYS . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 77' ' ' LEU . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 134' ' ' LEU . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.553 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.543 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 112' ' ' LEU . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.896 ' HA ' HG21 ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' A' ' 103' ' ' THR . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.605 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.631 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.65 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.803 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.727 HG12 HG22 ' A' ' 110' ' ' VAL . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 29' ' ' SER . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' VAL . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.619 HG21 ' O ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.622 ' CZ3' HG22 ' A' ' 108' ' ' THR . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.818 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 19' ' ' ALA . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.919 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 63' ' ' LEU . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 63' ' ' LEU . 47.1 p90 . . . . . 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.807 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 65' ' ' LEU . 25.0 tp60 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.573 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.925 ' HB2' HG11 ' A' ' 72' ' ' VAL . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.795 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.77 ' HG2' HG13 ' A' ' 72' ' ' VAL 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.857 HD11 ' HB ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.523 3.218 0 CA-C-O 122.199 1.0 . . . . 0.0 111.956 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 83' ' ' PHE . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.82 HG21 ' HB3' ' A' ' 134' ' ' LEU . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.743 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.799 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.743 HD21 HD13 ' A' ' 109' ' ' LEU . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.875 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.875 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.615 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' A' ' 105' ' ' THR . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.314 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.906 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.448 HD11 ' HE2' ' A' ' 130' ' ' MET . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 42' ' ' ILE . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 22' ' ' VAL . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.45 HG22 HG23 ' A' ' 7' ' ' ILE . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.581 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.858 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.678 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.661 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 63' ' ' LEU . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 63' ' ' LEU . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' ' OD1' ' A' ' 61' ' ' ASN . 17.5 p90 . . . . . 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.979 HD11 ' HE2' ' A' ' 85' ' ' MET . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.858 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG11 ' A' ' 72' ' ' VAL . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.965 HD13 HG12 ' A' ' 102' ' ' VAL . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 . . . . . 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.979 ' HE2' HD11 ' A' ' 63' ' ' LEU . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.731 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.896 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 68' ' ' GLN . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.523 3.187 0 CA-C-O 122.153 0.978 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.62 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.965 HG12 HD13 ' A' ' 77' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.552 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.821 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.598 ' OG1' HD22 ' A' ' 134' ' ' LEU . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 ' CG2' ' A' ' 102' ' ' VAL . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.801 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.594 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.801 HG23 ' HG ' ' A' ' 112' ' ' LEU . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.872 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 132' ' ' SER . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.616 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.861 0.362 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.662 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.85 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.705 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.721 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.41 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 HG22 ' A' ' 110' ' ' VAL . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 29' ' ' SER . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.85 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 19' ' ' ALA . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.97 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.853 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 63' ' ' LEU . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.72 HD23 HD13 ' A' ' 63' ' ' LEU . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 . . . . . 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 49' ' ' VAL . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 63' ' ' LEU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.97 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.9 tp60 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.549 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.727 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 78' ' ' LEU . 80.1 mt . . . . . 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 38.2 mm-40 . . . . . 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.507 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.633 ' HG2' HD12 ' A' ' 87' ' ' LEU . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.81 ' C ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.81 HD13 ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 89' ' ' THR . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.513 2.724 0 CA-C-O 122.319 1.057 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 87' ' ' LEU . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.727 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.943 HG21 ' HB3' ' A' ' 134' ' ' LEU . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 134' ' ' LEU . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 109' ' ' LEU . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.933 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.893 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' HG ' ' A' ' 112' ' ' LEU . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' CB ' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.432 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.711 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 25.8 t-80 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.868 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.719 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.571 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 29' ' ' SER . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HZ1' ' HZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 22' ' ' VAL . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.594 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.764 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.745 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.849 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.687 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.687 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG22 HD23 ' A' ' 63' ' ' LEU . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.882 HD12 ' HG ' ' A' ' 87' ' ' LEU . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD12 ' A' ' 65' ' ' LEU . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.582 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.844 HD13 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.888 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 82' ' ' GLU . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 102' ' ' VAL . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.46 ' CB ' ' HB3' ' A' ' 76' ' ' SER . 4.2 mp0 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.815 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.882 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.844 ' NH1' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 89' ' ' THR . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.828 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' ND2' ' HD3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 122.253 1.025 . . . . 0.0 111.682 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 113' ' ' MET . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.693 ' HB ' HD11 ' A' ' 87' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.914 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.924 HG21 HD13 ' A' ' 134' ' ' LEU . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.569 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.719 ' HA3' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.565 HG23 ' HG ' ' A' ' 112' ' ' LEU . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.76 ' HA ' HG21 ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.213 0.53 . . . . 0.0 110.051 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.969 ' HA ' HD12 ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.714 ' ND2' HD23 ' A' ' 10' ' ' LEU 0.267 0.0 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 7' ' ' ILE . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 13' ' ' ASP . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.627 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.914 ' HB1' HD22 ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.633 HG12 ' HE2' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.728 HG11 HG21 ' A' ' 42' ' ' ILE . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 22' ' ' VAL . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.728 HG21 HG11 ' A' ' 22' ' ' VAL . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.662 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.944 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 63' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HA ' HD22 ' A' ' 63' ' ' LEU . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 . . . . . 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 61' ' ' ASN . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' LEU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.617 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.0 tp60 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.569 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 104' ' ' LYS . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 78' ' ' LEU . 92.6 mt . . . . . 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 . . . . . 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.787 HD22 HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' CE ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.6 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 7.7 m-20 . . . . . 0 CA--C 1.447 -3.009 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.881 HG22 HD23 ' A' ' 111' ' ' LEU . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 130' ' ' MET . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 HG22 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.966 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.1 t30 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 112' ' ' LEU . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.406 ' HA ' HG21 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.759 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 110' ' ' VAL . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.403 0 CA-C-O 120.987 0.422 . . . . 0.0 111.038 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.684 ' ND2' ' HG ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.004 HD22 ' HB2' ' A' ' 19' ' ' ALA . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB2' HD23 ' A' ' 10' ' ' LEU 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.004 ' HB2' HD22 ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 42' ' ' ILE . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.594 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 39' ' ' PHE . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 46' ' ' GLU . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 . . . . . 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.804 HD12 ' HG ' ' A' ' 87' ' ' LEU . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.8 tp60 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.695 HG22 ' HE2' ' A' ' 85' ' ' MET . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 104' ' ' LYS . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.3 mp0 . . . . . 0 CA--C 1.561 1.386 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.695 ' HE2' HG22 ' A' ' 72' ' ' VAL . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.753 ' C ' HD13 ' A' ' 87' ' ' LEU . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.804 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.446 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.535 ' CE ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.535 HD23 ' CE ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' ' 20' ' ' ALA . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.614 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 112' ' ' LEU . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.881 ' HA ' HG21 ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 130' ' ' MET . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.664 ' HA ' HD23 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 HG21 ' A' ' 110' ' ' VAL . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.922 0.391 . . . . 0.0 110.945 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.646 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.653 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.693 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.661 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.848 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.4 HD11 ' HE2' ' A' ' 130' ' ' MET . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 29' ' ' SER . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 22' ' ' VAL . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 40' ' ' VAL . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.525 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.813 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 19' ' ' ALA . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.72 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.932 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.932 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.642 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.064 HD23 HD13 ' A' ' 63' ' ' LEU . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 63' ' ' LEU . 47.0 p90 . . . . . 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.064 HD13 HD23 ' A' ' 50' ' ' LEU . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 63' ' ' LEU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.433 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.808 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 84' ' ' SER . 24.5 mm-40 . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' SER . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.825 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.877 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.225 0 CA-C-O 122.208 1.004 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 113' ' ' MET . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.892 HG21 ' HB3' ' A' ' 134' ' ' LEU . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.765 HD13 HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 134' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 109' ' ' LEU . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.935 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.63 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.935 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.632 ' HA ' HG21 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.578 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.672 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.191 0.519 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.73 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.423 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.582 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 6' ' ' TYR . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 29' ' ' SER . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' HG13 ' A' ' 22' ' ' VAL . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.597 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 7' ' ' ILE . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 1.014 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.954 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.954 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 . . . . . 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.802 HD13 ' HG ' ' A' ' 50' ' ' LEU . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.014 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' HB3' HD12 ' A' ' 65' ' ' LEU . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.676 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' HE2' ' A' ' 85' ' ' MET . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.815 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.712 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.618 HD21 ' NZ ' ' A' ' 104' ' ' LYS . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.725 ' HE2' HG22 ' A' ' 72' ' ' VAL 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 89' ' ' THR . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.808 ' HD3' HD11 ' A' ' 73' ' ' ILE . 3.3 mtmt . . . . . 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 122.169 0.985 . . . . 0.0 111.93 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.59 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.845 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.791 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.597 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.472 ' HG ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.938 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.845 ' HG ' HG22 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.924 ' HG ' HG23 ' A' ' 123' ' ' ILE . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.729 ' HA ' HG13 ' A' ' 100' ' ' VAL . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.582 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.924 HG23 ' HG ' ' A' ' 112' ' ' LEU . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.626 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.584 0 CA-C-O 121.092 0.473 . . . . 0.0 110.811 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.931 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 122' ' ' LEU . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 10' ' ' LEU 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.574 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.931 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 42' ' ' ILE . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.617 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.853 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 7' ' ' ILE . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.952 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.61 HD13 HG21 ' A' ' 22' ' ' VAL . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 49' ' ' VAL . 29.8 p90 . . . . . 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' A' ' 87' ' ' LEU . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 63' ' ' LEU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB3' HD12 ' A' ' 65' ' ' LEU . 22.6 tp60 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' HE2' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.816 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.691 HD21 ' HE3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.842 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.816 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.842 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.605 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 5.3 m-20 . . . . . 0 CA--C 1.461 -2.475 0 CA-C-O 121.569 0.699 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 124' ' ' ASN . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.646 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.651 HG23 ' SG ' ' A' ' 127' ' ' CYS . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HE3' HD21 ' A' ' 77' ' ' LEU . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 134' ' ' LEU . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.538 HG21 HD23 ' A' ' 134' ' ' LEU . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 134' ' ' LEU . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 ' HB3' ' A' ' 20' ' ' ALA . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.827 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.548 ' HG2' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.103 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.723 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.827 HG23 HD12 ' A' ' 112' ' ' LEU . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.85 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' MET . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.749 ' SD ' HG13 ' A' ' 110' ' ' VAL . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 135' ' ' ARG . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.874 HD13 HG21 ' A' ' 110' ' ' VAL . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.539 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.875 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 110' ' ' VAL . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 42' ' ' ILE . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.541 ' CZ3' HG22 ' A' ' 108' ' ' THR . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 19' ' ' ALA . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.79 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 22' ' ' VAL . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.645 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 63' ' ' LEU . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE1' HD21 ' A' ' 63' ' ' LEU . 21.1 p90 . . . . . 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 72' ' ' VAL . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.944 HD13 HD23 ' A' ' 50' ' ' LEU . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.641 ' NE2' HG22 ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 87' ' ' LEU . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.725 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.788 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 HG12 ' A' ' 102' ' ' VAL . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 36.0 mm-40 . . . . . 0 CA--C 1.556 1.21 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.769 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.788 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.641 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.533 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.511 2.621 0 CA-C-O 122.336 1.065 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.543 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.739 HG22 HD22 ' A' ' 111' ' ' LEU . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 109' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 134' ' ' LEU . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.541 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 109' ' ' LEU . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.959 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.718 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.715 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.959 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' HG21 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.546 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.637 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 29.9 t-80 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.878 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' ASP . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 134' ' ' LEU . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.847 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.586 HG23 ' HB3' ' A' ' 19' ' ' ALA . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.968 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HD23 ' A' ' 63' ' ' LEU . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 HD13 ' A' ' 63' ' ' LEU . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.7 p90 . . . . . 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.974 HD11 ' HE2' ' A' ' 85' ' ' MET . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 63' ' ' LEU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.968 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB3' HD12 ' A' ' 65' ' ' LEU . 23.8 tp60 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' A' ' 87' ' ' LEU . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HE2' ' A' ' 90' ' ' LYS . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.94 ' HB2' HG11 ' A' ' 72' ' ' VAL . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.677 HD13 HG12 ' A' ' 102' ' ' VAL . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 78' ' ' LEU . 66.7 mt . . . . . 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 . . . . . 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.974 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.91 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.523 HG22 HE21 ' A' ' 68' ' ' GLN . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.518 2.947 0 CA-C-O 122.135 0.969 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 112' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.927 HG21 ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 87' ' ' LEU . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' HD23 ' A' ' 109' ' ' LEU . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.586 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.829 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.012 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.012 HG23 ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.927 ' HA ' HG21 ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.488 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.925 HD13 HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.875 0.369 . . . . 0.0 111.577 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.855 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.938 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.621 ' HB2' HD12 ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.556 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.938 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 110' ' ' VAL . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 42' ' ' ILE . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.855 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 7' ' ' ILE . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD12 ' A' ' 109' ' ' LEU . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 63' ' ' LEU . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.766 ' HA ' HD22 ' A' ' 63' ' ' LEU . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.727 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.9 p90 . . . . . 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 49' ' ' VAL . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.9 tp60 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.729 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.874 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.874 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 102' ' ' VAL . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.6 mp0 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.745 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.53 HG22 HE21 ' A' ' 68' ' ' GLN . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HD3' HD11 ' A' ' 73' ' ' ILE . 5.4 mmmt . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.521 3.103 0 CA-C-O 122.611 1.196 . . . . 0.0 113.358 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.921 HG21 ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 77' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.954 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 20' ' ' ALA . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.527 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.167 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.473 HG23 HD12 ' A' ' 112' ' ' LEU . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.921 ' HA ' HG21 ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.687 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.954 HD13 HG21 ' A' ' 110' ' ' VAL . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.419 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.481 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.452 0 CA-C-O 120.65 0.262 . . . . 0.0 111.063 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.957 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.588 HG22 HD11 ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.957 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 42' ' ' ILE . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 22' ' ' VAL . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.819 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 7' ' ' ILE . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.67 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.886 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.694 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.694 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.855 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.704 HD23 HD13 ' A' ' 63' ' ' LEU . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.6 p90 . . . . . 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.829 HD12 ' HG ' ' A' ' 87' ' ' LEU . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 65' ' ' LEU . 18.1 tp60 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.806 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 102' ' ' VAL . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.7 mt . . . . . 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 . . . . . 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.836 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.824 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 89' ' ' THR . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt . . . . . 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.511 2.619 0 CA-C-O 122.256 1.027 . . . . 0.0 111.423 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.877 HG21 ' HB3' ' A' ' 134' ' ' LEU . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.649 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.801 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.913 HG21 HD13 ' A' ' 134' ' ' LEU . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 110' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.728 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.638 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.728 HG23 ' HG ' ' A' ' 112' ' ' LEU . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.954 ' HA ' HG21 ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.478 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 132' ' ' SER . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.681 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.913 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.468 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.388 0 CA-C-O 120.891 0.377 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.659 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.69 HD21 HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.739 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.791 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.965 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 110' ' ' VAL . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 29' ' ' SER . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 19' ' ' ALA . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 1.021 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.685 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.801 HG22 HD23 ' A' ' 63' ' ' LEU . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.778 HD23 HD13 ' A' ' 63' ' ' LEU . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CD1' HD21 ' A' ' 63' ' ' LEU . 4.2 p90 . . . . . 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 87' ' ' LEU . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.021 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.457 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.779 ' SG ' HD23 ' A' ' 87' ' ' LEU . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 102' ' ' VAL . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 78' ' ' LEU . 32.2 mt . . . . . 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.457 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.609 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 4.5 m-20 . . . . . 0 CA--C 1.457 -2.609 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.909 ' HB ' HD22 ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.963 HG22 HD23 ' A' ' 111' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.555 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.744 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.558 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 134' ' ' LEU . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' A' ' 123' ' ' ILE . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . . . . . . 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.577 ' HA ' HG21 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.453 ' CB ' HG22 ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.621 ' SD ' HG13 ' A' ' 110' ' ' VAL . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 24.2 t-80 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 110' ' ' VAL . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.51 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.798 HD13 HD12 ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.568 HD21 ' CD2' ' A' ' 112' ' ' LEU 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.962 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.659 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.962 ' HB1' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 42' ' ' ILE . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HB3' HG11 ' A' ' 47' ' ' VAL . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 22' ' ' VAL . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 108' ' ' THR . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 30' ' ' VAL . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 19' ' ' ALA . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.941 ' CE1' HD12 ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.793 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HG11 ' A' ' 22' ' ' VAL . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.689 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.901 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD23 HD13 ' A' ' 63' ' ' LEU . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 63' ' ' LEU . 51.2 p90 . . . . . 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.637 HD13 HD23 ' A' ' 50' ' ' LEU . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 63' ' ' LEU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.941 HD12 ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' THR . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.649 HE21 HG22 ' A' ' 89' ' ' THR . 10.4 tp60 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 65' ' ' LEU . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.551 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG13 ' SD ' ' A' ' 85' ' ' MET . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.817 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 104' ' ' LYS . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 . . . . . 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 103' ' ' THR . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.791 ' SD ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.817 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.85 ' N ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HE21 ' A' ' 68' ' ' GLN . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.032 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.75 HG12 ' CD1' ' A' ' 77' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 77' ' ' LEU . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.96 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.478 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 134' ' ' LEU . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 102' ' ' VAL . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.567 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . . . . . . 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 112' ' ' LEU . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 1.032 ' HA ' HG21 ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 134' ' ' LEU . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.465 ' CE1' ' OH ' ' A' ' 6' ' ' TYR . 22.7 t-80 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB3' HG21 ' A' ' 105' ' ' THR . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.009 0.433 . . . . 0.0 111.293 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.601 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 32' ' ' ALA . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.055 HD11 ' HB3' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.476 ' N ' HD22 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.055 ' HB3' HD11 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 1.024 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.724 HD13 HD11 ' A' ' 134' ' ' LEU . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 42' ' ' ILE . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.603 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.826 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.831 ' CG2' HD13 ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.602 ' HA ' HG11 ' A' ' 40' ' ' VAL . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.783 ' CE1' HD12 ' A' ' 65' ' ' LEU . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 35' ' ' PRO . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.577 HD11 HD22 ' A' ' 65' ' ' LEU . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . . . . . . 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 1.1 p90 . . . . . 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 64' ' ' THR . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.766 ' C ' HD23 ' A' ' 65' ' ' LEU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.83 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.65 ' CD ' HG22 ' A' ' 89' ' ' THR . 15.0 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.83 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.794 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.617 ' CD1' HG12 ' A' ' 102' ' ' VAL . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.892 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.892 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.65 HG22 ' CD ' ' A' ' 68' ' ' GLN . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 112' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.98 HG21 ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.649 ' HB ' HD11 ' A' ' 87' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.652 HG23 ' SG ' ' A' ' 127' ' ' CYS . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.603 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 134' ' ' LEU . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.024 HD12 ' HB3' ' A' ' 20' ' ' ALA . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.589 HG23 HD12 ' A' ' 112' ' ' LEU . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.98 ' HA ' HG21 ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.7 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.891 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.454 0 CA-C-O 121.015 0.436 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.616 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.868 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.577 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.991 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.79 HG12 HG22 ' A' ' 110' ' ' VAL . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 29' ' ' SER . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 22' ' ' VAL . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 40' ' ' VAL . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.596 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.633 HG23 ' HB3' ' A' ' 19' ' ' ALA . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.831 HD23 HD13 ' A' ' 63' ' ' LEU . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 47' ' ' VAL . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 61' ' ' ASN . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 60' ' ' VAL . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD12 ' HG ' ' A' ' 87' ' ' LEU . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 65' ' ' LEU . 47.2 tp60 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.464 ' SG ' HD23 ' A' ' 87' ' ' LEU . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.901 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.774 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB2' HG11 ' A' ' 72' ' ' VAL . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 122.283 1.04 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.777 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.719 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.837 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HD3' HD11 ' A' ' 73' ' ' ILE . 2.1 mtmt . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 27.6 m-20 . . . . . 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.824 HG22 HD23 ' A' ' 111' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 127' ' ' CYS . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.752 HG21 ' HB3' ' A' ' 134' ' ' LEU . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.596 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.72 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . . . . . . 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.782 HG23 ' HG ' ' A' ' 112' ' ' LEU . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.572 ' HA ' HG21 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.465 ' HB3' HG21 ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 132' ' ' SER . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.646 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB2' ' OG1' ' A' ' 103' ' ' THR . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 129' ' ' GLU . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 110' ' ' VAL . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 87.51 -67.61 3.25 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.505 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -54.6 -44.31 72.93 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.081 -0.658 . . . . 0.0 109.28 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.21 -24.05 64.52 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.123 -0.361 . . . . 0.0 110.356 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.92 70.77 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.545 ' OH ' ' CG ' ' A' ' 133' ' ' HIS . 48.6 m-85 -73.96 -12.43 60.64 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 32' ' ' ALA . 18.2 mm -90.48 -26.25 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.737 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.45 -14.73 63.19 Favored 'General case' 0 C--O 1.188 -2.175 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.665 HD21 HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -62.28 -67.61 0.4 Allowed 'General case' 0 C--O 1.181 -2.518 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.919 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -42.88 -33.62 0.81 Allowed 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 124.347 1.059 . . . . 0.0 111.775 178.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -85.03 -45.38 12.18 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.605 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 0.91 46.51 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 125.011 1.325 . . . . 0.0 112.483 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 10' ' ' LEU 0.333 51.8 p-10 -91.25 -3.72 56.65 Favored 'General case' 1 N--CA 1.548 4.46 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -170.974 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . 33.93 30.61 0.01 OUTLIER Glycine 2 N--CA 1.54 5.57 0 CA-C-N 118.919 0.781 . . . . 0.0 113.043 -177.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' ASP . 29.7 m -155.88 -48.75 0.08 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.818 ' SG ' HD11 ' A' ' 112' ' ' LEU 0.402 0.5 OUTLIER -81.97 156.83 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.372 1.082 . . . . 0.0 113.188 178.586 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.514 ' N ' ' HA2' ' A' ' 114' ' ' GLY 0.254 0.0 OUTLIER -124.98 -51.15 1.68 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.019 -172.149 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.9 t0 -118.29 178.83 4.3 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.919 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -169.85 136.46 1.55 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.039 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -143.99 106.22 4.38 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 116.892 -1.923 . . . . 0.0 114.231 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 110' ' ' VAL . 17.8 mt -86.4 119.83 35.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 101.474 -3.528 . . . . 0.0 101.474 172.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 29' ' ' SER . 60.8 t -129.26 120.5 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.334 -173.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -69.5 84.86 0.26 Allowed Glycine 0 N--CA 1.506 3.337 0 N-CA-C 106.628 -2.589 . . . . 0.0 106.628 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -80.56 32.38 0.3 Allowed 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 123.62 0.768 . . . . 0.0 111.852 -177.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -66.41 -155.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.05 -58.05 4.4 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -101.34 124.12 42.27 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.8 Cg_endo -76.06 157.58 38.3 Favored 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 121.878 1.719 . . . . 0.0 110.377 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' HG13 ' A' ' 22' ' ' VAL . 80.9 p -157.4 158.35 35.73 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.2 t -98.55 97.59 6.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.715 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.3 m0 -69.23 -21.11 63.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.581 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.888 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 174.15 84.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.508 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.7 129.77 53.8 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 7' ' ' ILE . 61.7 t -50.61 106.7 0.68 Allowed Pre-proline 0 N--CA 1.519 3.013 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.791 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.1 Cg_endo -73.82 153.32 47.99 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.164 1.909 . . . . 0.0 112.748 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.24 -13.27 61.76 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 36.1 mmtt -96.36 -74.56 0.56 Allowed 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.113 0.956 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -179.39 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.974 0 O-C-N 121.596 -0.69 . . . . 0.0 111.382 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.949 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -58.13 -44.29 87.74 Favored 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.813 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -55.66 -23.31 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -81.35 20.68 0.83 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.3 mt -70.57 118.14 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.598 1.19 . . . . 0.0 111.774 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.691 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.4 p -106.45 -178.19 0.57 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.691 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.5 Cg_endo -72.56 1.21 6.5 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 120.771 0.981 . . . . 0.0 112.113 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.33 -63.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 pm0 -62.12 -32.73 73.34 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.336 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.04 -24.36 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.022 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.3 -28.68 69.68 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 63' ' ' LEU . 8.0 p -97.24 -33.8 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 O-C-N 122.168 -0.607 . . . . 0.0 110.709 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.961 HD23 HD13 ' A' ' 63' ' ' LEU . 7.7 mt -67.98 -18.83 64.85 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.869 0.366 . . . . 0.0 110.172 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.8 m -140.73 -6.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 122.308 -0.245 . . . . 0.0 111.121 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.63 144.24 5.82 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -10.48 50.2 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.971 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -46.58 135.79 8.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -112.12 27.73 9.39 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.5 t -170.05 -41.79 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 118.154 -1.419 . . . . 0.0 112.926 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HG22 ' A' ' 60' ' ' VAL . 19.1 p -46.2 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HD21 ' A' ' 63' ' ' LEU . 54.6 p90 -37.53 -20.82 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 12.1 m-85 -61.16 -8.24 3.39 Favored 'General case' 0 N--CA 1.516 2.873 0 CA-C-N 121.441 1.928 . . . . 0.0 112.2 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -121.59 -32.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.802 -0.561 . . . . 0.0 111.27 -178.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.442 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.9 p30 -88.66 -40.85 12.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.121 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 128.11 152.02 7.71 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.961 HD13 HD23 ' A' ' 50' ' ' LEU . 54.0 mt -80.5 -160.62 0.31 Allowed 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.7 p -158.41 128.55 6.01 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.949 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.56 99.95 4.35 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-O 121.952 0.882 . . . . 0.0 109.299 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.52 31.19 57.11 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 11.09 84.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HB3' HD12 ' A' ' 65' ' ' LEU . 17.7 tp60 -106.37 104.34 14.01 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 118.397 1.099 . . . . 0.0 108.962 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.85 109.0 2.74 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.057 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.472 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -103.19 -170.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.542 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 79.0 p -143.07 105.11 4.39 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.917 HG11 ' HB2' ' A' ' 75' ' ' ASP . 13.0 t -46.77 125.51 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 121.944 0.878 . . . . 0.0 111.106 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 31.6 mt -134.21 73.77 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 112.68 70.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.611 0 C-N-CA 126.213 1.805 . . . . 0.0 107.838 -178.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.917 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -70.61 105.38 3.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.581 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 9.5 m -141.51 35.14 1.65 Allowed 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 83' ' ' PHE . 10.5 tp -71.23 -15.01 62.43 Favored 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 123.154 0.581 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 9.0 mt -103.55 121.8 43.63 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.92 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.072 1.749 . . . . 0.0 114.941 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.6 t70 -101.32 24.28 9.77 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 171.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.43 28.22 8.65 Favored Glycine 0 C--N 1.364 2.138 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.2 mp0 -153.89 -58.29 0.12 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 51.38 11.93 0.13 Allowed 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.886 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -107.49 143.75 35.42 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 120.556 1.525 . . . . 0.0 109.798 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.844 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.88 126.51 25.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -92.13 78.34 5.22 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.757 -1.215 . . . . 0.0 110.048 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.922 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.65 112.0 23.76 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.811 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -109.82 149.09 30.34 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.528 -175.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.3 p -69.16 110.0 4.34 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -95.16 146.37 24.36 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -178.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.724 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -89.69 170.16 10.68 Favored 'General case' 0 N--CA 1.509 2.49 0 CA-C-O 121.668 0.747 . . . . 0.0 111.733 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 91' ' ' SER . 55.4 p -156.19 108.37 2.56 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.49 44.51 2.71 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.8 23.75 77.59 Favored Glycine 0 N--CA 1.506 3.311 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -84.93 168.78 18.92 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.802 -0.822 . . . . 0.0 110.007 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -91.67 137.67 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.415 2.743 . . . . 0.0 110.147 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.593 HG22 ' H ' ' A' ' 91' ' ' SER . 71.5 p -96.89 170.79 8.92 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.036 0.922 . . . . 0.0 109.387 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.946 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 47.8 m-85 -154.68 172.84 17.24 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.88 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -140.38 154.79 46.84 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 117.944 -1.502 . . . . 0.0 111.999 -176.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 113' ' ' MET . 12.8 t -139.74 138.81 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 124' ' ' ASN . 20.8 m -110.21 132.85 53.81 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.815 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -124.31 119.92 57.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 12.1 p -108.65 161.33 15.18 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HD3' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -142.93 141.52 31.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 31.5 p -106.98 -147.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -94.26 -16.89 23.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.507 -0.745 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 27.4 mtpt -136.73 0.92 2.5 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.675 -0.64 . . . . 0.0 111.567 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.715 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 27.0 p -129.95 168.86 16.02 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.251 -0.906 . . . . 0.0 110.286 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -133.34 89.06 2.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.053 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -83.59 142.22 13.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.694 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 HG13 ' A' ' 102' ' ' VAL . 9.5 mt -129.65 155.59 45.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HG ' HG23 ' A' ' 123' ' ' ILE . 12.5 tp -137.35 104.25 5.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.619 ' HA ' HG13 ' A' ' 100' ' ' VAL . 1.6 ttt -95.65 145.79 24.99 Favored 'General case' 0 C--N 1.268 -2.969 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.94 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.755 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.11 132.53 2.7 Favored Glycine 0 CA--C 1.464 -3.116 0 C-N-CA 118.798 -1.668 . . . . 0.0 114.561 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.946 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.565 0.1 OUTLIER -156.44 111.94 2.93 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 173.974 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.8 tt0 -119.8 89.67 3.17 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 101.54 -3.504 . . . . 0.0 101.54 155.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.27 0.61 0.05 OUTLIER Glycine 2 CA--C 1.683 10.537 1 CA-C-N 128.656 5.207 . . . . 0.0 108.679 -178.983 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.88 HG13 ' OD1' ' A' ' 99' ' ' ASN . 5.7 p -22.11 132.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.4 2.77 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -170.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -71.01 -53.54 14.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.529 -2.123 . . . . 0.0 108.845 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.07 21.93 6.45 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.33 -37.42 0.93 Allowed Glycine 0 N--CA 1.51 3.6 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.585 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.62 -21.53 48.34 Favored 'General case' 0 N--CA 1.512 2.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.918 HG23 ' HG ' ' A' ' 112' ' ' LEU . 26.3 mt -81.08 -38.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.651 ' HA ' HG21 ' A' ' 101' ' ' THR . 36.0 t-20 -60.68 -29.26 69.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.52 -36.29 33.38 Favored 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 18.6 mtmm -79.76 -13.28 59.55 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.62 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.418 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 1.8 t -91.79 -32.06 15.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.91 -33.55 76.28 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -84.07 -36.02 23.33 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.679 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.3 ttt -58.92 -44.35 91.28 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.89 -19.22 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.438 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -60.33 -32.95 71.73 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 64.5 t60 -77.42 -43.07 33.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 110' ' ' VAL . 1.2 mp -65.88 -12.82 57.42 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.901 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -89.16 -36.58 15.6 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -81.02 -3.38 51.59 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -84.55 -18.4 35.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 68.66 20.96 8.08 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.886 -0.509 . . . . 0.0 109.639 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.791 179.217 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.005 0.431 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.462 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -140.0 -36.47 0.12 Allowed Glycine 0 N--CA 1.508 3.477 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.526 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -47.66 -48.23 29.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.982 -0.716 . . . . 0.0 112.03 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -58.96 -24.22 62.37 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 121.61 -0.682 . . . . 0.0 111.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.63 -38.18 62.59 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 36.2 m-85 -73.18 -10.57 59.91 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.802 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.4 mm -90.6 -29.16 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 2.3 m-20 -66.16 -17.29 64.63 Favored 'General case' 0 C--O 1.198 -1.628 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -56.1 -37.83 69.91 Favored 'General case' 0 C--O 1.194 -1.826 0 CA-C-O 121.893 0.854 . . . . 0.0 110.021 176.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.956 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 mm? -75.96 -38.06 57.95 Favored 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.177 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 mmt -73.65 -28.51 61.82 Favored 'General case' 1 C--N 1.24 -4.166 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.556 -176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.79 25.48 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.5 OUTLIER -72.86 -2.04 19.15 Favored 'General case' 1 N--CA 1.575 5.808 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -173.331 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.56 35.09 0.01 OUTLIER Glycine 1 N--CA 1.56 6.953 0 CA-C-N 120.505 1.502 . . . . 0.0 111.756 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ASP . 4.1 m -145.41 -38.97 0.25 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -68.98 -171.33 0.3 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 16.0 tm0? -150.69 -44.63 0.12 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 5.4 t70 -133.01 -175.18 3.7 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.956 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.83 134.85 1.04 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.157 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.992 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -143.25 110.29 5.64 Favored 'General case' 0 N--CA 1.512 2.626 0 C-N-CA 116.867 -1.933 . . . . 0.0 114.916 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 110' ' ' VAL . 12.2 mt -87.08 131.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 42' ' ' ILE . 41.0 t -135.85 111.17 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.848 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.66 85.77 0.09 OUTLIER Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.521 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.28 36.53 0.69 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.063 0.545 . . . . 0.0 111.6 -177.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -64.14 -155.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.59 -56.94 3.94 Favored 'General case' 1 N--CA 1.54 4.028 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.39 120.96 50.23 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 32.6 Cg_endo -77.48 159.72 32.28 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.094 1.863 . . . . 0.0 111.141 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.7 p -166.22 155.04 11.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 40' ' ' VAL . 47.9 t -87.09 103.56 13.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.509 0.671 . . . . 0.0 109.236 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.63 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -70.15 -26.21 63.83 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.186 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.65 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.559 0.695 . . . . 0.0 111.619 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.04 133.41 56.04 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 7' ' ' ILE . 34.6 t -45.74 102.63 0.31 Allowed Pre-proline 0 N--CA 1.52 3.061 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.1 Cg_endo -69.21 130.48 20.08 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.142 1.895 . . . . 0.0 112.103 -176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -24.87 5.5 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.53 -94.08 0.12 Allowed 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 117.771 0.785 . . . . 0.0 113.067 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.1 m -152.76 -40.39 0.1 Allowed 'General case' 0 N--CA 1.524 3.24 0 O-C-N 120.894 -1.129 . . . . 0.0 112.844 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.74 ' CZ ' HD12 ' A' ' 65' ' ' LEU . 9.6 m-30 -59.93 -40.11 87.8 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 121.601 -0.687 . . . . 0.0 112.253 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -55.98 -21.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.3 28.75 1.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.3 mt -70.17 167.08 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.33 1.062 . . . . 0.0 109.814 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.637 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 21.0 p -156.77 177.45 2.08 Favored Pre-proline 0 N--CA 1.511 2.59 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.0 Cg_endo -70.07 -0.11 6.7 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.97 1.113 . . . . 0.0 112.131 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.27 -65.67 0.99 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.2 pm0 -58.99 -32.2 69.47 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.691 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.0 -25.31 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.3 -27.86 61.0 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 63' ' ' LEU . 12.4 p -97.47 -35.43 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.912 0 O-C-N 122.204 -0.586 . . . . 0.0 110.477 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD23 HD13 ' A' ' 63' ' ' LEU . 6.3 mt -69.18 -13.36 62.37 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.112 -0.367 . . . . 0.0 110.625 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.98 -6.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.9 -174.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -46.08 132.37 10.51 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -18.4 6.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -48.77 128.66 15.85 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.39 33.0 5.17 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.964 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.5 t -170.73 -10.95 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 118.261 -1.376 . . . . 0.0 114.19 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.4 p -79.26 -96.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 118.724 0.693 . . . . 0.0 111.329 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' CD2' HD21 ' A' ' 63' ' ' LEU . 29.3 p90 -38.02 -22.43 0.01 OUTLIER 'General case' 0 N--CA 1.531 3.592 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 27.3 m-85 -60.38 -2.4 0.48 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 120.227 1.376 . . . . 0.0 112.362 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.7 -31.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 O-C-N 121.77 -0.581 . . . . 0.0 110.711 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 8.6 p30 -93.15 -47.8 6.78 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.615 -0.678 . . . . 0.0 110.721 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.61 154.79 7.48 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD12 ' HG ' ' A' ' 87' ' ' LEU . 36.3 mt -82.11 -159.96 0.34 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.629 ' C ' HD23 ' A' ' 65' ' ' LEU . 20.4 p -163.27 122.96 2.17 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.806 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -135.27 107.77 7.37 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.99 0.9 . . . . 0.0 109.766 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.16 20.76 72.01 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 14.28 64.54 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 20.2 tp60 -105.37 99.82 9.41 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 117.908 0.854 . . . . 0.0 109.714 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -65.76 106.22 1.46 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.231 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.806 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.8 p -104.41 175.12 5.59 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.518 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 90.1 p -130.57 108.31 9.83 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.912 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 75' ' ' ASP . 14.3 t -47.86 125.16 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.787 0.803 . . . . 0.0 110.857 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.806 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 64.1 mt -132.89 74.54 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.106 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.7 ttt180 113.21 71.22 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 125.782 1.633 . . . . 0.0 108.235 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.802 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -69.99 99.18 1.39 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.101 0.953 . . . . 0.0 110.41 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -123.76 -1.16 8.46 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.599 177.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 104' ' ' LYS . 9.2 tt -39.63 -29.67 0.06 Allowed 'General case' 0 N--CA 1.52 3.041 0 C-N-CA 123.837 0.855 . . . . 0.0 111.425 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 80' ' ' ASP . 6.1 mt -96.74 126.0 41.59 Favored 'General case' 0 C--O 1.198 -1.634 0 C-N-CA 118.901 -1.119 . . . . 0.0 108.288 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.49 76.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.073 1.749 . . . . 0.0 114.639 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 78' ' ' LEU . 35.8 t70 -101.12 23.99 10.05 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 19.55 24.07 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 6.1 mp0 -147.9 -51.99 0.19 Allowed 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 42.44 52.4 4.72 Favored 'General case' 0 N--CA 1.536 3.828 0 CA-C-O 121.961 0.886 . . . . 0.0 110.155 -172.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 p -145.71 137.22 25.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.818 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -136.83 127.24 26.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -176.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.806 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -91.25 75.9 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.908 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -94.73 115.17 27.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.396 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.31 136.72 52.8 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 9.0 p -59.22 93.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HD3' ' CB ' ' A' ' 71' ' ' SER . 6.3 mtmm -81.97 156.29 24.77 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.368 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t -145.98 -172.08 3.84 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 65.3 p -154.41 177.43 11.17 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.375 0.607 . . . . 0.0 111.119 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.84 47.78 88.02 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.99 24.17 64.56 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -73.06 166.56 42.39 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 122.052 -0.675 . . . . 0.0 110.123 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.6 Cg_endo -93.29 120.91 0.41 Allowed 'Trans proline' 0 N--CA 1.436 -1.875 0 C-N-CA 123.007 2.471 . . . . 0.0 109.179 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 91' ' ' SER . 43.1 p -97.46 170.75 8.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 54.5 m-85 -143.31 145.05 32.38 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -118.74 146.34 44.84 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.673 -176.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 113' ' ' MET . 6.7 t -135.61 138.1 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.813 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -113.22 122.84 48.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 111' ' ' LEU . 7.6 t -113.5 122.87 68.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.7 p -105.07 176.45 5.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.311 0.577 . . . . 0.0 110.292 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 8.0 tptp -146.89 155.97 42.72 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.922 0.867 . . . . 0.0 112.053 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.882 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.1 p -130.15 -147.14 0.33 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' TYR . 3.9 t70 -100.25 -19.82 16.2 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.202 -0.936 . . . . 0.0 110.243 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -144.42 18.94 1.71 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.657 -0.652 . . . . 0.0 110.291 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.63 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 10.4 p -140.87 151.82 44.6 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.7 95.24 4.5 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -177.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 134' ' ' LEU . 3.2 t -88.04 147.75 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 109.804 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.992 HD12 ' HB3' ' A' ' 20' ' ' ALA . 6.8 mt -132.35 151.91 51.65 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.66 104.05 6.71 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.582 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -91.54 148.63 22.15 Favored 'General case' 0 CA--C 1.466 -2.274 0 C-N-CA 117.849 -1.54 . . . . 0.0 109.828 -178.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 123' ' ' ILE . . . -148.29 152.35 24.43 Favored Glycine 0 C--N 1.301 -1.408 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 51.8 mttt -127.43 164.81 21.05 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.56 ' O ' ' O ' ' A' ' 115' ' ' LYS . 22.2 tt0 -16.63 154.21 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.348 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -175.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.98 12.74 79.24 Favored Glycine 0 CA--C 1.562 3.015 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -169.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.833 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.13 93.17 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 CA-C-N 113.899 -1.151 . . . . 0.0 112.285 -174.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -77.25 -23.69 51.21 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.03 -14.0 63.2 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 -37.13 12.43 Favored Glycine 0 N--CA 1.504 3.233 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 -38.36 65.35 Favored 'General case' 0 N--CA 1.517 2.88 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.741 HG23 ' HG ' ' A' ' 112' ' ' LEU . 5.9 mt -67.14 -36.02 75.81 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.95 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -66.31 -26.05 67.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -81.43 -30.97 33.31 Favored 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -87.7 -11.58 47.87 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.026 -0.421 . . . . 0.0 109.924 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -89.53 -30.7 18.04 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.07 -34.42 75.11 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.77 -37.86 34.45 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-O 121.424 0.631 . . . . 0.0 109.461 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.6 ttt -58.88 -45.46 90.15 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.79 -17.64 46.88 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.312 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -59.09 -34.74 72.34 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.502 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 31.0 t-80 -81.14 -38.24 27.5 Favored 'General case' 0 C--O 1.199 -1.57 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.675 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.882 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.2 mp -66.15 -12.87 58.59 Favored 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.993 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -78.43 -4.16 46.98 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' HIS . 28.6 p -80.55 -15.25 57.14 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 77.38 22.72 0.93 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 18.7 m-85 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.11 -69.35 0.03 OUTLIER Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -47.82 -54.29 12.89 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.539 0.685 . . . . 0.0 110.403 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -56.6 -30.8 63.63 Favored 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.04 -33.92 68.37 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 3.8 m-30 -69.91 -17.03 63.31 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.834 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.94 -27.11 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.348 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -64.96 -17.03 64.04 Favored 'General case' 0 C--O 1.198 -1.655 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.511 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -60.24 -71.88 0.12 Allowed 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.974 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -39.69 -37.53 0.53 Allowed 'General case' 1 N--CA 1.557 4.889 0 C-N-CA 124.565 1.146 . . . . 0.0 111.785 178.517 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.41 -46.4 33.06 Favored 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.89 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.89 -4.93 58.74 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -101.17 -2.1 32.22 Favored 'General case' 1 N--CA 1.577 5.898 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.074 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.86 35.07 0.01 OUTLIER Glycine 1 N--CA 1.545 5.953 0 CA-C-N 118.691 0.678 . . . . 0.0 114.137 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 m -146.92 -54.61 0.24 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HA ' ' HA2' ' A' ' 114' ' ' GLY 0.252 0.5 OUTLIER -85.51 115.12 23.04 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.761 175.061 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 1.7 tm0? -88.67 -39.62 13.88 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.941 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 1.2 t70 -123.42 -176.51 3.46 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.853 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.55 123.78 0.67 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -127.96 103.26 7.15 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 116.607 -2.037 . . . . 0.0 113.851 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 110' ' ' VAL . 15.3 mt -83.09 110.4 18.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 29' ' ' SER . 41.1 t -121.12 116.0 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.011 -174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.52 85.38 0.11 Allowed Glycine 1 N--CA 1.516 4.031 0 N-CA-C 106.693 -2.563 . . . . 0.0 106.693 176.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -81.72 31.38 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 123.713 0.805 . . . . 0.0 112.114 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -70.78 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.18 -61.4 0.58 Allowed 'General case' 1 N--CA 1.541 4.123 0 CA-C-O 121.145 0.497 . . . . 0.0 109.941 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 p -107.87 124.93 33.37 Favored Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 28.9 Cg_endo -79.71 151.64 22.11 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 121.576 1.518 . . . . 0.0 110.644 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.9 p -155.85 161.38 40.62 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 40' ' ' VAL . 69.8 t -91.01 99.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.38 -21.93 63.75 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.553 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.834 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.9 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.006 -0.434 . . . . 0.0 110.115 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.59 132.29 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.6 t -49.41 115.73 5.15 Favored Pre-proline 0 N--CA 1.518 2.968 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HA ' HG11 ' A' ' 40' ' ' VAL . 36.2 Cg_endo -78.91 141.14 16.61 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.069 1.846 . . . . 0.0 111.992 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.85 -15.4 13.96 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.22 -90.1 0.41 Allowed 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 118.527 1.163 . . . . 0.0 112.803 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -159.67 -34.93 0.06 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 121.344 -0.848 . . . . 0.0 112.498 -176.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.908 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.4 m-30 -60.7 -40.94 94.1 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.712 -0.617 . . . . 0.0 112.217 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -60.18 -18.26 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -87.29 24.08 1.69 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 6.2 mt -75.22 125.21 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 122.626 1.203 . . . . 0.0 111.037 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.9 p -114.46 179.87 0.72 Allowed Pre-proline 0 N--CA 1.507 2.385 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.6 Cg_endo -70.25 0.23 6.33 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 121.324 1.349 . . . . 0.0 112.428 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 -63.32 1.36 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -61.17 -32.84 72.57 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.55 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.846 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.21 -22.8 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.84 -29.86 71.47 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.763 HG22 HD23 ' A' ' 63' ' ' LEU . 9.1 p -97.5 -34.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 O-C-N 122.152 -0.617 . . . . 0.0 110.11 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.917 HD23 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -64.11 -18.92 64.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.2 m -144.93 -6.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.918 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -52.99 179.69 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 -20.37 28.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -51.23 134.36 27.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.36 50.94 1.58 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.262 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -170.51 -11.28 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.0 p -93.83 -89.49 0.22 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.31 -0.869 . . . . 0.0 109.97 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 50.7 p90 -37.68 -20.84 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 21.4 m-85 -60.35 -9.69 3.83 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 120.88 1.673 . . . . 0.0 112.199 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.31 -32.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.859 -0.525 . . . . 0.0 110.556 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 19.3 p30 -91.44 -45.51 8.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 123.78 143.63 6.31 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.917 HD13 HD23 ' A' ' 50' ' ' LEU . 12.5 mt -63.41 -150.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.8 p -160.74 133.58 6.38 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -136.64 101.14 4.53 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-O 121.928 0.871 . . . . 0.0 109.29 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.68 33.14 56.34 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.85 12.46 83.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB3' HD12 ' A' ' 65' ' ' LEU . 24.6 tp60 -113.79 98.57 7.1 Favored 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.543 1.172 . . . . 0.0 108.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.83 122.07 14.47 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.32 0.581 . . . . 0.0 110.2 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -117.98 134.17 55.22 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 57.5 p -76.08 160.2 30.01 Favored 'General case' 1 C--O 1.136 -4.882 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.023 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.6 t -101.36 143.93 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 2.0 mp -140.51 72.12 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.269 0 CA-C-O 122.888 1.328 . . . . 0.0 107.47 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.4 ttm180 109.01 76.09 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 125.936 1.694 . . . . 0.0 108.778 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.602 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -73.87 102.14 3.98 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.695 0.759 . . . . 0.0 111.133 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -134.28 22.37 3.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HG12 ' A' ' 102' ' ' VAL . 14.3 tp -57.22 -15.85 6.86 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 123.642 0.777 . . . . 0.0 111.577 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ASP . 50.8 mt -105.51 125.97 51.59 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.36 76.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.945 1.698 . . . . 0.0 114.852 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 78' ' ' LEU . 23.9 t70 -101.26 26.05 7.56 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 171.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 29.94 10.08 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 8.5 mm-40 -155.76 -59.65 0.1 Allowed 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 55.23 6.29 0.15 Allowed 'General case' 0 N--CA 1.52 3.063 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.909 -172.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -100.13 133.28 44.75 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-N 120.141 1.337 . . . . 0.0 109.683 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.875 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -129.33 125.82 37.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -89.95 79.58 6.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.417 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.875 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -97.24 118.49 33.79 Favored 'General case' 0 CA--C 1.49 -1.35 0 C-N-CA 118.362 -1.335 . . . . 0.0 109.341 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -115.03 130.75 57.01 Favored 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 119.646 -0.821 . . . . 0.0 112.862 -176.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 p -57.32 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 2.2 mtmt -74.55 172.9 11.18 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.234 -0.916 . . . . 0.0 108.822 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -130.06 163.31 26.81 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.686 0.755 . . . . 0.0 110.536 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 91' ' ' SER . 43.8 p -156.95 109.8 2.54 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.27 52.02 1.19 Allowed Glycine 0 N--CA 1.505 3.245 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.32 23.18 66.2 Favored Glycine 0 N--CA 1.505 3.286 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -82.39 168.55 22.77 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.854 -0.792 . . . . 0.0 109.633 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -92.82 134.59 1.19 Allowed 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 123.377 2.718 . . . . 0.0 111.12 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' SER . 24.7 p -105.24 159.63 15.73 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 97' ' ' THR . 39.1 m-85 -145.29 134.01 22.24 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -105.22 137.71 42.57 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.954 1.252 . . . . 0.0 110.835 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.6 t -125.37 148.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.691 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HA ' ' A' ' 124' ' ' ASN . 87.4 m -124.37 122.8 38.68 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.935 HG12 HD13 ' A' ' 77' ' ' LEU . 2.1 t -110.25 118.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.651 0.739 . . . . 0.0 110.112 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.62 HG23 ' SG ' ' A' ' 127' ' ' CYS . 13.1 p -110.87 120.33 42.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 77' ' ' LEU . 1.4 tppp? -105.51 129.82 53.71 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.44 0.638 . . . . 0.0 109.765 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 134' ' ' LEU . 65.2 p -89.65 -145.63 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -97.47 -16.26 20.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 109.653 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 28.1 mttm -149.2 22.39 0.95 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.911 -0.493 . . . . 0.0 110.572 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.553 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 14.9 p -144.92 151.73 39.12 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.744 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -120.17 85.89 2.47 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -77.74 139.42 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.95 -1.094 . . . . 0.0 109.571 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -120.83 140.43 51.77 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -127.56 99.55 5.64 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.543 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 13.3 ttt -88.31 145.95 25.56 Favored 'General case' 0 N--CA 1.512 2.667 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.918 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.599 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -129.46 134.24 7.85 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 113.934 -1.484 . . . . 0.0 112.214 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.73 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 31.4 mttt -124.91 153.78 42.14 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 115' ' ' LYS . 23.7 tp10 -16.97 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.845 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 74.85 15.78 80.72 Favored Glycine 0 CA--C 1.562 3.017 1 N-CA-C 100.258 -5.137 . . . . 0.0 100.258 -168.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.73 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.2 p -101.54 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.382 1.994 0 CA-C-N 113.8 -1.2 . . . . 0.0 111.956 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -86.41 -29.96 22.47 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.9 -18.22 57.12 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.4 -35.95 11.39 Favored Glycine 0 N--CA 1.515 3.954 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.95 -36.01 67.07 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 112' ' ' LEU . 75.0 mt -67.65 -37.54 78.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.896 ' HA ' HG21 ' A' ' 101' ' ' THR . 43.4 t-20 -63.31 -28.54 70.08 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.05 -31.78 39.47 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 130' ' ' MET . 17.6 mtmm -87.29 -12.98 44.96 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 122.154 -0.341 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' A' ' 103' ' ' THR . 8.5 t -89.49 -35.33 16.02 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.13 -33.78 75.12 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 132' ' ' SER . 48.9 mt-10 -85.44 -30.57 23.43 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.122 0.487 . . . . 0.0 109.708 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.605 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.2 tpp -63.22 -42.01 99.21 Favored 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.92 -21.14 47.74 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.926 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.9 m -58.59 -32.58 69.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.455 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 2.7 t60 -78.76 -40.17 34.07 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -67.36 -10.11 47.89 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.556 178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -40.37 12.5 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -75.55 -7.87 55.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.411 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 16.7 p -79.97 -15.34 57.46 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 73.75 29.67 1.46 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.636 -0.665 . . . . 0.0 109.312 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 97.98 24.75 11.25 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.99 -45.43 64.51 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.647 -0.914 . . . . 0.0 110.399 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.79 -25.53 65.01 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 121.993 -0.442 . . . . 0.0 110.58 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.13 -36.45 69.4 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.631 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 35.0 m-85 -75.54 -9.78 58.88 Favored 'General case' 0 N--CA 1.523 3.178 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.818 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.4 -27.06 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.763 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.49 -13.01 61.94 Favored 'General case' 0 C--O 1.189 -2.126 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.65 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -59.41 -58.54 8.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.803 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.264 1.0 OUTLIER -47.7 -42.5 25.17 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.011 178.025 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.9 mmt -75.92 -37.39 58.8 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.755 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.98 -1.97 55.69 Favored 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.16 -1.86 35.52 Favored 'General case' 1 N--CA 1.562 5.168 0 CA-C-N 120.296 1.407 . . . . 0.0 114.387 -175.427 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 33.43 31.1 0.01 OUTLIER Glycine 1 N--CA 1.554 6.557 0 CA-C-N 119.282 0.946 . . . . 0.0 112.686 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' ASP . 18.1 m -143.12 -34.85 0.41 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.87 -172.22 0.36 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 5.6 tm0? -150.64 -46.13 0.12 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 3.4 t70 -132.51 -175.6 3.81 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.625 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -171.31 132.9 0.81 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.493 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -144.33 109.54 5.1 Favored 'General case' 0 N--CA 1.513 2.693 0 C-N-CA 116.81 -1.956 . . . . 0.0 114.843 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.727 HG12 HG22 ' A' ' 110' ' ' VAL . 41.6 mt -87.47 120.24 36.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 102.148 -3.279 . . . . 0.0 102.148 173.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 29' ' ' SER . 21.5 t -125.71 114.39 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.926 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.44 86.63 0.11 Allowed Glycine 1 N--CA 1.517 4.075 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 176.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -84.46 34.49 0.53 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -65.89 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.4 -58.43 2.96 Favored 'General case' 0 N--CA 1.538 3.966 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.0 p -103.36 124.25 38.83 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -81.25 151.1 17.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.877 1.718 . . . . 0.0 110.565 -177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' VAL . 78.5 p -155.53 162.3 40.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.619 HG21 ' O ' ' A' ' 40' ' ' VAL . 72.1 t -89.21 98.74 8.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.622 ' CZ3' HG22 ' A' ' 108' ' ' THR . 8.6 m0 -69.21 -22.14 63.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.818 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.71 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.178 0.513 . . . . 0.0 110.589 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.92 131.28 53.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 19' ' ' ALA . 16.2 t -48.64 103.48 0.37 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.824 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.9 Cg_endo -72.74 154.83 54.27 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.03 1.82 . . . . 0.0 112.808 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.09 -34.01 6.06 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -80.35 -94.87 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.848 -0.795 . . . . 0.0 112.874 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -153.46 -40.15 0.1 Allowed 'General case' 0 N--CA 1.517 2.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.322 -176.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.919 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.2 m-85 -57.93 -44.8 87.11 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 121.727 -0.608 . . . . 0.0 111.875 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.8 p -56.88 -21.53 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -81.79 20.49 0.95 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -72.81 130.51 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 CA-C-O 122.681 1.229 . . . . 0.0 110.777 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 p -118.81 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -69.5 -1.26 7.95 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 120.974 1.116 . . . . 0.0 112.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.55 -64.86 1.09 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -61.98 -31.14 71.47 Favored 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.289 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.7 t -82.38 -22.93 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -61.59 -28.85 70.45 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 58' ' ' PHE . 14.0 p -97.58 -36.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 O-C-N 122.168 -0.607 . . . . 0.0 109.751 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 63' ' ' LEU . 3.2 mt -65.9 -16.8 64.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -147.05 -2.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.499 -173.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -50.65 156.13 2.71 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -16.86 55.01 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -55.6 121.67 9.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.94 33.12 5.58 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.678 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 33.0 t -170.47 -10.4 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.711 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.4 p -85.55 -86.02 0.14 Allowed 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 119.602 1.092 . . . . 0.0 112.19 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 63' ' ' LEU . 47.1 p90 -37.53 -18.75 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.488 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 18.5 m-85 -60.33 -7.7 2.17 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-N 120.594 1.543 . . . . 0.0 112.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -30.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.651 -0.656 . . . . 0.0 111.575 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -87.9 -34.74 18.05 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.485 -0.759 . . . . 0.0 110.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 115.25 150.17 9.75 Favored Glycine 0 N--CA 1.478 1.44 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.807 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.6 mt -83.46 -153.54 0.14 Allowed 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.2 p -160.23 131.16 5.66 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.79 102.39 5.44 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.122 0.963 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 75.76 27.03 63.62 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.39 9.98 74.84 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 65' ' ' LEU . 25.0 tp60 -108.28 108.95 20.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 118.686 1.243 . . . . 0.0 110.398 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -59.9 112.31 1.8 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.307 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.414 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.5 p -113.28 162.88 15.5 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.573 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 76.4 p -122.67 109.4 14.22 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.0 t -47.85 128.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.669 0.747 . . . . 0.0 110.322 178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 9.8 mt -126.63 73.99 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER 97.95 79.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.404 -178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.925 ' HB2' HG11 ' A' ' 72' ' ' VAL . 11.3 t70 -69.54 101.21 1.56 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.415 ' HA ' ' CD ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -116.31 18.06 15.38 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 13.9 tp -54.72 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.391 1.076 . . . . 0.0 113.491 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.8 pt? -77.15 47.72 0.57 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 119.834 -1.791 . . . . 0.0 114.598 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 3.0 pt20 -111.39 57.86 0.63 Allowed 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.2 t70 -15.76 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 123.208 1.48 . . . . 0.0 113.068 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.62 15.0 25.99 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.675 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 5.9 mp0 -150.08 -54.37 0.16 Allowed 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.795 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 1.7 p90 19.8 58.48 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.07 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 p -147.79 133.8 19.23 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.77 ' HG2' HG13 ' A' ' 72' ' ' VAL 0.315 20.7 ttt -137.74 127.02 24.62 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -174.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 6.3 m-20 -92.56 75.66 5.09 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 120.486 -1.384 . . . . 0.0 111.016 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.857 HD11 ' HB ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -91.48 107.31 19.12 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.417 179.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 6.2 ptt180 -109.35 133.18 53.38 Favored 'General case' 0 N--CA 1.522 3.133 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.426 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.6 p -57.82 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.17 164.25 24.37 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.125 -0.985 . . . . 0.0 110.229 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.851 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -115.78 179.47 3.97 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.236 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -136.44 38.66 2.68 Favored 'General case' 0 N--CA 1.518 2.964 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.72 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.3 -107.38 0.44 Allowed Glycine 0 N--CA 1.51 3.581 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.47 13.32 64.2 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.851 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -82.9 168.72 21.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 CA-C-N 117.889 0.844 . . . . 0.0 109.964 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.7 Cg_endo -94.48 147.08 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.562 2.842 . . . . 0.0 110.969 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 91' ' ' SER . 17.8 p -119.62 156.0 31.23 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 115' ' ' LYS . 50.3 m-85 -143.4 139.96 30.22 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -116.35 141.18 48.5 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.956 -176.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' LEU . 14.7 t -128.97 143.07 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.611 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 124' ' ' ASN . 55.2 m -113.75 126.48 55.27 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.6 t -117.29 117.19 54.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 83' ' ' PHE . 2.2 p -99.12 160.54 14.2 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.546 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tppp? -137.75 139.41 40.07 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 121.498 0.666 . . . . 0.0 110.394 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.82 HG21 ' HB3' ' A' ' 134' ' ' LEU . 64.0 p -114.14 -144.01 0.39 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -96.15 -17.79 20.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.797 . . . . 0.0 109.986 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 2.2 mtmt -152.93 21.38 0.58 Allowed 'General case' 0 N--CA 1.518 2.929 0 O-C-N 121.582 -0.699 . . . . 0.0 110.725 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 21.8 p -138.38 153.53 48.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.963 -1.085 . . . . 0.0 108.195 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.743 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.71 85.79 2.46 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.799 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -80.47 143.39 12.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 O-C-N 121.204 -0.935 . . . . 0.0 109.053 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.743 HD21 HD13 ' A' ' 109' ' ' LEU . 13.5 mt -128.92 151.92 49.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.875 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -135.03 101.59 4.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.44 145.81 25.07 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 117.905 -1.518 . . . . 0.0 109.695 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -140.76 150.07 21.44 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 19.8 mttt -129.57 165.9 20.78 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' O ' ' A' ' 115' ' ' LYS . 8.6 tt0 -16.8 152.16 0.0 OUTLIER 'General case' 1 N--CA 1.545 4.318 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.4 79.28 Favored Glycine 0 CA--C 1.563 3.064 1 N-CA-C 100.729 -4.948 . . . . 0.0 100.729 -168.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.845 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.46 93.57 2.89 Favored 'Isoleucine or valine' 0 C--N 1.376 1.736 0 CA-C-N 113.886 -1.157 . . . . 0.0 111.656 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -73.85 -35.45 64.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.12 -20.32 47.97 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.24 -28.16 28.65 Favored Glycine 0 N--CA 1.507 3.427 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -41.41 60.41 Favored 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.875 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.6 mt -69.08 -34.45 63.76 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.376 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 101' ' ' THR . 50.2 t30 -64.15 -26.53 68.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -85.87 -30.63 22.75 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 8.7 mtmt -88.9 -11.4 44.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.091 -0.381 . . . . 0.0 110.654 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.1 t -91.93 -35.29 14.1 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 175.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.83 -30.86 71.88 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.53 -34.24 21.57 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.615 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.9 ttt -59.57 -45.37 92.06 Favored 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.39 -19.6 45.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.615 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.8 p -60.88 -29.42 69.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.529 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.5 t60 -80.35 -40.08 27.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' A' ' 105' ' ' THR . 3.4 mp -69.18 -8.35 44.84 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.499 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -38.07 11.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -5.67 55.39 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.3 p -80.1 -24.33 40.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 73.77 24.14 2.19 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.529 179.157 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.49 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 138.35 -136.03 7.83 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -47.51 -47.96 27.51 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.399 -0.471 . . . . 0.0 111.786 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -60.52 -22.36 63.52 Favored 'General case' 0 N--CA 1.524 3.275 0 O-C-N 121.507 -0.745 . . . . 0.0 111.59 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -77.07 -38.38 52.66 Favored 'General case' 0 N--CA 1.522 3.149 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.8 m-85 -73.79 -10.0 59.22 Favored 'General case' 0 N--CA 1.523 3.182 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 3.9 mm -90.33 -30.37 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.5 m-20 -63.35 -18.71 63.95 Favored 'General case' 0 C--O 1.19 -2.044 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.05 -43.18 66.45 Favored 'General case' 0 C--O 1.2 -1.512 0 CA-C-O 122.247 1.023 . . . . 0.0 109.661 176.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.906 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 mm? -68.99 -38.1 79.12 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.375 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 mmt -75.28 -29.38 60.1 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.599 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.8 -23.02 31.63 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -82.37 -1.76 50.86 Favored 'General case' 1 N--CA 1.569 5.521 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.132 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.95 34.6 0.01 OUTLIER Glycine 1 N--CA 1.56 6.925 0 CA-C-N 120.184 1.356 . . . . 0.0 112.115 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 8.1 m -145.72 -37.75 0.26 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.37 -173.31 0.54 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.7 tp60 -150.93 -43.18 0.12 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' CA ' ' HB3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -134.29 177.02 8.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.906 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -167.46 129.5 1.6 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 117.965 -1.016 . . . . 0.0 108.96 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . . . -138.94 108.54 6.2 Favored 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 116.644 -2.022 . . . . 0.0 114.106 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.448 HD11 ' HE2' ' A' ' 130' ' ' MET . 19.4 mt -84.41 119.37 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 102.669 -3.085 . . . . 0.0 102.669 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 42' ' ' ILE . 21.5 t -125.53 114.7 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.377 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.77 87.07 0.07 OUTLIER Glycine 1 N--CA 1.518 4.146 0 N-CA-C 105.956 -2.857 . . . . 0.0 105.956 175.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.49 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.22 34.71 0.63 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.22 -154.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -58.41 3.94 Favored 'General case' 1 N--CA 1.542 4.138 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -98.79 118.98 62.18 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HG3' ' CA ' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -79.79 152.34 22.25 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.227 1.952 . . . . 0.0 110.921 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 22' ' ' VAL . 67.5 p -156.04 154.53 31.16 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 40' ' ' VAL . 49.5 t -88.67 99.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.4 m0 -69.35 -23.94 63.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.043 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.54 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.958 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -120.12 130.82 54.8 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.45 HG22 HG23 ' A' ' 7' ' ' ILE . 14.7 t -49.54 109.58 1.29 Allowed Pre-proline 0 N--CA 1.518 2.964 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.581 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -70.66 147.25 56.69 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 121.862 1.708 . . . . 0.0 111.934 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.39 -24.15 28.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -80.92 -97.43 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.974 -0.721 . . . . 0.0 111.783 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.88 -41.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.051 -1.03 . . . . 0.0 111.349 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.858 ' CE1' HD13 ' A' ' 65' ' ' LEU . 4.6 m-30 -59.71 -40.84 89.3 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 122.11 -0.369 . . . . 0.0 111.126 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.678 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -54.65 -23.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -89.68 29.66 1.13 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.2 mt -69.12 170.79 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 CA-C-O 122.128 0.966 . . . . 0.0 109.86 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.661 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -158.73 179.47 1.36 Allowed Pre-proline 0 N--CA 1.504 2.257 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.661 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 29.3 Cg_endo -74.22 2.41 6.2 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.273 1.315 . . . . 0.0 111.873 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.16 -63.93 1.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.3 pm0 -58.59 -33.35 69.88 Favored 'General case' 0 N--CA 1.512 2.672 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.885 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -85.49 -21.81 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.715 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.87 -27.15 71.77 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 63' ' ' LEU . 14.5 p -97.28 -36.27 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 122.43 -0.453 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 63' ' ' LEU . 4.7 mt -65.28 -17.82 64.81 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -145.7 -2.43 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.764 -172.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.67 -160.88 0.05 OUTLIER Glycine 0 N--CA 1.498 2.803 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 54' ' ' ASP . 4.6 mmtt -92.03 -62.89 1.32 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' O ' ' CE1' ' A' ' 58' ' ' PHE . 3.4 t0 -26.02 91.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 122.45 1.119 . . . . 0.0 111.346 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -71.92 18.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.667 -1.151 . . . . 0.0 113.103 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.54 -19.8 0.08 Allowed 'General case' 0 N--CA 1.533 3.722 0 C-N-CA 119.024 -1.07 . . . . 0.0 113.866 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 60' ' ' VAL . 52.2 p -66.41 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' ' OD1' ' A' ' 61' ' ' ASN . 17.5 p90 -37.49 -21.31 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CE1' ' CB ' ' A' ' 75' ' ' ASP . 19.6 m-85 -61.24 -3.21 0.82 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.929 1.695 . . . . 0.0 112.739 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -120.42 -31.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 O-C-N 121.68 -0.638 . . . . 0.0 111.29 -178.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -87.55 -21.47 25.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.688 -0.632 . . . . 0.0 109.922 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 92.96 133.93 6.67 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.979 HD11 ' HE2' ' A' ' 85' ' ' MET . 12.7 mt -65.43 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.6 p -161.33 137.26 8.03 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.858 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -141.37 103.76 4.47 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-O 122.351 1.072 . . . . 0.0 109.557 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.66 29.33 57.86 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.02 85.65 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' A' ' 89' ' ' THR . 12.8 tm0? -107.94 106.97 17.47 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 118.667 1.233 . . . . 0.0 110.209 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 114.61 3.99 Favored 'General case' 0 N--CA 1.512 2.633 0 O-C-N 122.03 -0.418 . . . . 0.0 111.361 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.51 139.11 51.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 4.2 p -96.11 117.97 31.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.1 t -51.83 135.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.731 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.2 mt -134.94 75.42 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-O 123.7 1.714 . . . . 0.0 106.996 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER 92.04 92.88 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.986 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.214 -178.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG11 ' A' ' 72' ' ' VAL . 1.7 t70 -89.67 96.57 10.75 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 112.048 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -104.58 9.29 35.4 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.965 HD13 HG12 ' A' ' 102' ' ' VAL . 15.7 tp -42.1 -26.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 123.688 0.795 . . . . 0.0 112.015 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ASP . 5.6 mt -98.3 118.24 34.49 Favored 'General case' 0 C--O 1.202 -1.44 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.047 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -47.85 78.08 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 123.82 1.772 . . . . 0.0 115.062 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.8 t70 -101.01 23.87 10.14 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 111.916 -2.402 . . . . 0.0 104.574 171.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.97 26.84 8.17 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' CB ' ' OG ' ' A' ' 76' ' ' SER . 2.0 mp0 -153.61 -60.72 0.14 Allowed 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 58.11 1.32 0.15 Allowed 'General case' 1 N--CA 1.543 4.186 0 O-C-N 121.688 -0.633 . . . . 0.0 111.58 -173.672 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -94.41 132.02 39.48 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.442 1.474 . . . . 0.0 109.596 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.979 ' HE2' HD11 ' A' ' 63' ' ' LEU . 7.5 ttt -134.05 136.79 44.23 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.731 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -101.33 84.12 2.57 Favored 'General case' 1 N--CA 1.548 4.454 0 O-C-N 120.757 -1.214 . . . . 0.0 112.274 -177.023 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.896 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -96.58 108.65 21.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.912 -1.743 . . . . 0.0 108.193 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.7 OUTLIER -112.58 131.0 55.83 Favored 'General case' 0 N--CA 1.523 3.2 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.154 -176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 68' ' ' GLN . 2.4 p -56.91 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' CD ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -79.09 153.86 29.84 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 121.026 -1.046 . . . . 0.0 109.292 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.692 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -97.44 176.98 5.68 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.707 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -149.9 98.86 2.78 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.958 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.47 29.01 10.52 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.65 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.58 -16.4 31.51 Favored Glycine 0 N--CA 1.511 3.69 0 CA-C-N 118.235 1.017 . . . . 0.0 111.268 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.692 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -50.45 169.3 0.21 Allowed Pre-proline 0 N--CA 1.513 2.713 0 CA-C-N 118.237 1.018 . . . . 0.0 110.048 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.5 Cg_endo -90.88 137.42 2.25 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 123.163 2.576 . . . . 0.0 110.428 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 91' ' ' SER . 54.9 p -103.56 168.03 9.42 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CE2' ' HE2' ' A' ' 115' ' ' LYS . 53.7 m-85 -149.92 139.79 21.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -113.59 141.86 46.68 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 118.503 -1.279 . . . . 0.0 112.328 -176.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.62 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -129.79 144.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.899 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 124' ' ' ASN . 93.1 m -117.37 135.7 53.68 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.965 HG12 HD13 ' A' ' 77' ' ' LEU . 2.2 t -121.24 115.46 46.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.873 0.844 . . . . 0.0 109.163 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.552 HG23 ' SG ' ' A' ' 127' ' ' CYS . 11.3 p -107.05 124.07 49.13 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.058 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 4.0 tppp? -98.26 132.93 43.34 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.017 0.436 . . . . 0.0 110.357 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.821 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.5 p -100.89 -145.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -99.72 -6.77 26.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 63.6 mttt -156.98 16.15 0.29 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.619 -0.676 . . . . 0.0 111.044 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.598 ' OG1' HD22 ' A' ' 134' ' ' LEU . 9.4 p -143.83 160.06 41.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.19 -0.944 . . . . 0.0 109.944 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -123.02 85.57 2.44 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -76.3 138.01 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 121.237 -0.914 . . . . 0.0 109.499 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 ' CG2' ' A' ' 102' ' ' VAL . 4.0 mt -120.29 139.7 52.33 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.801 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.41 99.82 6.38 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -89.61 146.1 24.79 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.472 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -143.12 146.84 17.95 Favored Glycine 0 C--N 1.305 -1.162 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 7.9 mttt -126.03 164.03 21.74 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.566 ' O ' ' O ' ' A' ' 115' ' ' LYS . 12.3 tt0 -16.76 152.41 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.152 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -175.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.95 13.76 80.64 Favored Glycine 0 CA--C 1.566 3.268 1 N-CA-C 100.631 -4.988 . . . . 0.0 100.631 -168.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.827 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -101.94 102.45 13.55 Favored 'Isoleucine or valine' 0 C--N 1.382 2.006 0 CA-C-N 113.885 -1.158 . . . . 0.0 112.667 -174.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -81.43 -33.72 31.97 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.17 -15.91 61.79 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 -33.36 16.9 Favored Glycine 0 N--CA 1.501 2.98 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.594 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -78.83 -32.64 46.25 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.801 HG23 ' HG ' ' A' ' 112' ' ' LEU . 30.4 mt -70.35 -36.46 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.872 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.6 t30 -65.84 -24.2 66.84 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -84.82 -35.42 22.31 Favored 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -81.13 -12.15 59.3 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.632 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.1 t -88.08 -35.28 17.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -33.1 75.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 132' ' ' SER . 2.0 mm-40 -81.97 -33.94 29.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.616 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -61.05 -44.56 97.2 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.47 46.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.754 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 17.4 m -58.19 -31.81 67.66 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 9.2 t60 -80.75 -40.41 25.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.338 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.8 mp -68.06 -8.49 38.36 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.291 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -40.5 11.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtt85 -78.17 -5.23 51.13 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.8 p -82.54 -20.26 36.99 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 64.1 27.12 14.09 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.661 -1.161 . . . . 0.0 108.863 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -170.57 -64.46 0.04 OUTLIER Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.485 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -55.97 -42.64 76.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.235 -0.568 . . . . 0.0 110.062 179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 121.888 -0.508 . . . . 0.0 110.677 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -79.75 -36.74 36.81 Favored 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.662 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 42.0 m-85 -74.03 -11.94 60.48 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.85 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.2 mm -90.93 -26.97 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.985 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 172.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.1 m-20 -61.27 -20.51 62.95 Favored 'General case' 0 C--O 1.18 -2.576 0 O-C-N 120.427 -1.42 . . . . 0.0 107.474 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.705 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -51.19 -58.71 5.42 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.179 0.99 . . . . 0.0 108.409 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.721 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -49.57 -39.91 36.69 Favored 'General case' 0 CA--C 1.44 -3.27 0 CA-C-N 113.967 -1.47 . . . . 0.0 112.504 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.401 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 11.2 mmt -81.43 -33.02 32.39 Favored 'General case' 1 C--N 1.241 -4.15 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.908 -174.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 -3.24 58.04 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.19 -1.74 35.78 Favored 'General case' 1 N--CA 1.56 5.04 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -175.606 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 29.11 37.59 0.01 OUTLIER Glycine 1 N--CA 1.565 7.289 0 CA-C-N 119.95 1.25 . . . . 0.0 111.955 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.2 m -148.37 -39.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -68.84 -175.28 0.68 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.933 0.873 . . . . 0.0 109.223 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 22.7 tm0? -150.77 -45.16 0.12 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.7 t0 -128.94 178.68 6.21 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 10' ' ' LEU 0.254 . . -171.43 130.43 0.71 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.061 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -146.53 113.57 6.17 Favored 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 116.824 -1.95 . . . . 0.0 115.415 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 HG22 ' A' ' 110' ' ' VAL . 15.4 mt -86.73 123.01 39.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 102.053 -3.314 . . . . 0.0 102.053 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 29' ' ' SER . 27.8 t -128.57 113.88 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.216 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.28 86.31 0.08 OUTLIER Glycine 0 N--CA 1.514 3.852 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.36 36.83 0.6 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.091 0.557 . . . . 0.0 111.863 -177.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -66.15 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.87 -59.35 2.3 Favored 'General case' 1 N--CA 1.543 4.182 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 p -106.06 124.56 35.56 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 28.7 Cg_endo -78.25 156.56 29.53 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.001 1.801 . . . . 0.0 111.537 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.8 p -157.01 162.71 39.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 40' ' ' VAL . 65.1 t -92.35 100.05 10.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.2 m0 -69.75 -25.34 63.77 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.51 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.85 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.87 85.0 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 CA-C-O 121.181 0.515 . . . . 0.0 110.776 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -119.28 132.24 55.88 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 19' ' ' ALA . 60.3 t -47.93 108.7 0.95 Allowed Pre-proline 0 N--CA 1.516 2.855 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 40' ' ' VAL . 35.4 Cg_endo -74.03 147.05 37.91 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.165 1.91 . . . . 0.0 112.84 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.75 -18.5 37.39 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.24 -89.75 0.24 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 118.273 1.037 . . . . 0.0 112.959 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.36 -39.61 0.06 Allowed 'General case' 0 N--CA 1.525 3.314 0 O-C-N 120.953 -1.092 . . . . 0.0 112.204 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.97 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -59.88 -41.28 91.18 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -58.06 -20.29 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.14 27.05 1.45 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.7 mt -75.37 125.18 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.381 1.086 . . . . 0.0 110.366 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.29 -179.69 0.67 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.4 Cg_endo -69.83 -0.06 6.42 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 120.988 1.125 . . . . 0.0 112.189 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.7 -64.04 1.25 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -60.68 -34.1 73.83 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.24 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.853 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.77 -22.68 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.06 -31.42 72.72 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 63' ' ' LEU . 12.5 p -97.52 -34.34 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 O-C-N 122.341 -0.505 . . . . 0.0 110.268 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.72 HD23 HD13 ' A' ' 63' ' ' LEU . 5.1 mt -64.49 -18.73 65.06 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -140.53 -9.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.283 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -52.43 146.53 15.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -10.57 51.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 122.818 -0.225 . . . . 0.0 111.017 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -46.89 131.21 12.07 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.04 36.02 4.73 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.526 -175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -168.01 -32.66 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.998 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 p -67.57 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.362 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 25.0 p90 -37.24 -21.83 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.547 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 24.3 m-85 -60.75 -7.32 2.21 Favored 'General case' 0 N--CA 1.512 2.661 0 CA-C-N 121.128 1.785 . . . . 0.0 112.529 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.9 -30.94 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.825 -0.547 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.5 p30 -89.03 -39.83 13.4 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.241 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.04 147.37 7.72 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 49' ' ' VAL . 11.5 mt -75.58 -154.47 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 63' ' ' LEU . 12.4 p -160.21 129.07 4.92 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.97 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.19 106.65 7.27 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-O 121.934 0.873 . . . . 0.0 110.039 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.46 24.78 72.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 10.77 70.36 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.9 tp60 -112.01 105.92 14.44 Favored 'General case' 0 N--CA 1.52 3.031 0 CA-C-N 118.536 1.168 . . . . 0.0 110.901 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.47 116.49 4.36 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.304 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.3 p -112.13 160.49 17.5 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.549 ' OG ' ' HD3' ' A' ' 90' ' ' LYS . 92.3 p -115.37 114.93 25.77 Favored 'General case' 0 N--CA 1.524 3.239 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.8 t -49.44 112.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 121.477 0.656 . . . . 0.0 112.116 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.688 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -115.52 71.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER 102.96 110.4 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.124 -178.974 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -104.76 97.77 7.61 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.006 0.907 . . . . 0.0 112.453 -179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -122.1 6.6 9.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.727 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.1 tt -42.98 -26.71 0.15 Allowed 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.418 0.687 . . . . 0.0 111.353 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 78' ' ' LEU . 80.1 mt -99.57 120.39 39.59 Favored 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.677 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -47.91 76.84 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 126.036 1.734 . . . . 0.0 114.953 -174.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 78' ' ' LEU . 27.7 t70 -101.18 24.86 8.86 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 171.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.21 29.45 6.75 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 38.2 mm-40 -157.73 -60.0 0.08 Allowed 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.507 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 59.74 7.57 1.11 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 121.834 -0.541 . . . . 0.0 110.28 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.2 p -100.91 136.42 40.79 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 119.783 1.174 . . . . 0.0 109.232 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.633 ' HG2' HD12 ' A' ' 87' ' ' LEU . 2.8 ttt -142.96 130.89 21.65 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.81 ' C ' HD13 ' A' ' 87' ' ' LEU . 4.8 m-20 -95.35 144.54 25.81 Favored 'General case' 0 C--O 1.173 -2.925 0 C-N-CA 117.942 -1.503 . . . . 0.0 107.823 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.81 HD13 ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -152.43 117.26 5.11 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -120.12 135.54 54.92 Favored 'General case' 0 N--CA 1.525 3.323 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 3.1 p -59.26 93.53 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -77.34 175.1 10.06 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.132 -175.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.962 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t -125.38 176.79 6.56 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.147 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.5 p -97.37 -54.22 3.21 Favored 'General case' 0 N--CA 1.513 2.7 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.67 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.45 104.69 0.19 Allowed Glycine 0 N--CA 1.502 3.066 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.73 -14.3 61.96 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.962 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -74.12 172.13 9.35 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.746 -0.855 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.0 Cg_endo -93.26 130.49 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.263 2.642 . . . . 0.0 111.274 -177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 91' ' ' SER . 49.9 p -106.83 168.18 9.37 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 59.8 m-85 -146.51 135.19 22.2 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -111.95 143.91 42.14 Favored 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 118.493 -1.283 . . . . 0.0 112.186 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -129.79 157.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.065 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.5 m -123.08 159.04 29.31 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.753 ' HB ' HD11 ' A' ' 87' ' ' LEU . 8.4 t -150.57 114.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.014 -1.054 . . . . 0.0 108.517 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 6.6 p -101.63 167.07 10.35 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.116 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.727 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.6 tptp -141.07 147.74 39.06 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.488 0.661 . . . . 0.0 110.504 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.943 HG21 ' HB3' ' A' ' 134' ' ' LEU . 45.1 p -117.87 -141.95 0.36 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.31 -24.57 15.6 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.818 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 4.4 mttp -146.76 18.74 1.29 Allowed 'General case' 0 N--CA 1.515 2.795 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.37 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.632 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.8 p -134.61 147.66 50.25 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.087 -1.008 . . . . 0.0 108.409 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -116.33 92.4 3.87 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -177.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 134' ' ' LEU . 2.7 t -86.87 141.46 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.936 -1.103 . . . . 0.0 109.488 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.726 HD21 HD13 ' A' ' 109' ' ' LEU . 6.4 mt -131.5 152.48 50.69 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.933 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.1 tp -137.14 99.72 4.07 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.893 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -88.82 153.86 20.73 Favored 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.569 -176.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -149.37 153.14 24.98 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.257 0.92 . . . . 0.0 110.923 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 30.2 mttt -128.21 165.35 20.63 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 115' ' ' LYS . 7.4 tt0 -16.92 152.82 0.0 OUTLIER 'General case' 1 N--CA 1.543 4.192 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -175.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 11.79 83.99 Favored Glycine 0 CA--C 1.562 3.029 1 N-CA-C 100.681 -4.968 . . . . 0.0 100.681 -168.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.813 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -102.27 99.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.901 -1.15 . . . . 0.0 111.668 -175.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -76.67 -33.82 58.26 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.34 -14.11 61.15 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.31 -35.62 10.6 Favored Glycine 0 N--CA 1.511 3.662 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -75.27 -35.92 61.29 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.933 HG23 ' HG ' ' A' ' 112' ' ' LEU . 18.7 mt -65.0 -40.12 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.596 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.7 t30 -58.24 -31.04 67.02 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -81.51 -34.66 31.13 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' CB ' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.3 -11.96 59.66 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.759 -0.588 . . . . 0.0 110.67 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.432 ' CB ' ' CG2' ' A' ' 101' ' ' THR . 3.3 t -91.06 -32.74 15.77 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -33.52 75.87 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -81.58 -38.62 25.81 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.168 0.509 . . . . 0.0 109.889 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.711 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.2 -41.65 79.79 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -20.42 38.24 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.597 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.8 m -58.44 -33.17 69.4 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 25.8 t-80 -82.24 -39.52 22.92 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.4 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.1 mp -63.96 -13.53 46.82 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.469 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -88.01 -40.1 14.14 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -3.17 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 133' ' ' HIS . 29.1 p -87.02 -16.41 35.76 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.09 25.52 9.12 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.394 179.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.496 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 84.61 27.41 35.52 Favored Glycine 0 N--CA 1.506 3.313 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -49.76 -49.83 46.81 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 122.097 -0.649 . . . . 0.0 110.921 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.11 -24.47 54.32 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 122.122 -0.362 . . . . 0.0 110.766 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.6 -39.61 64.46 Favored 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 31.8 m-85 -73.18 -11.83 60.66 Favored 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.0 mm -90.3 -28.01 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 4.3 m-20 -65.32 -19.49 65.98 Favored 'General case' 0 C--O 1.185 -2.297 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.48 -59.57 4.41 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.411 1.101 . . . . 0.0 108.505 176.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.868 ' CG ' ' HB2' ' A' ' 19' ' ' ALA 0.26 0.7 OUTLIER -48.62 -42.21 33.44 Favored 'General case' 0 C--N 1.257 -3.442 0 CA-C-O 123.486 1.613 . . . . 0.0 110.971 177.03 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.8 mmt -74.64 -35.96 62.88 Favored 'General case' 1 C--N 1.237 -4.286 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.476 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.83 -5.38 59.19 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -100.03 -2.6 34.01 Favored 'General case' 1 N--CA 1.579 6.0 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.602 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 39.54 16.61 0.01 OUTLIER Glycine 2 N--CA 1.56 6.902 0 CA-C-N 120.023 1.283 . . . . 0.0 113.603 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 13' ' ' ASP . 5.5 m -133.58 -9.78 2.81 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.202 -1.175 . . . . 0.0 108.441 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.719 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -85.88 -172.36 4.05 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.954 0.883 . . . . 0.0 110.165 -177.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.571 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -151.37 -49.36 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 4.7 t70 -141.8 -171.43 3.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.712 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.65 133.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 117.921 -1.038 . . . . 0.0 108.275 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -141.75 110.44 6.12 Favored 'General case' 0 N--CA 1.517 2.909 0 C-N-CA 116.577 -2.049 . . . . 0.0 115.114 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 mt -86.25 125.39 40.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 29' ' ' SER . 60.3 t -132.86 116.09 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.035 -1.04 . . . . 0.0 112.35 -174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -66.6 85.47 0.11 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.2 p90 -82.22 29.74 0.41 Allowed 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 123.99 0.916 . . . . 0.0 112.531 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HZ1' ' HZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -62.85 -157.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.79 -56.73 4.24 Favored 'General case' 1 N--CA 1.544 4.227 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.13 124.96 35.72 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -82.14 161.62 17.92 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.952 1.768 . . . . 0.0 112.219 -176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 22' ' ' VAL . 21.5 p -161.89 159.05 26.29 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.0 t -93.51 99.72 10.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.594 ' CZ3' HG22 ' A' ' 108' ' ' THR . 15.9 m0 -70.06 -25.17 63.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.979 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.764 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.17 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 121.188 0.518 . . . . 0.0 110.732 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -122.96 131.91 53.92 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' ' OD1' ' A' ' 18' ' ' ASP . 43.4 t -49.07 108.01 0.88 Allowed Pre-proline 0 N--CA 1.521 3.089 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.745 ' HA ' HG11 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -73.95 146.65 37.67 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.841 1.694 . . . . 0.0 112.8 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.85 -30.43 7.45 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 5.5 mptp? -83.01 -92.54 0.07 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.815 -0.815 . . . . 0.0 112.979 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -41.66 0.06 Allowed 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.148 -0.97 . . . . 0.0 111.914 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.4 -45.69 84.28 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.965 -0.459 . . . . 0.0 111.996 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.849 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -56.4 -21.79 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.023 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -85.43 23.43 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.532 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.95 124.8 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 122.568 1.175 . . . . 0.0 111.064 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.687 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -110.85 -178.63 0.56 Allowed Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.687 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -69.63 0.1 6.02 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 121.105 1.203 . . . . 0.0 112.515 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.57 -66.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.8 pm0 -59.87 -31.81 70.13 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.795 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -81.04 -26.58 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.05 -28.32 63.67 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG22 HD23 ' A' ' 63' ' ' LEU . 13.6 p -96.71 -35.04 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.01 0 O-C-N 122.054 -0.674 . . . . 0.0 110.38 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 3.9 mt -69.14 -12.52 61.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 122.254 -0.279 . . . . 0.0 110.418 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.3 m -148.94 -28.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.695 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.05 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.37 107.94 1.58 Allowed Glycine 0 N--CA 1.51 3.61 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -30.94 58.08 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.444 -0.445 . . . . 0.0 110.195 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.09 73.64 10.23 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -171.68 52.0 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.519 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 22.9 t -69.02 -10.79 59.3 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.581 -0.699 . . . . 0.0 111.729 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.7 p -67.86 -54.66 17.21 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.423 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.547 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -38.64 -27.41 0.02 OUTLIER 'General case' 1 N--CA 1.545 4.28 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.476 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 35.3 m-85 -60.22 -10.55 4.68 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 121.021 -1.05 . . . . 0.0 112.564 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 57' ' ' SER . 2.6 m -123.62 -33.86 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 122.162 -0.336 . . . . 0.0 110.389 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 17.8 p30 -88.6 -49.33 6.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.879 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.23 147.08 5.66 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.732 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.882 HD12 ' HG ' ' A' ' 87' ' ' LEU . 14.1 mt -67.82 -155.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 63' ' ' LEU . 15.3 p -160.54 130.88 5.3 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -135.95 102.85 5.17 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 122.106 0.955 . . . . 0.0 110.519 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.5 71.48 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.93 8.36 63.48 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' HD12 ' A' ' 65' ' ' LEU . 26.7 tp60 -113.03 101.27 9.3 Favored 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 118.724 1.262 . . . . 0.0 109.211 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -68.28 121.5 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.47 0.653 . . . . 0.0 109.64 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 1.6 p -116.91 139.29 50.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.582 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 2.4 p -94.15 117.84 30.69 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.932 0.872 . . . . 0.0 113.058 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 75' ' ' ASP . 4.4 t -50.52 132.07 10.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.149 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.844 HD13 ' NH1' ' A' ' 88' ' ' ARG . 0.9 OUTLIER -126.08 70.47 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.187 -2.208 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 66.9 mtt-85 101.02 89.76 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 126.659 1.984 . . . . 0.0 108.778 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.888 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -82.47 115.16 21.35 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.614 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' CB ' ' A' ' 82' ' ' GLU . 2.0 m -139.07 16.68 2.63 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.69 HD11 HG12 ' A' ' 102' ' ' VAL . 9.6 tp -45.19 -25.73 0.4 Allowed 'General case' 0 N--CA 1.518 2.955 0 C-N-CA 123.291 0.636 . . . . 0.0 111.335 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.11 123.54 43.47 Favored 'General case' 0 C--O 1.202 -1.436 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -47.95 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.155 1.782 . . . . 0.0 115.005 -174.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -101.12 29.2 4.8 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.19 23.11 25.59 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 107.412 -2.275 . . . . 0.0 107.412 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.46 ' CB ' ' HB3' ' A' ' 76' ' ' SER . 4.2 mp0 -150.71 -57.98 0.17 Allowed 'General case' 0 C--N 1.369 1.447 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.77 3.54 0.21 Allowed 'General case' 0 N--CA 1.534 3.758 0 O-C-N 121.685 -0.634 . . . . 0.0 111.395 -173.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.2 p -100.91 147.53 26.03 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 120.508 1.504 . . . . 0.0 110.615 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.815 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -140.63 128.01 21.23 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.933 -177.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 m-20 -93.62 77.09 4.34 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.75 -1.219 . . . . 0.0 110.102 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.882 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.69 117.35 29.89 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.19 -1.569 . . . . 0.0 108.035 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.844 ' NH1' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -122.84 139.04 54.45 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.318 -176.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 1.5 p -58.53 111.56 1.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.828 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.84 146.13 24.42 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -177.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.3 t -95.1 165.54 12.37 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.332 0.587 . . . . 0.0 110.512 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.3 p -133.53 122.81 24.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.5 -88.19 1.46 Allowed Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.96 29.21 2.46 Favored Glycine 0 N--CA 1.506 3.359 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.632 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -78.13 167.51 35.07 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 122.091 -0.652 . . . . 0.0 109.938 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.588 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.0 Cg_endo -91.25 132.31 1.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.032 2.488 . . . . 0.0 110.586 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 91' ' ' SER . 23.0 p -95.16 158.24 15.55 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.786 0.803 . . . . 0.0 109.164 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.687 ' HB3' ' CG ' ' A' ' 115' ' ' LYS . 24.7 m-85 -149.27 157.45 43.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.627 ' CG ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -132.34 165.41 24.29 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.06 -1.65 . . . . 0.0 111.682 -176.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 113' ' ' MET . 13.2 t -152.88 137.4 9.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 124' ' ' ASN . 90.5 m -111.55 129.52 56.03 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.693 ' HB ' HD11 ' A' ' 87' ' ' LEU . 4.3 t -119.39 122.22 68.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-O 121.695 0.76 . . . . 0.0 109.34 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 24.5 p -111.61 150.41 30.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 3.1 tppp? -134.01 142.36 47.6 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.269 0.557 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.914 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.0 p -102.96 -147.32 0.38 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.49 -22.27 18.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.696 -0.628 . . . . 0.0 109.754 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 14.2 mttm -142.79 20.75 1.99 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.684 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.594 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.5 p -144.59 161.05 40.1 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -129.78 90.97 3.06 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.924 HG21 HD13 ' A' ' 134' ' ' LEU . 4.1 t -85.3 145.34 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.934 -1.104 . . . . 0.0 109.308 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.5 mt -131.75 154.9 48.57 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.06 106.1 8.4 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.569 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.16 142.0 30.39 Favored 'General case' 0 CA--C 1.441 -3.223 0 C-N-CA 117.866 -1.533 . . . . 0.0 107.623 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.753 ' C ' ' HG3' ' A' ' 115' ' ' LYS . . . -178.5 121.48 0.76 Allowed Glycine 1 CA--C 1.431 -5.175 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.984 -179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HG3' ' C ' ' A' ' 114' ' ' GLY 0.301 0.0 OUTLIER -164.17 117.29 1.4 Allowed 'General case' 1 N--CA 1.368 -4.525 0 C-N-CA 114.503 -2.879 . . . . 0.0 115.802 175.116 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 118' ' ' VAL . 11.1 tt0 -114.26 89.9 3.21 Favored 'General case' 0 C--O 1.26 1.656 1 N-CA-C 100.101 -4.037 . . . . 0.0 100.101 160.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.21 -0.74 0.07 OUTLIER Glycine 2 CA--C 1.659 9.09 0 CA-C-N 125.711 3.869 . . . . 0.0 108.46 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.857 HG21 ' CD1' ' A' ' 123' ' ' ILE . 8.9 p -26.45 138.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.39 2.362 0 C-N-CA 126.191 1.796 . . . . 0.0 114.737 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.48 -49.92 65.0 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.279 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.34 16.9 19.3 Favored Glycine 0 N--CA 1.506 3.308 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.64 -34.77 2.0 Allowed Glycine 0 N--CA 1.506 3.346 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -78.25 -36.91 46.31 Favored 'General case' 0 C--O 1.182 -2.495 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.857 ' CD1' HG21 ' A' ' 118' ' ' VAL . 44.7 mt -67.81 -36.57 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.76 ' HA ' HG21 ' A' ' 101' ' ' THR . 12.8 t30 -63.74 -26.73 68.78 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.81 -37.8 34.39 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 3.0 mppt? -75.45 -16.26 60.35 Favored 'General case' 0 N--CA 1.517 2.894 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 4.6 t -87.64 -33.19 18.9 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -30.46 70.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.463 0.649 . . . . 0.0 109.431 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -57.95 -44.63 87.09 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.23 -19.73 46.23 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.611 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -58.03 -33.5 69.05 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 68.3 t60 -80.86 -40.24 25.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.769 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -66.96 -11.67 57.33 Favored 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.358 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -38.09 12.03 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -81.11 -2.81 49.81 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 133' ' ' HIS . 52.6 p -81.14 -20.15 41.96 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 73.25 27.37 1.96 Allowed 'General case' 0 N--CA 1.512 2.671 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.124 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.461 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 115.3 -73.23 0.25 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.38 -36.81 61.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.811 -0.817 . . . . 0.0 110.051 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -58.98 -32.25 69.49 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.642 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.38 -32.4 68.44 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 62.3 m-85 -75.47 -12.9 60.33 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.969 ' HA ' HD12 ' A' ' 10' ' ' LEU . 22.4 mm -89.36 -22.04 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 171.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 1.6 m-20 -67.53 -20.54 65.43 Favored 'General case' 0 C--O 1.181 -2.519 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.714 ' ND2' HD23 ' A' ' 10' ' ' LEU 0.267 0.0 OUTLIER -67.3 -49.75 62.97 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 172.599 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 7' ' ' ILE . 96.0 mt -56.34 -27.45 55.89 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 111.258 -2.701 . . . . 0.0 111.102 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 11' ' ' MET . 5.9 mmt -102.21 -36.0 8.67 Favored 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.47 -0.45 37.39 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.951 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.2 p30 -73.1 -2.07 19.95 Favored 'General case' 0 N--CA 1.52 3.025 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.27 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 27.11 39.98 0.01 OUTLIER Glycine 1 N--CA 1.555 6.622 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.765 HG23 HG23 ' A' ' 118' ' ' VAL . 46.9 m -159.51 -24.83 0.07 Allowed 'General case' 0 CA--C 1.564 1.493 0 O-C-N 122.624 -0.339 . . . . 0.0 110.978 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 113' ' ' MET . 0.6 OUTLIER -87.55 -164.3 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.576 1.179 . . . . 0.0 112.161 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.627 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -151.01 -49.6 0.12 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -178.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 12.4 t0 -120.94 175.19 6.18 Favored 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.914 ' HB1' HD22 ' A' ' 10' ' ' LEU 0.335 . . -171.97 126.41 0.57 Allowed 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 117.694 -1.145 . . . . 0.0 111.163 -171.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.794 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -160.22 125.44 3.94 Favored 'General case' 0 N--CA 1.534 3.77 0 C-N-CA 115.321 -2.551 . . . . 0.0 117.334 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.633 HG12 ' HE2' ' A' ' 130' ' ' MET . 20.2 mt -83.44 141.46 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.728 HG11 HG21 ' A' ' 42' ' ' ILE . 40.1 t -145.76 116.51 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.021 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.85 84.09 0.38 Allowed Glycine 1 N--CA 1.516 4.001 0 N-CA-C 106.757 -2.537 . . . . 0.0 106.757 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' ' HE2' ' A' ' 104' ' ' LYS . 1.7 p90 -78.72 21.95 0.38 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.819 0.848 . . . . 0.0 112.718 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -56.69 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.559 1.072 . . . . 0.0 109.816 -178.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.44 -53.6 1.13 Allowed 'General case' 1 N--CA 1.551 4.618 0 CA-C-O 121.793 0.806 . . . . 0.0 109.044 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -108.87 119.46 48.91 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.7 Cg_endo -80.53 167.64 18.83 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.467 1.445 . . . . 0.0 111.599 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 22' ' ' VAL . 43.8 p -169.48 165.32 10.48 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 40' ' ' VAL . 36.8 t -98.29 102.99 14.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.4 m0 -69.54 -25.25 63.92 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -175.38 152.12 1.33 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 178.6 132.95 0.08 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.443 -0.786 . . . . 0.0 110.553 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 19' ' ' ALA . 92.0 t -51.06 104.81 0.45 Allowed Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -73.72 147.69 40.35 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.993 1.795 . . . . 0.0 112.267 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -4.91 57.2 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -105.75 -77.46 0.59 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.272 1.036 . . . . 0.0 112.45 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -174.78 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.228 -177.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 6.2 m-30 -62.26 -41.3 98.33 Favored 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.9 p -58.32 -20.38 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.58 28.22 1.55 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.728 HG21 HG11 ' A' ' 22' ' ' VAL . 3.1 mt -77.11 122.65 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.591 1.186 . . . . 0.0 110.328 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.662 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -113.26 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.51 2.544 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.911 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 25.5 Cg_endo -69.85 0.34 5.86 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 121.212 1.275 . . . . 0.0 112.164 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.66 -67.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.0 pm0 -57.66 -41.85 82.32 Favored 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.944 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -75.12 -24.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.937 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.56 -29.64 57.93 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 63' ' ' LEU . 9.7 p -98.36 -32.96 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 122.216 -0.579 . . . . 0.0 110.455 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HA ' HD22 ' A' ' 63' ' ' LEU . 1.8 mt -64.86 -20.61 66.51 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.033 0.444 . . . . 0.0 110.516 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 47' ' ' VAL . 3.8 m -140.28 -16.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.808 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -49.49 151.72 3.75 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-O 121.997 0.776 . . . . 0.0 111.21 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.87 20.4 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.09 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -40.56 126.86 2.4 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 122.917 0.487 . . . . 0.0 109.746 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.64 39.52 3.91 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.578 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -166.99 -58.1 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 118.958 -1.097 . . . . 0.0 113.042 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.1 p -43.5 -98.27 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.058 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CE2' ' CE1' ' A' ' 59' ' ' TYR . 38.0 p90 -36.75 -22.76 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.847 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 32.6 m-85 -60.85 -8.51 3.13 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 120.828 1.649 . . . . 0.0 112.659 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 57' ' ' SER . 34.7 m -115.44 -37.71 2.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.944 -0.472 . . . . 0.0 110.561 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 15.0 p30 -92.54 -48.85 6.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 134.02 146.85 5.53 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD11 HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -81.73 -143.62 0.05 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 63' ' ' LEU . 3.8 p -162.21 136.23 6.52 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 119.974 1.261 . . . . 0.0 109.421 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -131.62 102.89 6.09 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-O 122.252 1.025 . . . . 0.0 109.329 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 76.96 25.75 63.75 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.02 12.76 76.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.617 ' HB3' HD12 ' A' ' 65' ' ' LEU . 15.0 tp60 -103.99 106.17 16.59 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 118.113 0.957 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.1 tttp -66.76 106.65 1.92 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.432 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.415 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.2 p -115.22 123.75 49.65 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.295 1.045 . . . . 0.0 108.673 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.569 ' HA ' ' CA ' ' A' ' 62' ' ' GLY . 89.6 p -70.02 122.64 19.75 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -66.24 107.44 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.537 0.684 . . . . 0.0 111.584 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.6 mt -100.81 68.39 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 CA-C-O 124.12 1.914 . . . . 0.0 105.899 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER 106.84 116.76 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.893 0 CA-C-N 113.09 -1.868 . . . . 0.0 109.585 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -106.13 98.06 7.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.63 0.729 . . . . 0.0 112.078 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -124.4 27.27 7.05 Favored 'General case' 0 C--O 1.192 -1.94 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 104' ' ' LYS . 10.2 tt -64.2 -23.92 67.49 Favored 'General case' 0 N--CA 1.528 3.462 0 C-N-CA 123.253 0.621 . . . . 0.0 111.601 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 78' ' ' LEU . 92.6 mt -100.26 121.68 41.85 Favored 'General case' 0 C--O 1.2 -1.547 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.322 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.58 78.64 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 123.88 1.8 . . . . 0.0 114.968 -173.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.2 t70 -101.08 26.06 7.44 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 111.652 -2.522 . . . . 0.0 104.287 171.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.25 28.17 8.27 Favored Glycine 0 C--N 1.362 1.98 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.415 ' C ' ' CG ' ' A' ' 83' ' ' PHE . 2.5 mp0 -155.24 -63.4 0.12 Allowed 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.53 2.45 0.49 Allowed 'General case' 0 N--CA 1.531 3.604 0 C-N-CA 123.124 0.57 . . . . 0.0 110.375 -171.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.7 p -96.79 132.38 42.56 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.756 1.162 . . . . 0.0 109.633 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -133.18 124.46 27.49 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.6 m-20 -83.38 144.14 29.84 Favored 'General case' 0 CA--C 1.465 -2.308 0 C-N-CA 117.153 -1.819 . . . . 0.0 106.675 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.787 HD22 HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -144.84 142.48 29.97 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 3.7 ptt180 -150.01 126.89 11.1 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.868 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -55.29 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' CE ' ' HB3' ' A' ' 71' ' ' SER . 0.1 OUTLIER -83.39 138.1 33.64 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -130.48 -160.12 1.02 Allowed 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 120.99 0.424 . . . . 0.0 111.184 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -102.83 176.55 5.12 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 121.305 0.574 . . . . 0.0 111.616 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.96 88.3 0.47 Allowed Glycine 0 N--CA 1.506 3.331 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.58 -33.23 1.43 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -81.06 169.91 17.47 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 122.309 -0.524 . . . . 0.0 109.606 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 64.2 Cg_endo -99.17 125.03 0.15 Allowed 'Trans proline' 0 N--CA 1.435 -1.951 0 C-N-CA 123.057 2.505 . . . . 0.0 109.754 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.405 ' OG1' ' CE ' ' A' ' 115' ' ' LYS . 3.0 p -91.81 164.96 13.5 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 36.7 m-85 -146.15 144.63 30.08 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.719 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 7.7 m-20 -111.88 -166.29 1.06 Allowed 'General case' 0 CA--C 1.447 -3.009 0 O-C-N 120.805 -1.184 . . . . 0.0 108.579 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 87' ' ' LEU . 2.7 t -170.63 170.56 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-O 122.267 1.032 . . . . 0.0 109.98 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 124' ' ' ASN . 4.9 m -145.29 140.56 27.87 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.881 HG22 HD23 ' A' ' 111' ' ' LEU . 6.7 t -132.71 114.71 23.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 122.211 1.005 . . . . 0.0 109.199 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.3 p -107.56 107.36 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.125 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD3' HD21 ' A' ' 77' ' ' LEU . 5.7 tptm -100.97 119.73 39.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.08 0.467 . . . . 0.0 111.148 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 134' ' ' LEU . 46.5 p -79.1 -147.8 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.38 -26.36 17.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.509 -0.744 . . . . 0.0 109.89 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 32.1 mttt -144.69 27.97 1.32 Allowed 'General case' 0 N--CA 1.511 2.617 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.971 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 3.2 p -147.88 151.42 35.87 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -125.08 96.87 5.02 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -176.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 130' ' ' MET . 29.5 t -93.36 144.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.732 -1.23 . . . . 0.0 110.402 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 HG22 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -130.14 146.93 51.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.184 0.992 . . . . 0.0 108.545 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.966 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -137.27 97.63 3.53 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.57 ' HG2' HG22 ' A' ' 100' ' ' VAL . 1.1 tmt? -114.29 160.16 19.38 Favored 'General case' 0 C--O 1.167 -3.276 0 C-N-CA 118.901 -1.119 . . . . 0.0 112.977 -173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 132.52 161.61 10.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 117.019 1.567 . . . . 0.0 117.019 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HG3' ' N ' ' A' ' 99' ' ' ASN 0.411 10.0 mtmt -157.29 120.7 4.1 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 113.036 -1.582 . . . . 0.0 109.51 169.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.2 tt0 -111.55 92.43 4.03 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 162.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.34 -0.72 0.13 Allowed Glycine 2 CA--C 1.648 8.393 0 CA-C-N 123.136 2.698 . . . . 0.0 109.225 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.765 HG23 HG23 ' A' ' 15' ' ' THR . 14.4 p -39.16 155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 125.576 1.55 . . . . 0.0 114.992 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -85.48 -55.4 4.02 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 112.753 -2.021 . . . . 0.0 107.491 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.77 4.17 28.17 Favored Glycine 0 N--CA 1.508 3.499 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -103.74 -27.09 6.49 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.693 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.57 -37.76 49.89 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.966 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.0 mt -66.39 -37.49 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.1 t30 -62.83 -29.52 70.79 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -84.78 -31.55 23.87 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.574 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -82.3 -21.91 35.9 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 110.888 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.454 ' N ' HD23 ' A' ' 112' ' ' LEU . 3.0 t -84.01 -38.57 20.74 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.406 ' HA ' HG21 ' A' ' 103' ' ' THR . 24.7 t80 -61.33 -31.62 71.48 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 132' ' ' SER . 37.4 mt-10 -78.9 -36.03 42.61 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.759 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -56.43 -49.03 75.76 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . . . -69.35 -24.27 63.88 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 66.4 m -57.5 -32.42 67.0 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.512 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 19.7 t-80 -79.96 -38.79 31.52 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 110' ' ' VAL . 4.6 mp -68.8 -9.34 50.54 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.521 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -39.86 11.23 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -3.75 47.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 p -82.61 -19.97 37.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 79.63 30.77 0.27 Allowed 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.194 178.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.492 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 163.65 166.96 23.38 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -49.1 -53.18 21.79 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.133 -0.627 . . . . 0.0 111.038 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -56.26 -23.56 37.04 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.784 -0.572 . . . . 0.0 111.342 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -74.6 -42.24 59.04 Favored 'General case' 0 N--CA 1.53 3.53 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 15.7 m-85 -70.28 -12.21 61.43 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 5.6 mm -89.46 -30.71 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.8 m-20 -62.45 -19.91 63.99 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.684 ' ND2' ' HG ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.48 -39.47 91.03 Favored 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 123.517 0.727 . . . . 0.0 110.302 177.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.004 HD22 ' HB2' ' A' ' 19' ' ' ALA . 1.1 mp -86.45 -15.58 39.77 Favored 'General case' 0 C--N 1.252 -3.641 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.996 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.16 -33.99 13.8 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.38 -31.41 29.72 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.419 1.104 . . . . 0.0 112.497 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.639 ' HB3' ' O ' ' A' ' 9' ' ' ASN 0.39 33.3 p-10 -60.58 -4.59 0.95 Allowed 'General case' 1 N--CA 1.556 4.826 0 N-CA-C 119.171 3.026 . . . . 0.0 119.171 -174.237 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 31.41 32.78 0.01 OUTLIER Glycine 2 N--CA 1.542 5.713 0 CA-C-N 120.401 1.455 . . . . 0.0 112.52 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' ASP . 14.3 m -152.77 -49.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB2' HD23 ' A' ' 10' ' ' LEU 0.309 0.5 OUTLIER -83.36 121.27 26.92 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 123.313 1.53 . . . . 0.0 111.439 178.876 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -89.08 -36.79 15.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.914 -175.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 18.2 t70 -129.49 170.93 13.1 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.004 ' HB2' HD22 ' A' ' 10' ' ' LEU . . . -157.94 132.78 8.52 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 117.5 -1.238 . . . . 0.0 107.801 -176.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -142.01 104.82 4.55 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 116.518 -2.073 . . . . 0.0 115.413 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 mt -83.13 127.43 39.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 42' ' ' ILE . 34.1 t -130.77 110.86 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 118.929 -1.109 . . . . 0.0 111.813 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.52 88.06 0.1 OUTLIER Glycine 1 N--CA 1.517 4.036 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -85.04 33.53 0.54 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.4 mptm? -63.49 -157.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.74 -56.44 2.66 Favored 'General case' 1 N--CA 1.548 4.434 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -107.47 120.65 46.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -79.12 161.04 26.55 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.761 1.64 . . . . 0.0 111.101 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.8 p -166.06 164.09 18.17 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.1 t -91.35 102.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.5 m0 -69.47 -29.25 66.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.0 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.42 0.628 . . . . 0.0 110.896 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -121.95 133.24 54.84 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.6 t -47.71 107.25 0.7 Allowed Pre-proline 0 N--CA 1.515 2.795 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.0 Cg_endo -69.25 149.96 70.77 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.853 1.702 . . . . 0.0 111.824 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.08 -16.02 60.7 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -88.74 -115.46 0.06 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.73 -0.865 . . . . 0.0 111.133 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -136.97 -42.93 0.58 Allowed 'General case' 0 N--CA 1.513 2.703 0 O-C-N 121.006 -1.059 . . . . 0.0 111.232 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.3 m-30 -59.81 -42.42 93.43 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.878 -0.514 . . . . 0.0 111.764 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.594 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.2 -19.82 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.9 27.8 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 39' ' ' PHE . 3.0 mt -79.56 126.93 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 CA-C-O 122.779 1.276 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.4 p -115.29 -179.51 0.63 Allowed Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.381 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.19 -0.41 6.39 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.27 1.314 . . . . 0.0 112.309 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.36 -63.3 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.2 pm0 -61.51 -34.56 75.72 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.521 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -80.41 -23.4 11.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.98 -28.03 68.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 46' ' ' GLU . 13.3 p -97.39 -37.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 122.237 -0.567 . . . . 0.0 109.974 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 mt -66.26 -15.11 62.94 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.85 -4.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.479 -174.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -55.08 152.56 13.41 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -17.46 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.53 134.4 29.31 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -133.58 44.4 2.78 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.393 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 t -170.06 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 O-C-N 121.207 -0.933 . . . . 0.0 112.654 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -53.83 -90.25 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 36.5 p90 -37.24 -21.74 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.379 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 28.5 m-85 -61.11 -7.73 2.86 Favored 'General case' 0 N--CA 1.514 2.774 0 CA-C-N 121.059 1.754 . . . . 0.0 112.733 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 57' ' ' SER . 1.1 m -121.33 -33.64 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.84 -0.538 . . . . 0.0 111.682 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.6 p30 -84.59 -30.96 24.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.599 -0.841 . . . . 0.0 109.37 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 112.52 144.88 9.42 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.804 HD12 ' HG ' ' A' ' 87' ' ' LEU . 18.7 mt -71.04 -153.41 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 31.5 p -161.66 131.94 4.94 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.27 101.18 5.09 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-O 122.052 0.93 . . . . 0.0 108.988 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 76.46 29.32 58.24 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 10.98 83.3 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.8 tp60 -108.66 100.61 9.84 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 118.458 1.129 . . . . 0.0 110.16 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -56.61 114.74 2.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.473 ' O ' ' CA ' ' A' ' 62' ' ' GLY . 5.9 p -111.48 158.59 18.96 Favored 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 84.1 p -112.55 112.85 24.67 Favored 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.695 HG22 ' HE2' ' A' ' 85' ' ' MET . 8.8 t -48.63 116.85 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.75 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.6 mt -120.83 75.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 124.141 1.924 . . . . 0.0 107.002 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.3 ttm180 95.53 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.867 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.123 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -93.29 101.77 14.02 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.692 0.758 . . . . 0.0 111.891 -178.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -115.0 5.58 15.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 174.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 104' ' ' LYS . 20.2 tp -37.78 -33.9 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 C-N-CA 123.73 0.812 . . . . 0.0 111.823 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ASP . 90.7 mt -94.58 121.85 36.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.539 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -47.81 78.27 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.176 1.79 . . . . 0.0 114.541 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 78' ' ' LEU . 9.4 t70 -101.12 26.3 7.2 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 104.635 -2.358 . . . . 0.0 104.635 171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.26 26.07 11.67 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.3 mp0 -153.0 -60.39 0.14 Allowed 'General case' 0 C--N 1.37 1.475 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 58.24 3.33 0.25 Allowed 'General case' 0 N--CA 1.53 3.54 0 O-C-N 121.878 -0.514 . . . . 0.0 111.127 -172.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -92.54 130.65 38.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.972 1.26 . . . . 0.0 108.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.695 ' HE2' HG22 ' A' ' 72' ' ' VAL . 1.9 ttt -138.9 125.84 21.09 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.753 ' C ' HD13 ' A' ' 87' ' ' LEU . 3.1 m-20 -91.38 149.21 21.82 Favored 'General case' 0 C--O 1.184 -2.344 0 C-N-CA 117.658 -1.617 . . . . 0.0 108.694 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.804 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -158.68 112.31 2.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.5 ptt180 -117.14 133.66 55.73 Favored 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.446 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 5.0 p -59.81 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -73.98 170.92 14.43 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.934 0.873 . . . . 0.0 109.457 -175.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.743 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -122.89 163.65 19.92 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.128 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -109.81 75.0 0.92 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.714 0.769 . . . . 0.0 109.483 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.61 96.46 0.01 OUTLIER Glycine 0 N--CA 1.508 3.492 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.45 -35.11 5.17 Favored Glycine 0 N--CA 1.504 3.179 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -70.0 165.61 41.09 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.999 -0.706 . . . . 0.0 110.487 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.9 Cg_endo -91.5 131.8 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.412 2.741 . . . . 0.0 110.888 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 91' ' ' SER . 62.2 p -100.37 161.71 13.43 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 35.4 m-85 -143.16 107.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 m-20 -90.72 133.42 35.17 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.666 1.222 . . . . 0.0 113.294 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.2 t -118.24 155.75 20.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.718 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 124' ' ' ASN . 28.2 m -125.16 158.04 34.92 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 173.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 87' ' ' LEU . 14.9 t -148.49 121.44 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 120.456 -1.403 . . . . 0.0 109.585 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 3.0 p -109.86 131.11 55.36 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.535 ' CE ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.1 126.64 55.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.072 -178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.3 p -91.59 -145.27 0.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.96 -16.34 18.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.472 -0.768 . . . . 0.0 109.976 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -151.11 21.81 0.76 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 121.576 -0.703 . . . . 0.0 110.478 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.9 p -144.3 150.88 38.56 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.535 HD23 ' CE ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -122.77 88.96 3.02 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -176.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -83.95 141.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 110.402 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' ' 20' ' ' ALA . 9.0 mt -127.39 153.55 46.1 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.55 106.68 8.67 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.614 ' CB ' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -94.72 141.31 28.77 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.478 -176.66 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.654 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -132.18 132.85 6.85 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.731 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 2.1 mttt -114.78 158.84 21.32 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.0 tp10 -16.77 154.58 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.166 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 -175.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 71.78 15.02 75.71 Favored Glycine 0 CA--C 1.56 2.847 1 N-CA-C 100.959 -4.857 . . . . 0.0 100.959 -169.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.813 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.4 p -101.9 102.71 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.916 -1.142 . . . . 0.0 112.42 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -84.25 -35.26 23.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.13 -7.76 62.52 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 -39.66 8.91 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -73.52 -35.68 65.62 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 112' ' ' LEU . 69.5 mt -68.74 -37.75 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.881 ' HA ' HG21 ' A' ' 101' ' ' THR . 2.7 t30 -64.81 -29.27 70.23 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -82.35 -25.45 33.84 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 130' ' ' MET . 10.1 mtmt -88.25 -11.74 45.71 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.664 ' HA ' HD23 ' A' ' 112' ' ' LEU . 4.9 t -89.62 -32.19 17.21 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.83 -32.42 67.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -81.1 -37.48 28.87 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.66 ' O ' HD12 ' A' ' 134' ' ' LEU . 7.1 ttt -60.37 -46.82 88.58 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.86 57.5 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -63.46 -33.58 75.87 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 4.0 t60 -79.77 -38.39 33.27 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 HG21 ' A' ' 110' ' ' VAL . 2.7 mp -68.99 -10.48 57.7 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.964 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -88.1 -40.77 13.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -7.18 54.36 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.8 p -81.14 -18.75 45.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.18 32.53 3.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.759 -0.588 . . . . 0.0 109.666 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.5 2.047 0 CA-C-O 117.629 -1.177 . . . . 0.0 108.796 179.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 149.97 -98.48 0.19 Allowed Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -50.97 -42.56 60.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.141 -0.623 . . . . 0.0 110.945 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -59.59 -27.36 66.21 Favored 'General case' 0 N--CA 1.52 3.06 0 O-C-N 121.898 -0.501 . . . . 0.0 110.909 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -72.7 -36.11 67.76 Favored 'General case' 0 N--CA 1.521 3.081 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.646 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.1 m-85 -74.67 -11.33 60.15 Favored 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.1 mm -90.95 -25.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.721 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 172.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 3.6 m-20 -67.34 -18.94 65.36 Favored 'General case' 0 C--O 1.185 -2.316 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.653 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -49.99 -54.39 20.36 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 122.709 1.242 . . . . 0.0 108.218 176.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -54.67 -43.03 72.06 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 112.874 -1.967 . . . . 0.0 110.959 177.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.94 -30.8 62.75 Favored 'General case' 1 C--N 1.232 -4.538 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.539 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -11.2 56.37 Favored 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -96.73 -2.62 44.06 Favored 'General case' 1 N--CA 1.578 5.943 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 -172.41 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 38.12 21.12 0.01 OUTLIER Glycine 2 N--CA 1.569 7.561 0 CA-C-N 120.655 1.57 . . . . 0.0 112.997 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 13' ' ' ASP . 45.9 m -136.02 -27.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.693 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.45 -177.5 1.19 Allowed 'General case' 0 CA--C 1.556 1.173 0 CA-C-O 121.905 0.86 . . . . 0.0 109.707 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.661 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 1.0 OUTLIER -151.86 -51.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 8.3 t0 -131.27 -176.25 3.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.941 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.848 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.28 130.1 0.91 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 118.421 -0.8 . . . . 0.0 109.602 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -139.4 109.74 6.54 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 117.389 -1.724 . . . . 0.0 114.427 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.4 HD11 ' HE2' ' A' ' 130' ' ' MET . 13.9 mt -91.86 112.47 25.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 172.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 29' ' ' SER . 40.5 t -122.03 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 119.123 0.874 . . . . 0.0 112.166 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.34 84.83 0.13 Allowed Glycine 0 N--CA 1.512 3.701 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -82.0 32.42 0.38 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 122.323 -0.516 . . . . 0.0 111.883 -177.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -63.25 -154.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.14 -58.0 2.29 Favored 'General case' 1 N--CA 1.542 4.143 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 p -107.78 125.26 32.6 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 44' ' ' PRO . 30.4 Cg_endo -79.33 152.22 23.53 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.854 1.703 . . . . 0.0 110.831 -177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 22' ' ' VAL . 50.7 p -155.77 159.04 39.11 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 40' ' ' VAL . 42.4 t -89.99 100.57 11.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.525 ' CZ3' HG22 ' A' ' 108' ' ' THR . 10.1 m0 -69.05 -18.37 64.01 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.702 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.813 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 172.07 81.47 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.83 -0.543 . . . . 0.0 110.65 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -111.36 131.2 55.36 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 19' ' ' ALA . 62.1 t -47.63 102.68 0.32 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.66 149.13 73.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.005 1.804 . . . . 0.0 112.794 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.61 58.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -85.65 0.35 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.358 1.079 . . . . 0.0 112.53 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.2 m -161.63 -35.37 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.335 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.5 m-30 -63.17 -38.37 90.9 Favored 'General case' 0 N--CA 1.519 3.013 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.72 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.3 p -59.82 -18.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -89.27 25.7 1.83 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.932 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.9 mt -75.36 131.75 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 122.01 0.91 . . . . 0.0 108.865 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.8 p -124.89 176.27 2.48 Favored Pre-proline 0 N--CA 1.515 2.804 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.3 Cg_endo -69.73 2.52 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.478 1.452 . . . . 0.0 112.772 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.89 -65.9 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.932 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.1 pp20? -62.31 -29.31 70.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.224 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.4 t -81.01 -23.23 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.58 -31.56 67.3 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.642 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -94.8 -39.13 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.122 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.753 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.064 HD23 HD13 ' A' ' 63' ' ' LEU . 11.0 mt -59.08 -23.72 62.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.165 0.507 . . . . 0.0 110.136 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.9 m -131.52 -12.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.038 -175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -41.28 147.3 0.38 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -3.07 43.14 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.84 135.2 42.23 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.71 0.767 . . . . 0.0 109.192 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -99.49 18.16 18.55 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.279 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -170.21 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 C-N-CA 118.029 -1.468 . . . . 0.0 113.792 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.1 p -57.07 -97.7 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 63' ' ' LEU . 47.0 p90 -37.66 -21.94 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 23.9 m-85 -60.76 -6.65 1.84 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-N 120.529 1.513 . . . . 0.0 112.409 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -124.39 -32.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 O-C-N 121.786 -0.571 . . . . 0.0 111.33 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.2 p30 -84.57 -36.72 21.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.76 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 122.52 147.69 7.53 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.79 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.064 HD13 HD23 ' A' ' 50' ' ' LEU . 82.2 mt -81.59 -159.99 0.32 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 63' ' ' LEU . 11.3 p -160.62 128.52 4.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -134.67 101.49 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 122.154 0.978 . . . . 0.0 109.931 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.61 28.15 61.86 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.4 7.38 79.54 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.7 tp60 -103.66 105.52 15.77 Favored 'General case' 0 N--CA 1.512 2.65 0 CA-C-N 118.588 1.194 . . . . 0.0 109.761 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 12.4 tttt -68.77 108.29 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.172 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.433 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 2.8 p -102.0 -167.45 1.41 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 89.7 p -146.68 104.09 3.71 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 75' ' ' ASP . 18.6 t -43.83 122.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 121.643 0.735 . . . . 0.0 111.367 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 17.0 mt -132.72 70.71 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 51.8 mtt85 115.86 71.83 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 126.799 2.04 . . . . 0.0 108.743 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.808 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -70.88 95.71 1.19 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.117 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -119.6 16.37 12.84 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 10.0 tp -36.4 -62.4 0.46 Allowed 'General case' 0 N--CA 1.523 3.207 0 C-N-CA 124.896 1.278 . . . . 0.0 113.712 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.46 45.06 1.24 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.386 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HG2' ' CA ' ' A' ' 76' ' ' SER . 0.2 OUTLIER -110.8 58.24 0.61 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' GLN . 12.2 t70 -16.79 122.15 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.719 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.33 20.18 12.75 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.441 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 24.5 mm-40 -162.09 -65.35 0.05 Allowed 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' SER . 0.1 OUTLIER 42.85 12.76 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.7 p -95.83 139.33 32.2 Favored 'General case' 0 C--O 1.199 -1.561 0 CA-C-N 120.807 1.64 . . . . 0.0 109.633 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.825 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -132.44 120.81 22.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 2.4 m-20 -86.99 76.03 9.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.209 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.877 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.28 110.79 22.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 117.914 -1.515 . . . . 0.0 108.811 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 1.5 ptt180 -108.98 150.77 27.25 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.516 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.533 HG21 ' HZ3' ' A' ' 115' ' ' LYS . 6.1 p -70.31 110.89 5.52 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -99.69 135.13 41.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.667 ' H ' HG22 ' A' ' 97' ' ' THR . 1.0 OUTLIER -116.63 -166.27 1.14 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -177.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -83.99 -167.65 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.492 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.82 -76.99 0.16 Allowed Glycine 0 N--CA 1.51 3.588 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.72 22.29 5.8 Favored Glycine 0 N--CA 1.514 3.839 0 O-C-N 121.8 -0.823 . . . . 0.0 111.874 -178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -97.55 161.52 25.6 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.536 1.168 . . . . 0.0 109.683 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.5 Cg_endo -92.8 124.18 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.927 2.418 . . . . 0.0 110.136 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 91' ' ' SER . 66.8 p -91.96 172.0 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 1.036 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 35.1 m-85 -151.92 169.16 22.97 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.884 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -141.01 158.35 44.06 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.829 -175.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG13 ' HA ' ' A' ' 113' ' ' MET . 9.8 t -141.68 148.42 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.773 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 ' HA ' ' A' ' 124' ' ' ASN . 1.8 m -118.68 132.34 56.16 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 87' ' ' LEU . 3.9 t -119.97 119.7 60.95 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-O 121.752 0.787 . . . . 0.0 108.929 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.8 p -108.08 110.1 21.7 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.055 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -90.35 119.6 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.3 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.892 HG21 ' HB3' ' A' ' 134' ' ' LEU . 59.6 p -83.98 -143.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -92.12 -26.05 18.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.86 0.754 . . . . 0.0 109.927 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -147.12 20.13 1.24 Allowed 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.854 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 5.3 p -135.63 147.8 48.75 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.765 HD13 HD21 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -113.24 83.34 1.82 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 -177.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 134' ' ' LEU . 4.5 t -80.43 144.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 120.903 -1.123 . . . . 0.0 108.272 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.765 HD21 HD13 ' A' ' 109' ' ' LEU . 6.9 mt -133.37 151.58 51.85 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.935 ' HG ' HG23 ' A' ' 123' ' ' ILE . 1.8 tp -136.13 103.05 5.2 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.63 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -100.88 145.66 28.31 Favored 'General case' 0 C--N 1.268 -2.961 0 C-N-CA 118.411 -1.315 . . . . 0.0 107.884 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.707 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.46 146.69 11.4 Favored Glycine 1 CA--C 1.45 -4.004 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.75 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 1.036 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.542 12.8 mttt -163.42 113.4 1.33 Allowed 'General case' 0 CA--C 1.596 2.727 0 N-CA-C 121.03 3.715 . . . . 0.0 121.03 175.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 118' ' ' VAL . 6.4 tt0 -118.92 90.04 3.25 Favored 'General case' 0 C--O 1.261 1.678 0 N-CA-C 100.976 -3.712 . . . . 0.0 100.976 156.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.555 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.25 1.2 0.07 OUTLIER Glycine 2 CA--C 1.678 10.273 1 CA-C-N 127.819 4.827 . . . . 0.0 108.669 -179.043 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.884 HG13 ' OD1' ' A' ' 99' ' ' ASN . 7.3 p -25.33 137.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.401 2.841 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -171.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -74.64 -54.88 6.59 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.523 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.81 15.4 10.15 Favored Glycine 0 N--CA 1.503 3.147 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.74 -33.12 2.71 Favored Glycine 0 N--CA 1.506 3.318 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -79.59 -35.53 39.52 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.935 HG23 ' HG ' ' A' ' 112' ' ' LEU . 10.8 mt -68.73 -36.99 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.632 ' HA ' HG21 ' A' ' 101' ' ' THR . 25.1 t-20 -63.1 -25.88 68.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' HG3' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -83.72 -35.66 24.26 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.578 ' HD3' ' HG3' ' A' ' 125' ' ' LYS . 1.2 mppt? -77.52 -18.63 56.84 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.343 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 2.8 t -88.4 -35.42 17.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -62.71 -28.14 69.74 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 132' ' ' SER . 12.0 mt-10 -84.1 -37.98 21.34 Favored 'General case' 0 N--CA 1.517 2.9 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.672 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.5 ttt -57.37 -43.26 83.4 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.16 -20.87 43.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 19.7 m -57.59 -31.89 66.63 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 23.6 t-80 -81.47 -40.05 23.87 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -67.96 -9.78 48.14 Favored 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.414 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -40.48 11.43 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -79.68 -3.75 48.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.7 p -82.44 -19.73 38.36 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 75.91 14.6 2.61 Favored 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.601 179.461 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -134.51 55.9 0.73 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -50.88 -46.73 60.53 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 117.916 0.858 . . . . 0.0 110.023 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.3 -24.45 64.98 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 121.95 -0.469 . . . . 0.0 110.801 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.65 -37.2 70.84 Favored 'General case' 0 N--CA 1.528 3.456 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 18.0 m-85 -75.24 -11.91 60.17 Favored 'General case' 0 N--CA 1.516 2.839 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.8 mm -90.68 -24.54 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.6 2.886 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 172.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.32 -16.89 64.53 Favored 'General case' 0 C--O 1.177 -2.737 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 175.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.73 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.17 -60.39 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 19' ' ' ALA 0.267 0.6 OUTLIER -47.99 -41.37 25.16 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 123.211 1.482 . . . . 0.0 111.432 177.314 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.423 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 26.1 mmt -77.59 -35.89 52.46 Favored 'General case' 1 C--N 1.234 -4.438 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.212 -174.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.7 -3.54 58.6 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.8 -2.19 32.9 Favored 'General case' 1 N--CA 1.576 5.831 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -174.042 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 37.45 21.09 0.01 OUTLIER Glycine 2 N--CA 1.556 6.641 0 CA-C-N 119.528 1.058 . . . . 0.0 113.459 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' ASP . 41.5 m -140.16 -9.76 1.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.318 -1.107 . . . . 0.0 108.792 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -85.49 -175.72 5.79 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.12 0.962 . . . . 0.0 109.769 -178.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.582 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -151.65 -48.57 0.11 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 6.1 t0 -136.66 -177.79 4.89 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 10' ' ' LEU 0.252 . . -171.2 126.11 0.66 Allowed 'General case' 0 N--CA 1.513 2.722 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.683 -175.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -137.07 109.37 7.31 Favored 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 116.169 -2.213 . . . . 0.0 115.957 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 6' ' ' TYR . 9.8 mt -81.7 121.81 35.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 101.739 -3.43 . . . . 0.0 101.739 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 29' ' ' SER . 43.0 t -130.42 119.54 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -71.63 81.34 0.52 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 106.31 -2.716 . . . . 0.0 106.31 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' CE ' ' A' ' 104' ' ' LYS . 2.3 p90 -76.99 23.13 0.18 Allowed 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.799 0.839 . . . . 0.0 112.053 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -62.89 -153.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.22 -59.25 1.06 Allowed 'General case' 1 N--CA 1.542 4.151 0 CA-C-O 121.35 0.595 . . . . 0.0 109.785 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -110.29 127.74 26.52 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.3 Cg_endo -81.01 149.43 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.627 1.551 . . . . 0.0 111.1 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' HG13 ' A' ' 22' ' ' VAL . 51.6 p -153.49 166.22 33.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 40' ' ' VAL . 55.4 t -96.93 101.43 12.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.597 ' CZ3' HG22 ' A' ' 108' ' ' THR . 9.8 m0 -69.44 -25.9 64.34 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.844 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 177.73 83.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.3 0.571 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -114.79 132.35 56.5 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 7' ' ' ILE . 25.6 t -49.15 103.14 0.35 Allowed Pre-proline 0 N--CA 1.52 3.032 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -72.61 139.74 31.62 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.836 1.69 . . . . 0.0 112.382 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.5 -22.52 10.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -88.84 -84.56 0.21 Allowed 'General case' 0 N--CA 1.511 2.577 0 CA-C-N 117.8 0.8 . . . . 0.0 113.11 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -165.75 -38.29 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.869 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -176.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.014 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.6 m-30 -59.42 -38.47 80.71 Favored 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -59.19 -19.6 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.35 23.2 1.93 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.954 HG23 ' OE2' ' A' ' 46' ' ' GLU . 3.5 mt -70.14 133.93 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.852 0.834 . . . . 0.0 108.909 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 18.0 p -123.89 176.28 2.34 Favored Pre-proline 0 N--CA 1.51 2.55 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.41 2.62 4.29 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 121.815 1.677 . . . . 0.0 112.772 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.44 -63.97 1.22 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.954 ' OE2' HG23 ' A' ' 42' ' ' ILE . 2.0 pp20? -63.22 -30.77 71.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.322 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.898 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -80.69 -23.46 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -58.35 -28.44 61.9 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.5 p -95.57 -38.92 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.16 0 O-C-N 122.343 -0.504 . . . . 0.0 110.261 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -65.03 -13.93 59.14 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.06 -0.4 . . . . 0.0 110.618 177.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.4 m -145.64 -8.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.018 -176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -51.31 158.19 2.51 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -16.36 49.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.134 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HB3' ' CD2' ' A' ' 58' ' ' PHE . 7.6 t70 -39.62 113.46 0.34 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 123.077 0.551 . . . . 0.0 110.301 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -101.34 12.23 37.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.2 t -166.67 -47.14 0.02 OUTLIER 'General case' 0 N--CA 1.53 3.553 0 CA-C-N 120.433 1.47 . . . . 0.0 114.225 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.9 p -51.74 -81.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.21 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CE1' ' CE1' ' A' ' 59' ' ' TYR . 5.5 p90 -37.08 -22.23 0.01 OUTLIER 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 31.3 m-85 -60.7 -3.51 0.73 Allowed 'General case' 0 N--CA 1.519 3.016 0 CA-C-N 120.314 1.415 . . . . 0.0 112.28 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -121.8 -29.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.754 -0.591 . . . . 0.0 111.568 -178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -83.64 -29.66 27.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.542 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 106.37 149.16 16.63 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.802 HD13 ' HG ' ' A' ' 50' ' ' LEU . 15.8 mt -81.96 -159.04 0.27 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 20.5 p -157.47 135.31 10.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.014 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -136.01 96.45 3.41 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-O 122.523 1.154 . . . . 0.0 110.599 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.65 29.78 60.92 Favored Glycine 0 N--CA 1.476 1.318 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.11 4.21 69.13 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' HB3' HD12 ' A' ' 65' ' ' LEU . 19.7 tp60 -103.94 105.49 15.69 Favored 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 118.891 1.346 . . . . 0.0 110.215 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -66.14 109.7 2.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 1.8 p -104.47 -171.88 2.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 175.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.676 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 3.6 p -147.96 114.26 5.9 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.588 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' HE2' ' A' ' 85' ' ' MET . 4.5 t -44.21 126.38 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.344 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.815 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 8.2 mt -134.69 76.61 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.184 -2.353 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.7 mmp_? 96.12 81.91 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 126.598 1.959 . . . . 0.0 108.551 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.712 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -73.38 96.81 2.4 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.593 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.473 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -111.75 34.03 4.42 Favored 'General case' 0 C--O 1.185 -2.338 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 176.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.618 HD21 ' NZ ' ' A' ' 104' ' ' LYS . 19.3 tp -66.03 -54.29 27.75 Favored 'General case' 0 N--CA 1.516 2.841 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.77 43.46 1.54 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 120.604 -1.31 . . . . 0.0 111.412 -178.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 82' ' ' GLU . 4.2 pt20 -111.72 59.86 0.62 Allowed 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' GLN . 5.0 t70 -17.26 121.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.129 1.442 . . . . 0.0 112.798 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.17 29.22 6.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 106.799 -2.52 . . . . 0.0 106.799 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -170.94 -69.14 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.823 0.82 . . . . 0.0 110.176 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 45.36 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 p -87.52 134.72 33.57 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 120.873 1.669 . . . . 0.0 109.885 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.725 ' HE2' HG22 ' A' ' 72' ' ' VAL 0.275 7.3 ttt -128.88 129.88 46.12 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.815 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -95.94 79.97 3.3 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 120.287 1.403 . . . . 0.0 110.767 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -93.81 108.29 20.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 120.877 -1.139 . . . . 0.0 108.536 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -108.58 151.89 25.5 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.656 -176.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 6.9 p -71.9 94.72 1.47 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.808 ' HD3' HD11 ' A' ' 73' ' ' ILE . 3.3 mtmt -88.45 116.74 26.9 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.868 ' H ' HG22 ' A' ' 97' ' ' THR . 1.1 t -88.91 -168.1 2.08 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.047 -175.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -79.71 -166.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.155 -176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.72 101.92 1.59 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.2 -29.21 9.88 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -58.48 163.71 4.65 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 122.14 -0.623 . . . . 0.0 110.537 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.5 Cg_endo -90.69 128.59 1.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 123.14 2.56 . . . . 0.0 108.897 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.868 HG22 ' H ' ' A' ' 91' ' ' SER . 52.0 p -93.22 178.44 5.73 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.965 0.888 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.907 ' CD1' ' HB3' ' A' ' 115' ' ' LYS . 48.1 m-85 -154.07 173.64 15.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.742 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -144.6 155.39 43.61 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.93 -176.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.5 t -137.42 146.99 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.59 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.4 m -117.65 127.43 53.94 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.845 HG22 ' HG ' ' A' ' 111' ' ' LEU . 2.1 t -113.44 114.82 47.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 7.0 p -108.3 112.49 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.6 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -100.13 115.89 30.87 Favored 'General case' 0 N--CA 1.516 2.867 0 O-C-N 121.71 -0.619 . . . . 0.0 111.152 -178.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.791 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.5 p -74.89 -149.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -95.05 -17.77 21.59 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -142.97 17.83 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.761 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.597 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 6.1 p -147.58 160.12 42.99 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' HG ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -127.02 86.64 2.53 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.938 HG21 HD13 ' A' ' 134' ' ' LEU . 4.4 t -77.79 147.42 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 109.78 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.845 ' HG ' HG22 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -130.4 143.31 50.69 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.924 ' HG ' HG23 ' A' ' 123' ' ' ILE . 9.4 tp -132.39 97.17 4.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.729 ' HA ' HG13 ' A' ' 100' ' ' VAL . 8.0 ttt -89.65 143.33 26.9 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.645 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -165.59 138.68 5.36 Favored Glycine 0 CA--C 1.473 -2.568 0 C-N-CA 118.446 -1.835 . . . . 0.0 114.349 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.907 ' HB3' ' CD1' ' A' ' 98' ' ' PHE 0.556 74.7 mttt -160.86 113.62 1.97 Allowed 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 173.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -118.39 90.45 3.34 Favored 'General case' 0 C--O 1.263 1.771 0 N-CA-C 101.415 -3.55 . . . . 0.0 101.415 157.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.503 ' H ' ' HE1' ' A' ' 98' ' ' PHE . . . 53.83 1.1 0.08 OUTLIER Glycine 2 CA--C 1.676 10.108 1 CA-C-N 127.39 4.632 . . . . 0.0 108.228 -177.691 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.865 HG21 HD12 ' A' ' 123' ' ' ILE . 7.1 p -21.55 133.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.392 2.447 0 C-N-CA 127.178 2.191 . . . . 0.0 116.56 -171.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -74.55 -54.31 7.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.66 -2.064 . . . . 0.0 108.224 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.57 18.41 8.03 Favored Glycine 0 N--CA 1.505 3.271 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -114.34 -35.52 1.44 Allowed Glycine 0 N--CA 1.512 3.703 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.26 -38.04 60.69 Favored 'General case' 0 C--O 1.17 -3.105 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.924 HG23 ' HG ' ' A' ' 112' ' ' LEU . 27.1 mt -65.73 -35.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 101' ' ' THR . 8.0 t30 -62.05 -29.82 70.55 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.92 -37.37 29.69 Favored 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.8 mtmt -78.31 -12.97 60.04 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.193 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 101' ' ' THR . 3.7 t -91.14 -33.97 15.23 Favored 'General case' 0 C--O 1.204 -1.334 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -32.23 72.89 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.78 -42.57 40.27 Favored 'General case' 0 N--CA 1.517 2.888 0 CA-C-O 121.173 0.511 . . . . 0.0 109.87 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.626 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.9 ttt -57.25 -45.08 84.32 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.27 -17.92 56.0 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 109.476 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -61.35 -34.29 75.05 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 7.0 t60 -78.86 -38.29 38.22 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.891 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.938 HD13 HG21 ' A' ' 110' ' ' VAL . 2.1 mp -67.12 -12.38 59.83 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.166 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -85.21 -43.74 13.53 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -4.77 46.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.8 p -80.65 -22.04 40.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.34 22.03 1.75 Allowed 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.864 -0.523 . . . . 0.0 110.214 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.478 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 133.06 -43.92 1.24 Allowed Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.489 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.25 -57.54 8.57 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 122.071 -0.664 . . . . 0.0 110.811 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.48 -19.17 34.77 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 122.11 -0.369 . . . . 0.0 111.676 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -78.18 -37.3 46.07 Favored 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 2.7 m-85 -71.72 -15.55 62.2 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.853 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.2 mm -91.0 -27.23 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 173.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.7 OUTLIER -64.68 -15.24 61.08 Favored 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 175.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -61.54 -72.42 0.12 Allowed 'General case' 0 C--O 1.164 -3.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.931 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -40.34 -33.25 0.23 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.787 1.235 . . . . 0.0 112.53 178.496 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.4 mmt -83.96 -47.61 10.83 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.74 1.38 43.03 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.396 1.479 . . . . 0.0 112.523 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' THR 0.354 45.2 p-10 -89.07 -4.74 58.26 Favored 'General case' 0 N--CA 1.534 3.754 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -170.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 25.47 39.89 0.01 OUTLIER Glycine 1 N--CA 1.546 5.969 0 CA-C-N 118.922 0.783 . . . . 0.0 112.004 -176.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 122' ' ' LEU . 3.5 m -156.87 -56.37 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' HD12 ' A' ' 10' ' ' LEU 0.267 0.5 OUTLIER -79.65 -175.9 5.07 Favored 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.588 177.787 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.574 ' N ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -143.42 -48.05 0.3 Allowed 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -172.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 113' ' ' MET . 1.2 t70 -126.42 -177.84 4.13 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.931 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -167.72 132.0 1.79 Allowed 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.023 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -134.59 104.97 6.29 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 117.676 -1.61 . . . . 0.0 113.532 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.9 mt -86.94 117.36 31.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 101.717 -3.438 . . . . 0.0 101.717 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 42' ' ' ILE . 31.0 t -129.4 111.77 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 118.976 -1.09 . . . . 0.0 112.322 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.48 86.84 0.06 OUTLIER Glycine 1 N--CA 1.519 4.231 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.617 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -83.21 31.99 0.45 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 123.66 0.784 . . . . 0.0 112.239 -176.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.7 OUTLIER -63.91 -156.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.07 -57.32 3.95 Favored 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 p -104.9 120.99 48.19 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.6 Cg_endo -79.48 159.95 25.59 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.581 1.521 . . . . 0.0 111.302 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.2 p -162.73 154.88 18.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 40' ' ' VAL . 60.8 t -89.75 103.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 19.4 m0 -69.96 -26.53 64.15 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.643 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.853 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -178.43 85.35 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.203 0.525 . . . . 0.0 110.931 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -114.05 138.57 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 7' ' ' ILE . 74.5 t -50.1 105.08 0.47 Allowed Pre-proline 0 N--CA 1.516 2.844 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -71.0 158.48 55.22 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.306 2.004 . . . . 0.0 113.239 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.67 89.5 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.59 -70.45 0.81 Allowed 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 118.776 1.288 . . . . 0.0 112.499 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.42 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.278 0 O-C-N 121.451 -0.781 . . . . 0.0 111.01 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.952 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -60.78 -40.31 92.09 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.5 p -63.68 -16.37 18.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -89.87 21.39 3.62 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 22' ' ' VAL . 8.9 mt -68.82 116.88 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.282 1.039 . . . . 0.0 110.374 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.684 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 3.0 p -105.63 179.56 0.9 Allowed Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.684 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.7 Cg_endo -70.87 2.52 4.07 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 121.311 1.34 . . . . 0.0 112.36 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.88 -64.01 1.22 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -57.92 -37.03 73.33 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.933 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -79.32 -27.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -56.8 -28.36 57.13 Favored Glycine 0 N--CA 1.5 2.941 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 58' ' ' PHE . 14.9 p -98.4 -34.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.314 0 O-C-N 122.268 -0.548 . . . . 0.0 110.352 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 2.4 mt -68.44 -14.8 63.25 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.424 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' O ' ' A' ' 47' ' ' VAL . 2.6 m -145.71 -13.98 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 120.714 -0.394 . . . . 0.0 112.04 -175.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -45.74 136.84 7.64 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -27.32 4.18 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -57.84 126.61 28.14 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -136.23 51.42 2.02 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.547 0.689 . . . . 0.0 110.742 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -155.47 -10.49 0.11 Allowed 'General case' 0 N--CA 1.514 2.751 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.772 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.1 p -93.82 -87.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.562 -0.711 . . . . 0.0 110.652 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 49' ' ' VAL . 29.8 p90 -37.29 -22.05 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.235 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 24.7 m-85 -60.36 -3.05 0.56 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-N 120.147 1.339 . . . . 0.0 113.175 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.93 -31.36 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 121.758 -0.588 . . . . 0.0 110.69 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 9.9 p30 -94.66 -45.3 7.42 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.977 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 131.45 151.53 6.97 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' A' ' 87' ' ' LEU . 12.3 mt -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 63' ' ' LEU . 20.8 p -160.41 130.03 5.11 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.44 103.18 6.05 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 122.084 0.945 . . . . 0.0 109.95 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 72.71 29.53 65.31 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.69 14.14 73.86 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB3' HD12 ' A' ' 65' ' ' LEU . 22.6 tp60 -112.87 99.05 7.59 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 118.338 1.069 . . . . 0.0 109.74 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 64' ' ' THR . 0.0 OUTLIER -61.12 115.54 3.85 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.121 -179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 6.2 p -108.1 174.03 6.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.1 p -131.4 108.82 9.88 Favored 'General case' 0 N--CA 1.51 2.542 0 C-N-CA 119.321 -0.952 . . . . 0.0 113.478 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' HE2' ' A' ' 85' ' ' MET . 21.3 t -45.63 120.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.895 0.855 . . . . 0.0 111.016 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.816 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 14.0 mt -130.52 70.02 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.182 -2.476 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' MET . 60.2 mtt85 111.21 102.9 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 126.63 1.972 . . . . 0.0 107.11 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -102.7 112.45 25.23 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.903 0.859 . . . . 0.0 112.36 -178.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -132.51 9.75 4.35 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.844 176.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.691 HD21 ' HE3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -36.68 -30.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.72 0.808 . . . . 0.0 112.411 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mt -99.27 123.96 43.97 Favored 'General case' 0 C--O 1.201 -1.451 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.695 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -47.98 78.47 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 126.006 1.723 . . . . 0.0 115.314 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.08 31.05 3.79 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 170.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.02 17.73 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 2.6 mp0 -155.12 -61.93 0.12 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 57.68 0.11 0.1 Allowed 'General case' 1 N--CA 1.543 4.191 0 O-C-N 121.5 -0.75 . . . . 0.0 111.28 -172.678 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 11.4 p -90.49 143.27 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.04 1.291 . . . . 0.0 111.175 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.842 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -141.33 127.83 20.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.468 -178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.816 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.6 m-20 -90.86 76.89 6.28 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.386 -1.446 . . . . 0.0 111.096 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.842 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -96.2 116.88 29.69 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.25 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.605 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 2.1 ptt180 -113.61 135.23 54.15 Favored 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 119.506 -0.878 . . . . 0.0 113.271 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -57.55 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -75.9 148.32 38.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -178.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.787 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -97.62 174.78 6.47 Favored 'General case' 0 N--CA 1.516 2.835 0 CA-C-O 121.524 0.678 . . . . 0.0 112.169 -176.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -147.39 96.93 2.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.48 82.47 0.52 Allowed Glycine 0 N--CA 1.508 3.47 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.386 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.69 5.39 37.63 Favored Glycine 0 N--CA 1.506 3.302 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.643 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.787 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -78.71 160.42 72.04 Favored Pre-proline 0 N--CA 1.508 2.455 0 CA-C-N 119.355 1.577 . . . . 0.0 109.384 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 61.2 Cg_endo -91.02 132.75 1.56 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.046 2.497 . . . . 0.0 109.284 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.648 HG23 ' HB3' ' A' ' 91' ' ' SER . 1.9 p -94.49 164.61 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.633 ' CA ' ' HG3' ' A' ' 115' ' ' LYS . 42.2 m-85 -148.19 138.71 22.87 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 5.3 m-20 -113.57 151.06 32.13 Favored 'General case' 0 CA--C 1.461 -2.475 0 O-C-N 120.707 -1.245 . . . . 0.0 109.307 -175.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' A' ' 87' ' ' LEU . 11.2 t -136.17 149.98 27.74 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.466 -176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 124' ' ' ASN . 84.4 m -124.56 123.92 41.14 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.764 -3.05 . . . . 0.0 102.764 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.646 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.0 t -113.31 124.86 70.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.346 0.593 . . . . 0.0 109.89 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.651 HG23 ' SG ' ' A' ' 127' ' ' CYS . 21.5 p -116.17 113.36 22.97 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.691 ' HE3' HD21 ' A' ' 77' ' ' LEU . 3.6 tppp? -92.95 113.4 25.66 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 134' ' ' LEU . 62.3 p -71.73 -144.99 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -92.52 -30.56 15.62 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.229 -0.919 . . . . 0.0 109.963 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 21.5 mttm -136.35 13.54 3.26 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 121.734 -0.604 . . . . 0.0 110.522 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.538 HG21 HD23 ' A' ' 134' ' ' LEU . 2.5 p -132.26 154.13 49.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.35 86.24 2.52 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 134' ' ' LEU . 2.5 t -79.89 141.59 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 O-C-N 120.894 -1.129 . . . . 0.0 108.477 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 ' HB3' ' A' ' 20' ' ' ALA . 19.6 mt -127.64 146.48 50.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.827 HD12 HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -131.52 96.24 3.93 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.548 ' HG2' ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -103.45 157.79 16.79 Favored 'General case' 0 CA--C 1.44 -3.287 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.7 -174.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 17' ' ' GLN . . . 131.65 153.95 7.63 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 119.288 2.475 . . . . 0.0 119.288 173.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.742 ' HG2' HG11 ' A' ' 118' ' ' VAL 0.381 9.4 mtmt -151.21 119.07 6.17 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 112.472 -1.864 . . . . 0.0 107.942 167.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 118' ' ' VAL . 1.4 tt0 -112.65 92.45 4.02 Favored 'General case' 0 C--N 1.257 -3.435 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 163.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.57 -3.13 0.05 OUTLIER Glycine 2 CA--C 1.653 8.704 0 CA-C-N 123.775 2.988 . . . . 0.0 109.609 -177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 123' ' ' ILE . 7.6 p -35.64 139.32 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.616 -1.52 . . . . 0.0 114.114 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -78.94 -49.14 13.28 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 113.307 -1.77 . . . . 0.0 107.117 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.44 8.11 Favored Glycine 0 N--CA 1.508 3.451 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.89 -19.28 29.46 Favored Glycine 1 N--CA 1.518 4.103 0 CA-C-N 118.46 1.13 . . . . 0.0 111.104 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.723 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.74 -31.07 28.61 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 118' ' ' VAL . 50.2 mt -71.59 -38.36 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.85 ' HA ' HG21 ' A' ' 101' ' ' THR . 54.9 t30 -62.22 -30.71 71.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -83.84 -22.68 31.64 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' MET . 16.9 mtmm -88.49 -14.03 38.82 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.908 -0.495 . . . . 0.0 109.675 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.7 t -90.03 -31.56 17.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.37 -30.92 67.96 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' SER . 2.7 mm-40 -82.69 -44.91 15.11 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 121.438 0.637 . . . . 0.0 109.517 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.749 ' SD ' HG13 ' A' ' 110' ' ' VAL . 1.8 ttt -56.08 -46.86 78.86 Favored 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 135' ' ' ARG . . . -79.15 -22.29 45.28 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.697 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' GLU . 1.8 m -58.16 -33.09 68.83 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.493 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 19.1 t-80 -79.78 -39.24 31.36 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.874 HD13 HG21 ' A' ' 110' ' ' VAL . 1.8 mp -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.734 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 22.6 mmm180 -89.35 -37.98 14.49 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -80.82 -2.95 49.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 133' ' ' HIS . 26.7 p -84.25 -18.55 36.09 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.95 32.76 0.63 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.35 -1.309 . . . . 0.0 109.251 179.767 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.503 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -155.32 -106.38 0.26 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -48.42 -48.72 37.0 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 122.191 -0.594 . . . . 0.0 111.299 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -59.59 -23.42 62.92 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -75.18 -37.5 61.23 Favored 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 26.7 m-85 -74.4 -11.62 60.29 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.822 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.4 mm -90.89 -26.72 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.705 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 172.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -65.05 -18.38 65.26 Favored 'General case' 0 C--O 1.179 -2.634 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' HD13 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.48 -56.43 15.21 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.576 1.179 . . . . 0.0 108.209 176.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.875 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -51.47 -40.59 59.76 Favored 'General case' 0 CA--C 1.441 -3.25 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.872 178.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.3 mmt -78.77 -34.26 45.73 Favored 'General case' 1 C--N 1.237 -4.321 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.893 -175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.01 -4.39 58.7 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -99.63 -1.76 37.23 Favored 'General case' 1 N--CA 1.564 5.233 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.248 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.99 33.79 0.01 OUTLIER Glycine 1 N--CA 1.555 6.609 0 CA-C-N 119.754 1.161 . . . . 0.0 112.125 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 13' ' ' ASP . 16.0 m -146.1 -35.35 0.28 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.51 -172.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' CG ' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tm0? -150.82 -43.14 0.12 Allowed 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 25.2 t0 -134.62 -174.33 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.875 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.37 129.24 0.86 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.426 -0.796 . . . . 0.0 110.207 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -137.69 108.12 6.51 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 117.41 -1.716 . . . . 0.0 115.012 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 110' ' ' VAL . 19.3 mt -90.05 116.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 101.407 -3.553 . . . . 0.0 101.407 172.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 42' ' ' ILE . 22.8 t -125.79 111.6 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.288 -0.882 . . . . 0.0 112.434 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -64.46 86.6 0.07 OUTLIER Glycine 1 N--CA 1.52 4.287 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 176.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -85.16 33.9 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -64.93 -155.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.69 -57.77 2.59 Favored 'General case' 1 N--CA 1.546 4.34 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 p -105.81 119.17 53.32 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 29.6 Cg_endo -78.34 156.71 29.26 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.846 1.697 . . . . 0.0 111.34 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.6 p -162.24 156.35 21.54 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 40' ' ' VAL . 52.6 t -86.89 102.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.561 0.696 . . . . 0.0 109.649 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.541 ' CZ3' HG22 ' A' ' 108' ' ' THR . 14.6 m0 -69.8 -22.71 63.29 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 176.14 86.18 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 121.287 0.565 . . . . 0.0 110.558 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.96 133.39 56.05 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 19' ' ' ALA . 55.9 t -47.91 102.56 0.32 Allowed Pre-proline 0 N--CA 1.521 3.092 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.53 148.39 87.52 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.021 1.814 . . . . 0.0 112.474 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.13 -10.93 67.74 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -92.65 -86.85 0.23 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.707 -0.878 . . . . 0.0 112.135 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 66' ' ' GLY . 2.5 m -167.4 -36.59 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 121.262 -0.899 . . . . 0.0 111.854 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 9.8 m-30 -61.86 -35.24 77.72 Favored 'General case' 0 N--CA 1.516 2.854 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.79 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.4 p -57.94 -20.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -89.73 28.77 1.26 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 22' ' ' VAL . 2.9 mt -77.92 133.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.179 0.99 . . . . 0.0 109.231 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.645 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 40.0 p -122.57 177.46 1.61 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.2 Cg_endo -72.15 0.71 6.89 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 121.452 1.435 . . . . 0.0 112.002 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.75 -64.64 1.12 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 64' ' ' THR . 2.0 pm0 -61.28 -28.97 69.57 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.461 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -84.5 -23.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 122.027 -0.421 . . . . 0.0 109.944 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.15 71.22 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 58' ' ' PHE . 11.5 p -95.57 -34.86 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.069 0 O-C-N 122.337 -0.508 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 63' ' ' LEU . 7.1 mt -67.6 -17.64 64.7 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.179 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -147.43 -11.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.553 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.19 -123.88 0.01 OUTLIER Glycine 1 N--CA 1.524 4.563 0 CA-C-O 122.203 0.891 . . . . 0.0 111.572 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -71.11 0.14 8.33 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.31 0.644 . . . . 0.0 112.233 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 53' ' ' LYS . 7.4 t0 -16.96 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.297 0 C-N-CA 124.074 0.95 . . . . 0.0 113.502 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -165.96 -9.57 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.581 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 30.8 t -171.74 -57.31 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 120.14 1.336 . . . . 0.0 111.555 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 60' ' ' VAL . 13.5 p -38.36 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE1' HD21 ' A' ' 63' ' ' LEU . 21.1 p90 -38.12 -16.32 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 72' ' ' VAL . 11.0 m-85 -55.08 -14.29 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.787 2.085 . . . . 0.0 111.298 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 57' ' ' SER . 25.1 m -100.37 -39.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 122.217 -0.302 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 1.8 p30 -84.96 -57.79 2.96 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.86 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 133.01 147.06 5.68 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.944 HD13 HD23 ' A' ' 50' ' ' LEU . 22.7 mt -76.31 -160.2 0.14 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.1 p -160.89 125.67 3.64 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -126.43 100.41 6.25 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.26 22.22 68.47 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.99 66.46 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.641 ' NE2' HG22 ' A' ' 89' ' ' THR . 11.8 tm0? -93.44 100.44 12.75 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 118.353 1.076 . . . . 0.0 110.495 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.84 103.72 0.38 Allowed 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.036 -0.415 . . . . 0.0 110.711 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 87' ' ' LEU . 8.9 p -110.38 166.07 11.27 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.725 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -128.57 116.76 20.14 Favored 'General case' 0 N--CA 1.518 2.974 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.193 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.4 t -44.38 134.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.234 1.016 . . . . 0.0 112.428 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.788 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.5 mp -135.97 73.5 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.53 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 C-N-CA 125.563 1.545 . . . . 0.0 108.063 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' HG11 ' A' ' 72' ' ' VAL . 2.0 t70 -82.67 104.12 12.69 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.729 0.776 . . . . 0.0 110.21 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.19 -1.92 12.29 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 HD13 HG12 ' A' ' 102' ' ' VAL . 15.4 tp -31.54 -39.4 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 C-N-CA 124.157 0.983 . . . . 0.0 111.602 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' ASP . 40.8 mt -92.65 120.67 33.3 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -47.13 81.26 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 123.997 1.856 . . . . 0.0 114.296 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' LEU . 24.1 t70 -100.52 29.35 4.48 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 172.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.92 26.43 16.7 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 107.201 -2.36 . . . . 0.0 107.201 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 36.0 mm-40 -157.0 -55.06 0.08 Allowed 'General case' 0 C--N 1.369 1.419 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.0 OUTLIER 60.13 3.32 0.51 Allowed 'General case' 0 N--CA 1.533 3.714 0 O-C-N 121.753 -0.592 . . . . 0.0 109.973 -172.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.9 p -95.23 132.37 40.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.691 -1.256 . . . . 0.0 110.39 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.769 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.258 19.8 ttt -127.65 122.61 33.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -177.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.788 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -92.96 80.06 4.61 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 120.773 -1.204 . . . . 0.0 111.033 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.889 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.97 117.35 30.47 Favored 'General case' 0 CA--C 1.484 -1.588 0 O-C-N 120.294 -1.504 . . . . 0.0 107.668 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.634 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.4 OUTLIER -118.04 136.87 53.28 Favored 'General case' 0 N--CA 1.518 2.944 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.931 -176.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.641 HG22 ' NE2' ' A' ' 68' ' ' GLN . 2.5 p -57.41 101.49 0.07 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.07 167.44 15.8 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.869 0.842 . . . . 0.0 110.275 -175.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 97' ' ' THR . 1.5 t -131.42 178.92 6.35 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.862 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -121.8 38.12 4.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.38 0.609 . . . . 0.0 109.69 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.57 -74.57 0.56 Allowed Glycine 0 N--CA 1.506 3.345 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.82 -6.9 73.89 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.672 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -96.68 168.91 9.61 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.118 0.959 . . . . 0.0 110.223 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.9 Cg_endo -94.66 149.58 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.52 2.813 . . . . 0.0 110.56 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 91' ' ' SER . 12.5 p -120.6 155.2 34.24 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 97' ' ' THR . 47.4 m-85 -144.61 151.41 38.99 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -120.31 140.31 51.46 Favored 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.495 -176.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 113' ' ' MET . 2.1 t -131.1 142.32 43.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.763 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.543 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.3 m -113.7 143.26 44.91 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.739 HG22 HD22 ' A' ' 111' ' ' LEU . 15.1 t -131.81 111.32 18.39 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 13.1 p -103.43 132.86 49.33 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.348 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 109' ' ' LEU . 4.6 tppp? -110.4 131.21 55.25 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 134' ' ' LEU . 60.9 p -92.75 -143.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -97.49 -21.02 17.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.834 . . . . 0.0 108.854 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 36.5 mttt -149.77 27.16 0.81 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.758 -0.589 . . . . 0.0 110.903 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.541 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.4 p -146.34 150.43 35.71 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -114.94 87.62 2.69 Favored 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG21 HD13 ' A' ' 134' ' ' LEU . 4.0 t -85.35 141.76 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.785 -1.197 . . . . 0.0 108.477 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.861 HD21 HD13 ' A' ' 109' ' ' LEU . 8.7 mt -131.18 152.71 50.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.959 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.06 103.19 5.06 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.718 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -89.69 150.55 22.29 Favored 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.296 -177.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.24 152.65 24.23 Favored Glycine 0 C--N 1.308 -1.006 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.925 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 20.7 mttt -131.02 167.33 19.23 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 28.9 tt0 -17.11 155.62 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.481 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -175.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.01 14.56 73.56 Favored Glycine 0 CA--C 1.563 3.05 1 N-CA-C 101.007 -4.837 . . . . 0.0 101.007 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.811 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -102.39 104.3 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 CA-C-N 113.749 -1.225 . . . . 0.0 112.401 -174.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -85.99 -36.59 19.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.42 -16.65 44.65 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.59 -29.89 28.52 Favored Glycine 0 N--CA 1.513 3.783 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.715 HD13 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -77.98 -38.82 44.23 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.959 HG23 ' HG ' ' A' ' 112' ' ' LEU . 64.4 mt -67.69 -36.22 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' HG21 ' A' ' 101' ' ' THR . 42.8 t-20 -63.26 -28.57 70.12 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -31.02 22.99 Favored 'General case' 0 N--CA 1.516 2.855 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.229 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.546 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.92 -18.49 37.17 Favored 'General case' 0 N--CA 1.515 2.825 0 O-C-N 121.64 -0.663 . . . . 0.0 110.137 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.637 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.8 t -87.34 -34.66 18.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.7 -30.2 69.64 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 132' ' ' SER . 5.1 mt-10 -84.4 -28.6 26.8 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 134' ' ' LEU . 6.4 ttt -62.72 -44.78 95.34 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.59 -17.7 53.29 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.986 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 13.7 m -59.97 -32.32 70.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.575 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 29.9 t-80 -80.27 -39.71 28.35 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 HG21 ' A' ' 110' ' ' VAL . 3.4 mp -69.5 -7.15 35.63 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.139 -1.025 . . . . 0.0 110.322 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.34 -39.5 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -77.72 -7.48 56.58 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 p -80.05 -12.64 59.67 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 64.06 26.85 14.1 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.118 -0.944 . . . . 0.0 109.048 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -153.66 -48.85 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -48.78 -48.22 41.3 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.184 -0.598 . . . . 0.0 111.186 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -58.36 -27.02 63.82 Favored 'General case' 0 N--CA 1.516 2.854 0 O-C-N 121.898 -0.501 . . . . 0.0 110.673 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -71.14 -38.28 72.24 Favored 'General case' 0 N--CA 1.524 3.265 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 27.7 m-85 -74.58 -11.15 60.13 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.847 HD11 ' O ' ' A' ' 32' ' ' ALA . 8.2 mm -90.79 -26.32 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.616 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 1.3 m-20 -69.47 -13.26 62.25 Favored 'General case' 0 C--O 1.186 -2.256 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.79 -54.54 45.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.878 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -53.76 -41.12 66.83 Favored 'General case' 0 CA--C 1.44 -3.276 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.801 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.4 mmt -76.44 -34.81 58.74 Favored 'General case' 1 C--N 1.24 -4.158 0 CA-C-N 113.898 -1.501 . . . . 0.0 107.421 -176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.48 -4.84 59.16 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -100.02 -1.74 36.23 Favored 'General case' 1 N--CA 1.569 5.514 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.983 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 31.59 34.01 0.01 OUTLIER Glycine 1 N--CA 1.555 6.603 0 CA-C-N 119.749 1.159 . . . . 0.0 112.064 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' ASP . 13.8 m -144.76 -36.78 0.31 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -68.94 -171.62 0.32 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.429 ' HG3' ' CG ' ' A' ' 115' ' ' LYS . 6.3 tm0? -150.69 -44.65 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.5 t0 -131.22 -171.87 2.7 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.878 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.92 134.06 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.403 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -140.72 108.18 5.57 Favored 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 116.96 -1.896 . . . . 0.0 115.473 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.562 HD13 HD11 ' A' ' 134' ' ' LEU . 9.9 mt -88.83 126.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.02 113.12 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 118.744 -1.182 . . . . 0.0 113.123 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -64.78 87.62 0.08 OUTLIER Glycine 1 N--CA 1.521 4.307 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 176.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HE2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -87.59 34.45 0.71 Allowed 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 123.375 0.67 . . . . 0.0 112.787 -176.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -66.62 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.57 -58.88 2.42 Favored 'General case' 1 N--CA 1.54 4.052 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -104.38 118.91 55.57 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 30.8 Cg_endo -80.58 163.85 21.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.649 1.566 . . . . 0.0 111.436 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -166.26 153.84 10.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.2 t -86.51 102.13 11.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.2 m0 -70.22 -25.02 63.2 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.071 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.847 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.62 86.76 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.0 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ALA . . . -119.29 133.82 55.54 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.586 HG23 ' HB3' ' A' ' 19' ' ' ALA . 49.1 t -49.4 114.49 4.03 Favored Pre-proline 0 N--CA 1.52 3.03 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.35 152.9 44.8 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.185 1.923 . . . . 0.0 112.529 -176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.52 -17.96 56.92 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -90.83 -82.22 0.29 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 118.29 1.045 . . . . 0.0 112.778 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -175.54 -36.8 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.194 0 O-C-N 121.557 -0.714 . . . . 0.0 110.975 -177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.968 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.7 m-30 -58.92 -42.94 90.9 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.749 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.6 p -54.91 -23.45 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -88.87 27.5 1.32 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mt -72.69 120.68 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.739 0 CA-C-O 122.119 0.961 . . . . 0.0 110.287 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 2.8 p -105.62 179.41 0.92 Allowed Pre-proline 0 N--CA 1.509 2.48 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 26.3 Cg_endo -69.58 0.03 6.09 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.342 1.362 . . . . 0.0 112.198 177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.54 -63.24 1.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -61.21 -33.59 73.72 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.606 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -81.6 -22.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.12 -29.98 74.36 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.779 HG22 HD23 ' A' ' 63' ' ' LEU . 12.6 p -98.71 -31.02 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 O-C-N 122.293 -0.534 . . . . 0.0 109.871 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 HD13 ' A' ' 63' ' ' LEU . 6.0 mt -68.61 -16.68 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -145.55 -5.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.775 -173.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.97 -178.54 0.33 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -4.44 57.31 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 122.636 -0.332 . . . . 0.0 110.813 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.8 t0 -41.69 114.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.654 0.74 . . . . 0.0 110.196 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.68 10.68 27.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.356 -175.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 8.4 t -166.34 -56.99 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 117.833 -1.547 . . . . 0.0 115.04 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 60' ' ' VAL . 12.9 p -39.07 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.7 p90 -36.82 -23.35 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CE1' ' CE1' ' A' ' 58' ' ' PHE . 19.6 m-85 -61.11 -10.76 6.8 Favored 'General case' 0 N--CA 1.517 2.924 0 CA-C-N 120.595 1.543 . . . . 0.0 112.866 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 57' ' ' SER . 2.5 m -123.07 -33.32 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.971 -0.456 . . . . 0.0 111.252 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 23.0 p30 -83.21 -41.31 18.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 118.16 141.77 6.83 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-O 121.714 0.619 . . . . 0.0 112.179 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.974 HD11 ' HE2' ' A' ' 85' ' ' MET . 13.6 mt -66.9 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 63' ' ' LEU . 14.7 p -159.52 128.89 5.34 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.968 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -133.69 103.45 5.89 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.209 1.004 . . . . 0.0 110.168 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.75 26.21 71.99 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.12 64.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB3' HD12 ' A' ' 65' ' ' LEU . 23.8 tp60 -109.28 107.56 17.83 Favored 'General case' 0 N--CA 1.526 3.347 0 CA-C-N 118.491 1.146 . . . . 0.0 110.214 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.83 112.81 5.76 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.465 ' SG ' HD23 ' A' ' 87' ' ' LEU . 2.6 p -115.68 136.48 53.02 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 2.2 p -94.14 114.45 26.59 Favored 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -49.55 137.62 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.715 0.769 . . . . 0.0 110.293 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HE2' ' A' ' 90' ' ' LYS . 1.1 mt -130.14 75.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 89.44 87.15 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.998 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.94 ' HB2' HG11 ' A' ' 72' ' ' VAL . 13.2 t70 -77.0 109.16 10.59 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.418 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -118.04 -0.06 11.72 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.677 HD13 HG12 ' A' ' 102' ' ' VAL . 15.3 tp -36.61 -31.26 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 123.871 0.868 . . . . 0.0 111.373 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 78' ' ' LEU . 66.7 mt -96.85 128.03 43.4 Favored 'General case' 0 C--O 1.201 -1.494 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.004 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -47.55 76.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.348 1.859 . . . . 0.0 114.57 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 78' ' ' LEU . 12.8 t0 -101.58 29.65 4.74 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.52 31.14 22.59 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.2 mp0 -154.44 -56.83 0.11 Allowed 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 43.86 52.96 6.42 Favored 'General case' 0 N--CA 1.535 3.814 0 CA-C-O 121.911 0.862 . . . . 0.0 110.023 -172.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.9 p -146.47 128.52 15.55 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.974 ' HE2' HD11 ' A' ' 63' ' ' LEU 0.33 17.7 ttt -128.12 134.63 49.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -99.1 74.81 1.99 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.115 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.91 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.85 112.03 23.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.123 -1.611 . . . . 0.0 107.546 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 7.5 ptt180 -118.17 130.47 56.12 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.366 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.523 HG22 HE21 ' A' ' 68' ' ' GLN . 3.6 p -53.87 105.25 0.13 Allowed 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 105.429 -2.064 . . . . 0.0 105.429 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -87.65 169.62 11.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.159 0.98 . . . . 0.0 111.403 -174.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.8 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -132.44 179.07 6.35 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.039 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -135.13 88.17 2.4 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.319 0.58 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.67 -93.69 1.6 Allowed Glycine 0 N--CA 1.502 3.054 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.13 -9.66 36.17 Favored Glycine 0 N--CA 1.508 3.474 0 O-C-N 122.006 -0.702 . . . . 0.0 111.6 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.8 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -56.8 165.3 1.77 Allowed Pre-proline 0 N--CA 1.512 2.642 0 CA-C-N 118.73 1.265 . . . . 0.0 109.531 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.4 Cg_endo -89.33 140.65 3.85 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.336 2.691 . . . . 0.0 111.941 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.668 HG23 ' HB3' ' A' ' 91' ' ' SER . 25.4 p -116.36 156.24 27.05 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' A' ' 97' ' ' THR . 42.0 m-85 -144.5 130.4 19.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.2 m-20 -107.45 143.21 36.13 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 118.643 -1.223 . . . . 0.0 112.899 -175.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 112' ' ' LEU . 15.7 t -131.7 139.38 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.097 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.927 HG21 ' HA ' ' A' ' 124' ' ' ASN . 42.5 m -112.71 125.77 54.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 87' ' ' LEU . 7.0 t -115.51 121.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 83' ' ' PHE . 12.0 p -108.32 173.46 6.31 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.474 0.654 . . . . 0.0 110.001 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' HD23 ' A' ' 109' ' ' LEU . 3.0 tppp? -138.31 149.36 45.57 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.431 0.634 . . . . 0.0 110.272 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.858 HG21 ' HB3' ' A' ' 134' ' ' LEU . 43.1 p -118.22 -141.99 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.44 -29.68 17.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.423 -0.798 . . . . 0.0 110.196 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -152.54 23.48 0.61 Allowed 'General case' 0 N--CA 1.521 3.084 0 O-C-N 121.665 -0.647 . . . . 0.0 110.385 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.586 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -131.26 156.2 45.82 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.829 HD13 HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.58 95.02 4.51 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 -177.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -88.22 146.84 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 110' ' ' VAL . 8.4 mt -133.92 155.01 50.67 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.012 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -134.13 104.73 6.34 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 39' ' ' PHE . 4.6 tpp -89.61 147.49 23.89 Favored 'General case' 0 N--CA 1.516 2.855 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.088 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -144.21 146.7 17.46 Favored Glycine 0 C--N 1.303 -1.262 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 34.2 mttt -125.39 161.68 26.5 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -17.19 152.43 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.372 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 -175.81 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.7 13.16 82.37 Favored Glycine 0 CA--C 1.56 2.896 1 N-CA-C 100.798 -4.921 . . . . 0.0 100.798 -168.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.835 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.99 97.41 5.61 Favored 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.777 -1.212 . . . . 0.0 111.353 -175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -77.05 -30.3 55.55 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.33 -21.85 42.02 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.64 -32.01 34.91 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.77 -38.6 53.79 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.012 HG23 ' HG ' ' A' ' 112' ' ' LEU . 15.5 mt -65.3 -36.03 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.927 ' HA ' HG21 ' A' ' 101' ' ' THR . 21.4 t-20 -64.47 -30.26 71.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -79.9 -33.28 40.03 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -84.37 -12.65 54.11 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.713 -0.617 . . . . 0.0 110.442 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.488 ' N ' HD23 ' A' ' 112' ' ' LEU . 4.6 t -88.76 -32.54 17.86 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -35.23 79.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.65 -35.33 39.49 Favored 'General case' 0 N--CA 1.515 2.797 0 CA-C-O 121.26 0.552 . . . . 0.0 109.751 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.0 ttt -60.86 -45.77 93.22 Favored 'General case' 0 N--CA 1.508 2.439 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.41 -14.75 56.78 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -64.6 -33.35 75.71 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.553 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 17.8 t-80 -78.29 -42.07 31.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.925 HD13 HG21 ' A' ' 110' ' ' VAL . 0.6 OUTLIER -64.57 -14.03 55.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.391 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -41.34 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -81.13 -1.7 45.45 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 p -85.57 -23.01 27.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 72.87 27.29 2.17 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 20.9 m-85 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.455 -1.26 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.334 0.588 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . -157.17 -88.71 0.07 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -48.59 -44.09 36.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.214 -0.58 . . . . 0.0 111.577 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -58.48 -29.09 65.95 Favored 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.689 -0.632 . . . . 0.0 111.248 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -73.7 -35.62 65.17 Favored 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.599 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 47.2 m-85 -72.53 -10.48 59.84 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.855 HD11 ' O ' ' A' ' 32' ' ' ALA . 6.4 mm -91.15 -29.12 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 173.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 2.9 m-20 -59.75 -22.22 61.8 Favored 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -54.72 -43.93 73.03 Favored 'General case' 0 C--O 1.19 -2.052 0 CA-C-O 122.686 1.232 . . . . 0.0 110.137 176.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.938 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 1.7 mm? -74.13 -21.82 59.72 Favored 'General case' 0 C--N 1.244 -3.998 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.497 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.2 mmt -93.58 -21.88 19.15 Favored 'General case' 0 C--N 1.255 -3.523 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.31 -53.92 5.38 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.348 0.0 OUTLIER -66.76 -0.51 3.02 Favored 'General case' 1 N--CA 1.562 5.128 0 N-CA-C 121.418 3.859 . . . . 0.0 121.418 -174.434 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.51 13.97 0.01 OUTLIER Glycine 2 N--CA 1.582 8.407 0 CA-C-N 121.261 1.846 . . . . 0.0 114.623 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ASP . 24.5 m -120.13 -42.12 2.6 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 102.908 -2.997 . . . . 0.0 102.908 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.621 ' HB2' HD12 ' A' ' 10' ' ' LEU . 11.4 p -67.39 145.35 55.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.676 -2.056 . . . . 0.0 106.807 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.556 ' N ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -130.9 -41.47 1.15 Allowed 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -174.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 3.0 t70 -139.21 -176.2 4.44 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.938 ' HB2' ' CG ' ' A' ' 10' ' ' LEU . . . -170.8 143.59 2.12 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.29 105.55 4.23 Favored 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 117.439 -1.704 . . . . 0.0 114.412 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 110' ' ' VAL . 7.6 mt -87.08 119.8 35.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 102.265 -3.235 . . . . 0.0 102.265 173.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 42' ' ' ILE . 16.1 t -127.26 114.6 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.5 -174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.53 86.22 0.11 Allowed Glycine 1 N--CA 1.524 4.509 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 176.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -84.44 33.66 0.51 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.439 0.695 . . . . 0.0 112.297 -176.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.8 -153.83 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -59.62 1.68 Allowed 'General case' 1 N--CA 1.539 4.013 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.1 p -104.88 127.31 29.06 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.8 Cg_endo -82.35 151.95 15.68 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.669 1.579 . . . . 0.0 110.943 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.4 p -154.15 156.81 37.87 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 40' ' ' VAL . 54.3 t -89.56 101.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.03 -21.44 64.12 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.989 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.855 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 173.96 84.03 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 CA-C-O 121.312 0.577 . . . . 0.0 110.791 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.74 132.13 55.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 7' ' ' ILE . 78.8 t -50.07 106.98 0.7 Allowed Pre-proline 0 N--CA 1.515 2.794 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -71.53 141.3 38.0 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.221 1.947 . . . . 0.0 111.965 -177.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.51 -2.75 32.55 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -111.89 -73.98 0.65 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.502 1.151 . . . . 0.0 112.054 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -176.82 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.279 0 O-C-N 121.376 -0.827 . . . . 0.0 111.629 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.931 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.4 m-30 -57.89 -41.67 83.05 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' O ' HG21 ' A' ' 30' ' ' VAL . 1.8 p -56.44 -21.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -85.45 22.53 1.52 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.675 -0.641 . . . . 0.0 109.369 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 2.7 mt -70.5 119.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 122.339 1.066 . . . . 0.0 110.467 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -108.22 -179.17 0.65 Allowed Pre-proline 0 N--CA 1.51 2.555 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -71.32 0.21 7.13 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 120.878 1.052 . . . . 0.0 112.054 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.31 -64.62 1.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.7 pm0 -59.68 -36.06 75.73 Favored 'General case' 0 N--CA 1.52 3.032 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.892 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD12 ' A' ' 109' ' ' LEU . 1.5 t -78.58 -23.96 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.34 75.7 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 63' ' ' LEU . 7.6 p -91.9 -34.08 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.14 0 O-C-N 122.144 -0.621 . . . . 0.0 109.656 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.766 ' HA ' HD22 ' A' ' 63' ' ' LEU . 10.2 mt -75.54 -10.23 59.27 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.953 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -152.21 -34.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.843 -175.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.13 116.47 5.1 Favored Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -33.4 1.99 Allowed 'General case' 0 N--CA 1.519 3.001 0 CA-C-O 121.397 0.618 . . . . 0.0 110.116 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -79.45 88.5 5.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' HB2' ' CD2' ' A' ' 58' ' ' PHE . 28.8 ptt85 -166.61 51.62 0.08 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.025 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 27.4 t -89.84 -10.88 43.71 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.259 -0.9 . . . . 0.0 110.842 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.5 p -80.54 -60.35 2.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.849 -0.532 . . . . 0.0 110.51 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.727 ' CE1' HD21 ' A' ' 63' ' ' LEU . 1.9 p90 -37.9 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.532 3.664 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 32.9 m-85 -60.28 -8.97 2.89 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 120.519 -1.363 . . . . 0.0 112.133 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' SER . 2.5 m -118.0 -35.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.974 -0.454 . . . . 0.0 109.833 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 12.5 p30 -89.86 -52.92 4.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.651 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 134.85 149.67 5.94 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.445 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 49' ' ' VAL . 4.2 mt -70.69 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.4 p -160.44 124.15 3.54 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.931 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -125.83 103.89 8.03 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 122.405 1.098 . . . . 0.0 110.111 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 38' ' ' THR . . . 74.75 24.16 73.06 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.24 12.19 61.9 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 65' ' ' LEU . 20.9 tp60 -107.49 107.44 18.29 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 118.542 1.171 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.75 109.86 2.6 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.764 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.9 p -116.97 140.0 49.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.729 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.2 p -101.25 120.69 40.62 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 122.033 0.921 . . . . 0.0 112.773 -176.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.874 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -47.25 131.38 4.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.205 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.799 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 mp -133.61 71.14 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.256 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 7.6 ttt85 112.31 72.81 0.0 OUTLIER 'General case' 1 N--CA 1.54 4.072 0 C-N-CA 125.862 1.665 . . . . 0.0 108.786 -179.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.874 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -72.81 107.79 5.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.942 0.877 . . . . 0.0 110.507 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 1.9 m -140.71 22.07 2.32 Favored 'General case' 0 C--O 1.197 -1.672 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.796 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.783 HD11 HG12 ' A' ' 102' ' ' VAL . 10.0 tp -52.31 -25.72 10.27 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.465 0.706 . . . . 0.0 111.673 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 80' ' ' ASP . 66.2 mt -99.08 124.65 44.24 Favored 'General case' 0 C--O 1.202 -1.443 0 C-N-CA 119.092 -1.043 . . . . 0.0 108.442 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.38 78.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.895 1.678 . . . . 0.0 114.626 -173.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' LEU . 18.9 t70 -101.06 25.69 7.84 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 171.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.69 29.58 9.17 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 2.6 mp0 -156.78 -57.42 0.09 Allowed 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 103' ' ' THR . 0.1 OUTLIER 53.1 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.533 3.722 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.071 -173.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.6 p -101.42 144.02 30.73 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 120.956 1.707 . . . . 0.0 110.034 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.745 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -138.46 125.71 21.62 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.45 -177.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -91.24 76.05 6.07 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.853 -1.155 . . . . 0.0 111.311 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.5 116.99 28.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 4.3 ptt180 -121.45 141.52 50.93 Favored 'General case' 0 N--CA 1.512 2.662 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.142 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.53 HG22 HE21 ' A' ' 68' ' ' GLN . 5.5 p -59.72 105.14 0.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HD3' HD11 ' A' ' 73' ' ' ILE . 5.4 mmmt -95.78 141.96 28.63 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.6 t -119.19 -166.21 1.23 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.733 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.6 p -85.43 -168.84 2.38 Favored 'General case' 0 N--CA 1.508 2.44 0 CA-C-O 121.388 0.613 . . . . 0.0 111.707 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.59 105.94 2.03 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.76 10.47 40.42 Favored Glycine 0 N--CA 1.505 3.277 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 91' ' ' SER . . . -100.2 164.66 15.94 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.831 -0.805 . . . . 0.0 109.842 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.0 Cg_endo -90.34 127.44 1.4 Allowed 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.773 2.315 . . . . 0.0 109.278 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 22.8 p -103.22 177.48 4.83 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.677 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 52.7 m-85 -152.33 151.99 31.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.586 ' OD1' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -129.16 171.62 12.23 Favored 'General case' 0 N--CA 1.521 3.103 0 CA-C-N 121.03 1.741 . . . . 0.0 113.358 -174.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 t -154.43 144.23 13.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.921 HG21 ' HA ' ' A' ' 124' ' ' ASN . 91.0 m -118.79 126.65 52.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 77' ' ' LEU . 3.7 t -115.29 123.83 71.25 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-O 121.494 0.664 . . . . 0.0 109.288 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.671 HG23 ' SG ' ' A' ' 127' ' ' CYS . 12.4 p -113.49 127.75 56.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 77' ' ' LEU . 2.4 tppp? -110.79 135.36 51.49 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 134' ' ' LEU . 72.7 p -93.27 -144.66 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.73 -20.92 19.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.52 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -147.85 24.27 1.07 Allowed 'General case' 0 N--CA 1.512 2.632 0 O-C-N 121.686 -0.634 . . . . 0.0 110.761 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.7 p -141.99 160.8 39.48 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -127.26 85.37 2.36 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.954 HG21 HD13 ' A' ' 134' ' ' LEU . 2.6 t -81.42 144.17 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 120.931 -1.106 . . . . 0.0 108.257 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 20' ' ' ALA . 13.3 mt -128.33 155.62 44.37 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -134.85 99.95 4.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.555 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 1.6 ttt -90.63 147.76 23.09 Favored 'General case' 0 C--N 1.272 -2.778 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.987 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.674 ' O ' HG11 ' A' ' 118' ' ' VAL . . . -178.78 118.67 0.62 Allowed Glycine 0 CA--C 1.456 -3.607 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.667 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 98' ' ' PHE 0.319 0.0 OUTLIER -165.28 117.86 1.18 Allowed 'General case' 0 N--CA 1.403 -2.821 0 C-N-CA 115.23 -2.588 . . . . 0.0 117.924 176.307 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 118' ' ' VAL . 14.8 tt0 -114.39 90.37 3.32 Favored 'General case' 0 C--O 1.255 1.382 1 N-CA-C 100.07 -4.048 . . . . 0.0 100.07 159.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 55.33 -0.19 0.1 OUTLIER Glycine 2 CA--C 1.664 9.397 1 CA-C-N 126.042 4.019 . . . . 0.0 108.942 -177.989 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.805 HG21 HD12 ' A' ' 123' ' ' ILE . 8.8 p -27.11 144.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.386 2.155 0 C-N-CA 126.648 1.979 . . . . 0.0 115.436 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -74.66 -55.64 5.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.018 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 120.31 -11.8 10.53 Favored Glycine 0 N--CA 1.512 3.759 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.444 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.36 -27.64 29.77 Favored Glycine 1 N--CA 1.518 4.167 0 CA-C-N 118.302 1.051 . . . . 0.0 110.906 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -78.48 -39.37 38.56 Favored 'General case' 0 N--CA 1.52 3.025 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.805 HD12 HG21 ' A' ' 118' ' ' VAL . 50.5 mt -71.1 -32.37 47.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.921 ' HA ' HG21 ' A' ' 101' ' ' THR . 39.8 t-20 -64.44 -26.89 68.65 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 122' ' ' LEU . 6.1 mmtm -78.57 -40.16 35.56 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -81.82 -9.62 59.56 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.994 -0.441 . . . . 0.0 111.123 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.671 ' SG ' HG23 ' A' ' 103' ' ' THR . 5.5 t -89.58 -33.71 16.6 Favored 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.32 -33.34 75.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-O 121.346 0.593 . . . . 0.0 109.785 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.687 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.8 ttt -56.98 -46.03 82.51 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.85 -18.6 53.74 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.832 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.0 p -59.86 -33.36 71.69 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 46.0 t60 -79.33 -40.9 29.15 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.954 HD13 HG21 ' A' ' 110' ' ' VAL . 1.9 mp -68.01 -10.25 52.18 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.991 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -91.42 -38.53 12.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -80.78 -2.82 48.65 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 p -85.05 -17.07 38.59 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 66.77 29.28 8.6 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.419 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 4.4 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -117.65 -83.52 0.95 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.481 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -50.87 -49.83 58.34 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 122.197 -0.59 . . . . 0.0 111.063 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -59.04 -20.26 51.51 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.898 -0.502 . . . . 0.0 110.867 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.26 -39.72 53.69 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 29.1 m-85 -73.81 -10.15 59.38 Favored 'General case' 0 N--CA 1.516 2.87 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.819 HD11 ' O ' ' A' ' 32' ' ' ALA . 4.2 mm -90.5 -29.68 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.193 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -67.0 -16.42 64.35 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -57.17 -35.26 69.36 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-O 121.904 0.859 . . . . 0.0 109.856 176.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.957 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 1.5 mm? -80.0 -35.99 36.57 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.261 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.3 mmt -75.49 -26.48 58.2 Favored 'General case' 1 C--N 1.243 -4.065 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.09 -37.53 21.92 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 1.3 p30 -70.42 -2.22 13.12 Favored 'General case' 1 N--CA 1.568 5.434 0 N-CA-C 117.276 2.325 . . . . 0.0 117.276 -171.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 30.91 33.44 0.01 OUTLIER Glycine 1 N--CA 1.563 7.163 0 CA-C-N 120.967 1.712 . . . . 0.0 112.344 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.588 HG22 HD11 ' A' ' 123' ' ' ILE . 6.6 m -141.16 -40.81 0.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -69.18 -172.54 0.43 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 39.3 tp60 -151.13 -41.79 0.12 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 113' ' ' MET . 4.9 t70 -134.0 -175.57 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.957 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.76 133.21 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.878 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 39' ' ' PHE . . . -142.81 110.23 5.73 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 116.494 -2.082 . . . . 0.0 115.355 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 mt -86.71 124.71 40.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 101.608 -3.479 . . . . 0.0 101.608 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 42' ' ' ILE . 25.8 t -131.42 114.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.283 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -63.06 86.5 0.05 OUTLIER Glycine 1 N--CA 1.521 4.339 0 N-CA-C 106.684 -2.566 . . . . 0.0 106.684 176.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -86.32 34.63 0.63 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.869 0.868 . . . . 0.0 112.712 -175.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -69.3 -155.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -57.01 6.76 Favored 'General case' 0 N--CA 1.533 3.706 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.7 p -98.93 118.63 62.54 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 33.3 Cg_endo -80.22 159.18 23.32 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.032 1.821 . . . . 0.0 111.424 -176.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 22' ' ' VAL . 27.1 p -163.57 160.74 23.39 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 40' ' ' VAL . 76.6 t -93.25 99.54 9.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 108' ' ' THR . 17.7 m0 -69.95 -25.64 63.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.819 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 178.83 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.208 0.528 . . . . 0.0 110.594 178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.0 131.66 54.43 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 7' ' ' ILE . 41.2 t -50.07 104.4 0.42 Allowed Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.67 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.8 Cg_endo -72.31 147.0 46.52 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.007 1.804 . . . . 0.0 112.656 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.31 -24.36 14.2 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -90.55 -93.79 0.13 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 118.002 0.901 . . . . 0.0 112.544 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.04 -38.65 0.09 Allowed 'General case' 0 N--CA 1.522 3.133 0 O-C-N 121.061 -1.024 . . . . 0.0 112.857 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.886 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.8 m-30 -59.64 -43.44 93.86 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.641 -0.662 . . . . 0.0 112.026 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 35' ' ' PRO . 1.9 p -55.51 -19.69 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -85.66 24.71 1.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.1 mt -75.11 135.91 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-O 122.938 1.352 . . . . 0.0 111.065 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.694 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 5.4 p -125.9 -178.22 0.69 Allowed Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 113.663 -1.608 . . . . 0.0 107.121 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.694 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 27.5 Cg_endo -71.16 -1.06 9.0 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 120.982 1.121 . . . . 0.0 112.098 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.83 -64.02 1.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -62.01 -36.09 80.51 Favored 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.855 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.26 -23.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -63.26 -27.73 71.12 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 58' ' ' PHE . 14.5 p -100.09 -29.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.756 0 O-C-N 122.064 -0.668 . . . . 0.0 110.346 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.704 HD23 HD13 ' A' ' 63' ' ' LEU . 4.2 mt -73.5 -14.27 61.2 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -146.14 -21.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -47.92 160.81 0.47 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -70.65 -4.71 24.81 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.036 -0.582 . . . . 0.0 111.186 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 13.0 t70 -20.41 125.51 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 124.2 1.0 . . . . 0.0 112.257 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -89.59 -7.11 55.51 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 31.4 t -170.69 -49.83 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 120.627 1.558 . . . . 0.0 114.171 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -35.16 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.6 p90 -37.06 -25.66 0.01 OUTLIER 'General case' 0 N--CA 1.537 3.901 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 20.0 m-85 -60.96 -5.94 1.61 Allowed 'General case' 0 N--CA 1.519 3.021 0 CA-C-N 120.451 1.478 . . . . 0.0 112.669 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.54 -29.12 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.793 -0.567 . . . . 0.0 111.371 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 24.4 p30 -92.2 -34.84 14.13 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.784 -0.573 . . . . 0.0 111.758 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.15 153.46 9.03 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.829 HD12 ' HG ' ' A' ' 87' ' ' LEU . 15.8 mt -86.06 -154.14 0.2 Allowed 'General case' 0 N--CA 1.52 3.058 0 O-C-N 122.047 -0.678 . . . . 0.0 109.253 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 17.9 p -160.28 133.84 6.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -135.78 102.94 5.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-O 121.879 0.847 . . . . 0.0 109.379 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.87 58.36 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.42 84.11 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 65' ' ' LEU . 18.1 tp60 -109.49 101.7 10.63 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 118.449 1.124 . . . . 0.0 109.608 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 117.33 4.44 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.082 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 4.0 p -108.59 176.02 5.26 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 80.5 p -131.66 106.24 8.03 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 75' ' ' ASP . 7.5 t -46.89 121.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 121.541 0.686 . . . . 0.0 110.411 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.3 mt -128.5 75.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 101.82 78.97 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 0 CA-C-N 113.257 -1.792 . . . . 0.0 108.624 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.806 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.66 112.07 8.38 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.096 0.951 . . . . 0.0 110.781 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -131.65 0.26 3.96 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.394 176.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 102' ' ' VAL . 21.9 tp -41.98 -29.76 0.24 Allowed 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.634 0.774 . . . . 0.0 110.538 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 78' ' ' LEU . 89.7 mt -95.54 125.5 40.18 Favored 'General case' 0 C--O 1.199 -1.578 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.494 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' A' ' 83' ' ' PHE . 8.9 pt20 -47.82 76.53 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.924 1.69 . . . . 0.0 114.834 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 22.3 t70 -101.09 22.95 11.5 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 171.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 28.54 8.54 Favored Glycine 0 C--N 1.366 2.22 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.0 mp0 -155.13 -54.11 0.09 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER 44.85 51.67 8.4 Favored 'General case' 0 N--CA 1.531 3.625 0 CA-C-O 121.601 0.715 . . . . 0.0 109.448 -172.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -145.18 136.43 24.98 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.836 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.3 132.05 33.14 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -175.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.824 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -94.02 76.01 4.12 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.771 -1.172 . . . . 0.0 110.272 -179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.97 111.13 22.79 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.343 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -110.75 137.67 48.12 Favored 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.49 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 98' ' ' PHE . 5.4 p -62.81 93.56 0.06 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 9.9 mtmt -78.31 168.03 20.45 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.204 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.733 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -116.92 177.95 4.52 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.627 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 95' ' ' ALA . 72.9 p -141.5 88.59 2.15 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.555 0.693 . . . . 0.0 110.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.9 96.64 0.01 OUTLIER Glycine 0 N--CA 1.501 3.018 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.73 -14.21 65.75 Favored Glycine 0 N--CA 1.505 3.3 0 O-C-N 122.031 -0.688 . . . . 0.0 112.017 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.733 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -91.34 164.95 22.74 Favored Pre-proline 0 N--CA 1.508 2.463 0 CA-C-N 118.706 1.253 . . . . 0.0 110.985 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.7 Cg_endo -92.93 151.88 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.379 2.719 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 91' ' ' SER . 46.9 p -116.12 170.5 8.46 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 97' ' ' THR . 61.9 m-85 -155.8 152.68 28.73 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -123.5 143.63 50.05 Favored 'General case' 0 N--CA 1.511 2.619 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.423 -177.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 113' ' ' MET . 3.8 t -134.01 136.92 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.774 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 124' ' ' ASN . 97.9 m -112.07 124.2 51.9 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 87' ' ' LEU . 10.3 t -115.06 124.91 72.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.623 HG23 ' SG ' ' A' ' 127' ' ' CYS . 15.9 p -109.71 170.07 8.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' H ' ' HB2' ' A' ' 83' ' ' PHE . 3.1 tppt? -143.86 143.15 31.18 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.512 0.672 . . . . 0.0 111.092 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.877 HG21 ' HB3' ' A' ' 134' ' ' LEU . 63.1 p -110.5 -145.93 0.4 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.42 -16.74 18.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 109.694 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 26.9 mttt -147.15 21.51 1.22 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.743 -0.598 . . . . 0.0 110.682 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.649 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 15.5 p -146.65 153.48 40.35 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.053 -1.029 . . . . 0.0 109.197 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.801 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -119.83 93.6 4.12 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.913 HG21 HD13 ' A' ' 134' ' ' LEU . 3.0 t -86.19 145.21 8.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 121.027 -1.045 . . . . 0.0 108.438 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 110' ' ' VAL . 6.3 mt -131.8 153.5 50.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.728 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -130.83 103.01 6.32 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.638 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -90.32 148.32 22.93 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.089 -1.444 . . . . 0.0 109.412 -178.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' CYS . . . -143.98 150.62 22.64 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.83 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 9.1 mttp -134.27 165.95 23.92 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tp10 -16.46 149.68 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 116' ' ' GLU . . . 75.77 13.99 82.54 Favored Glycine 0 CA--C 1.565 3.218 1 N-CA-C 100.61 -4.996 . . . . 0.0 100.61 -168.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.83 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 1.1 p -101.72 98.09 6.45 Favored 'Isoleucine or valine' 0 C--N 1.378 1.844 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.881 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -79.47 -37.17 37.47 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.58 -20.82 46.67 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.05 -27.13 26.85 Favored Glycine 0 N--CA 1.51 3.632 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -83.85 -31.32 25.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.728 HG23 ' HG ' ' A' ' 112' ' ' LEU . 57.4 mt -72.3 -36.54 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.954 ' HA ' HG21 ' A' ' 101' ' ' THR . 44.7 t30 -65.38 -28.75 69.49 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -79.65 -34.27 40.6 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.478 ' CD ' ' HB3' ' A' ' 13' ' ' ASP . 11.0 mtmm -83.19 -12.28 57.04 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 103' ' ' THR . 7.3 t -85.91 -32.71 21.49 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -35.67 81.29 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 132' ' ' SER . 3.3 mt-10 -78.07 -33.45 50.82 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-O 121.172 0.51 . . . . 0.0 109.945 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.681 ' O ' HD12 ' A' ' 134' ' ' LEU . 5.1 ttt -63.03 -42.58 99.81 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.28 -16.36 49.69 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.223 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 22.6 m -61.37 -34.21 74.94 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 49.9 t60 -78.49 -39.45 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.913 HD13 HG21 ' A' ' 110' ' ' VAL . 1.7 mp -68.41 -10.38 54.76 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.8 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -37.45 12.84 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.94 -3.6 52.09 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.6 p -82.82 -15.31 52.11 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 70.97 35.26 1.71 Allowed 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 118.29 -0.862 . . . . 0.0 108.944 179.375 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 5' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -122.94 -107.6 1.88 Allowed Glycine 0 N--CA 1.506 3.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.468 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -53.46 -44.97 69.36 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 122.021 -0.694 . . . . 0.0 110.389 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -63.01 -19.32 64.24 Favored 'General case' 0 N--CA 1.511 2.609 0 O-C-N 122.009 -0.432 . . . . 0.0 111.079 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.601 ' HB2' ' HB1' ' A' ' 1' ' ' ALA . . . -78.3 -38.54 42.15 Favored 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.659 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 19.5 m-85 -74.44 -11.4 60.22 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 7.3 mm -90.66 -28.1 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.363 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 3.1 m-20 -64.61 -18.85 65.28 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.69 HD21 HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -53.36 -50.01 65.95 Favored 'General case' 0 C--O 1.172 -3.002 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -59.72 -40.25 87.39 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.298 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -78.08 -28.54 48.8 Favored 'General case' 1 C--N 1.233 -4.476 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.711 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.91 -30.48 26.3 Favored 'General case' 0 N--CA 1.517 2.925 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -72.97 -1.94 19.03 Favored 'General case' 1 N--CA 1.554 4.76 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -172.384 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.25 40.17 0.01 OUTLIER Glycine 1 N--CA 1.57 7.624 0 CA-C-N 120.756 1.616 . . . . 0.0 110.658 179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 13' ' ' ASP . 27.0 m -149.81 -37.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -71.39 -171.21 0.59 Allowed 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.678 0.751 . . . . 0.0 110.085 -178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.739 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 0.6 OUTLIER -151.42 -45.85 0.11 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 177.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 7.4 t0 -136.04 -178.6 5.22 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.791 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -170.3 125.62 0.76 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.253 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.965 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -138.03 108.02 6.35 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 116.795 -1.962 . . . . 0.0 114.91 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 110' ' ' VAL . 12.3 mt -84.72 116.52 28.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 29' ' ' SER . 32.5 t -125.11 115.21 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.379 -0.826 . . . . 0.0 112.813 -174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 31' ' ' TRP . . . -66.33 85.09 0.1 Allowed Glycine 1 N--CA 1.517 4.052 0 N-CA-C 106.484 -2.646 . . . . 0.0 106.484 175.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -84.86 35.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.456 0.702 . . . . 0.0 112.115 -176.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -66.46 -153.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.8 -59.68 1.87 Allowed 'General case' 1 N--CA 1.54 4.041 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 p -105.35 122.63 42.24 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 44' ' ' PRO . 30.1 Cg_endo -79.83 151.98 21.96 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.702 1.601 . . . . 0.0 111.266 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.1 p -154.24 157.54 38.9 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 40' ' ' VAL . 53.4 t -88.54 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' HG22 ' A' ' 108' ' ' THR . 13.4 m0 -69.86 -27.99 65.29 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.849 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.55 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.279 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.1 132.42 56.35 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 19' ' ' ALA . 46.3 t -49.83 103.31 0.36 Allowed Pre-proline 0 N--CA 1.518 2.975 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 31.6 Cg_endo -74.07 153.8 46.91 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.087 1.858 . . . . 0.0 113.176 -175.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.26 55.03 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -89.2 -71.77 0.58 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.807 -0.82 . . . . 0.0 111.373 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER 179.42 -36.33 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.207 0 O-C-N 121.584 -0.697 . . . . 0.0 110.669 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.021 ' CE1' HD13 ' A' ' 65' ' ' LEU . 3.1 m-85 -59.15 -43.83 92.07 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -56.46 -21.36 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -85.72 22.2 1.68 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 3.1 mt -71.28 118.95 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-O 122.582 1.182 . . . . 0.0 110.825 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.685 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p -106.89 179.21 0.93 Allowed Pre-proline 0 N--CA 1.505 2.291 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.0 Cg_endo -68.67 1.08 4.04 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 121.189 1.259 . . . . 0.0 112.559 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.97 -64.44 1.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.9 pm0 -59.64 -33.11 71.11 Favored 'General case' 0 N--CA 1.518 2.929 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -82.27 -24.26 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -60.76 -27.75 67.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.801 HG22 HD23 ' A' ' 63' ' ' LEU . 13.1 p -98.67 -34.27 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.363 0 O-C-N 122.062 -0.669 . . . . 0.0 109.836 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.778 HD23 HD13 ' A' ' 63' ' ' LEU . 5.5 mt -68.77 -15.35 63.48 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.727 HG22 ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -149.08 -4.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.991 -173.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -60.16 178.63 2.76 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -8.48 59.21 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.997 -0.602 . . . . 0.0 110.411 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -48.65 120.42 3.75 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.464 0.65 . . . . 0.0 109.48 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -116.83 32.55 6.09 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.393 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -165.24 -70.11 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.974 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 p -38.72 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CD1' HD21 ' A' ' 63' ' ' LEU . 4.2 p90 -37.01 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.537 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CE1' ' CZ ' ' A' ' 58' ' ' PHE . 24.6 m-85 -60.82 -8.47 3.08 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 120.609 1.549 . . . . 0.0 112.811 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.52 -30.85 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.592 . . . . 0.0 111.085 -177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.8 p30 -86.95 -40.14 15.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 120.076 -0.649 . . . . 0.0 109.751 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 121.6 146.79 7.48 Favored Glycine 0 N--CA 1.477 1.425 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.254 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 87' ' ' LEU . 8.6 mt -76.28 -155.23 0.06 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.8 p -158.5 128.38 5.88 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.021 HD13 ' CE1' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -132.78 104.91 6.84 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 122.281 1.038 . . . . 0.0 110.176 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 38' ' ' THR . . . 75.02 23.45 74.51 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.85 11.5 67.85 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.457 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -110.19 103.92 12.68 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 118.439 1.12 . . . . 0.0 110.798 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -60.9 113.13 2.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.082 -0.386 . . . . 0.0 111.595 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.779 ' SG ' HD23 ' A' ' 87' ' ' LEU . 8.4 p -110.54 152.13 26.77 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 97.8 p -106.05 121.5 44.26 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' ASP . 3.5 t -56.75 104.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 122.101 0.953 . . . . 0.0 112.916 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.7 mt -106.25 64.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.59 2.517 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.3 mmp_? 119.08 122.45 0.0 OUTLIER 'General case' 1 N--CA 1.544 4.266 0 C-N-CA 126.314 1.845 . . . . 0.0 109.636 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 85' ' ' MET . 0.2 OUTLIER -124.09 89.42 3.08 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.486 1.136 . . . . 0.0 111.502 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 65.8 m -126.63 36.32 4.49 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 102' ' ' VAL . 19.2 tp -75.09 -6.92 52.08 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.041 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 78' ' ' LEU . 32.2 mt -110.41 121.8 46.18 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -47.85 76.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.632 1.682 . . . . 0.0 115.323 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 78' ' ' LEU . 13.9 t70 -101.51 24.63 9.41 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.95 26.9 9.91 Favored Glycine 0 C--N 1.362 1.982 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -149.4 -64.31 0.22 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -176.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 55.02 0.81 0.03 OUTLIER 'General case' 1 N--CA 1.539 4.014 0 CA-C-O 118.585 -0.721 . . . . 0.0 112.631 -173.78 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 p -93.67 130.2 39.7 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.727 1.603 . . . . 0.0 109.424 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.664 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -141.38 130.38 23.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 12.0 m-20 -94.64 147.43 23.3 Favored 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 118.033 -1.467 . . . . 0.0 108.372 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -152.17 137.35 17.42 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -136.65 136.15 38.88 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 118.491 -1.283 . . . . 0.0 114.035 -174.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.457 ' HB ' ' NE2' ' A' ' 68' ' ' GLN . 1.1 p -56.75 91.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -83.63 134.25 34.8 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 104.745 -2.316 . . . . 0.0 104.745 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 2.4 t -111.91 -163.26 0.84 Allowed 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.846 0.355 . . . . 0.0 111.222 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -128.89 168.07 16.47 Favored 'General case' 0 N--CA 1.516 2.871 0 CA-C-O 121.959 0.885 . . . . 0.0 112.078 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.49 -115.42 1.11 Allowed Glycine 0 N--CA 1.497 2.742 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.479 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 53.73 0.58 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -99.96 167.6 10.79 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 122.427 -0.455 . . . . 0.0 110.112 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 64.7 Cg_endo -95.7 123.1 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 122.93 2.42 . . . . 0.0 108.253 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 91' ' ' SER . 22.0 p -90.48 177.85 6.27 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.825 ' HA ' ' HB2' ' A' ' 115' ' ' LYS . 57.5 m-85 -151.84 157.09 41.44 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.836 ' N ' ' HG3' ' A' ' 115' ' ' LYS . 4.5 m-20 -127.83 -171.47 2.45 Favored 'General case' 0 CA--C 1.457 -2.609 0 O-C-N 120.946 -1.096 . . . . 0.0 109.732 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.909 ' HB ' HD22 ' A' ' 87' ' ' LEU . 3.4 t -169.69 165.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-O 122.017 0.913 . . . . 0.0 109.262 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 124' ' ' ASN . 3.1 m -134.95 158.07 45.25 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.963 HG22 HD23 ' A' ' 111' ' ' LEU . 4.4 t -147.33 115.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 120.408 -1.433 . . . . 0.0 110.258 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 10.3 p -110.18 113.17 25.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.271 -178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.555 ' HB2' HD11 ' A' ' 77' ' ' LEU . 4.9 tppp? -95.17 115.83 27.94 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.744 HG21 ' HB3' ' A' ' 134' ' ' LEU . 71.4 p -79.9 -145.5 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -96.16 -17.64 20.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 39.7 mttt -151.3 23.08 0.73 Allowed 'General case' 0 N--CA 1.515 2.79 0 O-C-N 121.623 -0.673 . . . . 0.0 110.569 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.558 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 8.0 p -143.12 154.46 43.94 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.62 87.44 2.75 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 134' ' ' LEU . 2.3 t -83.0 136.82 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.875 -1.141 . . . . 0.0 108.962 -177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.965 HD12 ' HB3' ' A' ' 20' ' ' ALA . 4.5 mt -123.2 139.37 54.12 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.914 ' HG ' HG23 ' A' ' 123' ' ' ILE . 10.1 tp -127.28 95.17 4.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.91 153.92 20.25 Favored 'General case' 0 CA--C 1.446 -3.054 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.719 -177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 17' ' ' GLN . . . 163.51 139.25 2.59 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 118.119 2.008 . . . . 0.0 118.119 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HG3' ' N ' ' A' ' 99' ' ' ASN 0.269 0.0 OUTLIER -171.18 116.07 0.43 Allowed 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.815 -1.693 . . . . 0.0 111.482 165.499 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.2 tt0 -115.49 91.9 3.75 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 161.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.03 -2.89 0.05 OUTLIER Glycine 2 CA--C 1.662 9.236 0 CA-C-N 125.116 3.598 . . . . 0.0 110.104 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.769 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 6.3 p -38.29 150.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 125.845 1.658 . . . . 0.0 114.717 -176.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -75.66 -55.14 5.94 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 112.773 -2.012 . . . . 0.0 108.722 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.72 14.58 12.24 Favored Glycine 0 N--CA 1.511 3.647 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.95 -25.47 3.59 Favored Glycine 0 N--CA 1.513 3.778 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -84.12 -31.42 25.25 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.914 HG23 ' HG ' ' A' ' 112' ' ' LEU . 51.0 mt -70.68 -39.25 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.577 ' HA ' HG21 ' A' ' 101' ' ' THR . 37.4 t-20 -62.13 -35.51 78.95 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -84.86 -18.86 33.51 Favored 'General case' 0 N--CA 1.517 2.891 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.986 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 13' ' ' ASP . 13.4 mtmt -89.2 -14.82 35.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.066 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.453 ' CB ' HG22 ' A' ' 101' ' ' THR . 1.9 t -92.99 -30.48 15.31 Favored 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -67.56 -32.03 72.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.76 -35.07 24.63 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.621 ' SD ' HG13 ' A' ' 110' ' ' VAL . 4.4 ttt -59.52 -44.03 93.27 Favored 'General case' 0 N--CA 1.511 2.575 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.75 50.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.283 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 m -61.17 -31.11 70.85 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.546 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 24.2 t-80 -80.53 -39.9 27.0 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.047 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 110' ' ' VAL . 2.9 mp -63.63 -15.69 58.91 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.55 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -39.86 16.76 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -77.87 -3.36 41.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 133' ' ' HIS . 17.6 p -87.07 -15.31 38.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 76.23 27.44 0.87 Allowed 'General case' 0 N--CA 1.518 2.932 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.192 179.626 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 6' ' ' TYR . . . 118.29 -60.43 0.48 Allowed Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.51 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -51.42 -47.56 62.95 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 122.027 -0.69 . . . . 0.0 109.78 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -61.05 -41.55 96.82 Favored 'General case' 0 N--CA 1.517 2.895 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -63.13 -24.92 68.11 Favored 'General case' 0 N--CA 1.534 3.762 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 6.8 m-30 -79.76 -32.33 41.01 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.798 HD13 HD12 ' A' ' 10' ' ' LEU . 40.3 mm -71.73 -17.89 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.7 m-20 -73.44 -39.67 64.8 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.568 HD21 ' CD2' ' A' ' 112' ' ' LEU 0.25 0.1 OUTLIER -63.43 -59.9 4.06 Favored 'General case' 0 C--O 1.154 -3.971 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 173.149 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.962 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 9.7 mt -31.77 -38.24 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 110.562 -3.017 . . . . 0.0 113.363 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -102.92 -36.05 8.36 Favored 'General case' 0 CA--C 1.613 3.383 0 CA-C-O 123.032 1.396 . . . . 0.0 108.915 176.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -84.38 2.9 38.37 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 0.0 115.185 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -57.75 -0.37 0.07 Allowed 'General case' 1 N--CA 1.547 4.411 0 CA-C-N 121.413 1.915 . . . . 0.0 110.856 -170.751 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.82 15.38 57.82 Favored Glycine 1 N--CA 1.555 6.627 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 123' ' ' ILE . 1.5 m -160.73 -8.88 0.05 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 C-N-CA 124.378 1.071 . . . . 0.0 108.66 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.659 ' HB3' ' CG ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -86.08 -176.71 6.06 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.011 0.91 . . . . 0.0 109.209 -176.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.432 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -151.21 -46.45 0.11 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 173.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 39' ' ' PHE . 9.9 t0 -120.56 172.58 7.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.962 ' HB1' ' HB3' ' A' ' 10' ' ' LEU 0.304 . . -171.02 127.43 0.71 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 117.564 -1.208 . . . . 0.0 109.364 -172.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -158.34 119.12 3.38 Favored 'General case' 0 N--CA 1.534 3.741 0 C-N-CA 115.675 -2.41 . . . . 0.0 117.271 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 34.9 mt -81.83 141.03 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 171.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 42' ' ' ILE . 56.1 t -143.66 118.19 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 120.93 -1.106 . . . . 0.0 112.134 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -70.74 84.56 0.37 Allowed Glycine 1 N--CA 1.521 4.309 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 177.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -79.73 27.09 0.3 Allowed 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.779 0.832 . . . . 0.0 112.728 -177.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -60.98 -159.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 119.132 0.878 . . . . 0.0 108.669 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.43 -55.38 6.15 Favored 'General case' 0 N--CA 1.534 3.769 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -103.03 114.81 64.95 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.48 ' HB3' HG11 ' A' ' 47' ' ' VAL . 30.7 Cg_endo -79.03 156.95 26.76 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.85 1.7 . . . . 0.0 110.497 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 22' ' ' VAL . 88.0 p -165.93 168.76 15.47 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 40' ' ' VAL . 29.3 t -95.54 103.85 15.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 108' ' ' THR . 12.2 m0 -69.53 -30.38 68.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -166.54 143.39 4.9 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB2' HG13 ' A' ' 30' ' ' VAL . . . -174.05 142.27 0.83 Allowed 'General case' 0 N--CA 1.521 3.087 0 O-C-N 121.247 -0.908 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 19' ' ' ALA . 58.8 t -59.25 109.05 1.61 Allowed Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -75.04 145.6 31.5 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.2 1.933 . . . . 0.0 112.561 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 -10.87 67.25 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -86.03 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.979 0.89 . . . . 0.0 111.473 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.5 m -167.58 -34.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.029 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.941 ' CE1' HD12 ' A' ' 65' ' ' LEU . 11.3 m-30 -64.13 -39.75 94.7 Favored 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.793 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.0 p -58.38 -21.09 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -93.14 29.51 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HG11 ' A' ' 22' ' ' VAL . 3.7 mt -72.5 156.25 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 CA-C-O 122.144 0.973 . . . . 0.0 108.465 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.689 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 20.3 p -146.38 -178.93 0.85 Allowed Pre-proline 0 C--N 1.286 -2.182 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.9 Cg_endo -73.08 0.1 8.33 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.082 1.188 . . . . 0.0 111.996 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.86 -66.09 0.93 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -59.19 -30.7 68.4 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.003 178.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.901 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -86.66 -22.22 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 122.121 -0.362 . . . . 0.0 111.034 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.69 71.24 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 9.3 p -94.73 -38.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 122.456 -0.438 . . . . 0.0 110.745 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD23 HD13 ' A' ' 63' ' ' LEU . 3.5 mt -62.83 -20.33 64.95 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.855 0.359 . . . . 0.0 110.794 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.6 m -134.32 -9.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.682 -176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -43.53 129.78 6.1 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -14.49 32.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -52.42 135.13 33.95 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.7 36.81 3.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.506 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -170.16 -35.7 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.922 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.3 p -52.18 -104.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 63' ' ' LEU . 51.2 p90 -37.57 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 22.9 m-85 -60.8 -5.8 1.48 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 121.379 1.9 . . . . 0.0 112.063 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.78 -33.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 121.78 -0.575 . . . . 0.0 110.995 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 22.5 p30 -86.09 -40.39 15.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.667 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 71' ' ' SER . . . 125.16 147.06 6.95 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.637 HD13 HD23 ' A' ' 50' ' ' LEU . 80.7 mt -76.61 -162.65 0.27 Allowed 'General case' 0 N--CA 1.533 3.701 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 63' ' ' LEU . 10.9 p -161.78 123.31 2.8 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.941 HD12 ' CE1' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -131.99 104.37 6.8 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' THR . . . 77.26 24.63 65.54 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.36 9.72 75.45 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.649 HE21 HG22 ' A' ' 89' ' ' THR . 10.4 tp60 -103.12 106.0 16.42 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 118.415 1.107 . . . . 0.0 109.477 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.79 105.79 3.9 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.813 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.485 ' SG ' HD21 ' A' ' 65' ' ' LEU . 9.3 p -100.75 -170.56 1.87 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.551 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 88.3 p -140.89 114.62 8.94 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG13 ' SD ' ' A' ' 85' ' ' MET . 4.2 t -53.68 118.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.57 1.176 . . . . 0.0 112.717 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.817 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 4.5 mt -119.62 71.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.423 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 176.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 97.31 110.06 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.158 0 C-N-CA 125.715 1.606 . . . . 0.0 110.037 -179.209 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -102.7 108.49 19.76 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.116 0.96 . . . . 0.0 111.98 -179.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -121.66 1.02 9.98 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.027 176.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 104' ' ' LYS . 3.2 tp -41.11 -28.74 0.1 Allowed 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 124.163 0.985 . . . . 0.0 111.76 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 80' ' ' ASP . 2.1 mt -97.3 127.25 43.1 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -47.67 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.712 1.72 . . . . 0.0 114.773 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 78' ' ' LEU . 28.0 t0 -101.24 28.31 5.49 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 171.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.66 28.91 22.85 Favored Glycine 0 C--N 1.36 1.891 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 3.1 mp0 -153.84 -53.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER 44.56 47.35 8.46 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-O 121.679 0.752 . . . . 0.0 110.331 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 103' ' ' THR . 87.8 p -144.55 132.34 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.791 ' SD ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -130.01 142.74 50.59 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.817 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 5.4 m-20 -97.48 126.71 42.91 Favored 'General case' 1 C--O 1.143 -4.504 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 176.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.85 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -146.08 116.08 7.36 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 24.2 ptt180 -123.16 145.87 48.25 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HE21 ' A' ' 68' ' ' GLN . 10.7 p -65.64 103.08 0.81 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -81.8 171.3 14.69 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.041 -174.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.77 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -121.98 161.11 23.52 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.638 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.2 p -106.89 -80.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.644 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.0 96.56 0.86 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.53 21.13 62.21 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.77 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -81.77 166.98 34.33 Favored Pre-proline 0 N--CA 1.509 2.485 0 O-C-N 121.853 -0.792 . . . . 0.0 109.287 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 59.6 Cg_endo -89.64 131.09 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.179 2.586 . . . . 0.0 111.162 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 68.7 p -100.88 165.83 11.15 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.462 ' CE1' ' HD3' ' A' ' 115' ' ' LYS . 45.5 m-85 -145.57 113.82 6.62 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -100.9 136.11 41.27 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-O 122.894 1.331 . . . . 0.0 113.207 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.8 t -116.38 168.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.925 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.032 HG21 ' HA ' ' A' ' 124' ' ' ASN . 96.8 m -141.1 129.89 22.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.75 HG12 ' CD1' ' A' ' 77' ' ' LEU . 7.0 t -127.09 123.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.179 -176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 83' ' ' PHE . 20.3 p -110.58 158.15 18.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.373 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 77' ' ' LEU . 1.1 tppp? -142.53 143.07 32.35 Favored 'General case' 0 N--CA 1.514 2.767 0 CA-C-O 121.494 0.664 . . . . 0.0 110.16 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.96 HG21 ' HB3' ' A' ' 134' ' ' LEU . 54.5 p -102.57 -146.31 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -95.0 -17.31 22.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.527 -0.733 . . . . 0.0 109.331 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.478 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 50.4 mttt -144.72 17.45 1.63 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.725 -0.609 . . . . 0.0 110.97 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 18.8 p -141.3 165.35 27.75 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.858 -1.152 . . . . 0.0 108.606 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -138.44 91.74 2.57 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 134' ' ' LEU . 43.4 t -84.69 147.49 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.784 -1.198 . . . . 0.0 109.597 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 102' ' ' VAL . 8.3 mt -131.44 152.0 51.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -137.91 101.24 4.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.567 ' HA ' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -99.75 145.91 27.15 Favored 'General case' 0 N--CA 1.532 3.633 0 C-N-CA 118.227 -1.389 . . . . 0.0 111.926 -177.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.769 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -142.32 140.84 10.27 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 44.4 mttt -112.09 167.45 10.39 Favored 'General case' 0 C--O 1.197 -1.678 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.4 tt0 -16.75 151.22 0.0 OUTLIER 'General case' 1 N--CA 1.547 4.416 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -176.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.28 83.58 Favored Glycine 0 CA--C 1.561 2.969 1 N-CA-C 100.696 -4.962 . . . . 0.0 100.696 -168.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.861 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.8 OUTLIER -101.94 105.79 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 114.08 -1.06 . . . . 0.0 112.081 -175.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -83.88 -38.5 21.05 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.11 3.43 61.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.17 -32.42 5.55 Favored Glycine 0 N--CA 1.512 3.755 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -38.91 53.67 Favored 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 112' ' ' LEU . 94.5 mt -65.43 -37.41 80.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 1.032 ' HA ' HG21 ' A' ' 101' ' ' THR . 35.0 t-20 -66.17 -26.39 67.39 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -84.12 -27.29 28.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 29.2 mtmm -90.9 -12.78 35.09 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.957 -0.464 . . . . 0.0 111.036 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.6 t -92.29 -39.43 11.5 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.68 -37.08 86.35 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' SER . 24.2 mm-40 -76.46 -34.84 58.69 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 134' ' ' LEU . 20.0 tpp -62.71 -36.29 82.49 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.68 55.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 34.5 m -60.23 -28.62 68.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.465 ' CE1' ' OH ' ' A' ' 6' ' ' TYR . 22.7 t-80 -77.54 -41.29 39.63 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB3' HG21 ' A' ' 105' ' ' THR . 4.1 mp -66.33 -14.35 61.91 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -88.26 -38.52 15.15 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.8 mtm105 -80.79 -2.98 49.35 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 138' ' ' GLN . 28.2 p -85.12 -14.8 45.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER 80.16 29.48 0.25 Allowed 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.038 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . -151.77 -100.27 0.2 Allowed Glycine 0 N--CA 1.513 3.786 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -48.68 -45.33 38.8 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 121.936 -0.743 . . . . 0.0 111.293 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -64.68 -19.87 65.98 Favored 'General case' 0 N--CA 1.518 2.971 0 O-C-N 121.78 -0.575 . . . . 0.0 111.988 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . -82.31 -36.94 26.47 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 4.9 m-85 -73.7 -11.89 60.55 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.826 HD11 ' O ' ' A' ' 32' ' ' ALA . 9.5 mm -89.6 -32.9 5.8 Favored 'Isoleucine or valine' 0 C--O 1.272 2.286 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 13.6 m-20 -53.87 -25.13 18.43 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -48.23 -61.75 1.83 Allowed 'General case' 0 C--O 1.179 -2.654 0 CA-C-O 122.546 1.165 . . . . 0.0 108.3 175.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.055 HD11 ' HB3' ' A' ' 19' ' ' ALA 0.273 6.3 mt -44.49 -35.86 2.68 Favored 'General case' 0 C--N 1.259 -3.358 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.286 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.461 ' HG2' ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -86.13 -29.88 22.95 Favored 'General case' 0 C--N 1.253 -3.605 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.073 -173.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.49 -31.3 29.38 Favored 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 9' ' ' ASN 0.291 0.0 OUTLIER -95.47 17.31 14.88 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 120.485 3.513 . . . . 0.0 120.485 -174.653 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 19.37 39.46 0.01 OUTLIER Glycine 2 N--CA 1.588 8.775 0 CA-C-N 119.753 1.161 . . . . 0.0 115.211 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' ASP . 3.0 m -144.69 -50.12 0.27 Allowed 'General case' 0 N--CA 1.533 3.686 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LEU 0.272 14.8 p -67.58 157.03 35.37 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 112.359 -2.201 . . . . 0.0 105.971 174.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.415 ' CB ' ' HG3' ' A' ' 115' ' ' LYS . 6.2 tm0? -150.65 -27.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 111.534 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' N ' HD22 ' A' ' 10' ' ' LEU . 30.6 t70 -151.9 96.39 2.21 Favored 'General case' 0 N--CA 1.535 3.82 0 CA-C-O 121.88 0.848 . . . . 0.0 109.509 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.055 ' HB3' HD11 ' A' ' 10' ' ' LEU . . . -90.89 115.3 27.82 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.024 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -113.75 102.26 10.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.479 -1.288 . . . . 0.0 112.392 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.724 HD13 HD11 ' A' ' 134' ' ' LEU . 4.3 mt -80.77 128.22 38.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 42' ' ' ILE . 41.5 t -131.62 111.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.686 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -65.85 87.57 0.1 Allowed Glycine 1 N--CA 1.519 4.197 0 N-CA-C 106.771 -2.532 . . . . 0.0 106.771 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' CZ ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -86.41 31.77 0.65 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 123.1 0.56 . . . . 0.0 112.388 -176.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -64.29 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.8 -58.06 1.77 Allowed 'General case' 1 N--CA 1.545 4.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 p -106.84 121.4 45.05 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -78.42 162.29 28.01 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.901 1.734 . . . . 0.0 111.707 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 22' ' ' VAL . 19.6 p -167.02 162.35 15.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 40' ' ' VAL . 64.8 t -93.3 102.42 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.603 ' CZ3' HG22 ' A' ' 108' ' ' THR . 11.5 m0 -69.82 -27.93 65.29 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.126 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.826 ' O ' HD11 ' A' ' 7' ' ' ILE . . . -179.41 82.4 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.488 0.661 . . . . 0.0 110.899 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' ALA . . . -115.85 132.1 56.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.831 ' CG2' HD13 ' A' ' 10' ' ' LEU . 48.1 t -49.68 115.24 4.84 Favored Pre-proline 0 N--CA 1.527 3.404 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.602 ' HA ' HG11 ' A' ' 40' ' ' VAL . 34.1 Cg_endo -72.95 145.1 39.51 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.134 1.889 . . . . 0.0 112.434 -176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.55 -17.96 45.45 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' N ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -86.93 -89.02 0.13 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 117.943 0.872 . . . . 0.0 111.342 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -168.51 -39.04 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 O-C-N 121.476 -0.765 . . . . 0.0 110.881 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.783 ' CE1' HD12 ' A' ' 65' ' ' LEU . 9.5 m-30 -60.15 -41.03 91.9 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 121.912 -0.493 . . . . 0.0 111.975 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 35' ' ' PRO . 2.2 p -56.98 -21.3 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -91.4 28.4 1.7 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 39' ' ' PHE . 2.4 mt -72.66 160.54 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-O 122.848 1.308 . . . . 0.0 110.531 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 10.5 p -147.96 179.68 1.13 Allowed Pre-proline 0 N--CA 1.506 2.37 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.664 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.6 Cg_endo -72.9 1.42 6.5 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.106 1.204 . . . . 0.0 112.088 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.94 -64.11 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . 1.5 pm0 -60.28 -34.12 73.29 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.652 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.844 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -82.52 -22.92 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -59.78 -27.94 64.93 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -96.53 -37.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.219 0 O-C-N 122.181 -0.599 . . . . 0.0 110.062 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.577 HD11 HD22 ' A' ' 65' ' ' LEU . 2.3 mt -68.64 -12.26 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.295 -0.253 . . . . 0.0 110.656 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 47' ' ' VAL . 1.1 m -147.63 -24.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.575 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.542 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -65.85 114.33 6.52 Favored Glycine 0 N--CA 1.512 3.726 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 -31.82 63.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.431 -0.452 . . . . 0.0 110.193 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -84.6 74.48 10.41 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 1.6 tpt180 -171.44 52.96 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.5 t -69.33 -10.22 56.9 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.579 -0.701 . . . . 0.0 110.977 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -73.87 -55.57 6.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.004 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' A' ' 55' ' ' ARG . 1.1 p90 -38.23 -28.32 0.02 OUTLIER 'General case' 1 N--CA 1.56 5.027 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' CZ ' ' A' ' 58' ' ' PHE . 92.2 m-85 -57.83 -10.09 1.56 Allowed 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.56 -29.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 122.117 -0.365 . . . . 0.0 111.009 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 58' ' ' PHE . 20.7 p30 -88.06 -41.31 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.825 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 70' ' ' CYS . . . 132.81 159.48 9.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 64' ' ' THR . 7.9 mt -90.8 -155.95 0.41 Allowed 'General case' 0 N--CA 1.529 3.499 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.766 ' C ' HD23 ' A' ' 65' ' ' LEU . 17.7 p -161.41 128.21 3.95 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.83 HD21 ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -143.0 108.26 5.0 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.88 26.94 54.91 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 107.991 -2.044 . . . . 0.0 107.991 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.38 81.24 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.65 ' CD ' HG22 ' A' ' 89' ' ' THR . 15.0 tm0? -110.12 106.9 16.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 1.7 ttmt -72.74 113.94 10.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 110.063 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.83 ' SG ' HD21 ' A' ' 65' ' ' LEU . 4.7 p -99.85 179.48 4.51 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 92.5 p -134.34 107.68 7.76 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.461 0.648 . . . . 0.0 112.404 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 75' ' ' ASP . 8.2 t -46.11 124.7 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.834 0.826 . . . . 0.0 111.081 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.794 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 13.1 mt -130.32 72.35 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 8.2 ttm180 111.43 75.01 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.569 0 C-N-CA 125.72 1.608 . . . . 0.0 107.986 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -72.15 104.82 3.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.899 0.857 . . . . 0.0 111.022 -178.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -129.11 -1.7 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.197 177.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.617 ' CD1' HG12 ' A' ' 102' ' ' VAL . 6.7 tt -38.62 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.455 0 C-N-CA 123.834 0.854 . . . . 0.0 112.026 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 80' ' ' ASP . 39.4 mt -98.43 127.91 44.57 Favored 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.979 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -47.69 74.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 126.451 1.901 . . . . 0.0 114.829 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 78' ' ' LEU . 8.2 t0 -101.14 23.83 10.28 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.84 27.79 10.85 Favored Glycine 0 C--N 1.36 1.884 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 4.0 mp0 -153.18 -56.03 0.12 Allowed 'General case' 0 C--N 1.364 1.235 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 103' ' ' THR . 0.2 OUTLIER 43.01 56.84 3.91 Favored 'General case' 0 N--CA 1.531 3.578 0 CA-C-O 121.699 0.761 . . . . 0.0 109.759 -172.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 p -147.85 132.51 17.84 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.892 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -137.11 121.65 18.38 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -176.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.794 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 3.8 m-20 -86.4 73.76 10.08 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.856 -1.153 . . . . 0.0 110.699 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.892 HD12 ' HG2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -94.56 118.18 31.29 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.423 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -110.65 153.46 25.19 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -175.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.65 HG22 ' CD ' ' A' ' 68' ' ' GLN . 2.9 p -81.19 100.85 9.32 Favored 'General case' 0 C--O 1.205 -1.261 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 171.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -81.82 172.45 13.33 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 122.102 0.953 . . . . 0.0 110.994 -172.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.83 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.4 t -143.14 178.41 7.72 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.778 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 p -97.26 -31.66 12.31 Favored 'General case' 0 N--CA 1.515 2.78 0 CA-C-O 121.112 0.482 . . . . 0.0 109.836 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.49 -72.12 0.12 Allowed Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.68 -25.35 74.26 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -64.08 167.05 8.68 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 122.05 -0.676 . . . . 0.0 109.285 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 63.2 Cg_endo -97.5 136.84 0.42 Allowed 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 123.235 2.623 . . . . 0.0 112.282 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 91' ' ' SER . 69.6 p -112.51 152.8 28.37 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 89' ' ' THR . 25.9 m-85 -139.71 88.24 2.23 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -72.79 132.53 43.71 Favored 'General case' 0 N--CA 1.512 2.657 0 CA-C-O 122.407 1.099 . . . . 0.0 111.992 -174.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 112' ' ' LEU . 3.1 t -119.64 143.27 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.443 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.98 HG21 ' HA ' ' A' ' 124' ' ' ASN . 89.9 m -116.24 123.97 49.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 174.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.649 ' HB ' HD11 ' A' ' 87' ' ' LEU . 5.1 t -112.67 120.38 62.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.652 HG23 ' SG ' ' A' ' 127' ' ' CYS . 5.2 p -104.9 174.56 5.82 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.698 0.761 . . . . 0.0 110.433 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.549 ' HE3' ' CZ ' ' A' ' 24' ' ' TYR . 20.2 tptm -142.56 145.26 33.4 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.265 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 134' ' ' LEU . 42.0 p -116.4 -139.35 0.37 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.59 -24.19 14.82 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.229 0.922 . . . . 0.0 109.738 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -148.99 16.74 0.96 Allowed 'General case' 0 N--CA 1.52 3.041 0 O-C-N 121.707 -0.62 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.603 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 13.5 p -130.08 150.83 51.17 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -120.4 96.07 4.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 134' ' ' LEU . 2.2 t -88.01 145.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.776 -1.202 . . . . 0.0 110.183 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.024 HD12 ' HB3' ' A' ' 20' ' ' ALA . 12.1 mt -126.09 146.87 49.74 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 127' ' ' CYS . 0.1 OUTLIER -129.1 103.8 7.2 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -89.05 146.62 24.72 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 118.819 -1.153 . . . . 0.0 108.471 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.786 ' C ' HG21 ' A' ' 118' ' ' VAL . . . -131.32 118.19 2.32 Favored Glycine 0 C--N 1.3 -1.449 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.775 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 13.6 mttt -102.83 159.56 15.37 Favored 'General case' 0 C--O 1.198 -1.638 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.58 ' O ' ' O ' ' A' ' 115' ' ' LYS . 25.8 tt0 -17.12 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.639 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -175.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.37 14.96 77.08 Favored Glycine 0 CA--C 1.564 3.102 1 N-CA-C 100.698 -4.961 . . . . 0.0 100.698 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.786 HG21 ' C ' ' A' ' 114' ' ' GLY . 1.4 p -101.83 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.385 2.132 0 CA-C-N 114.004 -1.098 . . . . 0.0 112.273 -174.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.25 -40.7 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.28 41.65 2.74 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.9 -45.86 0.04 OUTLIER Glycine 1 N--CA 1.517 4.039 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -66.7 -32.44 73.75 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.671 HD11 HG23 ' A' ' 118' ' ' VAL . 85.8 mt -65.76 -36.45 77.59 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.98 ' HA ' HG21 ' A' ' 101' ' ' THR . 9.7 t-20 -60.34 -31.45 70.31 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -27.12 30.63 Favored 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' HD3' ' CB ' ' A' ' 13' ' ' ASP . 18.7 mtmt -89.31 -10.24 47.51 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.871 -0.518 . . . . 0.0 110.329 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 112' ' ' LEU . 7.0 t -90.66 -31.1 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -34.8 78.94 Favored 'General case' 0 C--O 1.211 -0.924 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.31 -36.99 29.09 Favored 'General case' 0 N--CA 1.521 3.11 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.7 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.29 -45.61 87.64 Favored 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.4 -14.4 46.39 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.467 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 94.8 p -62.73 -33.88 76.02 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.589 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 3.1 t60 -81.56 -37.6 27.47 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.676 -1.21 . . . . 0.0 108.361 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.891 ' HB3' HG21 ' A' ' 105' ' ' THR . 1.3 mp -67.18 -11.6 57.79 Favored 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.443 177.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -88.4 -42.32 12.25 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -5.67 47.69 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 134' ' ' LEU . 22.4 p -78.96 -21.88 46.49 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 73.74 28.26 1.63 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.037 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 6' ' ' TYR . . . 119.96 32.41 1.18 Allowed Glycine 0 N--CA 1.506 3.338 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -52.92 -45.65 67.72 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.873 -0.781 . . . . 0.0 110.559 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.07 -21.47 61.49 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 122.0 -0.438 . . . . 0.0 110.963 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . . . -76.22 -37.76 57.3 Favored 'General case' 0 N--CA 1.516 2.859 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.616 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 45.0 m-85 -72.51 -11.44 60.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.829 HD11 ' O ' ' A' ' 32' ' ' ALA . 13.6 mm -90.71 -28.66 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 5' ' ' ALA . 0.6 OUTLIER -62.65 -18.73 62.87 Favored 'General case' 0 C--O 1.183 -2.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -53.37 -51.02 63.85 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 122.426 1.108 . . . . 0.0 109.006 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.868 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -58.45 -38.77 78.2 Favored 'General case' 0 CA--C 1.429 -3.698 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.333 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 18.5 mmt -79.58 -32.88 42.02 Favored 'General case' 1 C--N 1.24 -4.176 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.06 59.34 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -97.3 -1.58 44.37 Favored 'General case' 1 N--CA 1.564 5.246 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.51 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 27.57 39.98 0.01 OUTLIER Glycine 1 N--CA 1.567 7.427 0 CA-C-N 120.475 1.489 . . . . 0.0 111.014 179.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 13' ' ' ASP . 2.3 m -148.78 -38.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -74.34 -172.11 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.749 0.785 . . . . 0.0 109.489 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.577 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 2.0 tm0? -151.45 -48.97 0.11 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 5.8 t0 -123.7 179.55 4.75 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.217 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.868 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . . . -171.06 128.97 0.74 Allowed 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.321 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.991 ' HB3' HD12 ' A' ' 111' ' ' LEU . . . -144.48 108.74 4.8 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.587 -2.045 . . . . 0.0 115.542 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.79 HG12 HG22 ' A' ' 110' ' ' VAL . 21.0 mt -83.21 122.77 37.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 101.629 -3.471 . . . . 0.0 101.629 172.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 29' ' ' SER . 48.6 t -131.3 122.38 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.303 -174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' PRO . . . -73.88 82.64 0.73 Allowed Glycine 0 N--CA 1.505 3.235 0 N-CA-C 105.561 -3.016 . . . . 0.0 105.561 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CE2' ' HE3' ' A' ' 104' ' ' LYS . 1.4 p90 -78.74 26.79 0.23 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.182 0.993 . . . . 0.0 112.28 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HE3' ' CH2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -63.02 -158.42 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.99 7.45 Favored 'General case' 0 N--CA 1.534 3.738 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -102.22 110.51 62.79 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.8 Cg_endo -75.45 157.26 40.98 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.754 1.636 . . . . 0.0 111.235 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.607 ' O ' HG13 ' A' ' 22' ' ' VAL . 20.9 p -163.04 165.94 24.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 40' ' ' VAL . 50.0 t -98.64 103.03 14.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.596 ' CZ3' HG22 ' A' ' 108' ' ' THR . 20.8 m0 -69.33 -21.79 63.81 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.694 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' O ' HD11 ' A' ' 7' ' ' ILE . . . 175.13 86.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 CA-C-O 121.19 0.519 . . . . 0.0 110.742 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' HB3' HG11 ' A' ' 30' ' ' VAL . . . -118.3 136.84 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.633 HG23 ' HB3' ' A' ' 19' ' ' ALA . 44.5 t -49.6 104.14 0.41 Allowed Pre-proline 0 N--CA 1.52 3.062 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.591 ' HA ' HG11 ' A' ' 40' ' ' VAL . 32.0 Cg_endo -70.05 150.75 66.91 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.13 1.886 . . . . 0.0 112.8 -175.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.0 -17.58 59.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.73 -81.97 0.23 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.797 -0.825 . . . . 0.0 112.31 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 66' ' ' GLY . 1.3 m -169.26 -41.02 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.218 -0.926 . . . . 0.0 111.465 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.939 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 9.3 m-30 -60.09 -41.89 93.43 Favored 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 30' ' ' VAL . 2.1 p -55.75 -20.91 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -91.59 28.65 1.68 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 22' ' ' VAL . 2.6 mt -72.66 150.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 122.503 1.144 . . . . 0.0 109.346 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 44' ' ' PRO . 12.4 p -138.55 178.12 1.8 Allowed Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.08 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 43' ' ' THR . 28.1 Cg_endo -69.63 1.9 3.94 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.344 1.363 . . . . 0.0 112.689 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.16 -66.38 0.91 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 64' ' ' THR . 1.6 pm0 -56.61 -36.65 69.67 Favored 'General case' 0 N--CA 1.526 3.328 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.432 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.6 t -79.65 -29.89 13.32 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.502 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.53 -31.48 29.24 Favored Glycine 0 N--CA 1.512 3.764 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 63' ' ' LEU . 12.9 p -99.08 -33.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 O-C-N 122.26 -0.553 . . . . 0.0 110.393 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.831 HD23 HD13 ' A' ' 63' ' ' LEU . 6.8 mt -65.71 -14.99 62.37 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 47' ' ' VAL . 4.1 m -145.17 -13.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.07 -132.39 0.01 OUTLIER Glycine 1 N--CA 1.522 4.421 0 CA-C-O 122.26 0.922 . . . . 0.0 112.776 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -69.29 -0.93 6.9 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 123.159 0.584 . . . . 0.0 112.475 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' OD2' HD21 ' A' ' 78' ' ' LEU . 41.4 t0 -17.8 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.89 -10.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.491 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 31.3 t -172.24 -50.21 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.9 p -43.73 -103.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.689 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' A' ' 63' ' ' LEU . 3.3 p90 -37.03 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 56' ' ' SER . 7.7 m-85 -55.6 -17.62 5.97 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 121.654 2.025 . . . . 0.0 110.931 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 57' ' ' SER . 31.8 m -93.6 -43.18 13.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.813 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 60' ' ' VAL . 2.4 p30 -87.58 -58.03 2.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.207 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 71' ' ' SER . . . 133.83 152.98 6.9 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD12 ' HG ' ' A' ' 87' ' ' LEU . 6.7 mt -79.77 -156.0 0.11 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' LEU . 18.3 p -161.37 130.92 4.73 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD22 ' CZ ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -137.39 106.09 5.88 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 122.903 1.335 . . . . 0.0 111.844 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 38' ' ' THR . . . 78.25 21.95 69.12 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.75 12.51 68.85 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 65' ' ' LEU . 47.2 tp60 -110.26 105.49 14.56 Favored 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 118.275 1.038 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -62.23 116.74 5.26 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.464 ' SG ' HD23 ' A' ' 87' ' ' LEU . 7.6 p -110.52 154.04 24.24 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.901 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.3 p -117.0 121.01 40.15 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 122.032 0.92 . . . . 0.0 110.742 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.774 HG11 ' HB2' ' A' ' 75' ' ' ASP . 2.6 t -51.35 115.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.901 HD12 ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -111.92 64.6 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.047 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 174.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 42.2 mtt-85 111.01 138.12 0.0 OUTLIER 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 126.261 1.825 . . . . 0.0 108.739 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB2' HG11 ' A' ' 72' ' ' VAL . 23.4 t70 -141.94 92.45 2.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.131 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' CA ' ' A' ' 83' ' ' PHE . 3.3 m -120.59 41.55 3.23 Favored 'General case' 0 C--O 1.172 -3.004 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 18.1 tp -67.39 -66.94 0.5 Allowed 'General case' 0 N--CA 1.535 3.821 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -110.99 51.33 0.78 Allowed 'General case' 0 N--CA 1.514 2.763 0 O-C-N 120.029 -1.669 . . . . 0.0 109.649 -179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 76' ' ' SER . 2.2 pt20 -110.31 -108.86 0.34 Allowed 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.41 63.34 0.87 Allowed 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' CE1' ' A' ' 83' ' ' PHE . . . 76.62 -15.14 6.2 Favored Glycine 1 N--CA 1.523 4.496 0 O-C-N 120.646 -1.284 . . . . 0.0 112.342 177.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.62 -63.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.675 1.238 . . . . 0.0 109.97 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.777 ' HA ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER 60.61 -2.27 0.19 Allowed 'General case' 0 N--CA 1.513 2.681 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.911 -174.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -82.88 124.76 30.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.09 1.314 . . . . 0.0 108.963 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.719 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -140.69 126.9 19.72 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HB2' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-20 -93.57 149.92 20.84 Favored 'General case' 0 CA--C 1.466 -2.255 0 C-N-CA 117.603 -1.639 . . . . 0.0 108.591 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.837 ' HG ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -156.21 128.95 7.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 99' ' ' ASN . 0.3 OUTLIER -125.02 151.88 44.99 Favored 'General case' 0 N--CA 1.52 3.039 0 C-N-CA 118.264 -1.374 . . . . 0.0 112.723 -175.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -76.47 89.59 3.25 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HD3' HD11 ' A' ' 73' ' ' ILE . 2.1 mtmt -81.71 125.21 30.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.782 ' OG ' ' HB3' ' A' ' 95' ' ' ALA . 1.2 t -89.6 177.61 6.5 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.924 0.869 . . . . 0.0 112.267 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.0 p -83.02 -31.53 27.39 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.215 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.22 -53.05 0.48 Allowed Glycine 0 N--CA 1.503 3.163 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.29 -14.15 66.93 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.782 ' HB3' ' OG ' ' A' ' 91' ' ' SER . . . -85.55 170.61 12.62 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.843 -0.798 . . . . 0.0 110.079 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 60.9 Cg_endo -96.03 160.61 1.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.381 2.721 . . . . 0.0 109.414 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 89' ' ' THR . 16.3 p -122.06 166.75 14.03 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.785 ' O ' HG23 ' A' ' 89' ' ' THR . 43.9 m-85 -152.46 102.03 2.71 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.659 ' H ' ' HG2' ' A' ' 115' ' ' LYS . 27.6 m-20 -74.51 139.03 43.54 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-O 122.495 1.14 . . . . 0.0 110.692 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' A' ' 87' ' ' LEU . 2.9 t -128.51 158.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.369 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.231 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 m -125.66 161.24 27.7 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.824 HG22 HD23 ' A' ' 111' ' ' LEU . 5.1 t -148.12 113.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-O 122.394 1.092 . . . . 0.0 109.557 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 127' ' ' CYS . 12.5 p -106.45 103.95 13.53 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.688 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 24' ' ' TYR . 5.2 tptm -90.16 112.53 24.05 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 121.709 -0.619 . . . . 0.0 110.627 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.752 HG21 ' HB3' ' A' ' 134' ' ' LEU . 29.8 p -76.74 -146.66 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -92.14 -39.8 11.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.415 -0.803 . . . . 0.0 110.042 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.7 mttm -126.95 14.67 7.39 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.802 -0.561 . . . . 0.0 110.83 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.596 HG22 ' CZ3' ' A' ' 31' ' ' TRP . 7.0 p -135.28 157.78 46.03 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -125.92 91.99 3.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 134' ' ' LEU . 2.4 t -87.3 137.6 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.71 -1.244 . . . . 0.0 109.065 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 20' ' ' ALA . 3.4 mt -126.0 145.75 50.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -132.3 93.93 3.35 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 178.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.72 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.3 ttt -98.76 159.85 14.67 Favored 'General case' 0 N--CA 1.513 2.711 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.429 -175.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 17' ' ' GLN . . . 145.12 148.54 4.84 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 119.412 2.525 . . . . 0.0 119.412 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.725 ' HA ' ' CG1' ' A' ' 118' ' ' VAL 0.434 18.8 mttt -151.96 118.53 5.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 111.717 -2.242 . . . . 0.0 106.759 167.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -112.72 91.89 3.82 Favored 'General case' 0 C--N 1.244 -3.996 1 N-CA-C 98.83 -4.508 . . . . 0.0 98.83 161.696 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.46 -0.82 0.13 Allowed Glycine 2 CA--C 1.653 8.668 0 CA-C-N 123.798 2.999 . . . . 0.0 109.216 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.725 ' CG1' ' HA ' ' A' ' 115' ' ' LYS . 12.6 p -35.37 154.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.391 2.371 0 O-C-N 120.486 -1.597 . . . . 0.0 113.816 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -99.07 -45.05 6.07 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.351 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.03 115.02 3.92 Favored Glycine 0 N--CA 1.503 3.121 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.83 -35.84 2.2 Favored Glycine 0 N--CA 1.505 3.276 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -38.76 42.64 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.782 HG23 ' HG ' ' A' ' 112' ' ' LEU . 86.6 mt -65.5 -36.55 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.572 ' HA ' HG21 ' A' ' 101' ' ' THR . 24.2 t30 -63.41 -28.67 70.14 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -81.04 -33.78 33.3 Favored 'General case' 0 N--CA 1.517 2.889 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -82.73 -15.43 51.87 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.914 -0.491 . . . . 0.0 110.15 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.465 ' HB3' HG21 ' A' ' 101' ' ' THR . 3.3 t -89.69 -31.41 17.5 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -69.35 -30.05 67.99 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 132' ' ' SER . 8.1 mm-40 -83.97 -36.12 23.46 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.646 ' O ' HD12 ' A' ' 134' ' ' LEU . 4.9 ttt -59.42 -45.35 91.76 Favored 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB2' ' OG1' ' A' ' 103' ' ' THR . . . -80.05 -17.23 53.29 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.627 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 129' ' ' GLU . 25.8 p -61.53 -30.97 70.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.545 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 36.7 t60 -80.53 -39.96 26.88 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 110' ' ' VAL . 3.1 mp -69.69 -8.07 44.66 Favored 'General case' 0 N--CA 1.516 2.839 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.585 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -93.53 -37.53 11.86 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -81.41 -3.55 53.17 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 p -81.5 -21.16 38.85 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 74.72 29.55 1.08 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.071 179.175 . . . . . . . . 0 0 . 1 stop_ save_